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Titre:	Développement	de	nanoparticules	à	base	de	platine	visant	à	améliorer	la	destruction	de	cellules	cancéreuses	par	des	rayons	gamma	et	par	ions	carbone		
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Résumé:	 La	 radiothérapie	 basée	 sur	l'utilisation	 des	 photons	 de	 haute	 énergie	(rayons	 X)	 est	 l'approche	 la	 plus	 courante	dans	le	traitement	du	cancer.	Toutefois,	elle	est	limitée	par	la	tolérance	des	tissus	sains.	Par	 conséquent,	 il	 est	 d'un	 intérêt	 majeur	de	développer	des	nouvelles	 techniques	 et	protocoles	 pour	 améliorer	 le	 ciblage	 des	effets	 de	 la	 radiation	 dans	 les	 tumeurs.	Dans	 cette	 perspective,	 la	 hadronthérapie	(irradiation	 de	 la	 tumeur	 par	 des	 protons	ou	 des	 ions	 carbone	 de	 haute	 énergie)	 est	considérée	 comme	 l'une	 des	 techniques	oncologiques	 les	 plus	 prometteuses	 et	efficace.	 Le	 dépôt	 d'énergie	 des	 ions	 est	maximum	en	fin	de	parcours	(pic	de	Bragg)	sans	dépôt	d'énergie	derrière	la	tumeur,	ce	qui	 permet	 de	 mieux	 cibler	 la	 tumeur.	Pourtant,	 l’utilisation	 de	 cette	 modalité	reste	 limitée	du	fait	de	 la	dose,	petite	mais	significative,	 reçue	 par	 les	 tissus	 sains	situés	 à	 l'entrée	 du	 faisceau,	 causant	 des	effets	secondaires.	Pour	 améliorer	 les	 performances	 des	thérapies	 par	 radiation,	 une	 nouvelle	stratégie	 basée	 sur	 la	 combinaison	 de	nanoparticules	métalliques	 (NPs)	 avec	 des	rayonnements	 ionisants	 a	 été	 développée.	Cette	 stratégie	 innovante	 a	 été	 largement	étudiée	 par	 le	 groupe	 Nanomédicine	 et	
Hadronthérapie	 à	 l'Institut	 des	 Sciences	Moléculaires	 d'Orsay,	 groupe	 que	 j'ai	rejoint	pour	ma	thèse	de	doctorat.		En	effet,	 les	nanoparticules	ont	une	chimie	de	 surface	 remarquable	 qui	 permet	 de	 les	fonctionnaliser	avec	des	ligands	qui	les		
rendent	plus	 futiles	et	moins	reconnus	par	des	 macrophages.	 Cela	 permet	 une	accumulation	 importante	 de	 nano-agents	dans	 les	 tumeurs.	 Par	 conséquent,	 en	utilisant	 des	 nano-agents,	 la	 sélectivité	 du	traitement	 peut	 être	 améliorée,	 ce	 qui	pourrait	 augmenter	 l'indice	 thérapeutique	des	médicaments	 anticancéreux	 classiques	ou	amplifier	l'effet	du	rayonnement.	Le	 but	 de	 mon	 travail	 a	 été	 donc	 le	développement	 de	 nouvelles	nanoparticules	 non-toxiques	 à	 base	 de	platine	 (Pt	 NPs)	 visant	 à	 améliorer	 la	destruction	 des	 cellules	 cancéreuses	 par	des	rayons	gamma	et	par	ions	carbone.	Une	méthode	originale	de	synthèse	en	une	seule	 étape	 combinant	 la	 radiolyse	 et	 la	PEGylation	 in	 situ	 a	 été	 optimisée.	 Cette	méthode	 a	 permis	 d'obtenir	 des	 Pt	 NP	stables	et	prêts-à-l'emploi	avec	une	taille	et	forme	homogène.	Différents	techniques	ont	été	 utilisées	 pour	 caractériser	 les	propriétés	 physico-chimiques	 des	nanoparticules.	 Les	 Pt	 NP	 consistent	 en	petits	 noyaux	métalliques	 sphériques	 (~	3	nm)	 revêtus	 du	 poly	 (éthylène	 glycol),	 un	polymère	 biocompatible	 bien	 connu	 et	largement	 utilisé	 en	 nanomédecine.	 Les	 Pt	NPs	ont	un	diamètre	hydrodynamique	(dH)	moyen	d'environ	9	nm.	Ces	caractéristiques	physico-chimiques	des	Pt	NP	permettent	de	prédire	 le	 ciblage	 de	 la	 tumeur	 et	 la	clairance	in	vivo	(dH	<	10	nm).	L'impact	biologique	de	ces	nouvelles	Pt	NPs	a	 été	 évalué	 sur	 deux	 lignées	 de	 cellules	cancéreuses	humaines;	HeLa	et	U87-MG.			
  
	Les	 conditions	 non-toxiques	 ont	 été	déterminées	 par	 survie	 clonogénique	 à	différentes	 concentrations	 de	 Pt.	 Il	 a	 été	observé	 que	 les	 Pt	 NPs	 ont	 un	 mode	d'internalisation	 qui	 dépend	 fortement	 de	la	lignée	cellulaire.	Celles-ci	sont,	dans	tous	les	 cas,	 localisées	 exclusivement	 dans	 le	cytoplasme.	Les	NPs	de	platine	développés	dans	 ce	 travail	 permettent	 d’amplifier	significativement	 la	destruction	de	 cellules	cancéreuses	en	utilisant	des	rayons	gamma	et	un	faisceau	médical	d’ions	carbone	(290	MeV	 /	 uma).	 Le	 facteur	 d'amplification	(dénoté	 AF,	 Amplification	 Factor	 en	anglais)	 des	 Pt	 NPs	 à	 2	 Gy	 est	 supérieur	lorsque	des	ions	carbone	sont	utilisés	pour	irradier	des	cellules	HeLa.	Le	AF	augmente	de	14%	(rayons	gamma)	à	44%	en	utilisant	des	 ions	C6+,	un	 résultat	 très	encourageant	pour	l'hadronthérapie.	Les	mécanismes	moléculaires	à	l’origine	de	cet	effet	ont	été	étudiés	grâce	à	l’utilisation	d’une	 nanosonde	 biologique	 (un	 plasmide	d’ADN)	 et	 des	 rayons	 gamma.	 Ces	expériences	ont	montré	que	les	Pt	NPs	sont	responsables	 de	 l’augmentation	 de	dommages	nanométriques	(>	2	nm)	via	 les	effets	directs	et	indirects	du	rayonnement.			
	Ces	 lésions	 de	 taille	 nanométrique	 sont	d'une	grande	 importance	car	elles	peuvent	être	 létaux	 pour	 les	 cellules.	 Cet	 effet	 est	attribué	 à	 des	 processus	 électroniques	d’activation	et	de	re-neutralisation	de	la	NP	qui	 engendre	 une	 forte	 perturbation	 dans	le	 volume	 nanométrique	 qui	 l’entoure	 tel	que	 la	 production	 groupée	 de	 radicaux	libres	 fortement	 réactifs	 et	 toxiques.	 Les	résultats	 suggèrent	 également	 l'effet	 du	plasmon	 métallique	 des	 NPs	 dans	 le	mécanisme	d'amplification.	En	 conclusion,	 ce	 travail	 à	 l’interface	 de	 la	physique,	 chimie	 et	 biologie	 montre	 les	capacités	 des	 NPs	 à	 base	 de	 platine	 à	améliorer	 l’éradication	 par	 radiation	 des	cellules	 cancéreuses,	 en	 particulier,	 à	améliorer	 les	 performances	 de	 l'hadron-thérapie.	 De	 plus,	 les	 méthodes	 et	protocoles	 mis	 en	 place	 dans	 ce	 travail	permettent	 de	 développer	 des	 nouvelles	nanoparticules	multi-fonctionnelles	dans	le	domaine	 de	 la	 thérapie	 guidée	 par	imagerie,	théranostic.	
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Abstract:	 Radiotherapy,	 based	 on	 the	 use	of	 high-energy	 photons	 (X-rays),	 is	 the	most	 common	 approach	 in	 cancer	treatment.	 However,	 its	 implementation	 is	limited	 by	 the	 tolerance	 of	 healthy	 tissue.	Therefore,	 it	 is	 of	 major	 interest	 the	development	 of	 new	 techniques	 and	protocols	 to	 improve	 the	 selectivity	 of	 the	radiation	 effects	 within	 the	 tumor.	 In	 this	perspective,	 the	 hadrontherapy	 (tumor	irradiation	 by	 high-energy	 protons	 or	carbon	 ions)	 is	 considered,	 among	 others,	as	one	of	 the	most	promising	and	effective	oncological	 techniques.	 The	 energy	deposition	of	 ions	 in	depth	 is	maximum	at	the	 end	 of	 the	 track	 (Bragg	 peak)	with	 no	energy	 deposition	 behind	 the	 tumor.	However,	 this	modality	 remains	 restricted	by	 the	 lower	 but	 significant	 damage	induced	to	the	normal	tissue	located	at	the	entrance	 of	 the	 ion	 beam	 causing	 side	effects.		To	 improve	 the	 performance	 of	 radiation	therapies,	 a	 new	 strategy	 based	 on	 the	combination	 of	 metallic	 nanoparticles	(NPs)	 with	 ionizing	 radiations	 has	 been	evaluated.	 This	 innovative	 strategy	 has	been	 largely	 studied	 by	 the	 group	
Nanomedicine	and	Hadrontherapy	 from	the	Institute	 of	 Molecular	 Sciences	 in	 Orsay,	group	that	I	joined	for	my	PhD.	Indeed,	NPs	have	 a	 remarkable	 surface	 chemistry	 that	allows	 their	 functionalization	 with	 ligands	that	 make	 them	 less	 recognized	 by	macrophages,	 which	 allows	 an	 important	accumulation	of	the	nano-agents	selectively	into	 the	 tumors	 (Enhanced	 Permeability	and	Retention	(EPR)	effect).		
Hence,	 the	 treatment	 selectivity	 may	 be	enhanced	 using	 nano-agents,	 which	 might	increase	 the	 therapeutic	 index	 of	conventional	 anti-cancer	 drugs	 or	 amplify	the	effect	of	radiation.		The	 goal	 of	my	work	was	 thus	 to	 develop	novel	 non-toxic	 platinum	 based	nanoparticles	 (Pt	 NPs)	 to	 enhance	 cancer	cell	killing	using	γ-rays	and	carbon	ions.	An	optimized	one-step	method	of	synthesis,	combining	 radiolysis	 with	 in	 situ	PEGylation,	 was	 successfully	 established.	This	 method	 enabled	 to	 obtain	 stable	 and	ready-to-use	 Pt	 NPs	 with	 a	 uniform	 size	and	 shape.	 Complementary	 techniques	were	 used	 to	 characterize	 the	 physico-chemical	 properties	 of	 nanoparticles.	 The	Pt	 NPs	 consist	 on	 small	 spherical	 metallic	cores	(~3	nm)	coated	with	the	well-known	biocompatible	poly	(ethylene	glycol),	which	is	largely	used	in	nanomedicine.	The	Pt	NPs	have	 an	 average	 hydrodynamic	 diameter	(dH)	 of	 about	 9	 nm.	 The	 physico-chemical	characteristics	 of	 Pt	 NPs	 allow	 predicting	tumor	targeting	and	in	vivo	clearance	(dH	<	10	nm).	The	 biological	 impact	 of	 Pt	 NPs	 was	evaluated	 in	 two	 human	 cancer	 cell	 lines;	HeLa	 and	 U87-MG.	 The	 non-toxic	conditions	were	determined	by	performing	clonogenic	 assays	 with	 different	 Pt	concentrations.	 It	 has	 been	 observed	 that	Pt	 NPs	 have	 an	 internalization	 pathway	that	 strongly	 depends	 on	 the	 cell	 line.	These	are,	in	all	cases,	exclusively	localized	in	the	cytoplasm.		
  
	The	 Pt	 NPs	 developed	 in	 this	 work	significantly	 enhanced	 cancer	 cell	 killing	using	γ-rays	and	medical	carbon	 ions	(290	MeV/uma).	The	amplification	factor	(AF)	of	Pt	NPs	at	2	Gy	is	greater	when	carbon	ions	are	 used	 to	 irradiate	 HeLa	 cells.	 The	 AF	increases	 from	 14%	 using	 γ-rays	 to	 44%	using	C6+	ions,	a	very	encouraging	result	for	hadrontherapy.		The	molecular	mechanisms	underlying	this	effect	were	investigated	through	the	use	of	a	bio-nanoprobe	(plasmid	DNA)	and	γ-rays.	These	experiments	showed	that	Pt	NPs	are	responsible	 for	 the	 increase	of	nanometric	molecular	 damage	 (>2	 nm)	 via	 the	 direct	and	 indirect	 effects	 of	 radiation.	 Nanosize	lesions	are	of	great	importance	as	they	may	be	lethal	to	cells.			
	This	 effect	 is	 attributed	 to	 an	 electronic	activation	 processes	 and	 to	 the	 re-neutralisation	 of	 NPs,	 which	 generates	 a	strong	 perturbation	 in	 the	 surrounding	nanometer	 volume	 producing	 highly	reactive	and	toxic	free	radical	clusters.	The	experimental	 results	 also	 suggested	 the	effect	 of	 the	 NPs	 plasmon	 in	 the	amplification	mechanism.	In	 conclusion,	 this	work	at	 the	 interface	of	physics,	 chemistry	 and	 biology	 shows	 the	potential	 of	 platinum	 NPs	 to	 improve	 the	eradication	 of	 cancer	 cells	 by	 radiation,	 in	particular,	 to	 improve	 the	 performance	 of	hadrontherapy.	 In	 addition,	 the	 methods	and	protocols	developed	in	this	work	allow	synthesizing	 and	 evaluating	 novel	 multi-modal	Pt	NPs	for	theranostic.			
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INTRODUCTION	
General	motivation	
Cancer	 is	 the	 first	 cause	of	death	 in	 industrial	 societies.	Around	50%	of	patients	 receive	radiotherapy	as	part	of	their	treatment.	This	modality	can	be	used	alone	or	in	combination	with	 chemotherapy	 or	 surgery.	 Conventional	 radiotherapy	 is	 based	 on	 the	 use	 of	 high-energy	 (1-20	 MeV)	 X-rays.	 Thanks	 to	 the	 high	 penetration	 of	 X-rays	 in	 tissues,	 this	modality	 is	 used	 to	 treat	 deeply	 sited	 tumors	 in	 a	 non-invasive	way.	 Unfortunately	 this	radiation	 is	 not	 tumor	 selective	 and	 severe	 side	 effects	 to	 patients	 are	 induced	 due	 to	damage	 in	healthy	tissues.	Hence,	concentration	of	radiation	effects	 in	 tumors	 is	a	major	challenge	in	radiation	therapies	and	new	strategies	have	been	proposed.		
New	 radiation	 modalities	 such	 as	 Intensity-Modulated	 Radiation	 Therapy	 (IMRT),	cyberKnife	 and	 hadrontherapy	 have	 been	 developed	 in	 this	 purpose.	 These	 approaches	have	 been	 improved	 by	 taking	 into	 account	 the	 topological	 features	 of	 tumors	 and	 the	physical	 properties	 of	 the	 ionizing	 beam.	 In	 particular,	 hadrontherapy	 is	 one	 of	 the	promising	modality,	which	 is	 based	 on	 carbon	 ions	 radiation.	 The	 advantage	 of	 charged	particles	rests	on	their	physical	properties,	to	deposit	the	maximum	energy	at	the	end	of	their	track	(defined	as	the	Bragg	peak).	Hence	the	dose	deposited	after	the	tumor	is	close	to	 zero.	 This	 ballistic	 property	 is	 a	 strong	 advantage	 compared	 to	 other	modalities,	 and	hadron	 (or	 proton)	 therapy	 is	 currently	 used	 to	 treat	 tumors	 seated	 in	 badly	 sensitive	organs,	e.g.	eyes,	brain	and	neck.	In	spite	of	this	superior	property,	this	modality	remains	limited	by	the	 low	but	significant	dose	deposited	at	the	entrance	of	the	track,	which	also	damages	normal	tissue.		
In	 the	 last	 decades,	 a	 new	 strategy	 based	 on	 the	 combination	 of	 nanomedicine	 with	radiotherapy	has	been	developed	to	amplify	the	effect	of	ionizing	radiations.	In	particular,	nanoparticles	containing	heavy	atoms	(high-Z	NPs),	such	as	platinum	and	gold,	have	been	proposed	 as	 potential	 nano-radio-enhancers.	 The	 versatility	 of	 nanoparticles	 surface	chemistry	opens	the	perspectives	to	functionalize	NPs	with	tumor	targeting	molecules	and	contrast	 agents	 to	 concentrate	 them	 in	 the	 tumors.	 Thus	 this	 innovative	 strategy	 is	expected	to	improve	radiation	effects	selectively	in	the	tumor.	
Surprisingly,	little	has	been	proposed	for	the	combination	of	NPs	and	hadrons.	The	group	Nano-Hadron	 at	 the	 Institute	 of	 Molecular	 Sciences	 in	 Orsay	 (ISMO)	 was	 the	 first	 to	propose	 this	 strategy	 (thesis	 of	 Erika	 Porcel	 2008-11).	 They	 have	 shown	 that	
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nanostructured	platinum	atoms	(Pt	NPs)	activated	by	carbon	ions	amplify	the	induction	of	nanometer	 size	 molecular	 damage.	 Unfortunately,	 these	 first	 Pt	 based	 nano-radio-enhancers	were	found	toxic	in	cells.		
Aim	of	the	present	work	
The	aim	of	my	work	was	to	develop	stable,	biocompatible	and	non-toxic,	platinum	based	nanoparticles	able	to	amplify	radiation	effects.		
To	this	purpose,	the	nanoparticles	synthesis	was	optimized	using	radiolysis,	a	singular	but	very	advantageous	sustainable	method	to	synthesize	small	high-Z	NPs.	In	order	to	assure	biocompatibility	 and	 low	 toxicity,	 the	 Pt	 NPs	 were	 coated	 with	 poly(ethylene	 glycol)	(PEG),	a	soluble	biocompatible	polymer	widely	used	in	nanomedicine.		
This	 work	 includes:	 i)	 the	 synthesis	 and	 characterization	 of	 stable,	 biocompatible	 and	sterile	 PEGylated	 platinum	 NPs,	 ii)	 their	 biological	 impact	 in	 cells	 (toxicity,	 uptake	 and	localization),	 iii)	 the	 in	 vitro	 characterization	 of	 their	 properties	 to	 enhance	 radiation	effects	(photon	and	ion	beam)	and	iv)	the	understanding	of	molecular	scale	mechanisms.	Finally,	a	new	type	of	platinum	based	bimetallic	NPs	have	been	also	developed.		
Description	of	the	manuscript	organization	
In	 Chapter	 I,	 an	 overview	 of	 different	 nanotechnological	 developments	 for	 biomedical	applications	 is	 presented.	 In	 addition,	 the	 state-of-the-art	 on	 nanomedicine	 and	 its	combination	with	 radiotherapies	 is	 shown	 together	with	 the	 theoretical	 framework	 that	allows	 a	 better	 understanding	 of	 the	 physical,	 chemical	 and	 biological	 processes	 taking	place	 when	 ionizing	 radiations	 interact	 with	 a	 metallic	 nanoparticle.	 In	 Chapter	 II,	 the	materials	and	methods	used	in	this	work	are	summarized.	In	Chapter	III,	the	main	results	obtained	for	the	PEGylated	platinum	nanoparticles,	namely	PtPEG-OH	NPs,	are	presented	and	 discussed.	 The	 potentiality	 of	 PtPEG-OH	 NPs	 to	 enhance	 the	 performance	 of	hadrontherapy	 is	 particularly	 addressed	 in	 this	 chapter.	 The	 proposition	 of	 mono-	 and	bimetallic	gold-platinum	nanoparticles	as	nano-radio-enhancers	is	shown	in	Chapter	IV.		
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Chapter	I:	NANOTECHNOLOGY	FOR	BIOMEDICAL	APPLICATIONS	
State-of-the-art	
1 Nanotechnology	The	revolutionary	concept	of	nanotechnology	started	in	1959	when	the	physicist	Richard	Feynman	(Nobel	Prize	in	Physics	-	1965)	expressed	that	“the	principles	of	physics,	as	far	as	 I	 can	 see,	 do	not	 speak	 against	 the	 possibility	 of	manoeuvring	 things	 atom	by	 atom”.	However,	 it	 was	 until	 1974	 that	 the	 word	 “nanotechnology”	 was	 firstly	 employed	 by	Professor	Norio	Taniguchi	to	define	ultrahigh	precision	machines.	In	the	80’s,	the	modern	nanotechnology	era	began	with	 the	development	of	 the	Scanning	Tunnelling	Microscope	(STM)	and	the	Atomic	Force	Microscope	(AFM),	 in	which	scientists	were	able	to	observe	and	 manipulate	 individual	 atoms	 and	 molecules.	 Therefore,	 nanoscience	 and	nanotechnology	 are	 the	 study	 and	 application	 of	 extremely	 small	 objects	 (10-9	 m)	 that	involves	 the	 understanding	 of	 the	 fundamental	 physics,	 chemistry	 and	 biology	 of	nanometre-scale	objects.	
1.1 Methods	for	nanomaterials	preparation		In	 the	 nano-world,	 the	 properties	 of	 a	 material	 strongly	 depend	 on	 its	 size	 and	 shape.	These	 characteristics	 define	 the	 applicability	 of	 e.g.	 plasmonic	 metallic	 nanostructures,	quantum	semiconductors	and	magnetic	nanoparticles.	There	are	two	main	approaches	in	the	synthesis	of	nanomaterials	known	as	the	bottom-up	and	top-down	approaches.		
The	 top-down	approach	 is	 based	on	 the	use	 of	macroscopic	materials	 that	 are	modified	through	an	externally-controlled	process	in	order	to	reach	nanometer	size	structures.	This	approach	is	commonly	used	in	electronics	to	prepare	integrated	circuits	within	structures	smaller	than	100	nm	(photolithography).	The	implementation	of	this	method	is	generally	complex	and	expensive	due	to	its	instrumentation.	
On	the	other	hand,	the	bottom-up	approach	is	based	on	a	self-assembly	process	that	leads	to	 the	 formation	 of	 nanostructures.	 In	 this	 process	 basic	 units	 such	 as	 atoms	 and	molecules,	 are	 combined	 into	 larger	 stable	 structures.	 Common	 examples	 are	 quantum	
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dots	 [1]	 and	 nanoparticles	 (NPs)	 formation	 from	 colloidal	 initial	 suspensions	 [2].	 The	manufacturing	cost	mainly	depends	on	 the	abundance	and	marketing	competition	of	 the	primary	units,	as	well	as,	on	the	final	product	design	and	synthetic	route.		
The	described	methods	to	synthetize	NPs	are	illustrated	in	Figure	I	-	1.	
	
Figure	I	-	1.	Schematic	of	the	bottom-up	and	top-down	approaches	used	in	the	synthesis	of	nanomaterials.	By	 comparing	 both	manufacturing	processes,	 the	 bottom-up	method	 is	more	 suitable	 in	the	 synthesis	 of	 nanomaterials	 with	 a	 wider	 range	 of	 applications.	 This	 method	 is	 less	expensive,	 more	 versatile	 and	 technologically	 simple	 to	 implement	 in	 academia	 and	industry	 (scalability).	 The	 bottom-up	 approach	 is	 further	 classified	 into:	 i)	 gas	 phase	(pyrolysis)	and	 ii)	 liquid	phase	 fabrication	(e.g.	 solvothermal	and	sol-gel	method).	 In	 the	next	section,	we	address	the	use	of	the	liquid	phase	approach	in	the	case	of	metallic	NPs	preparation.	
																																								 																					
[1]	Liu	R	et	al.	(2011)	J.	Am.	Chem.	Soc.	133	15221–3	[2]	Sau	T	K	and	Rogach	A	L	(2012)	Complex-shaped	metal	nanoparticles:	Bottom-up	syntheses	and	applications		
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1.1.1 Metallic	NPs	preparation	via	chemical	synthesis	
Metallic	 nanoparticles	 are	 commonly	 prepared	 in	 liquid	 phase,	 through	 a	method	 often	denoted	as	 chemical	 colloidal	 synthesis.	This	method	 involves	 the	chemical	or	biological	reduction	 of	 metal	 salts,	 photochemical	 or	 electrochemical	 pathways,	 or	sonochemical/thermal	decomposition	of	metal	compounds	in	aqueous	or	organic	solvents	[2].	The	process	takes	place	 in	the	presence	of	additives	such	as	surfactants,	 ligands	and	polymers,	which	allows	 controlling	 the	 size	 and	 shape	of	nanoparticles.	 Colloids	may	be	stabilized	through	electrostatic	or	steric	forces.	The	first	stabilization	mechanism	involves	repulsive	forces	generated	by	an	electric	double	layer	formed	at	the	nanoparticle	surface	(ions)	while	 the	 second	 consists	 in	 a	 barrier	 created	 by	 adsorbed	 polymers/surfactants	(brushes).	 Advantageously,	 these	 colloidal	 nanomaterials	 are	 suitable	 for	 further	integration	 into	 more	 complex	 systems	 and	 devises,	 opening	 a	 great	 number	 of	applications.		
For	 instance,	 gold	 nanoparticles	 (Au	 NPs)	 are	 commonly	 prepared	 via	 chemical	 routes.	The	conventional	method	involves	the	reduction	of	HAuCl4	by	the	action	of	citrate	ions	in	water.	This	method	 is	known	as	 the	Turkevich	method	[3]	and	 leads	 to	 the	 formation	of	quasi-spherical	 Au	 NPs	 with	 an	 average	 core	 diameter	 of	 about	 12	 and	 20	 nm.	 The	protocol	has	been	optimized	to	enhance	the	size,	shape	homogeneity	and	stability	of	NPs	[4]	 [5].	 More	 interestingly,	 the	 use	 of	 thiol	 functionalized	 polymers	 allowed	 obtaining	highly	stable	Au	NPs	[6],	as	gold	may	react	with	hydrogen	sulphide	[7]	[8].	Thus,	smaller	Au	NPs,	with	a	diameter	size	ranging	from	1.5	to	5.2	nm,	can	be	successfully	synthetized	by	 means	 of	 thiol	 ligands	 [6].	 In	 particular,	 the	 use	 of	 thiol-poly(ethylene	 glycol)	derivatives	are	of	great	interest	for	the	biomedical	application	of	Au	NPs	[9]	[10].	
In	 this	work,	 I	 evaluated	 the	biological	 impact	of	 advanced	Au	NPs.	These	nanoparticles	were	provided	by	Gloria	Jiménez	Sánchez,	PhD	student	at	the	University	of	Franche-Comté	(Besançon,	France)	supervised	by	Prof	S.	Roux.	Briefly,	these	Au	NPs	were	synthesized	by																																									 																					[3]	Turkevich	J	et	al.	(1951)	Discuss.	Faraday	Soc.	11	55–75	[4]	Frens	G	(1973)	Nat.	Phys.	Sci.	241	20–2	[5]	Slot	J	W	and	Geuze	H	J	(1981)	J.	Cell	Biol.	90	533–6	[6]	Brust	M	et	al.	(1994)	Chem.	Commun.	801–2	[7]	Woehrle	G	H	et	al.	(2005)	J.	Am.	Chem.	Soc.	127	2172–83	[8]	Roux,	S	et	al.	Int.	J.	Nanotechnology	[9]	Eck	W	et	al.	(2008)	ACS	Nano	2	2263–72	[10]	Wuelfing	W	P	et	al.	(1998)	J.	Am.	Chem.	Soc.	120	12696–7	
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reducing	HAuCl4	with	NaBH4	in	a	methanol/water	mixture.	The	dithiolated	derivate	of	the	diethylenetriaminepentaacetic	acid	(DTPA),	named	DTDTPA,	was	used	as	ligand	to	ensure	the	 quasi-irreversible	 grafting	 of	 gold	 nanoparticles,	 providing	 higher	 colloidal	 stability	[11].	
Platinum	nanoparticles	 (Pt	NPs)	are	also	synthetized	via	 chemical	 reduction	of	platinum	ions	in	aqueous	or	organic	solutions	[12]	[13].	These	methods	commonly	use	the	K2PtCl4	precursor	 and	 reducing	 agents	 such	 as	 NaBH4.	 Thus,	 the	 main	 limitations	 of	 preparing	metallic	NPs	via	chemical	methods	are:	 i)	 the	use	of	multi-step	routes,	 ii)	 the	addition	of	reducing	agents,	iii)	the	heating	of	the	aqueous	or	organic	solutions	to	initiate	the	reaction	and	iv)	the	necessity	of	purification	and	sterilization	steps	for	biomedical	concerns.		
In	this	work,	metallic	nanoparticles	were	prepared	in	water	via	a	photochemical	method	that	involves	the	use	of	ionizing	photons	(γ-rays)	to	reduce	metal	salts	and	obtain	purely	metallic	 nanoparticles	 through	 a	 one-step	 method.	 The	 description	 of	 this	 method	 is	presented	in	the	next	section.	
1.1.2 Metallic	NPs	preparation	via	water	radiolysis	
1.1.2.1 Water	radiolysis	
The	process	of	water	radiolysis	can	be	summarized	by	the	following	reactions	occurring	at	different	time	scales	(time	by	which	each	event	is	estimated	to	be	complete)	[14]:	
H!O ⇝ H2 O∙! + !!     and     H!O∗	 10-16	s	 Equation	I	-	1	H!O∙! +  H!O →  OH∙ + H!O!	 10-14	s	 Equation	I	-	2	H!O∗ → H∙ +  OH∙,H! + O∙   	 10-13	s	 Equation	I	-	3	!! + nH!O → !!"! 	 10-12	s	 Equation	I	-	4	
Equation	I	-	1	represents	the	initial	electronic	excitation	of	a	water	molecule,	which	takes	place	on	 the	 time	scale	of	 an	electronic	 transition.	The	positive	 radical	H!O∙!	 undergoes	the	ion-molecule	reaction	of	Equation	I	-	2	in	~10-14	s.	The	excited	H!O∗	state	dissociates	
																																								 																					[11]	Alric	C	et	al.	(2013)	Nanoscale	5	5930–9	[12]	Mironava	T	et	al.	(2013)	Toxicol.	Vitr.	27	882–9	[13]	Long	N	V	et	al.	(2010)	Nanotechnology	21	035605	[14]	Buxton	G	V	(1987)	Radiation	Chemistry:	Principles	and	Applications	pp	321–49	
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as	 shown	 in	 Equation	 I	 -	 3	 and	 the	 secondary	 electrons	 released	 to	 the	 medium	 are	solvated	in	~10-12	s.	Water	radiolysis	is	illustrated	in	Figure	I	-	2.		
	
Figure	I	-	2.	Scheme	of	the	transient	species	produced	during	water	radiolysis,	without	or	in	the	presence	of	a	diluted	solute	acting	as	a	radical	scavenger	[15].	A	 fraction	of	 the	products	 in	reactions	Equation	I	 -	2	and	Equation	I	 -	4	 then	diffuse	to	encounter	another	species	and	react	to	form	molecular	and	secondary	radical	products.	
1.1.2.2 Redox	properties	of	aqueous	solutions		
In	 this	 work,	 metallic	 NPs	 were	 synthetized	 by	 water	 radiolysis	 in	 the	 perspective	 to	produce	 ready-to-use	biocompatible	NPs.	Water	 radiolysis	generates	 free	 radicals	acting	as	strong	reducing	or	oxidizing	agents.	The	redox	properties	of	these	primary	radicals	(see	
Figure	I	-	2)	are:	
• !!"! :	a	powerful	reductant	with	a	standard	reduction	potential	of		E∘ H!O / e!"! =  −2.87 V	
•  H∙:	a	powerful	reductant	only	in	acidic	conditions	with	a	standard	reduction	potential	of	E∘  H!/H∙ =  −2.31 V	
• OH∙:	a	powerful	oxidant	with	a	standard	oxidation	potential	of																																										 																					[15]	Rodgers	M	A	J	(1987)	Radiation	Chemistry:	Principles	and	Aplications	
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E∘  OH∙/OH! =  1.90 V	in	neutral	solutions	and		E∘  H!,OH∙/H!O =  2.72 V	in	acidic	solutions	
The	hydrated	electron	!!"! 	and	the	hydrogen	atom H∙	atom	react	by	attaching	to	a	vacant	orbital	of	an	acceptor	molecule	such	as	a	metal	ion	M!"!!	by:	
!!"! +M!! → M !!! !	 	 	 	 	 	 	 	 Equation	I	-	5	H⋅+ M!! → H!+ M !!! !	 	 	 	 	 	 	 Equation	I	-	6	
where	n	is	the	charge	of	the	metal	ion.	
The	 hydroxyl	 radical	 OH∙	 oxidizes	 inorganic	 ions	 by	 a	 simple	 one-electron	 transfer	process:	
OH∙ + S! → S!!! + OH!	 	 	 	 	 	 	 Equation	I	-	7	where	S	is	a	diluted	solute	acceptor.	
In	radiation	chemistry,	the	reduction	or	oxidation	of	the	solute(s)	are	responsible	for	the	production	of	new	compounds.	As	water	radiolysis	induces	approximately	the	same	yields	of	 reducing	 and	 oxidizing	 radicals	 one	 of	 these	 processes	 may	 be	 favored	 by	 the	production	 of	 reactive	 or	 inert	 secondary	 radicals	 [16].	 These	 secondary	 radicals	 are	produced	 by:	 i)	 the	 irradiation	 of	 diluted	 organic	 solvents	 (as	 alcohols)	 or	 ii)	 by	 the	irradiation	of	polymers.	In	this	work	the	first	strategy	is	not	used	and	only	the	presence	of	polymers	may	modify	the	yields	of	the	reducing	and	oxidizing	reactions.	
1.1.2.3 Radiolytic	reduction	and	atom	coalescence	
The	synthesis	of	metallic	nanoparticles	by	 radiolysis	was	a	major	 challenge	of	my	work.	The	method	consists	of	reducing	positive	metal	complexes	(PtII	for	Pt	NPs	and	AuIII	for	Au	NPs)	down	to	the	metallic	state	via	radiolysis.	The	metal	 ions	are	reduced	by	!!"! 	and	  H∙	 as	shown	in	Equation	I-	5	and	Equation	I-	6.	
Multivalent	 ions,	 as	PtII,	 are	 reduced	down	 to	 the	zero-valent	 state	according	 to	a	multi-step	reaction	mechanism	which	involves	intermediate	species:																																									 																					[16]	Buxton	G	V	(2008)	An	overview	of	the	radiation	chemistry	of	liquids	Radiation	Chemistry	
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Pt!! → Pt!	 	 	 	 	 	 	 	 	 Equation	I	-	8	
and	
Pt! → Pt!	 	 	 	 	 	 	 	 	 Equation	I	-	9	
The	 uniform	 energy	 deposition	 into	 the	 irradiated	 medium	 leads	 to	 a	 homogeneous	distribution	of	metal	atoms	and	nucleation	sites	in	the	solution.	Since	the	binding	energy	between	 two	metal	 atoms	 is	 stronger	 than	 the	 atom–solvent	 or	 atom–ligand	 interaction	energies,	metal	 clusters	 are	 formed	with	 a	 remarkable	monodispersity	 through	 a	multi-step	coalescence	process	[17]:	
Pt! → Pt!! → Pt!!!! 	 	 	 	 	 	 	 	 Equation	I	-	10	where	x	is	the	number	of	Pt	atoms	forming	the	cluster	(coalescence).	
At	high	dose	rate,	as	that	used	in	this	work	(see	source	dosimetry	in	Chapter	II	–Section	
3.1.2),	all	reducing	species	are	produced	and	scavenged	by	the	metal	ions	within	a	short	time,	 following	 by	 coalescence	 of	 the	well	 dispersed	 atoms	 [18].	 The	 size	 of	 the	 atomic	cluster	 (Pt!!!! )	 is	 delimited	 in	 situ	 by	 the	 presence	 of	 polymeric	molecules	which	 act	 as	stabilizer.	 Polymers	 containing	 functional	 groups	with	 good	 affinity	 to	 the	metal	 ensure	the	 anchoring	 of	 the	molecules	 at	 the	nanoparticle	 surface	 (see	 surface	 chemistry	 of	Au	and	Pt	in	Section	5.1).	Thus,	the	polymer	chains	stabilize	the	nanoparticle	by	electrostatic	repulsion	or	steric	hindrance.	Moreover,	the	stabilizer	does	not	chemically	reduce	the	ions	because	 this	 may	 induce	 the	 development	 of	 the	 atomic	 clusters	 (production	 of	 bigger	NPs)	[19].	
Due	to	the	remarkable	reduction	power	of	radicals,	radiolysis	is	also	a	suitable	method	in	the	synthesis	of	clusters	containing	two	or	more	metals	[20],	materials	of	great	interest	for	various	 applications	 (e.g.	 catalysis	 [21]).	 It	 was	 shown	 by	 pulse	 radiolysis	 of	 mixed	metallic	 solutions	 that	 electron	 transfer	 occurs	 from	 less	 noble	 atoms	 to	 the	 ions	 of	 the																																									 																					[17]	Remita	H	and	Remita	S	 (2010)	Metal	Clusters	and	Nanomaterials:	Contribution	of	Radiation	Chemistry	
Recent	Trends	in	Radiation	Chemistry	p	607	[18]	Belloni	J	and	Mostafavi	M	(2001)	Stud.	Phys.	Theor.	Chem.	87	411–52	[19]	 Belloni	 J	 and	 Remita	 H	 (2008)	 Metal	 clusters	 and	 nanomaterials	 Radiation	 chemistry:	 from	 basics	 to	
applications	in	material	and	life	sciences		[20]	Belloni	J	et	al.	(1998)	New	J.	Chem.	22	1239–55	[21]	Mirdamadi-Esfahani	M	et	al.		(2010)	Gold	Bull.	43	49–56	
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most	 noble	metal,	which	 leads	 to	 a	 favorable	 reduction	 of	 this	 last	metal,	 resulting	 in	 a	core-shell	 structure.	 Indeed,	 this	 process	 depends	 on	 the	 redox	 potential	 (tendency	 of	chemical	species	to	acquire	electrons)	of	the	complex	metal	ions	used	as	precursors.	The	optical	absorption	band	(see	surface	plasmon	in	Section	5.2.2)	is	progressively	shifted	in	these	mixtures	[17].	At	high	dose	rate	(e.g.	pulses	of	an	electron	beam	with	a	few	kGy.s-1)	the	reduction	of	all	ions	can	be	achieved	rapidly	without	any	inter-metal	electron	transfer.	In	 this	 case,	 the	 coalescence	 takes	 place	 between	 the	 various	 atoms	 according	 to	 their	abundance	in	the	solution	and	independently	on	their	potential.	Thus,	an	alloyed	structure	may	be	formed	by	radiolysis	[19].	
1.1.2.4 Irradiation	of	polymers	
The	 irradiation	 of	 polymers,	 used	 as	 stabilizers	 for	 colloidal	 NPs	 synthesis,	 leads	 to	contrasting	 behaviors	 depending	 on	 its	 composition	 (repetition	 monomeric	 units).	Possible	 effects	 of	 ionizing	 radiation	 in	 polymers	 are	 chain	 scission	 and	 cross-linking	 of	polymeric	 chains	 [22].	 The	 chemical	 changes	 induced	 by	 irradiating	 polymers	 are	summarized	in	Figure	I	-	3.	The	effect	of	polymers	irradiation	in	the	synthesis	of	metallic	nanoparticles	is	discussed	in	Chapter	III	and	IV	in	relation	with	the	NPs	developed	in	this	work.	
	
Figure	I	-	3.	Illustration	of	chemical	events	that	can	be	induced	by	high-energy	radiation	in	polymers	[22].	
																																								 																					[17]	Remita	H	and	Remita	S	 (2010)	Metal	Clusters	and	Nanomaterials:	Contribution	of	Radiation	Chemistry	
Recent	Trends	in	Radiation	Chemistry	p	607	[19]	 Belloni	 J	 and	 Remita	 H	 (2008)	 Metal	 clusters	 and	 nanomaterials	 Radiation	 chemistry:	 from	 basics	 to	
applications	in	material	and	life	sciences	[22]	Coqueret	X	(2008)	Radiation	chemistry:	from	basics	to	applications	in	material	and	life	sciences	p	131	
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1.2 Applications	of	nanomaterials		
Nowadays,	nanoparticles	are	widely	used	in	fields	such	as	electronics,	fuel	cells,	cosmetics,	textile	 industry,	 car	 industry,	 self-cleaning	 surfaces,	 depollution,	 catalysis,	 photonics,	biology	and	medicine.		
Notably,	in	the	last	decades	human	has	conducted	nanoscience	research	to	the	imitation	of	nature	 and	 its	 perfect	 processes.	 For	 instance,	 we	 have	 been	 inspired	 from	 natural	photosynthesis	 to	 enhance,	 by	 involving	 nanotechnology,	 electronic	 processes	 to	efficiently	produce	clean	energy	[23]	[24].	At	the	same	time,	we	are	constantly	looking	for	the	 optimal	 use	 of	 the	 renewable	 natural	 resources,	 such	 as	 sunlight,	 for	 the	 benefit	 of	society.	 Within	 this	 perspective,	 titanium	 dioxide	 can	 be	 doped	 with	 or	 metallic	nanoclusters	 [25]	 [26]	 to	 enhance	 its	 photocatalytic	 activity	 in	 the	 spectral	 range	 of	sunlight.		
The	Fantastic	Voyage,	a	science	fiction	film	directed	by	Richard	Fleischer	in	1966,	tells	us	the	story	of	a	submarine	crew	who	is	reduced	down	to	a	microscopic	size	and	venture	into	the	 body	 of	 an	 injured	 scientist	 to	 repair	 the	 damage	 to	 his	 brain.	 The	 perfect	 human	machine	 sometimes	 needs	 to	 be	 “fixed”	 and	 this	 process	 may	 start	 at	 the	 nanoscale.	Knowledge	 on	 the	 human	 body,	 its	 metabolic	 and	 enzymatic	 mechanisms,	 allowed	scientists	 developing	 efficient	 nano-tool	 to	 detect	 (labs	 on	 chips)	 and	 to	 treat	 diseases.	Today	 we	 are	 reaching	 the	 nano-robotic	 (self-propelled	 nanoparticles)	 era.	 A	 clear	example	 is	 the	 shared	 Nobel	 Prize	 in	 Chemistry	 2016,	 between	 Jean-Pierre	 Sauvage	(France),	 J.	 Fraser	 Stoddart	 (UK),	 and	 Ben	 L.	 Feringa	 (Netherlands)	 for	 the	 “design	 and	synthesis	of	molecular	machines”,	nanomachinery	for	a	wide	variety	of	applications,	which	will	be	a	Fantastic	Voyage.		
This	 PhD	 project	 is	 the	 first	 stop	 in	 a	 voyage	 to	 developing	 efficient	 biocompatible	platinum	based	nanoparticles	(Pt	NPs)	to	enhance	radiation	therapies.	In	the	next	section,	an	overview	on	the	applicability	of	nanotechnology	in	medicine	is	presented.	
																																								 																					[23]	Kay	A	et	al.	(1994)	J.	Phys.	Chem.	98	952–9	[24]	Ryu	J	et	al.	(2011)	Adv.	Mater.	23	1883–8	[25]	Méndez-Medrano	M	G	et	al.	(2016)	J.	Phys.	Chem.	C	120	5143–54	[26]	Luna	A	L	et	al.	(2016)	Appl.	Catal.	B	Environ.	191	18–28	
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2 Nanomedicine	The	application	of	nanotechnology	in	medicine	with	the	perspective	to	prevent,	diagnose	and	treat	diseases	is	named	nanomedicine.	Due	to	the	versatility	of	nanomaterials	(surface	chemistry),	specific	ligands	such	as	antibodies,	peptides	and	small	molecules	(fluorescent	and	targeting	agents	Figure	I	-	4)	can	be	conjugated	to	develop	selective	diagnostic	tools	or	 therapeutic	nano-agents,	enhancing	the	physico-chemical	properties	and	selectivity	of	conventional	pharmaceutical	drugs.		
	
Figure	I	-	4.	Scheme	of	a	multi-modal	nanoparticle	for	molecular	imaging,	drug	delivery	and	therapy.	By	 regulation,	 all	 potential	 nano-therapeutics	 (organic	 (polymeric)	 or	 inorganic	nanostructures)	must	 exhibit	 a	 safe	 behavior	 after	 intravenous	 injection	 by	 preferential	accumulation	 in	 the	 malignant	 side	 and	 easily	 renal	 elimination	 in	 vivo.	 The	 bio-distribution	and	clearance	of	nanoparticles	are	both	influenced	by:	i)	physiological	factors	such	as	bloodstream,	opsonisation,	endothelial	permeability	and	ii)	their	physico-chemical	properties	such	as	size,	shape,	charge	and	surface	chemistry.	In	particular,	it	is	commonly	considered	that	inorganic	nanoparticles	with	sizes	smaller	than	some	tens	of	nanometers,	do	 not	 accumulate	 in	 undesired	 organs,	minimizing	 toxicity	 risks	 [27]	 [28].	 The	 surface	charge	of	nanoparticles	also	plays	an	important	role	in	their	uptake.	For	instance,	positive	charged	nanoparticles	adsorb	plasma	proteins	by	opsonisation,	which	causes	their	capture	by	phagocytes	and	further	accumulation	in	the	liver	and	spleen	(with	pores	of	about	100	
																																								 																					
[27]Choi	H	S	et	al.	(2007)	Nat.	Biotechnol.	25	1165–70	[28]	Michelle	L	et	al.	(2008)	Nanomedicine	(Lond)	3	703–17	
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nm)	[29]	[30].	In	contrast,	neutral	or	negatively	charged	nanoparticles	circulate	for	longer	time	 as	 the	 opsonisation	 phenomenon	 rarely	 occurs.	 Thus,	 all	 these	 properties	must	 be	carefully	characterized	in	the	development	of	potential	nano-therapeutics.	
2.1 Drug	delivery	
The	 most	 common	 approach	 in	 nanomedicine	 is	 the	 use	 of	 polymeric	 or	 inorganic	nanoparticles	 containing	 encapsulated,	 dispersed,	 absorbed	 or	 conjugated	 therapeutic	molecules	 as	 selective	 drug	 delivery	 systems.	 These	 nano-agents	 are	 known	 as	nanocarriers.		
The	physico-chemical	properties	and	biological	performance	of	a	nanocarrier	is	optimized	in	order	to	successfully	release	the	active	compound	in	the	affected	organ.	The	nanocarrier	formulation	 and	 its	 conjugation	 with	 the	 drug	 is	 of	 great	 importance	 for	 a	 targeted	therapy.	 Cell-specific	 targeting	 may	 be	 accomplished	 by	 using	 active	 or	 passive	mechanisms.	The	active	approach	uses	recognition	ligands	such	as	antibodies	attached	to	the	surface	of	the	carrier,	or	by	the	use	of	physical	controlled	stimuli	(e.g.	temperature,	pH	or	magnetism).	The	passive	approach	 is	a	result	of	enhanced	permeability	and	retention	(EPR)	effect,	which	occurs	in	leaky	tissues	of	tumors	[31].	
Drug	delivery	systems	are	mainly	used	to	treat	infectious	or	genetic	diseases	and	cancer.	Nanocarriers	 are	 mainly	 found	 as	 liposomes	 and	 lipid	 nanoparticles	 (80	 –	 300	 nm),	dendrimers	 (1	 –	 10	 nm),	 polymers	 (10	 –	 100	 nm),	 silica	 (10	 –	 300	 nm)	 or	 carbon	nanomaterials	(1	–	5	nm)	[32].	
Liposomes	 were	 the	 first	 to	 be	 investigated	 as	 drug	 carriers	 [33]	 [34].	 Liposomes	 are	vesicles	 composed	 by	 phospholipids	 and	 steroids	 (e.g.	 cholesterol)	 that	 increase	 the	solubility	of	 anticancer	drugs	and	 thus	 their	 therapeutic	 effect	 [35].	 Smaller	 carriers	are	based	on	polymeric	nanoparticles,	made	from	biocompatible	and	biodegradable	materials,	which	are	considered	as	more	promising	drug	carriers	than	liposomes	[36]	[37].	The	first																																									 																					[29]	Alexis	F	et	al.	(2008)	Mol.	Pharm.	5	505–15	[30]	Albanese	A	et	al.	(2012)	Annu.	Rev.	Biomed.	Eng.	14	1–16	[31]	Acharya	S	and	Sahoo	S	K	(2011)	Adv.	Drug	Deliv.	Rev.	63	170–83	[32]	Wilczewska	A	Z	et	al.	(2012)	Pharmacol.	Reports	64	1020–37	[33]	Bangham	A	D	and	Horne	R	W	(1964)	J.	Mol.	Biol.	8	660–8	[34]	Saunders	L	and	Thomas	I	L	(1958)	J.	Chem.	Soc.	483	[35]	dos	Santos	Giuberti	C	et	al.	(2011)	J.	Liposome	Res.	21	60–9	[36]	You	J	et	al.	(2013)	J.	Nanoparticle	Res.	15	2123	
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developments	were	devised	as	polymeric	carriers	for	vaccines	and	anticancer	drugs	[38].	For	instance,	the	delivery	of	anticancer	drugs	that	does	not	cross	the	blood-brain	barrier,	such	as	doxorubicin,	has	been	enhanced	by	the	use	of	polymeric	nanoparticles	[39]. Under	the	existing	regulatory	framework,	medicinal	products	containing	nanoparticles	in	form	of	liposomes	 (e.g.	 Caelyx,	 Myocet),	 polymer	 protein	 conjugates	 (e.g.	 PegIntron,	 Somavert),	polymeric	 substances	 (e.g.	 Copaxone)	 or	 suspensions	 (e.g.	 Rapamune,	 Emend)	 have	already	been	authorized	in	EU	and	the	US. 
Inorganic	 nanoparticles	 are	 important	 multifunctional	 platforms	 in	 nanomedicine.	 For	instance,	nanostructures	 composed	of	metal-organic	 frameworks	 (nanoMOFs)	 are	 stable	biocompatible	 nano-agents	with	 the	 ability	 of	 efficiently	 adsorb	 and	 release	 therapeutic	molecules	 [40]	 [41].	 Silica	 based	 nanoparticles	 are	 used	 as	 nanoreservoirs	 and	nanocarriers	 of	 commonly	 prescribed	 drugs	 to	 enhance	 their	 tolerance	 and	 therapeutic	efficiency	 [42]	 [43].	 The	 sol-gel	 chemistry	 allows	developing	 porous	 silica	 nanoparticles	for	drug	delivery	purposes.	These	carriers	have	been	largely	investigated	in	the	treatment	of	 Parkinson’s	 disease	 [44].	 An	 alternative	 silica	 composite	 containing	 titania	 is	successfully	used	in	clinics	for	the	treatment	of	diabetic	foot	ulcers	[45].	
2.2 Medical	imaging	
Nanomedicine	 plays	 also	 a	 key	 role	 in	 medical	 imaging.	 In	 this	 context,	 different	approaches	have	been	investigated.		
Among	the	optical	approaches,	nano-probes	for	fluorescence	imaging	consist	in	polymeric	or	 inorganic	 based	 nanoparticles	 functionalized	 with	 near-infrared	 fluorescent	 markers	(NIRF).	 The	 NIRF	 spectral	 window,	 from	 650	 up	 to	 900	 nm,	 allows	 imaging	 biological	tissues	with	minimum	auto-fluorescence	overlapping	[46].	The	main	advantages	of	NIRF	dye-containing	nanoparticles	are:	 i)	higher	photostability	and	biocompatibility,	 ii)	better	
																																								 																																								 																																								 																																								 																		[37]	Gref	R	et	al.	(2012)	Adv.	Drug	Deliv.	Rev.	64	316–26	[38]	Couvreur	P	et	al.	(1982)	J.	Pharm.	Sci.	71	790–2	[39]	Gulyaev	A	E	et	al.	(1999)	Pharm.	Res.	16	1564–9	[40]	Agostoni	V	et	al.	(2015)	Sci.	Rep.	5	7925	[41]	Baati	T	et	al.	(2013)	Chem.	Sci.	4	1597–607	[42]	López	T	et	al.	(2016)	J.	Encapsulation	Adsorpt.	Sci.	06	47–55	[43]	López	Goerne	T	M	et	al.	(2013)	J.	Nanomater.	2013	[44]	López	T	et	al.	(2015)	Mater.	Lett.	161	160–3	[45]	López	T	and	Rodríguez	C	E	(2015)	Rev.	la	Fac.	Med.	la	UNAM	58	5–12	[46]	He	X	et	al.	(2010)	Rev.	Nanomedicine	Nanobiotechnology	2	349–66	
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water	 solubility,	 iii)	 enhanced	 fluorescence	 signal	 and	 iv)	 higher	 versatility	 for	bioconjugation	[46].		
Another	 approach	 is	 based	 on	 the	 intrinsic	 properties	 of	 nanoparticles.	 For	 instance,	magnetic	 nanoparticles,	 such	 as	 iron	 oxide	 and	 gadolinium	 oxide,	 are	 used	 as	 contrast	agents	 to	 improve	 the	 performance	 of	 the	 medical	 Magnetic	 Resonance	 Imaging	 (MRI)	[47]	[48].	More	interestingly,	magnetic	nanoparticles	can	also	be	used	as	nanocarriers	for	targeted	drug	delivery	[49]	[50].		
Finally,	the	radiolabeling	of	polymeric	nanoparticles	is	an	emerging	field	used	to	combine	positron	 emission	 tomography	 (PET)	 or	 single	 photon	 computed	 tomography	 (SPECT)	with	drug	delivery.	Radiolabeling	of	PET	isotopes	with	a	very	wide	range	of	half-lives	[51]	enables	 therapy	 planning	 and	 monitoring	 by	 molecular	 imaging	 from	 the	 time	 of	administration	to	several	days	or	weeks.	
2.3 Other	advances	
2.3.1 Theranostic	
Multi-modal	 nanoparticles	 are	 particularly	 of	 great	 interest	 to	 achieve	 theranostic,	 an	approach	 based	 in	 the	 use	 of	 a	 single	 hybrid-nano-agent	 for	 simultaneous	 targeted	diagnostic	and	treatment	(Figure	I	-	5).		
The	 diagnosis	 is	 mainly	 achieved	 through	 the	 magnetic	 properties	 of	 the	 nanomaterial	(MRI).	 The	 treatment	 may	 imply	 drug	 delivery	 systems	 [52]	 or	 the	 activation	 of	 nano-agents	by	an	external	stimulus	(radiation).		
																																								 																					[47]	Sun	C	et	al.	(2008)	Adv.	Drug	Deliv.	Rev.	60	1252–65	[48]	Bridot	J-L	et	al.	(2007)	J.	Am.	Chem.	Soc.	129	5076–84	[49]	Dobson	J	(2006)	Drug	Dev.	Res.	67	55–60	[50]	Tietze	R	et	al.	(2015)	Biochem.	Biophys.	Res.	Commun.	468	463–70	[51]	Stockhofe	K	et	al.	(2014)	Pharmaceuticals	(Basel).	7	392–418	[52]	Fernandez-Fernandez	A	et	al.	(2011)	Appl.	Biochem.	Biotechnol.	165	1628–51	
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Figure	I	-	5.	Theranostic	approach	using	nanoparticles	(adapted	from	[53]).	
Many	hybrid-nano-agents	based	on	the	magnetically	active	Fe3O4	have	been	proposed	for	imaging	 and	 therapeutic	 applications.	 [54].	 These	 developments	 include	 the	 coating	 of	Fe3O4	with	Au	NPs	[55]	and	FePt	alloy	NPs	[56],	which	combine	the	magnetic	properties	of	iron	oxide	with	the	remarkable	optical	properties	of	metal	nanoparticles.	In	particular,	Au	NPs	are	remarkable	nano-agents	in	cancer	diagnosis,	as	X-ray	and	computed	tomography	contrast	agents,	and	treatment	[57]	[58].	
On	the	other	hand,	lanthanide	elements	(with	high	atomic	number)	have	a	large	range	of	properties	that	make	them	attractive	as	contrast	and	therapeutic	agents	[59].	For	instance,	gold	nano-cores	containing	gadolinium	chelates,	are	used	not	only	as	a	contrast	agent	due	to	the	presence	of	gadolinium	(paramagnetic	properties	for	MRI)	but	also	for	therapy	due	to	 the	 strong	 X-ray	 absorption	 of	 gold	 [60].	 An	 extended	 study	 of	 the	 potentialities	 of	gadolinium-based	 nanoparticles	 (GBNs)	 has	 provided	 encouraging	 results	 by	 combining	imaging	 and	 therapy	 [59].	GBNs	have	been	 largely	 studied	 as	 a	new	 range	of	 agents	 for																																									 																					[53]	Ramos-Cabrer	P	and	Campos	F	(2013)	Int.	J.	Nanomedicine	8	951–60	[54]	Ho	D	et	al.	(2011)	Acc.	Chem.	Res.	44	875–82	[55]	Heng	Yu	et	al.	(2005)	Nano	Lett.	5	379–82	[56]	Hong	R	et	al.	(2005)	Chem.	Mater.	17	4617–21	[57]	Hainfeld	J	F	et	al.	(2006)	Br.	J.	Radiol.	79	248–53	[58]	Butterworth	K	T	et	al.	(2016)	Nanomedicine	11	2035–47	[59]	Bridot	J-L	et	al.	(2009)	J.	Mater.	Chem.	19	2328	[60]	Debouttière	P-J	et	al.	(2006)	Adv.	Funct.	Mater.	16	2330–9	
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theranostic,	 using	 different	 ionizing	 radiation	 sources	 as	 high-energy	 photons	 [61],	neutrons	[59]	and	carbon	ions	[62].	
2.3.2 Photothermal	
This	modality	 is	based	on	the	surface	plasmon	phenomena	of	noble	metal	nanoparticles.	When	the	metal	nanoparticle,	e.g.	Au	or	Ag,	is	much	smaller	than	the	wavelength	of	light,	coherent	oscillation	of	the	conduction	band	electrons	are	induced	by	interaction	with	the	electromagnetic	field.	This	resonance	is	called	Surface	Plasmon	Resonance	(SPR)	(see	the	SPR	 effect	 of	metallic	NPs	 in	Section	5.2.2)	 [63].	 Thus,	 electromagnetic	 radiation	 at	 the	frequency	of	the	metal	NP	plasmon	is	efficiently	absorbed	and	rapidly	converted	into	heat	[64].	This	energy	propagates	into	the	medium	to	locally	increase	the	temperature	and	kill	targeted	 cells.	The	absorption	band	of	NPs	has	 to	be	 located	 in	 the	near-infrared	 region	which	is	the	wavelength	range	penetrating	living	tissue.	Within	this	purpose,	the	size	and	shape	of	NPs	has	 to	be	optimized.	 In	 this	 context,	mainly	gold	based	nanoparticles	have	been	investigated,	among	them	gold	nanorods	[65]	and	gold	nanoshells	[66]	[67].	Less	is	known	about	 the	 applicability	 of	 other	metal	 based	NPs,	 such	 as	 silver	 and	platinum,	 in	photothermal	treatment.	For	instance,	non-cytotoxic	Pt	NPs	(5-6	nm	core,	stabilized	with	PVP)	may	generate	a	9	°C	increase	in	temperature	when	interacting	with	a	near-IR	1064	nm	laser	leading	to	photothermal	triggered	cell	death	(Neuro	2A	cancer	cells)	[68].	
2.3.3 Sensitization	
A	 sensitizer	 is	 a	 drug	 or	 biomolecule	 that	 makes	 cells	 more	 sensitive	 to	 a	 specific	treatment.	 These	 agents	 mainly	 inhibit	 cells	 reparation	 pathways.	 For	 instance,	 a	radiosensitizer	 is	 used	 in	 combination	 with	 radiation	 therapy	 to	 modify	 the	 biological	response	of	cells	 to	radiation.	The	vectorization	of	 radiosensitizers	 is	a	new	approach	 in	the	 treatment	 of	 radio-resistant	 tumors.	 Polymeric	 nanoparticles	 are	 used	 within	 this	purpose.	 The	 incorporation	 of	 short	 interfering	 DNA	 molecules	 (Dbait)	 with	 polymers	impairs	 the	 repair	 of	 chromosomal	 damage,	 which	 makes	 cells	 more	 sensitive	 to	 the																																									 																					[61]	Miladi	I	et	al.	(2015)	Nanomedicine	Nanotechnology,	Biol.	Med.	11	247–57	[62]	Porcel	E	et	al.	(2014)	Nanomedicine	10	1601–8	[63]	Eustis	S	and	El-Sayed	M	A	(2006)	Chem.	Soc.	Rev.	35	209–17	[64]	Link	S	and	El-Sayed	M	A	(2000)	Int.	Rev.	Phys.	Chem.	19	409–53	[65]	Huang	X	et	al.	(2006)	J.	Am.	Chem.	Soc.	128	2115–20	[66]	Pattani	V	P	and	Tunnell	J	W	(2012)	Lasers	Surg.	Med.	44	675–84	[67]	Yang	P	et	al.	(2012)	Chemistry	18	9294–9	[68]	Manikandan	M	et	al.	(2013)	Biomaterials	34	5833–42	
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effects	 of	 radiation.	 This	 strategy	 is	 known	 as	 nucleic	 acid-based	 cancer	 molecular	therapies	[69].	The	combination	of	cholesterol	and	Dbait	is	a	promising	alternative	in	the	field	[70]	[71].	
3 Radiation	therapies	
3.1 Conventional	radiotherapy	
Radiotherapy	 is	 the	most	 common	 approach	 to	 treat	 cancer,	 used	 in	 about	 50%	 of	 the	cases.	Conventional	radiotherapy	based	on	the	use	of	high	energy	photons	(X-rays)	is	the	most	 common	 approach	 in	 clinical	 settings.	 X-rays	 are	 generated	 by	 medical	 linear	accelerators	 with	 energies	 in	 the	 order	 of	 few	 MeV	 (between	 1	 and	 25	 MeV).	 These	ionizing	beams	have	the	ability	to	penetrate	tissue,	allowing	the	treatment	of	tumors	in	a	non-invasive	 way.	 Unfortunately,	 high-energy	 photons	 present	 a	 significant	 lack	 of	selectivity	 (see	 dose	 deposition	 profile	 in	 comparison	 with	 ions	 in	 Figure	 I	 -	 6)	 and	provoke	damage	not	only	in	abnormal	cells	but	also	in	healthy	tissues,	which	induces	side	effects	to	patients.	This	effect	is	explained	by	the	physical	properties	of	photons	and	their	interaction	 with	 biological	 matter	 at	 the	 energy	 of	 the	 treatment	 (see	 interaction	 of	photons	with	matter	in	Section	6.1.1).		
Therefore,	the	improvement	of	radiation	therapy	is	a	major	challenge.	In	this	perspective,	new	 methods	 are	 explored	 to	 maximize	 the	 dose	 deposition	 in	 tumors	 through	 the	developement	 of	 more	 selective	 techniques	 such	 as	 Intensity-Modulated	 Radiation	Therapy	(IMRT),	cyberknife	and	hadrontherapy.	
3.2 Hadrontherapy:	an	alternative	approach	for	targeted	cancer	treatment	
Hadron	 beams	 for	 medical	 applications	 were	 first	 proposed	 by	 the	 physicist	 Robert	 R.	Wilson	in	1946	[72].	They	were	first	tested	by	the	Lawrence	Berkeley	National	Laboratory	(LBNL)	 in	1954	 and	more	 than	2500	patients	were	 treated	with	proton,	 helium,	 carbon	and	neon	ions.	Despite	the	encouraging	results,	the	LBNL's	clinical	treatment	program	was	interrupted	 in	 1993[73].	 In	 1994	 the	 Heavy	 Ion	Medical	 Accelerator	 (HIMAC),	 the	 first																																									 																					[69]	Dutreix	M	et	al.	(2010)	Mutat.	Res.	704	182–9	[70]	Berthault	N	et	al.	(2011)	Cancer	Gene	Ther.	18	695–706	[71]	Schlegel	A	et	al.	(2012)	Mol.	Ther.	—	Nucleic	Acids	1		[72]	Wilson	R	R	(1946)	Radiology	47	487–91	[73]	Berkeley	Lab	News	Center	
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dedicated	 carbon-ion	medical	 facility	 inspired	by	 the	work	at	Berkeley	Lab,	was	built	 at	NIRS	in	Chiba,	Japan	[74].  
Hadrontherapy	 commonly	 uses	 protons	 (proton-therapy)	 and	 carbon	 ions	 (carbon-therapy)	 beams	 in	 the	 range	 from	 70	 to	 400	MeV/a.m.u.	 Hadrontherapy	 is	 particularly	suited	to	treat	tumors	seated	in	sensitive	organs	(e.g.	head,	neck	and	eyes)	and	childhood	cancers	 (e.g.	 central	 nervous	 system	 tumors)	 due	 to	 the	 ballistic	 effect	 and	 efficiency	 of	ions	[75].	The	physical	processes	taking	place	when	ions	interact	with	matter	(in	the	case	of	NPs	and	biological	systems)	are	addressed	in	Section	6.1.2.	
Indeed,	hadron	beams	enhance	the	tumor	selectivity	of	conventional	radiotherapy	due	to	their	dose	deposition	profile	in	tissue	(see	Figure	I	-	6).	
	
Figure	I	-	6.	Principle:	illustration	of	the	dose	deposition	profile	of	X-rays	(in	blue)	and	ions	at	the	rising	Bragg	peak	(in	black)	and	the	Spread-out	Bragg	Peak	(SOBP)	(in	red).	This	unique	characteristic	allows	the	deposition	of	maximum	energy	into	a	relatively	well-defined	 volume	 (Bragg	 peak)	 while	 sparing	 the	 surrounding	 healthy	 tissue.	 As	 hadron	beams	are	stopped	by	penetrating	tissues	(over	a	few	centimeters),	a	basically	zero	energy	is	deposited	behind	the	tumor.	In	addition,	fast	ions	(in	particular	carbon	ions)	experience	less	scattering	 in	comparison	with	X-rays,	which	facilitates	the	delivery	of	high	radiation	doses	to	targets	in	close	proximity	to	critical	structures	[76]	(Figure	I	-	7).	Thus,	ions	are	biologically	 more	 efficient	 than	 X-rays	 (relative	 biological	 effectiveness,	 RBE),	 which	allows	 increasing	 the	 therapeutic	 index	 of	 radiotherapies	 in	 the	 treatment	 of																																									 																					
[74]	Hirao	Y	et	al.	(1992)	Nucl.	Phys.	A	538	541–50	[75]	Laramore	G	E	(2009)	Curr.	Opin.	Oncol.	21	224–31	[76]	McDonald	M	W	and	Fitzek	M	M	(2010)	Curr.	Probl.	Cancer	34	257–96	
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radioresistant	 tumors	 (e.g.	 glioblastoma	 and	 chordoma).	 These	 properties	 allow	considering	hadrontherapy	as	a	more	powerful	oncological	technique.	
	
Figure	I	-	7.	Schematic	comparison	between	the	energy	deposition	of	conventional	radiotherapy	and	hadrontherapy	to	treat	a	brain	tumor	(adapted	from	[77]).	Therefore,	in	spite	of	the	high	cost,	since	the	early	1990s	new	hadron	facilities	have	been	built	particularly	 in	Europe	and	North	America	 [78]	 [79].	New	hadron-beam	centers	are	under	construction.	France	has	two	operating	proton	therapy	centers,	the	Center	of	André	Lacassagne	in	Nice	and	the	Center	of	Protontherapy	in	Orsay.	 In	addition,	protontherapy	treatments	 will	 be	 soon	 available	 in	 Toulouse	 at	 the	 Institut	 Claudius	 Regaud	 and	 one	carbon	 facility,	 ARCHADE	 in	 Caen	 is	 in	 project.	 The	 experimental	 research	using	 carbon	beams	is	mainly	conducted	at	GANIL,	Caen	[80].	
During	 the	 treatment,	 ions	 may	 be	 delivered	 by:	 i)	 passive	 spreading	 or	 ii)	 active	spreading	 [81].	 In	 clinic,	 the	 most	 common	 delivery	 method	 is	 the	 passive	 spreading,	which	 uses	 scattering	 materials	 to	 sufficiently	 broaden	 the	 Bragg	 Peak	 for	 total	 tumor	coverage.	This	technique	is	known	as	spread-out	of	the	Bragg	peak	(SOBP)	(see	red	profile	in	Figure	I	-	6).	Using	this	irradiation	mode,	the	dose	deposition	at	the	entrance	of	the	ion	beam	 is	 accumulated	 and	 remains	 significant	 in	 front	 of	 the	 tumor,	 which	 induces	 side	effects	to	the	patients.	Therefore,	an	innovative	strategy	combining	metal	based	NPs	with	radiations	 has	 been	 evaluated.	 In	 this	 strategy,	 NPs	 will	 accumulate	 into	 the	 tumor	 to	locally	increase	the	effect	of	radiation	and	thus	reduce	the	total	dose.																																										 																					[77]	Proton	therapy:	The	new	weapon	of	choice	against	cancer	is	coming	to	Australia	[78]	Schardt	D	(2016)	Hadrontherapy	Basic	Concepts	in	Nuclear	Physics:	Theory,	Experiments	and	Applications		[79]	UniversitätsKlinikum	Heidelberg:	Therapy	centers	in	the	world	[80]	France	Hadron	-	Home	[81]	Lomax	A	(2007)	Med.	Phys.	34	2552	
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In	 this	work,	 in	vitro	 experiments	were	performed	at	 the	Heavy	 Ion	Medical	Accelerator	(HIMAC)	 in	 Chiba	 using	 this	 SOBP	 strategy	 (see	 experimental	 conditions	 Chapter	 III	 –	
Section	3.3.2)	with	Pt	NPs.	
Thus,	 the	 main	 motivation	 of	 this	 work	 is	 the	 improvement	 of	 radiotherapies	 by	combining	the	advantages	of	targeted	nanomedicine	with	photons	and	carbon	ions.	
4 Nanoparticles	for	radiation	therapies	Heavy	 atoms	 (high-Z,	mostly	metals)	 containing	 compounds	 have	 been	 used	 as	 a	 novel	strategy	to	enhance	the	biological	impact	of	radiations.	The	combination	of	chemotherapy,	by	 means	 of	 cis-Pt,	 with	 photons	 (X-rays)	 showed	 encouraging	 in	 vivo	 results	 in	 the	treatment	of	gliomas	[82].	However,	due	to	the	high	toxicity	of	cis-Pt	(DNA	cross-linking),	the	 radio-enhancement	 of	 platinum	 atoms	 was	 not	 fully	 understood.	 The	 principle	 of	combining	 high-Z	 atoms	with	 irradiation	was	 then	 elucidated	 in	 cells	 loaded	with	 non-toxic	 molecular	 complexes	 [83].	 The	 enhancement	 of	 radiobiological	 effects	 by	 heavy	atoms	was	explained	in	terms	of	early	physical	events	and	Auger	de-excitation	processes	[84].	 In	 the	 perspective	 of	 targeted	 radiotherapy,	 this	 strategy	 failed	 by	 lack	 of	 tumor	selectively.	An	improved	approach	consisted	on	combining	high-Z	containing	nano-agents	with	radiations	[85].	
Radiation	 dose	 enhancement	 by	 high-Z	 based	 nanoparticles,	 such	 as	 metallic	nanoparticles,	 is	 a	 promising	 alternative	 in	 cancer	 therapeutics.	 Through	 an	 astute	nanoparticle	design,	an	efficient	tumoral	drug	accumulation	is	achieved,	which	induces	an	increase	 of	 the	 local	 dose	 deposition	 (targeting)	 while	 preserving	 healthy	 tissues.	Therefore,	metal-based	nanoparticles	 have	 been	 the	 object	 of	 intense	 experimental	 [86]	and	 theoretical	 research	 [87]	 to	 better	 understand,	 from	 a	 physical,	 chemical	 and	biological	 point	 of	 view,	 the	 enhancing	 effect	 of	 nanoparticles	 interacting	 with	 ionizing	radiation.	For	instance,	core-shell	(metal-ligand)	platinum	nanoparticles	and,	more	often,	
																																								 																					[82]	Biston	M-C	et	al.	(2004)	Cancer	Res.	64	2317–23		[83]	Usami	N	et	al.	(2008)	Int.	J.	Radiat.	Biol.	84	603–11	[84]	Kobayashi	K	et	al.	(2010)	Mutat.	Res.	704	123–31	[85]	Kong	T	et	al.	(2008)	Small	4	1537–43	[86]	Retif	P	et	al.	(2015)	Theranostics	5	1030–44	[87]	McMahon	S	J	et	al.	(2011)	Radiother.	Oncol.	100	412–6	
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nanostructured	cis-Pt	delivery	systems	are	under	study	to	enhance	the	therapeutic	effect	of	platinum	by	minimizing	its	toxicity	[88].	
A	molecular	approach	is	commonly	adopted	to	characterize	the	radiation	enhancing	effect	of	 high-Z	 NPs.	 This	 approach	 consists	 in	 using	 plasmids	 (DNA-based	molecular	 probes)	[89]	 [90].	 This	 allows	 evaluating	 the	 nanoparticles	 induced	 nanosize	 biological	 damage	trigged	by	radiation,	which	has	been	demonstrated	using	photons	and	fast	ions	[89]	[91]	[62]	 [92]	 [93].	 Experiments	 in	 the	 presence	 of	 a	 radical	 scavenger	 (DMSO),	 provide	insights	 in	 the	 NPs	 radio-enhancement	 mechanism	 [91]	 [94],	 which	 has	 been	 also	demonstrated	in	cells	[95].		
Au-core	 NPs	 are	 commonly	 used	 in	 combination	 with	 photons	 (see	 state-of-the-art	 in	
Section	4.1).	Nevertheless,	in	2010,	our	group	opened	new	possibilities	in	combining	Pt-core	NPs	with	carbon	ions	to	improve	the	performance	of	hadrontherapy	[91]	(see	state-of-the-art	in	Section4.2).	This	Pt-core	NPs	coated	with	poly	(acrylic	acid)	were	found	toxic	in	cells	and	improvements	were	needed.	This	is	the	object	of	my	work.	
4.1 Photons		
In	the	pioneer	work	of	Hainfeld	and	co-workers,	it	was	demonstrated	in	vivo	that	Au	NPs	(1.9	nm	–	glucose	coating)	prolonged	the	life	of	mice	treated	with	160	kV	X-rays	[96]	[97].	Nowadays,	 beyond	 Au	 NPs	 that	 are	 considered	 as	 the	 most	 promising	 nano-radio-enhancers	 [98],	 nanostructures	 composed	 of	 other	 heavy	 elements	 such	 as	 hafnium	(NBTXR3)	 [58]	 and	 gadolinium	 (AGuIX)	 [99]	 (developed	 respectively	 by	 the	 companies	Nanobiotix,	Paris,	France	and	NH-TherAguix,	Lyon-Grenoble,	France)	are	currently	tested	in	clinic.																																										 																					[58]	Butterworth	K	T	et	al.	(2016)	Nanomedicine	11	2035–47	[62]	Porcel	E	et	al.	(2014)	Nanomedicine	10	1601–8		[88]	Wang	X	and	Guo	Z	(2013)	Chem.	Soc.	Rev.	42	202–24	[89]	Porcel	E	et	al.	(2011)	J.	Phys.	Conf.	Ser.	261	012004	[90]	McMahon	S	J	et	al.	(2011)	J.	Phys.	Chem.	C	115	20160–7	[91]	Porcel	E	et	al.	(2010)	Nanotechnology	21	85103	[92]	Wyer	J	et	al.	(2009)	Phys.	Med.	Biol.	54	4705–21	[93]	Schlatholter	T	et	al.	(2016)	Int.	J.	Nanomedicine	11	1549	[94]	Sicard-Roselli	C	et	al.	(2014)	Small	10	3338–46	[95]	Jain	S	et	al.	(2011)	Int.	J.	Radiat.	Oncol.	Biol.	Phys.	79	531–9	[96]	Hainfeld	J	F	et	al.	(2004)	Phys.	Med.	Biol.	49	N309–15	[97]	Hainfeld	J	F	et	al.	(2008)	J	Pharm	Pharmacol	4	977–85	[98]	Her	S	et	al.	(2015)	Adv.	Drug	Deliv.	Rev.	[99]	Verry	C	et	al.	(2016)	Nanomedicine	11	2405–17	
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The	main	metal-core	NP	used	in	radio-enhancement	is	Au-core	NP,	which	notable	features	include	 their	 unique	physical,	 chemical	 and	optical	 properties	 (SPR).	 Extensive	 research	work	 has	 been	 conducted	 in	 vitro	 [95]	 and	 in	 vivo	 [58]	 [see	 Review	 article	 98].	 For	instance,	 the	 radio-enhancement	 of	 PEGylated	 gold	 nanoparticles	 under	 gamma	irradiation	was	found	size-dependent	 in	vitro	and	 in	vivo.	In	vitro	experiments	(HeLa	cell	model)	 showed	 that	 NPs	with	 sizes	 ranging	 from	 5	 to	 50	 nm,	 decrease	 cell	 survival	 by	necrosis	and	apoptosis.	In	vivo	tests	demonstrated	that	these	NPs	sizes	decrease	the	tumor	volume	and	weight	with	size-dependent	liver	accumulation	[100].		
In	 clinic,	 the	 big	 challenge	 is	 the	 effective	 treatment	 of	 brain	 tumors.	 Current	 treatment	approaches	are	limited	in	large	part	by	the	cumulative	dose	(conventional	radiotherapy	in	sensitive	organs)	and	the	blood-brain	barrier	(BBB)	that	blocks	the	delivery	of	anticancer	agents	 to	 the	 tumor	 tissue.	 The	 combination	 of	 PEGylated-gold	 nanoparticles	 with	radiotherapy	 has	 been	 thus	 proposed	 as	 a	 remarkable	 improved	 protocol	 against	glioblastoma	[101].	
Glioblastoma	 and	 other	 head-neck	 type	 of	 cancer	 can	 be	 more	 efficiently	 treated	 with	hadron	 beams.	 The	 next	 section	 is	 an	 overview	 of	 recent	 results	 presenting	 the	 radio-enhancement	of	metal	based	NPs	in	combination	with	fast	ions	(protons	and	carbon	ions).	
4.2 Ions	
Less	 is	 known	 about	 the	 biological	 impact	 of	 metal-core	 NPs	 combined	 with	 ions.	 The	radio-enhancement	 of	 protons	 (40	 MeV	 –	 single	 Bragg	 peak)	 by	 means	 of	 metallic	nanoparticles	 (gold	 and	 iron)	was	 firstly	 demonstrated	 by	Kim	 and	 co-workers	 in	 2010	[102].	 They	 observed	 the	 amplification	 of	 cell-killing	 and	 enhancement	 of	 tumor	regression	 in	 a	 CT26	mouse	model.	 Even	 if	 the	 enhancing	 physico-chemical	mechanism	proposed	in	this	work	was	controversial	[103]	[104],	this	work	evidenced	for	the	first	time	the	 radio-enhancement	 of	 protons	 by	 metallic	 NPs.	 As	 follow,	 the	 enhancing	 effect	 of	particularly	Au	NPs	has	been	largely	studied	in	cellular	and	animal	models	[105].		
																																								 																					[100]	Zhang	X-D	et	al.	(2012)	Biomaterials	33	6408–19	[101]	Joh	D	Y	et	al.	(2013)	PLoS	One	8	e62425	[102]	Kim	J-K	et	al.	(2010)	Nanotechnology	21	425102	[103]	Le	Sech	C	(2012)	Nanotechnology	23		[104]	Dollinger	G	(2011)	Nanotechnology	22	[105]	Terakawa	A	et	al.	(2011)	X-Ray	Spectrom.	40	198–201	
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The	 improvement	 on	 the	 effect	 of	 carbon	 ions	 has	 been	 also	 evaluated	 [106]	 [107].	 For	instance,	 Kaur	 and	 co-workers	 proved	 in	 vitro	 (HeLa)	 the	 radiation	 enhancing	 effect	 of	glucose	capped	Au	NPs	combined	with	carbon	 ions	(62	MeV).	However,	 the	effect	of	cell	uptake	 and	 cell	 line	 was	 not	 discussed.	 These	 two	 parameters,	 together	 with	 NPs	localization,	are	crucial	in	the	radio-enhancement	process.		
Nevertheless,	this	effect	is	not	exclusive	of	gold.	During	my	thesis	work,	the	group	showed	that	 the	 activation	 of	 Pt-core	 NPs	 (as	 well	 as	 for	 GBNs	 in	 theranostic)	 leads	 to	 the	amplification	 of	 the	 nanosize	 damage	 induced	 by	 fast	 protons	 (150	 MeV)	 [93].	 This	enhancing	effect	has	been	explained	as	an	electron	emission	(Auger	and	valence	electrons)	and	 ROS	 production	 amplification	 in	 the	 close	 vicinity	 of	 NPs,	 which	 reinforce	 the	nanoscopic	character	of	the	biological	perturbation	(Figure	I	-	8).		
	
Figure	I	-	8.	Schematic	of	the	amplification	effect	of	nanoparticles	at	the	nanoscopic	scale	[91].	In	summary,	the	use	of	Pt-core	NPs	for	hadron	therapy	is	an	extremely	interesting	field	of	research,	which	is	poorly	exploited.	This	work	is	the	first	to	show	the	radio-enhancement	effect	of	Pt	NPs	in	cells	irradiated	with	photons	and	medical	carbon	ions.	
																																								 																					[91]	Porcel	E	et	al.	(2010)	Nanotechnology	21	85103	[93]	Schlatholter	T	et	al.	(2016)	Int.	J.	Nanomedicine	11	1549	[106]	Kaur	H	et	al.	(2013)	Nucl.	Instruments	Methods	Phys.	Res.	Sect.	B	301	7–11	[107]	Liu	Y	et	al.	(2015)	Phys.	Medica	31	210–8	
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5 The	choice	of	gold	and	platinum	NPs	Notably,	 metallic	 NPs	 have	 been	 largely	 used	 in	 combination	 with	 radiotherapies.	 This	section	aims	to	give	an	overview	of	the	physico-chemical	and	electronic	properties	of	gold	and	 platinum,	 key	 properties	 on	 the	 biological	 impact	 and	 radiation	 enhancing	 effect	 of	NPs.	
5.1 Physico-chemical	properties,	surface	chemistry	and	applications	of	Au	and	Pt	
5.1.1 Gold	
Gold	(Au)	is	considered	as	the	first	metal	discovered	by	man	thousands	of	years	ago.	It	is	a	rare	metal	with	abundance	in	earth’s	crust	of	about	0.004	ppm	(3.1x10-7	%)	[108].	Gold	is	extremely	malleable.	 It	 is	 an	 excellent	 thermal	 and	 electrical	 conductor,	 which	 strongly	reflects	infrared	radiation.	
From	the	chemical	point	of	view,	gold	presents	exceptional	characteristics.	 It	 is	 the	most	noble	of	noble	metals	forming	a	huge	variety	of	compounds. The	nobility	of	the	gold,	as	of	other	metals,	 rest	 on	 their	 large	 number	 of	 valence	 d-electrons	 which	 are	 available	 for	bonding.	The	electron	shell	configuration	of	Au	is	shown	in	Figure	I	-	9.	
	
Figure	I	-	9.	Electron	shell	configuration	diagram	of	gold.	Gold	compounds	usually	present	oxidation	states	ranging	from	-1	to	+5.	However,	AuI	and	AuIII	dominate	gold	chemistry.	The	reactivity	of	Au	has	been	largely	investigated	[109].	For	instance,	 AuI	 (aurous	 ion)	 is	 the	 most	 common	 oxidation	 state	 within	 soft	 ligands	compounds,	 which	 are	 typically	 linear.	 For	 instance,	 most	 drugs	 based	 on	 gold	 are	 AuI																																									 																					
[108]	It’s	Elemental	-	The	Periodic	Table	of	Elements	[109]	Joost	M	(2015)	Synthesis	and	Original	Reactivity	of	Copper	and	Gold	Complexes	
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derivatives	[110].	The	gold	atom	centred	in	AuIII	complexes,	e.g.	gold	chloride	(Au2Cl6),	are	8-electrons	 (d8) square	 planar	 compound	with chemical	 bonds that	 have	 both covalent and ionic character	[109].	In	particular,	AuIII	complexes	are	largely	used	as	precursors	in	the	 synthesis	 of	 Au	 NPs.	 In	 this	 work,	 I	 used	 as	 precursor	 the	 HAuCl4	 complex	 for	 the	radiolytic	synthesis	of	Au	NPs	(see	method	in	Chapter	II	–	Section	1.2).		
Metallic	 gold	 (Au0)	 is	 an	 inert	material	 as	 it	 is	 not	 attacked	 by	 oxygen	 (corrosion).	 It	 is	unaffected	 by	 most	 acids.	 However,	 aqua	 regia,	 a	 1:3	 mixture	 of	 nitric	 acid and hydrochloric	acid,	dissolves	gold	oxidizing	the	metal	to	+3	ions.		
The	 main	 applications	 of	 gold	 are:	 coinage,	 ornaments,	 jewellery,	 electronics,	 medicine	and	 food.	 Particularly,	 due	 to	 the	 enhanced	 physical,	 chemical,	 optical,	 electronic	 and	catalytic	 properties	 of	 Au	 NPs	 [111],	 which	 depend	 on	 their	 size,	 shape	 and	 surface	chemistry,	 Au	NPs	 are	 largely	 used	 as	 biosensors,	 catalysts	 and	 as	 optical	 devises	 [112]	[113].	The	surface	chemistry	(study	of	the	chemical	reactions	at	solid–liquid	interface)	of	Au	NPs	 has	 the	 potential	 to	 increase	 or	 decrease	 the	 stability	 and	 biological	 impacts	 of	NPs.	 The	 surface	 of	 Au	 NPs	 is	 commonly	 capped	with	 amine	 or	 thiol	 functional	 groups	containing	 molecules	 or	 polymers	 such	 as	 polyallylamine	 hydrochloride	 (PAH),	cetyltrimethylammonium	 bromide	 (CTAB),	 mercaptopropionic	 acid	 (MPA)	 [114],	diethylenetriaminepentaacetic	 acid	 (DTPA)	 [11]	 and	 thiol-poly(ethylene	 glycol)	 (PEG)	[115].		
The	most	 relevant	 characteristics	 of	 gold	 for	 this	 work	 are	 summarized	 (together	 with	platinum)	in	Table	I	-	1	(next	section).	
5.1.2 Platinum	
Platinum	(Pt)	 is	a	rare	metal	discovered	 in	 the	sixteenth	century	 in	 the	Choco	district	of	Columbia	[116].	The	occurrence	of	platinum	group	metals	(Ru,	Rh,	Pd,	Os,	Ir	and	Pt)	is	less	
																																								 																					[11]	Alric	C	et	al.	(2013)	Nanoscale	5	5930–9	[110]	Frank	Shaw	III	C	(1999)	Chem.	Rev.	99	2589–600	[111]	Haruta	M	et	al.	(1987)	Chem.	Lett.	16	405–8	[112]	Louis	C	and	Pluchery	O	(2012)	Gold	Nanoparticles	for	Physics,	Chemistry	and	Biology	[113]	Granmayeh	Rad	A	et	al.	(2011)	Phys.	Procedia	22	203–8	[114]	Bozich	J	S	et	al.	(2014)	Environ.	Sci.	Nano	1	260–70	[115]	Oh	N	and	Park	J-H	(2014)	ACS	Nano	8	6232–41	[116]	McDonald	D	(1960)	History	of	Platinum	
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than	2%	by	weight	of	the	earth’s	crust	and	platinum	abundance	is	estimated	to	be	0.005	ppm	[117].	
Platinum	 electrical	 and	 thermal	 properties	 are	 internationally	 used	 as	 the	 basics	 for	calibration	and	reference	(e.g.	electrodes).	In	this	context,	the	choice	of	platinum	rests	on	its	 stability,	 inertness	 (as	 Pt0)	 and	 high	 purity.	 Pure	 platinum	 is	 a	 lustrous,	 ductile,	 and	malleable	material.	The	main	characteristics	of	platinum	considered	in	this	work,	together	with	gold,	are	summarized	at	the	end	of	the	section	in	Table	I	-	1.	
The	 applicability	 of	 platinum	 depends	 on	 it	 nobility	 (number	 of	 valence	 d-electrons),	bonding	 a	 range	 of	 simple	 substrates	 such	 as	 hydrogen,	 carbon,	 monoxide,	 olefins	 and	acetylenes	[118].	The	electron	shell	configuration	of	Pt	is	shown	in	Figure	I	-	10.	
	
Figure	I	-	10.	Electron	shell	configuration	diagram	of	platinum.	Oxygen	 easily	 attacks	 platinum,	 which	 is	 commonly	 found	 in	 the	 +2	 and	 +4	 oxidation	states.	Elemental	platinum	is	generally	unreactive.	However,	when	it	is	dissolved	in	aqua	
regia,	 it	 forms	 hexachloroplatinic	 acid	 (H2PtCl6)	 which	 is	 probably	 the	 most	 important	platinum	 compound	 (PtIV)	 as	 it	 serves	 as	 the	 precursor	 for	 many	 others.	 The	 tetra-coordinated	PtII	complexes	usually	adopt	16-electron	(d16)	square	planar	geometries	(cis	or	trans),	which	may	be	used	in	chemotherapy	[119].		
Thus,	the	applicability	of	platinum	is	based	on	its	physico-chemical	properties.	Platinum	is	principally	 used	 in	 catalysis	 to:	 i)	 oxidize	 carbon	monoxide,	 hydrogen	 and	 any	 unburnt																																									 																					
[117]	Robson	G	G	(1985)	Platinum	1985		[118]	Hartley	F	R	(1991)	Chemistry	of	the	platinum	group	metals :	recent	developments		[119]	McAuliffe	C	A	et	al.	(1991)	Chemistry	of	the	platinum	group	metals :	recent	developments		
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hydrocarbons	 (automobilist	 industry)	and	 ii)	 reduce	 the	oxides	of	nitrogen	 [120].	 In	 the	chemical	 industry,	 platinum	 is	 widely	 used	 as	 catalyst	 in	 the	 oxidation	 of	 ammonia	 to	nitric	 acid	 and	 in	 the	 selective	 hydrogenation	 and	 dehydrogenation	 (polymeric	 and	pharmaceutical	industries).	Additionally,	platinum	is	largely	used	in	electronic	devises	due	to	its	thermal	properties.	
At	 the	 nanoscale,	 Pt	 may	 be	 capped	 with	 molecules	 or	 polymers	 containing	 carboxylic	(COO-)	 and	hydroxyl	 (-OH)	 functional	 groups	 [121].	 Indeed,	 colloidal	 Pt	NPs	 are	usually	stabilized	 by	 covalent	 bonding,	 electrostatic	 interaction	 or	 chemisorption	 with	 these	functional	groups	[121]	[122].	Other	good	candidates	to	modify	the	surface	chemistry	of	Pt	NPs	 are	 thiol-containing	 polymers	 [56]	 resulting	 in	 an	 enhanced	 colloidal	 stability.	 The	summary	table	of	the	metals	is	presented	below.	
Table	I	-	1.	Summary:	characteristics	and	physical	properties	of	gold	and	platinum	[123].	
Property	 Units	 Au	 Pt	
Electronic	configuration	 -	 [Xe]	4f14	5d10	6s1	 [Xe]4f14	5d9	6s1	
Atomic	number	 -	 79	 78	
Atomic	weight	 g.mol-1	 196.97	 195.09	
Atomic	radius	 nm	 0.144	 0.139	
Ionization	potentials	–				1st	 eV	 9.2	 9.0	
2nd	 eV	 20.2	 18.56	
3rd	 eV	 30	 28	
4th	 eV	 44	 41	
Crystal	structure	 -	 FCC	 FCC	
Lattice	constant	 nm	 0.40782	 0.39242	
Fermi	energy	 eV	 5.1	 6.3	
Standard	potential	 eV	 +	1.69	(Au+	àAu0)	+1.50	(Au3+	à	Au0)	 +1.19	(Pt2+	à	Pt0)	+0.76	(Pt4+	à	Pt0)	
Electronegativity		(Pauling	scale)	 	 2.54	 2.28																																									 																					[56]	Hong	R	et	al.	(2005)	Chem.	Mater.	17	4617–21	[120]	Searles	R	A	(1988)	Platin.	Met.	Rev.	32	123–9	[121]	Schrader	I	et	al.	(2015)	J.	Phys.	Chem.	C	119	17655–61	[122]	Ono	L	K	et	al.	(2011)	J.	Phys.	Chem.	C	115	16856–66	[123]	The	Photographic	Periodic	Table	of	the	Elements	
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5.2 Optical	properties	of	NPs	
As	 already	mentioned,	materials	 at	 the	nano-scale	present	 remarkable	physico-chemical	properties	that	largely	differ	from	the	bulk.	This	is	explained	by	the	increased	number	of	the	 surface	 atoms	 when	 decreasing	 the	 size	 of	 the	 NP.	 Indeed,	 electrons	 in	 a	 small	conductive	 metallic	 NP	 flow	 freely	 due	 to	 their	 atomic	 confinement	 enhancing	 the	electronic	properties	of	the	bulk.	This	effect	is	briefly	described	in	the	next	section.	More	interestingly,	 this	 confinement	 results	 in	 the	 enhancement	 of	 the	 surface	 plasmon	resonance	(SPR)	of	metal	(see	description	Section	5.2.2).		
5.2.1 Electronic	structure:	from	the	atom	to	the	solid	
In solid-state	 physics,	 the band	 theory	 describes	 the	 electron	 band	 structure	 of	 bulk	materials.	 Electrons	 in	 an	 atom	 occupy	 discrete	 energy	 levels	 (see	 for	 an	 example	 the	electron	 shell	 configuration	 diagram	 of	 gold	 and	 platinum	 in	 Section	 5.1).	When	 these	atoms	 are	 spaced	 close	 together,	 a	 large	 number	 of	 energy	 levels	 overlap	 resulting	 in	energy	 bands;	 the	 so	 called	 valence	 and	 conduction	 band.	 A	 nanoparticle	 is	 in	 an	intermediate	state	with	an	electron	band	structure	between	the	atom	and	the	bulk.		
Figure	I	-	11.	shows,	for	gold,	the	evolution	of	its	electronic	structure	from	the	atom	to	the	solid.	
	
Figure	I	-	11.	Electronic	structures	of	a	gold	atom,	nanoparticle	and	solid	(adapted	from	[124]).	
																																								 																					[124]	Louis	C	and	Pluchery	O	(2012)	Gold	nanoparticles	for	physics,	chemistry	and	biology	
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In	the	particular	case	of	gold,	 from	the	atom	to	the	solid,	 the	6s	and	6p	bands	hybridize.	The	 5d	 band,	 the	 highest	 fully	 occupied,	 is	 named	 valence	 band	 and	 the	 6sp,	 the	 lowest	vacant,	 is	 named	 conduction	 band.	 The	 Fermi	 level	 (EF	 in	Figure	 I	 -	 12)	 represents	 the	highest	occupied	energy	level	in	the	conduction	band.	The	inter-band	transitions	from	the	
d	core	electrons	in	the	valence	band	to	electronic	levels	in	the	conduction	band,	localized	on	top	of	the	Fermi	level	(vacuum,	white	bands	in	Figure	I	-	12),	take	place	from	an	energy	threshold	 low	 enough	 to	 be	 reached	with	 photons	 from	 the	 visible	 or	 near	 UV	 spectral	region	(see	Fermi	energy	of	gold	and	platinum	in	Table	I	-	1).	 
 
Figure	I	-	12.	Scheme	of	the	transition	from	discrete	energy	levels	of	atoms	to	electronic	band	structures	(adapted	from	[124]).	Thus,	 the	 atomic	 confinement	 leads	 to	 an	 amplification	 of	 the	 absorption	 and	 the	appearance	of	the	plasmon,	which	is	observed	by	absorption	spectroscopy.	
5.2.2 The	plasmon	effect	of	metallic	NPs	
When	 a	 metallic	 nanoparticle	 is	 much	 smaller	 than	 the	 wavelength	 of	 light,	 coherent	oscillation	 of	 the	 conduction	 band	 electrons	 are	 induced	 by	 interaction	 with	 the	electromagnetic	field,	this	resonance	is	called	Surface	Plasmon	Resonance	(SPR)	[63].	
	
	
	[63]	Eustis	S	and	El-Sayed	M	A	(2006)	Chem.	Soc.	Rev.	35	209–17	[124]	Louis	C	and	Pluchery	O	(2012)	Gold	nanoparticles	for	physics,	chemistry	and	biology	
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Figure	I	-	13.	Schematic	Surface	Plasmon	Resonance	(adapted	from	[125]).	Plasmons	 are	 described	 as	 the	 oscillations	 of	 free	 electrons	 as	 consequence	 of	 the	induction	 of	 a	 dipole	 moment	 in	 the	 material	 due	 to	 electromagnetic	 waves.	 These	electrons	 migrate	 in	 the	 nanomaterial	 to	 restore	 its	 initial	 state.	 However,	 as	 the	 light	waves	oscillate,	it	leads	to	a	constant	shift	in	the	dipole	forcing	the	electrons	to	move	at	the	same	frequency	as	the	light	(see	illustration	in	Figure	I	-	13).	
This	 unique	 property	 of	 metallic	 nanoparticles	 made	 them	 the	 focus	 of	 several	interdisciplinary	researches,	with	applications	including	solar	cells,	catalysis,	spectroscopy	and	signal	enhancement	for	imaging	and	cancer	treatment.	
5.3 Impact	in	biological	systems:	metal	compounds	and	NPs	
Metal	 compounds	have	been	used	 in	medicine	 since	 the	 early	19th	 and	20th	 centuries	 to	treat	 a	wide	variety	of	diseases	 [126]	 [110].	 Since	1987,	 cisplatin	 (cis-Pt	 (PtII)),	 the	 first	platinum	 containing	 anti-cancer	 drug	 approved	 by	 the	 Food	 and	 Drug	 Administration	[127],	 has	 been	worldwide	 used	 in	 the	 treatment	 of	 various	 types	 of	 cancers.	 Since	 the	discovery	of	cis-Pt,	other	platinum	based	drugs	have	been	development	for	the	treatment	of	endocrine-related	cancers	 [128].	Moreover,	by	1989,	gold	(I)	and	gold	(III)	containing	molecules	 [110]	 were	 shown	 to	 have	 anti-cancer	 properties,	 results	 that	 inspired	 the	future	 application	of	metal	 compounds	 against	 cancer.	However,	 the	main	 limitations	 to	conventional	 cancer	 therapy	 in	 the	 chemo-modality	 include;	 harsh	 side	 effects,	 drug	resistance	and	lack	of	solubility	and	selectivity.	Cancer	nanomedicine	has	the	potential	to																																									 																					[110]	Frank	Shaw	III	C	(1999)	Chem.	Rev.	99	2589–600	[125]	Juan	M	L	et	al.	(2011)	Nat.	Photonics	5	349–56	[126]	Felson	D	T	et	al.	(1990)	Arthritis	Rheum.	33	1449–61	[127]	Centre	for	Drug	Evaluation	and	Research	(1978)	FDA	Oncol.	Tools	[128]	Apps	M	G	et	al.	(2015)	Endocr.	Relat.	Cancer	22	R219–33	
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overcome	 these	 limitations	 by	 the	 use	 of	 nanostructured	 drug	 delivery	 systems	 [see	Review	article	88]	and	therapeutic	agents	[see	Review	article	129]	for	a	targeted	and	more	efficient	 medicine.	 In	 particular,	 by	 combining	 drugs	 or	 nano-agents	 containing	 heavy	atoms	with	radiation,	a	significant	treatment	enhancement	might	be	achieved	[see	Review	articles	130	and	86].	
Bulk	Au0	is	non-toxic	and	non-irritating	when	ingested,	therefore	it	is	sometimes	used	as	a	food	decoration,	e.g.	in	alcoholic	drinks.	At	the	same	time,	Au	NPs	are	considered	the	less	toxic	 metallic	 nanoparticles	 in	 biomedical	 concerns	 [131].	 As	 already	 discussed	 the	toxicity	of	metallic	NPs	depends	on	their	surface	functionalization	[132]	[133].	Due	to	the	catalytic	 activity	 of	 platinum	 and	 its	 use	 in	 chemotherapy,	 the	 toxicity	 evaluation	 of	 Pt-core	 NPs	 has	 been	 a	 current	 object	 of	 research	 [134]	 [135]	 [136]	 [137],	 toxicity	 that	mainly	leads	to	DNA	damage.	
6 Interaction	of	ionizing	radiation	with	NPs	Ionizing	radiations	are	electromagnetic	waves,	ions	or	electrons	that	are	energetic	enough	to	remove	electrons	from	atoms	or	molecules.	
In	 this	work,	γ-rays	 and	 carbon	 ions	were	used.	γ-rays	 from	 60Co	 and	 137Cs	 sources	 (see	description	 in	 Chapter	 II	 –	 Section	 3.1)	 were	 used	 to	 synthesize	 metallic	 NPs	 and	 to	irradiate	 both,	 the	 bio-nanoprobe	 (a	 plasmid	 DNA	 based	 molecular	 probe)	 and	 cells.	Carbon	 ions	 from	 the	 medical	 accelerator	 (HIMAC-Chiba,	 Japan)	 (see	 description	 in	
Chapter	 II	 –	 Section	 3.3)	 were	 used	 in	 the	 irradiation	 of	 cells	 (HeLa).	 The	 interaction	processes	 of	 ionizing	 photons,	 ions	 and	 electrons	 with	 condensed	 matter	 (NPs	 and	biological	matter)	are	described	in	this	section.	
																																								 																					[86]	Retif	P	et	al.	(2015)	Theranostics	5	1030–44	[88]	Wang	X	and	Guo	Z	(2013)	Chem.	Soc.	Rev.	42	202–24	[129]	Bhattacharyya	S,	et	al.	(2011)	Pharm.	Res.	28	237–59	[130]	Kwatra	D	et	al.	(2013)	Transl.	Cancer	Res.	2	330–42	[131]	Alkilany	A	M	and	Murphy	C	J	(2010)	J.	Nanopart.	Res.	12	2313–33	[132]	Książyk	M	et	al.	(2015)	Bull.	Environ.	Contam.	Toxicol.	94	554–8	[133]	Asharani	P	V	et	al.	(2011)	Nanotoxicology	5	43–54	[134]	Asharani	P	V	et	al.	(2010)	Nanomedicine	(Lond)	5	51–64		[135]	Pelka	J	et	al.	(2009)	Chem	Res	Toxicol	22	649–59	[136]	Elder	A	et	al.	(2007)	Adv.	Mater.	19	3124–9	[137]	Mironava	T	et	al.	(2013)	Toxicol.	In	Vitro	27	882–9	
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6.1 Activation	processes	by	incident	photons,	ions	and	electrons	
6.1.1 Activation	by	incident	photons	
Photons	 are	 elementary	 particles	 with	 zero	 mass	 and	 zero	 charge.	 Depending	 on	 its	energy,	 the	 photon	 can	 interact	 with	 matter	 through	 different	 physical	 processes	 to	activate	 NPs	 and	 induce	 biological	 damage.	 This	 interaction	 leads	 to	 a	 partial	 or	 total	transfer	of	the	photon	energy	to	an	electron.		
Ionizing	 photons	 interact	with	matter	 by	 three	 different	 processes:	 photoelectric	 effect,	Compton	effect	and	electron-positron	pair	production.	
• The	photoelectric	process,	 illustrated	in	Figure	I	-	14,	 takes	place	in	the	range	of	102<E0<106	eV	(see	Figure	I	-	17	for	targets	such	as	H,	C,	N	and	O).		
	
Figure	I	-	14.	Photoelectric	effect.	A	 photon	 is	 completely	 absorbed	 by	 an	 atom	 and	 an	 energetic	 photoelectron	 is	 ejected	from	one	of	the	bound	shells	of	the	atom	(mostly	ionization	of	inner	shell	electrons)	[138].	This	 process	 leads	 to	 the	 production	 of	 positive	 ionic	 species	 in	 the	 target.	 The	photoelectron	is	ejected	with	a	kinetic	energy:	
E! = hν! − E!	 	 	 	 	 	 	 	 	 Equation	I	-	11	The	photoelectric	cross-section,	the	probability	that	this	interaction	occurs,	increases	with	the	mass	 of	 the	 targeted	 atom	 and	 decrease	 with	 the	 energy	 of	 the	 incident	 photon	 as	follows:	
																																								 																					[138]	Blanc	D	and	Portal	G	(1999)	Précis	de	physique	nucléaire		
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! = !"# !!!!!! 	 	 	 	 	 	 	 	 	 Equation	I	-	12	
• The	Compton	effect,	illustrated	in	Figure	I	-	15,	is	characterized	by	the	interaction	of	 the	 incident	 photon	with	 an	 outer	 shell	 electron.	 This	 process	 is	 dominant	 in	 the	range	of	105	<	E0	<	107	eV	(see	Figure	I	-	17	for	targets	such	as	H,	C,	N,	O,	Pt	and	Au).	
	
Figure	I	-	15.	Compton	effect.	The	incoming	photon	with	energy	hν0	is	scattered	at	the	angle	θ	(the	scattering	angle).	The	energy	 loss	 resulting	 from	 this	 interaction	 is	 transferred	 to	an	outer	 shell	 electron	 (also	called	recoiled	electron),	which	 is	ejected	from	the	atom.	The	energy	hν’	of	 the	scattered	photon	is	given	by	the	following	relation	[139]:	
ℎ!! = !!!!!!(!!!"#$)	 	 	 	 	 	 	 	 Equation	I	-	13	where	! = !!!!!!!		and	!!	is	the	rest	mass	of	the	electron.	The	cross-section	of	the	Compton	effect	only	depends	on	the	energy	of	the	incident	photon	as	shown	in	the	Klein	and	Nishina	following	expression	[140][139]:		
!!" = 2!!!! !!!!! !(!!!)!!!! − !" (!!!!)! + !" (!!!!) !! − !!!!(!!!!)! 		 	 	 Equation	I	-	14	
where	!! 	is	the	classical	electron	radius	given	by	!! = !!!!!! = 2.819×10!!" m.	
																																								 																					
[139]	Mayles,	P	et	al.	(2007)	Handbook	of	radiotherapy	physics.	Theory	and	practice		[140]	Klein	O	and	Nishina	Y	(1929)	Z.	Phys.	52	853–68	
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For	ℎ!!	>	 0.5	MeV,	 the	 cross-section	 of	 the	Compton	 effect	 is	 inversely	 proportional	 to	ℎ!!	 and	 slightly	 varies	with	 the	mass	 of	 the	 traversed	material.	Notably,	 this	 process	 is	dominant	for	photons	used	in	conventional	radiotherapy	[141].	
• The	electron-positron	pair	production,	 illustrated	 in	Figure	 I	 -	16,	 takes	place	at	energies	higher	than	1.02x106	eV.		
	
Figure	I	-	16.	Electron-positron	pair	production.	In	 this	 mechanism	 the	 incoming	 photon	 is	 absorbed	 by	 the	 electric	 field	 of	 the	 atomic	nucleus,	which	causes	the	creation	of	an	electron	(negatron)-positron	pair	emitted	as	the	sum	of	their	kinetic	energies	(T-	+	T+)	by:	
T! + T! = ℎ!! − 2!!!!	 	 	 	 	 	 	 	 Equation	I	-	15	The	 two	 ejected	 particles	 (e-	 and	 e+)	 share	 the	 kinetic	 energy	 available	 and	 slow	 down	through	 successive	 collisions	 with	 the	 surrounding	 medium.	 Once	 the	 positron	 is	thermalized,	 it	 interacts	with	a	 low-energy	electron	 from	 the	 surrounding	medium.	This	reaction	 is	known	as	annihilation.	Momentum	and	energy	are	conserved	 in	 this	process:	two	photons	of	0.511	MeV	are	emitted	at	180°	from	each	other.	
The	cross	section	of	the	electron-positron	pair	production	is	proportional	to	the	square	of	the	atomic	number	of	the	target	and	becomes	important	at	energies	higher	than	4!!!!.		
																																								 																					
[141]	Gazda	M	J	and	Coia	L	R	(2005)	Principles	of	radiation	therapy	Cancer	Management:	a	multidisciplinary	
approach		
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In	summary,	Figure	I	-	17	illustrates	the	relevance	of	the	three	interactions	as	function	of	the	 photon	 energy	 (in	 MeV)	 and	 atomic	 number	 of	 the	 target.	 Three	 regions	 can	 be	distinguished:	
• At	 low	energy,	 up	 to	0.1	MeV,	we	observe	 that	 the	photoelectric	 effect	 dominates.	This	effect	vanishes	when	the	incident	photons	have	energies	higher	than	0.7	MeV.	Notably,	 the	 photoelectric	 effect	 is	 more	 important	 in	 the	 presence	 of	 high-Z	containing	 compounds	 such	 as	 gold	 and	platinum	 (red	 and	 green	horizontal	 lines,	
Figure	 I	 -	17)	 than	 in	biological	 systems,	which	mainly	 contain	 carbon,	hydrogen,	oxygen	and	nitrogen	atoms	(blue	lines,	Figure	I	-	17).		
• In	the	middle	energy	region,	between	0.1	and	10	MeV,	we	observe	that	the	Compton	effect	 dominates.	 This	 effect	 characterizes	 the	 interaction	 of	 γ-rays.	 For	 instance,	60Co	γ-rays	produce	e-	of	0.6	MeV	in	average,	which	are	energetic	enough	to	induce	further	 matter	 ionizations.	 The	 Compton	 process	 is	 nearly	 independent	 of	 the	atomic	 number	 of	 the	 target	 (see	 !!" = 2!!!! !!!!! !(!!!)!!!! − !" (!!!!)! + !" (!!!!) !! −!!!!(!!!!)! 		 	 	 Equation	I	-	14).		
• In	 the	 high	 energy	 region,	 higher	 than	 7	 MeV,	 the	 pair	 production	 becomes	important	and	is	dominant	for	energies	above	10	MeV.	It	strongly	depends	on	the	atomic	number	of	the	target.	
	
Figure	I	-	17.	Processes	involved	in	the	interaction	of	photons	with	matter	as	function	of	the	incident	energy	and	atomic	number	of	the	target.	
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In	conclusion,	the	photoelectric	and	Compton	effect	are	the	two	main	processes	involve	at	the	energy	used	to	produce	nanoparticles	or	to	irradiate	bio-systems	(see	vertical	dotted	lines	in	Figure	I	-	17).	
6.1.2 Activation	by	incident	ions	
Fast	 ions	 mainly	 interact	 with	 the	 electrons	 of	 the	 targeted	 material	 (outer	 orbital	electrons)	 through	 coulomb	 interaction.	 This	 interaction	 occurs	 at	 certain	 distance	between	 the	 incident	 particle	 and	 the	 target	 electron,	 which	 is	 known	 as	 the	 impact	parameter.	In	this	process,	illustrated	in	Figure	I	-	18,	the	incident	ion	transfers	energy	to	the	target	to	ionize	and	excite	the	atoms	of	the	medium	with	a	small	deflection	depending	on	the	ion	mass	(momentum	transfer).	
	
Figure	I	-	18.	Schematic	representation	of	the	energy	loss	by	a	charged	particle	interacting	with	the	target	electrons	at	a	distance	defined	as	the	impact	parameter.	The	energy	transfer	depends	on	the	charge	and	velocity	of	the	projectile,	independently	of	its	mass.	Indeed,	the	inelastic	collision	with	bound	atomic	electrons	is	the	major	process	of	energy	loss	at	energies	of	interest	in	hadrontherapy.	
Using	 non-relativistic	 collision	 theory,	 the	 second	 law	 of	 Newton	 and	 the	 Coulomb	 law	describing	the	force	between	charged	particles,	the	energy	transfer	Q	is	given	by	[139]:	
! = !!!!!!!!!!!! 	 	 	 	 	 	 	 	 	 Equation	I	-	16		
[139]	Mayles,	P	et	al.	(2007)	Handbook	of	radiotherapy	physics.	Theory	and	practice	
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where	 b	 is	 the,	 impact	 parameter;	m	 is	 the	mass	 of	 the	 electron;	 z	 is	 the	 charge	 of	 the	primary	 particle	 (in	 units	 of	 the	 electronic	 charge	 e);	 v	 is	 the	 velocity	 of	 the	 primary	particle;	and	the	constant	k=	8.9875x109	Nm2	C-2.	
The	maximum	energy	transfer	Qmax	 from	an	ion	with	mass	M	and	kinetic	energy	T,	 to	an	electron	with	mass	m	(in	rest)	at	b=	0	can	be	calculated	by:	
!!"# = 4! !"!!! !		 	 	 	 	 	 	 	 Equation	I	-	17	For	instance,	the	interaction	of	carbon	ions	C6+	with	M=	12	u.m.a.	and	a	kinetic	energy	of	290	 MeV/u.m.a.	 (T=	 12	 x	 290	 =	 3480	 MeV)	 might	 produce	 the	 emission	 of	 secondary	electrons	along	 the	path	 (m=	5.5	10-4	u.m.a.)	with	kinetic	 energies	 ranging	 from	0	up	 to	Qmax	~600	keV,	electrons	 that	are	energetic	enough	to	excite	and	 ionize	 the	surrounding	medium	and	produce	damage	to	biomolecules.	
After	 inelastic	 collisions	 with	 electrons,	 incident	 particles	 slow	 down	 reaching	 energies	below	100	keV	(end	of	the	track)	allowing	the	interaction	with	the	nucleus	of	the	targeted	atoms.	The	 inelastic	 interactions	with	 the	nucleus	result	 in	 the	deflection	of	 the	 incident	particle	associated	with	a	nuclear	reaction	or	bremsstrahlung,	which	energy	deposition	is	negligible	in	clinical	applications.		
When	a	particle	 is	 almost	 at	 the	end	of	 its	 track,	 its	 capacity	 to	 ionize	 increases	 rapidly,	giving	rise	to	the	Bragg	peak	(described	in	Section	3.2).	The	particle	does	not	deposit	any	further	energy	beyond	this	point	and	thus	the	dose	is	practically	zero	after	the	tumor.		
In	 conclusion,	 the	 energy	 loss	 of	 ions	 traversing	 a	medium	 (e.g.	 tissue)	 is	mainly	due	 to	interactions	 with	 electrons.	 Indeed,	 along	 the	 path	 of	 the	 incident	 ion,	 the	 electronic	energy	loss	is	three	orders	of	magnitude	higher	than	the	loss	of	nuclear	energy.	Thus,	NPs	can	be	activated	by	the	secondary	electrons	emitted	on	an	ion	path.	
6.1.3 Activation	by	incident	electrons	
The	 Coulomb	 interaction	 of	 secondary	 electrons	 with	 the	 electrons	 of	 the	 medium	 can	produce	elastic	or	inelastic	scattering.		
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a)	 b)	
Figure	I	-	19.	Interaction	of	secondary	electrons	by	elastic	and	inelastic	scattering.	By	elastic	scattering	(Figure	I	-	19a),	secondary	electrons	conserve	their	energy	(E0)	but	are	strongly	deviated.	The	probability	of	this	process	increases	with	the	atomic	number	of	the	target	(Z)	and	decrease	with	E0.	Hence,	this	process	is	more	important	for	low	energy	electrons,	which	only	reach	a	few	hundreds	of	eV.	
By	inelastic	scattering	(Figure	I	-	19b),	secondary	electrons	transfer	partially	their	kinetic	energy	to	electrons	in	the	medium.	The	cross-section	of	inelastic	scattering	is	proportional	to	Z/E02.	Hence,	 this	process	 ionizes	 the	medium	 through	 the	 scattering	of	 the	 incoming	secondary	 electron	 and	 an	 electron	 emission,	 which	 leads	 to	 the	 creation	 of	 atomic	vacancies	in	the	target.	
Other	interaction	processes	such	as	the	Bremsstrahlung	effect	(radiative	pathway)	and	the	dissociative	electron	attachment	 [142]	are	negligible	 in	 the	activation	of	NPs.	Due	 to	 the	atomic	 confinement	 in	NPs,	 the	 activation	 via	 plasmon	 excitation/relaxation	 is	 of	major	interest	in	this	work.	This	effect	is	described	below.		
6.2 Plasmon	excitation/relaxation	
Ionizing	radiations	as	photons,	 ions	and	electrons	may	interact	with	a	solid	to	excite	and	ionize	the	surrounding	medium.		
																																								 																					
[142]	 Porcel	 E	 (2011)	 Utilisation	 des	 nanoparticules	 pour	 améliorer	 les	 performances	 de	 la	 hadronthérapie	Thèse	de	doctorat	
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In	particular,	metallic	solids	such	as	NPs	are	commonly	considered,	independently	of	their	atomic	 structure,	 as	 a	 plasma	 of	 free	 electrons	 (previously	 described	 in	 Section	 5.2.2).	The	 interaction	 of	 ionizing	 radiation	 with	 free	 electrons	 leads	 to	 a	 collective	 electronic	excitation,	 i.e.	 the	excitation	of	 the	surface	plasmon	of	 the	metal	 (Figure	I	 -	20).	The	de-excitation	of	 the	plasmon	may	 induce	the	emission	of	a	photon	(radiative	process)	or	an	electron	(non-radiative	process).		
	
Figure	I	-	20.	Collective	electronic	excitation	of	the	plasmon	in	a	metallic	nanoparticle.	This	 process	 has	 been	 proposed	 as	 the	 major	 excitation/relaxation	 mechanism	 when	metallic	nanoparticles	are	activated	by	incident	radiation	[143].	
6.3 Relaxation	processes	
After	 ionization	the	 target	 is	 left	 in	a	highly	excited	state	(positive	charge).	 In	particular,	when	inner	shells	are	ionized,	the	electrons	reorganize	in	order	for	the	system	to	get	back	to	 its	 fundamental	 state.	 The	 excess	 energy	 associated	 with	 this	 phenomenon	 can	 be	released	 through	 two	 possible	 processes:	 fluorescence	 (radiative	 process)	 or	 Auger	 de-excitation	(non-radiative	process).	These	two	mechanisms	are	described	below.	
6.3.1 Fluorescence		
When	a	vacancy	is	formed	in	the	K-shell	of	the	target	atom,	electronic	de-excitation	takes	place	and	the	excess	energy	is	released	through	X-ray	emission	(radiative	process).	In	this	process,	illustrated	in	Figure	I	-	21,	the	energy	of	the	emitted	X-ray	photon	is	given	by:	
E = ℎν = E! − E!"	 	 	 	 	 	 	 	 Equation	I	-	18																																									 																					[143]	Verkhovtsev	A	V	et	al.	(2015)	J.	Phys.	Chem.	C	119	11000–13	
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Figure	I	-	21.	Electronic	relaxation	via	fluorescence.	
6.3.2 Auger	electron	emission	
The	Auger	process	was	observed	in	1922	by	Lise	Meitner	and	described	in	1923	by	Pierre	Victor	 Auger	 [144].	 Auger	 effects	 can	 take	 place	 when	 inner	 shells	 are	 ionized.	 The	interactions	of	secondary	electrons	with	 the	 target	may	also	 ionize	 inner-shell	electrons.	The	ionization	of	an	inner	shell	is	thus	followed	by	Auger	de-excitation	and	the	emission	of	Auger	 electrons.	 This	 process	 is	 illustrated	 in	 Figure	 I	 -	 22	 in	 the	 case	 of	 a	 K	 L1	 L2,3	transition.		
	
Figure	I	-	22.	Scheme	of	left:	ionization,	middle:	electron	emission,	right:	Auger	de-excitation.	The	Auger	electron	is	emitted	with	a	kinetic	energy	(Ek):	
E! =  E! − E! − E!	 	 	 	 	 	 	 	 Equation	I	-	19	
																																								 																					[144]	Hardouin	Duparc	O	(2009)	Int.	J.	Mater.	Res.	100	1162–6	
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with	E1:	energy	of	 the	 incident	photon	(or	secondary	electron),	E2:	binding	energy	of	 the	photoelectron	 (emitted	 from	 the	 K-shell	 orbital)	 and	 E3:	 binding	 energy	 of	 the	 Auger	electron.	
The	 Auger	 de-excitation	 process	 continues	 till	 the	 complete	 rearranging	 of	 the	 electron	cloud	 is	 achieved	 (Auger	 cascade).	 This	 process	 leads	 to	 an	 amplified	 electron	 emission	and	to	the	production	of	a	positively	charged	atom	and	thus	positively	charged	NP.	
6.3.3 Radiative	versus	non	radiative	de-exciation	
The	 radiative	 and	 non-radiative	 de-excitation	 processes	 described	 above	 are	 in	competition.	The	total	transition	rate	 is	a	sum	of	both	processes.	The	Auger	yield	(ωA)	 is	related	to	the	fluorescence	(X-ray)	yield	(ωX)	by	the	following	relation	[145]:	
ω! = 1 − ω! = 1 − !!!!!!!		 	 	 	 	 	 	 Equation	I	-	20	where	WX	is	the	X-ray	transition	probability	and	WA	is	the	Auger	transition	probability.	
In	the	case	of	K-shell	vacancies,	the	fluorescence	yield	increases	with	the	atomic	number	of	the	target	(Figure	I	-	23).	The	Auger	effect	is	dominant	for	light	elements	such	as	C,	N,	O	and	P,	the	main	constituents	of	biological	systems.		
	
Figure	I	-	23.	Fluorescence	and	Auger	electron	yields	as	a	function	of	the	atomic	number	for	K	shell	vacancies.	(https://en.wikipedia.org/wiki/Auger_electron_spectroscopy#/media/File:Auger_xray_wiki_in_png_format.png)																																									 																					[145]	Feldman	L	C	and	Mayer	J	W	(1986)	Fundamentals	of	surface	and	thin	film	analysis	
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For	heavy	elements,	the	Auger	relaxation	becomes	dominant	when	L	shell	 is	 ionized.	For	instance,	 in	 the	 case	 of	 Pt,	 following	 ionization	 of	 the	 K-shell,	 the	 atoms	 are	 relaxed	 in	about	only	4%	by	Auger	emission.	However,	after	ionization	of	the	L-shell,	platinum	atoms	relax	in	about	97%	by	the	Auger	de-excitation	process	[145].	
6.4 Electron	capture	by	positively	charged	sites		
After	relaxation	processes	by	Auger	cascades,	atoms	(or	clustered	atoms	as	nanoparticles)	are	left	positively	charged.	For	instance,	when	platinum	is	ionized	in	L-shell,	the	atoms	de-excite	with	 the	 emission	 of	 10	Auger	 electrons.	 The	 platinum	 atom	 is	 thus	 left	with	 ten	positive	 charges.	 The	 atom	 neutralizes	 via	 capture	 of	 electrons	 from	 surrounding	molecules	(water),	as	shown	in	Figure	I	-	24.	
	
Figure	I	-	24.	Positively	charged	atom	neutralizes	via	capture	of	electrons	from	surrounding	water	molecules.		!! +M!! → M !!! !…  !! +M! → M!	 	 	 	 	 Equation	I	-	21	
M=	Pt,	Au,	Gd	etc	
This	process	was	never	mentioned	before	 in	 the	 field	of	 the	radiobiology.	 In	 the	present	work,	 electron	 capture	may	 take	 place	 between	 radiation	 induced	 activation	 of	metallic	nanoparticles	 and	 surrounding	 water	 molecules.	 This	 phenomenon	 has	 been	 recently	described	by	Stumpf	and	co-workers	in	the	case	of	semiconductors	[146]		
																																								 																					[146]	Stumpf	H	(1971)	Phys.	der	Kondens.	Mater.	13	101–17	
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7 Objectives	of	this	work	The	 aim	 of	 my	 work	 is	 the	 development	 of	 small	 Pt	 based	 nanoparticles,	 stable,	biocompatible	 and	with	 properties	 of	 enhancing	 the	 effects	 of	 ionizing	 radiation	 (nano-radio-enhancement	commonly	called	radiosensitization)	by	an	optimized	radiolytic	route.	This	aims,	as	represented	in	Figure	I	-	25,	as	an	end	point	at	improving	the	performances	of	hadrontherapy.		
	
Figure	I	-	25.	Platinum	based	nanoparticles	for	radio-enhancement:	perspective	of	improving	hadrontherapy.	
The	research	objectives	of	this	study	are	listed	below:	
• Improved	synthesis	of	platinum	based	nanoparticles	(small,	stable	and	biocompatible).	
• Physico-chemical	characterization	of	Pt	NPs	(size,	shape,	composition	and	stability).	
• Evaluation	of	Pt	NPs	biological	impact	(toxicity,	uptake	and	localization).	
• Characterization	 of	 the	 radio-enhancing	 properties	 of	 NPs	 under	 γ-rays	 and	medical	carbon	ions.	
• Understanding	of	molecular	scale	mechanisms.	
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CHAPTER	II:	MATERIALS	AND	METHODS	All	the	experimental	protocols	and	analytical	methods	used	in	this	work	are	described	in	this	chapter.		
In	 Section	 1,	 the	 method	 and	 experimental	 conditions	 used	 to	 synthesize	 PEGylated	metallic	nanoparticles	are	presented.		
In	Section	2,	the	characterization	techniques	and	samples	preparation	protocols	used	to	determine	the	physico-chemical	features	of	nanoparticles	are	described.	
In	 Section	 3	we	 present	 and	 describe	 the	 radiation	 sources	 used	 in	 this	 work	 for	 the	synthesis	of	nanoparticles	and	to	irradiate	biological	samples.		
Finally,	 in	Section	4	we	 show	 the	biological	models,	 from	cells	 to	biomolecules,	 used	 to	evaluate	the	in	vitro	impact	of	nanoparticles.	
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1. Synthesis	of	platinum	based	nanoparticles	
In	 this	 section,	 the	 experimental	 conditions	 used	 to	 prepare	 mono-	 and	 bimetallic	platinum	 based	 nanoparticles	 are	 presented.	 I	 optimized	 a	 radiolytic	 method	 to	 obtain	soluble,	biocompatible	and	non-toxic	Pt	NPs	using	only	US	Food	and	Drug	Administration	(FDA)	approved	polymers.	Radiolysis	 is	a	well-known	reproducible	and	clean	method	 to	obtain	dispersed	and	homogenous	metallic	NPs	[1]	[2]	[3].	The	optimization	of	the	method	was	 carried	 out	 in	 collaboration	 with	 Dr.	 Hynd	 Remita	 at	 the	 Laboratoire	 de	 Chimie	Physique	(Université	Paris-Saclay,	UMR8000	CNRS).	
1.1 Monometallic	PEGylated	platinum	nanoparticles		
The	 first	 platinum	nanoparticles	 produced	by	 radiolysis	with	biomedical	 purposes	were	developed	in	the	thesis	of	Dr.	Erika	Porcel	under	the	direction	of	Prof.	Sandrine	Lacombe	and	 in	 collaboration	 with	 Dr.	 Hynd	 Remita	 [4].	 These	 nanoparticles	 consisted	 on	 3	 nm	platinum	 core	 particles	 stabilized	 with	 poly	 (acrylic	 acid)	 (Pt-PAA	 NPs)	 [5].	 They	 were	toxic	 for	 cells	 at	 low	 concentrations	 (<1.2x109	 Pt-PAA	NPs	 for	 CHO	 cells),	which	 limited	their	use	for	radiotherapy	concerns.	Hence,	the	aim	of	my	work	was	to	improve	the	Pt	NPs	formulation	to	decrease	their	cytotoxicity	and	to	open	perspectives	of	tumor	targeting.		
In	order	to	decrease	the	cytotoxicity	of	Pt-core	NPs	several	biocompatible,	biodegradable	and	water-soluble	polymers	were	proposed	 [6]	 and	 tested.	Table	 II	 -	1	summarizes	 the	polymers	used	in	this	work.	
	
	
	
	
	
																																																																											[1]	Belloni	J	et	al.	(1998)	New	J.	Chem.	22	1239–55	[2]	Henglein	A	(1989)	Chem.	Rev.	89	1861–73	[3]	Remita	H	and	Remita	S	(2010)	Recent	Trends	in	Radiation	Chemistry	(World	Scientific)	[4]	Porcel	E	(2011)	Thèse	de	Doctorat	(Université	Paris-Sud	11)	[5]	Porcel	E	et	al.	(2010)	Nanotechnology	21	85103	[6]	Marin	E	et	al.	(2013)	Int.	J.	Nanomedicine	8	3071–91	
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Table	II	-	1.	Bio-compatible	and	water	soluble	polymers	used	for	in	situ	metal	nanoparticles	surface	coating.	
Name	and	structural	chemical	formula	 Molecular	Weight	(g.mol-1)	Poly	(ethylene	glycol)	
PEG-OH	 	 600	1000	3000	O-(2-aminoethyl)	poly(ethylene	glycol)	 	 3000	Poly(ethylene	glycol)	diamine	
PEG-2NH2	 	 2000	3000	Poly(ethylene	glycol)		bis(carboxymethyl)	ether	 	 600	D-(+)-Glucose	 	 180.16	Poly(vinyl	alcohol)	Mowiol®	8-88	 	 ~67	000	Poly	(ethylene	glycol)-block-poly	(propylene	glycol)-block-poly	(ethylene	glycol)	Pluronic	F-68	 	 8350	In	 particular,	 poly	 (ethylene	 glycol)	 (PEG)	 is	 widely	 used	 in	 the	 field	 of	 polymer-based	drug	delivery	and	nanomedicine.	It	is	nontoxic	and	has	been	approved	by	the	FDA	and	the	EU	for	internal	consumption	[7].		
In	a	very	early	stage	of	this	work,	two	main	PEG	derivatives,	PEG-OH	and	PEG-2NH2,	were	found	to	be	the	most	promising	biocompatible	polymers	for	nanoparticles	developments	by	 radiolysis	 in	 water.	 I	 developed	 two	 types	 of	 monometallic	 platinum	 nanoparticles	using	PEG	coatings;	the	PEGylated	platinum	nanoparticles,	named	as	PtPEG-OH	NPs,	using	the	standard	PEG-OH	(Mw=	1000	g.mol-1,	n	~	22.3	repeating	units)	and	PtPEG-2NH2	NPs	using	the	homobifunctional	PEG-2NH2	(Mw=	2000	g.mol-1,	n	~	44.6	repeating	units).	In	the	next	 sections,	 the	 experimental	 method	 and	 protocols	 used	 to	 synthetize	 PEGylated	platinum	nanoparticles	are	described.	
1.1.1 Description	of	the	synthesis	
In	 this	 work,	 the	 synthesis	 of	 biocompatible	 metallic	 nanoparticles	 was	 optimized	 by	combining	radiolysis	with	 in	situ	PEGylation.	The	principles	of	this	method	are	described	in	this	section.		
																																																																											[7]	Knop	K	et	al.	(2010)	Angew.	Chemie	-	Int.	Ed.	49	6288–308		
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1.1.1.1 Radiolysis	
Radiolysis	 is	 a	 well-known	method	 to	 prepare	 colloidal	 metallic	 nanoparticles	 (see	 the	theoretical	 framework	 in	 Chapter	 I	 –	 Section	 1.1.2).	 The	 radiolytic	 synthesis	 of	nanoparticles	 is	 performed	 at	 room	 temperature	 and	 atmospheric	 pressure.	 It	 leads	 to	homogeneous	reduction	and	nucleation	in	the	bulk.		
The	physico-chemical	processes	taking	place	during	the	radiolytic	reduction	of	metal	ions	in	 aqueous	 solution	have	been	 already	described	 [8]	 [9]	 [3]	 (see	detailed	description	 in	
Chapter	 I	 –	 Section	 1.1.2.1).	 Briefly,	 the	 irradiation	 of	 deoxygenated	 water	 with	 high-energy	radiation	(X-rays,	γ-rays,	electrons	or	ions)	induces	the	excitation	and	ionization	of	water	molecules,	which	leads	to	the	production	of	radiolytic	molecular	and	radical	species	
(Equation	 II	 -	 1).	 Those	 species	 that	 are	 homogeneously	 distributed	 in	 the	 bulk	 act	 as	strong	reducing	or	oxidizing	agents.	
H!O       !!!"#$       e!"! , H!O!, H∙, OH∙,  H!,  H!O!   	 	 	 	 Equation	II	-	1	Solvated	 electrons	 e!"! 	 and	 hydrogen	 atoms	 H∙	 are	 strong	 reducing	 agents	 with	 the	respective	 redox	 potentials:	 E∘ H!O / e!"! =  −2.87 V	 and	 E∘ H!/ H⋅ =  −2.31 V,	 that	efficiently	reduce	dissolved	metal	ions	down	to	the	zero-valent	state.	In	the	case	of	a	free	or	complexed	monovalent	metal	 ion	Mn+,	 the	reduction	proceeds	through	Equation	I	–	5	and	Equation	I	–	6	(see	Chapter	I	–	Section	1.1.2.2):	
Multivalent	 ions,	 as	PtII,	 are	 reduced	down	 to	 the	zero-valent	 state	according	 to	a	multi-step	 reaction	mechanism	which	 involves	 intermediate	valences,	Pt!! → Pt!	 and	Pt! → Pt!	(see	Chapter	I	–	Section	1.1.2.3).	
The	 uniform	 energy	 deposition	 into	 the	 irradiated	 total	medium	 leads	 to	 homogeneous	distribution	of	metal	atoms	and	nucleation	sites	in	the	solution	and	thus	the	formation	of	metal	clusters	with	remarkable	monodispersity.	
1.1.1.2 In	situ	PEGylation		
The	 PEGylation	 term	 refers	 to	 the	 decoration	 and	 stabilization	 of	 a	 particle	 surface	 by	covalently	grafting	or	entrapping	and	adsorption	of	PEG	chains.	The	in	situ	term	indicates	
																																																																											[8]	Treguer	M	et	al.	(1998)	J.	Phys.	Chem.	B	102	4310–21	[9]	Remita	H	et	al.	(2005)	Radiat.	Phys.	Chem.	72	575–86	
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that	 the	surface	coating	takes	place	at	 the	time	the	nanoparticle	 is	synthetized,	 in	a	one-step	synthetic	route.	
The	in	situ	surface	coating	of	platinum	nanoparticles	was	accomplished	by	performing	the	radiolytic	reaction	in	the	presence	of	PEG.	PEG	limits	the	nucleation	and	growth	steps	in	order	 to	 obtain	 homogenous	 colloidal	 nanoparticles.	 The	 main	 advantages	 of	 using	radiolysis	 are	 that:	 i)	 no	 reducing	 chemical	 agent	 is	 added,	 as	 the	 reducing	 species	 are	induced	 by	 water	 radiolysis	 and	 ii)	 the	 nanoparticles	 can	 be	 synthesized	 in	 water.	PEGylation	 takes	 place	 during	 the	 radiolytic	 synthesis,	 thus	 metallic	 nanoparticles	stabilized	 by	 PEG	 are	 obtained	 in	 a	 bio-compatible	 solvent.	 Moreover,	 the	 colloidal	solutions	sterilized	by	the	irradiation	can	be	directly	used	in	biological	samples.	
1.1.2 Experimental	protocol	
In	the	synthesis	of	PEGylated	platinum	nanoparticles,	tetraammine	platinum	(II)	chloride	(Pt	 (NH3)4	 Cl2)	 was	 used	 as	 precursor.	 This	 compound	 is	 non-toxic	 and	 can	 be	 safely	handled.	Moreover,	it	contains	less	chloride	than	other	potential	precursors.	Chloride	ions	(Cl-)	are	radical	scavenger,	which	may	reduce	the	yield	of	the	synthesis.		
Briefly,	aqueous	solutions	containing	Pt	(NH3)4	Cl2	and	PEG	(PEG-OH	or	PEG-2NH2)	were	deaerated	by	nitrogen	bubbling	(ca.	15	min)	and	then	irradiated	by	γ-rays	(E=	1.33	MeV,	LET=	0.2	keV.μm-1)	with	a	dose	rate	of	ca.	95.5	Gy.min-1	 (see	dose	rate	determination	 in	
Section	 3.1).	 Inert	 atmospheric	 conditions	 (N2)	 were	 used	 to	 avoid	 recombination	 of	solvated	electrons	with	solvated	oxygen	and	back	oxidations	of	very	small	metal	clusters.	Approximately	10	kGy	at	95.5	Gy.min-1	were	used	to	completely	reduce	10-3	mol.L-1	of	PtII	(see	XPS	results	in	Chapter	III	-	Section	1.3).		
Figure	II	-	1	shows	the	synthesis	of	PEGylated	platinum	nanoparticles	by	radiolysis	and	in	
situ	PEGylation.	It	 illustrates	a	colloidal	aqueous	solution	containing	a)	10-3	mol.L-1	of	the	PtII	complex	prior	irradiation	and	b)	10-3	mol.L-1	PtPEG-OH	NPs	obtained	after	irradiation.	Thus,	the	concentration	of	PtPEG-OH	NPs	is	always	expressed	in	moles	of	Pt	per	liters	of	solvent	(water,	typically	Vwater=	10	ml).	
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Figure	II	-	1.	Principle	of	the	synthesis	of	PEGylated	platinum	nanoparticles	by	gamma	rays	water	radiolysis	and	in	situ	PEGylation.	The	synthesis	was	optimized	by	varying	the	PEG-OH:Pt	molar	ratio	from	ca.	1	up	to	100.	The	PEG-OH	molar	concentration	was	estimated	from	H	(OCH2CH2)n	OH	with	n=	1	and	thus	Mw=	62	g.mol-1	(monomeric	unit).	
The	NPs	prepared	using	PEG-OH	with	a	PEG-OH:Pt	molar	ratio	of	ca.	100	were	the	most	stable	(see	results	in	Chapter	III	–	Section	1.2.1).	They	were	particularly	characterized	as	radio-enhancers	 in	 living	 cells	 and	 at	 molecular	 level	 (bio-nanoprobe)	 (see	 results	 in	
Chapter	III	–	Section	2.3).		
1.2 Mono-	and	bimetallic	PEGylated	gold-platinum	nanoparticles	
The	 new	 radiolytic-PEGylation	 method	 was	 applied	 to	 the	 synthesis	 of	 bimetallic	nanoparticles.	 The	 in	 situ	 PEGylation	 was	 performed	 in	 the	 presence	 of	 the	homobifunctional	 PEG-2NH2	 (Mw=	 2000	 g.mol-1).	 In	 particular,	 for	 monometallic	 gold	nanoparticles,	we	evaluated	the	effect	of	the	PEG	chain	length	using	PEG-2NH2	of	different	molecular	weight	(2000	and	3000	g.mol-1).	
Briefly,	 mono	 and	 bimetallic	 nanoparticles	 were	 synthetized	 at	 10-3	 mol.L-1	 using	 the	Pt(NH3)4Cl2	and	HAuCl4	precursors.	Bimetallic	nanoparticles	were	prepared	using	a	Pt:Au	molar	 ratio	 of	 1.	 The	 PEG-2NH2	 was	 used	 with	 a	 molar	 ratio	 PEG:MT	 (MT=	 total	 metal	content)	 of	 ca.	 50.	 The	 PEG-2NH2	 molar	 concentration	 was	 estimated	 from	 H2N	(OCH2CH2)n	CH2CH2	NH2	with	n=	1	and	thus	Mw=	104	g.mol-1.	
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The	 solutions	 containing	 the	 precursor(s)	 and	 PEG-2NH2	 were	 deaerated	 by	 nitrogen	bubbling	and	 irradiated	with	 increasing	doses,	 from	0.5	kGy	up	 to	10	kGy,	 to	 follow	 the	reduction	 of	 the	 metal	 ions	 (AuIII	 and	 PtII)	 and	 nanoparticles	 formation	 by	 UV-visible	spectroscopy.	 These	 solutions	 were	 irradiated	 at	 the	 maximum	 of	 dose	 rate	 (ca.	 95.5	Gy.min-1).	
The	radiation	enhancing	effect	of	mono-	and	bimetallic	nanoparticles	on	the	induction	of	nanosize	damage	was	 evaluated	 at	molecular	 level	 using	 the	bio-nanoprobe	 (see	 results	
Chapter	IV	–	Section	2).	
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2. Methods	for	nanoparticles	characterization	
The	physico-chemical	 characterization	 of	 the	 as-synthetized	 nanoparticles,	 term	used	 to	refer	to	fresh	nanoparticles	after	synthesis,	includes:	
• Structure:	crystallinity,	size	and	shape		
• Composition:	purity,	elemental	analysis,	surface	chemistry	and	coating	density	
• Stability:	agglomeration-sedimentation	effects	in	relevant	physiological	media	
Table	 II	 -	 2	 enlists	 the	 different	 techniques	 used	 in	 this	 work	 to	 characterize	 the	nanoparticles.	 We	 also	 enlisted	 the	 methods	 used	 to	 elucidate	 the	 novel	 properties	 of	these	 potential	 nano-radio-enhancers.	 The	 instrumentation	 and	 samples	 preparation	protocols	 are	 presented	 in	 the	 section	 indicated	 in	 the	 first	 column.	 The	 fundamental	principle	of	each	technique	is	described	in	the	Appendix	A.	
Table	II	-	2.	Methods	for	nanoparticles	characterization.	
Section	 Characterized	feature	 Method	 Sample	preparation	
2.1	 Metal	ions	reduction	and	NPs	formation	 UV-Visible	spectroscopy	 Diluted	colloidal	NPs	2.1	 Size,	shape	and	crystallinity	 TEM	 NPs	dried	under	atmospheric	conditions	
2.3	 Hydrodynamic	size	Stability	and	level	of	aggregation	 DLS	 Diluted	colloidal	NPs		2.4	 Surface	charge	 Zeta	potential		 Diluted	colloidal	NPs		2.5	 Chemical	composition	 XPS	 NPs	dried	under	atmospheric	conditions		2.6	 Functional	composition	 FTIR	 NPs	dried	under	atmospheric	conditions	4.1.3	 Cytotoxicity	 Clonogenic	assay	 Human	 cancer	 cell	 lines	 in	culture	4.1.5.1	 Uptake	quantification		 ICP-OES	ICP-MS	 Cell	 pellets	 after	 NPs	incubation	 in	 human	 cancer	cell	cells	4.1.5.1	4.1.5.1	 Localization	in	cells	 NanoSIMS		TEM	 Fixed	cells	
4.1.4	 Cell	killing	radio-enhancement	 Clonogenic	assay	 Irradiation	 of	 living	 cells	with	 γ-rays	 and	 medical	carbon	ions		4.2	 Molecular	damage	radio-enhancement	 Agarose	gel	electrophoresis	 γ-rays	irradiation	of	the	bio-nanoprobe	(plasmid	DNA)		
CHAPTER	II	 MATERIALS	AND	METHODS		
	 68	
2.1 UV-Visible	spectroscopy	
2.1.1 Instrumentation		
The	main	characterization	 technique,	used	 to	 follow	 the	 reduction	of	 the	metal	 ions	and	nanoparticles	formation,	was	the	ultraviolet–visible	spectroscopy.	All	measurements	were	performed	 at	 the	 Laboratoire	 de	 Chimie	 Physique	 (Université	 Paris-Saclay,	 UMR8000	CNRS)	using	an	Agilent	8453	UV-visible	Spectroscopy	System.	
2.1.2 Samples	preparation	
The	 as-synthetized	 nanoparticles,	 if	 prepared	 at	 10-2	 mol.L-1,	 were	 diluted	 in	 ultrapure	water	 to	 a	 final	 concentration	 of	 10-3	 mol.L-1	 and	 measured	 at	 room	 temperature	 in	 a	quartz	 cell	 (Hellma	 Analytics,	 l=	 0.2	 cm).	 A	 blank	 consisting	 in	 ultrapure	 water	 was	measured	before	sampling	(see	results	Chapter	III	for	PtPEG-OH	NPs	and	Chapter	IV	for	mono-	and	bimetallic	PEG-2NH2	NPs).		
2.2 Transmission	Electron	Microscopy	(TEM)		
2.2.1 Instrumentation		
Two	 TEM	 facilities	 were	 used	 in	 collaboration	 to	 characterize	 the	 metallic	 core	 size,	crystallinity	 and	 morphology	 of	 the	 as-synthetized	 nanoparticles.	 The	 fundamental	principle	of	TEM	is	described	in	the	Appendix	A-1.	
A	JEOL	100CXII	microscope	at	an	accelerating	voltage	of	100	kV	operated	by	Dr.	Patricia	Beaunier	at	the	Laboratoire	de	Réactivité	de	Surfaces	(Université	Paris	VI,	in	collaboration	with	 Dr.	 Hynd	 Remita)	was	 used	 for	 the	 imaging	 and	 crystallographic	 determination	 of	metallic	NPs.		
A	 JEOL	 2200FS	microscope	 at	 an	 accelerating	 voltage	 of	 200	 kV	was	 used	 at	 the	 IBiSA	platform	 (Institut	 Curie,	 Orsay)	 in	 collaboration	 with	 Dr.	 Marco	 Sergio	 and	 Dr.	 Sylvain	Trepout	to	determine	the	size	and	morphology	of	NPs	before	incubation	within	cells.	
2.2.2 Samples	preparation	
Drops	of	as-synthetized	nanoparticles	were	deposited	on	copper	grids	specially	treated	by	Dr.	 Beaunier	 or	 on	 commercial	 carbon-formvar	 copper	 grids	 (200	mesh,	 Agar	 Scientific	Ltd)	 and	 observed	 after	 natural	 drying	 under	 the	 JEOL	 100CXII	 or	 JEOL	 2200FS	respectively.	The	nanoparticles	size	distribution	histograms	were	built	by	analyzing	more	
MATERIALS	AND	METHODS	 CHAPTER	II		
	 69	
than	2000	particles	using	the	ImageJ	1.46r	software.	In	the	case	of	PtPEG-OH	NPs,	results	are	presented	and	discussed	 in	Chapter	 III	 –	Section	1.2.	 For	 the	mono-	and	bimetallic	PEGylated	gold-platinum	nanoparticles,	results	can	be	found	in	Chapter	IV	–	Section	1.1.	
2.3 Dynamic	Light	Scattering	(DLS)	
The	 hydrodynamic	 diameter	 (dH)	 indicates	 the	 size	 of	 colloidal	 particles	 including	 the	metal	core	(determined	by	TEM),	the	particle	coating	(polymer/ligand)	and	the	solvation	shell	 (surrounding	solvent,	water).	The	 fundamental	principle	of	DLS	 is	described	 in	 the	
Appendix	A-2.	
Knowledge	on	the	dH	size	of	nanoparticles	 in	suspension	provides	 important	clues	about	possible	interactions	with	biological	systems.	It	is	commonly	accepted	that	nanomaterials	with	sizes	smaller	than	some	tens	of	nanometers,	do	not	accumulate	in	undesired	organs	and	are	more	easily	eliminated	by	renal	clearance,	minimizing	toxicity	risks	[10]	[11].	
2.3.1 Instrumentation		
In	this	work,	the	dH	of	the	as-synthesized	nanoparticles	was	determined	by	DLS.	We	used	a	Zetasizer	Nano-ZS	 (laser	He-Ne,	 633	 nm)	 from	Marven	 Instrument	 Ltd,	 in	 collaboration	with	 Dr.	 Laure	 Catala	 at	 the	 Institut	 de	 Chimie	 Moléculaire	 et	 des	 Matériaux	 d'Orsay	(ICMMO	-	UMR8182	CNRS).	
2.3.2 Samples	preparation	
Firstly,	we	analyzed	the	dH	of	the	as-synthetized	nanoparticles.	These	nanoparticles	were	diluted	in	ultrapure	water	to	a	final	concentration	of	5x10-4	mol.L-1	and	measured	at	room	temperature	 in	a	semi-micro	polystyrene	(PS)	cuvette.	The	size	distribution	 is	shown	by	number	as	the	mean	of	three	independent	NPs	batches.	Results	on	the	PtPEG-OH	NPs	are	presented	 and	 discussed	 in	 Chapter	 III	 –	 Section	 1.2.	 For	 the	 mono-	 and	 bimetallic	PEGylated	gold-platinum	nanoparticles,	results	can	be	found	in	Chapter	IV	–	Section	1.1.	
Secondly,	we	investigate	the	stability	of	particularly	PtPEG-OH	NPs	in	different	media	by	measuring	 the	 dH	 of	 nanoparticles	 suspensions.	We	 studied	 the	 influence	 of	 time	 (time	post	dilution	preparation).	Diluted	samples	(5x10-4	mol.L-1)	in	ultrapure	water,	phosphate	
																																																																											[10]	Choi	H	S	et	al.	(2007)	Nat.	Biotechnol.	25	1165–70	[11]	Michelle	L	et	al.	(2008)	Nanomedicine	(Lond)	3	703–17	
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saline	buffer	(PBS),	NaCl,	Tris-EDTA	buffer	(TE)	and	Dulbecco’s	Modified	Eagle’s	Medium	(DMEM)	were	 analyzed,	 in	 a	 semi-micro	 PS	 disposable	 cuvette,	 immediately	 and	 1,	 3,	 6	and	22	h	after	dilution	preparation	at	37°C.	The	size	distribution	is	presented	by	intensity	(see	results	in	Chapter	III	–	Section	1.5).	
2.4 Zeta	potential	(ζ-potential)	
The	 ζ-potential	 of	 nanoparticles	 developed	with	medical	 purposes	 is	 another	 important	feature	that	must	be	well	characterized.	In	particular,	a	positive	or	a	negative	ζ-potential	may	determine	the	interaction	and	uptake	of	nanoparticles	by	living	organisms	[12].	The	fundamental	principle	of	the	ζ-potential	measurements	is	described	in	the	Appendix	A-3.	
The	ζ-potential	strongly	depends	on	the	composition	of	the	particles	suspensions,	which	is	mainly	affected	by:	
• ionic	concentration		
• type	of	ions		
• presence	of	surfactants	or	polyelectrolytes	
• pH	
For	 instance,	homogenously	highly	charged	particles	 (>	+30	mV	or	>	 -30	mV)	will	 resist	flocculation	and	aggregation	for	longer	periods	making	such	samples	more	stable.	In	this	work,	 we	 firstly	 evaluated	 the	 ζ-potential	 of	 the	 as-synthetized	 nanoparticles	 and	 then	their	stability	as	function	of	pH.	
2.4.1 Instrumentation	
We	 determined	 the	 ζ-potential	 of	 colloidal	 nanoparticles	 using	 the	 Zetasizer	 Nano-ZS	already	described	(Section	2.3.1).	
2.4.2 Samples	preparation	
Firstly,	 we	 analyzed	 the	 ζ-potential	 of	 the	 as-synthetized	 nanoparticles	 (pH	 ~6),	 which	were	diluted	 in	ultrapure	water	 to	a	 final	 concentration	of	10-3	mol.L-1	 and	measured	at	room	temperature.	A	disposable	folded	capillary	cell	was	used	with	this	purpose.	
																																																																											[12]	Zhang	Y	et	al.	(2008)	Biomed.	Microdevices	10	321–8	
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In	 particular,	 we	 evaluated	 the	 influence	 of	 pH	 in	 the	 ζ-potential	 of	 the	 PtPEG-OH	NPs.	Nanoparticles	were	 diluted	 in	 aqueous	 solutions	 containing	NaCl	 [0.01mol.L-1]	 to	 a	 final	concentration	10-3	mol.L-1	 and	 then	adjusted	 to	 the	desired	pH	ranging	 from	3	up	 to	11.	The	isoelectric	point	of	nanoparticles	was	thus	determined.	This	point	indicates	the	pH	at	which	 nanoparticles	 carries	 no	 net	 electrical	 charge,	 i.e.	 ζ=	 0	 mV	 (point	 of	 zero	 charge	(PZC)).	 All	 values	 reported	 in	 Chapter	 IV	 -	 Section	 1.5.1	 are	 the	 mean	 ±	 standard	derivation	of	triplicate	measurements.	
2.5 X-ray	Photoelectron	Spectroscopy	(XPS)	
X-ray	 Photoelectron	 Spectroscopy,	 also	 known	 as	 Electron	 Spectroscopy	 for	 Chemical	Analysis	(ESCA),	is	widely	used	to	analyse	the	chemical	composition	of	surfaces.	Its	ability	to	 explore	 the	 first	 few	 atomic	 layers,	 1-10	 nm,	 and	 assign	 the	 elemental	 composition	(empirical	formula),	chemical	state	and	electronic	state	of	the	elements	within	a	material,	makes	 XPS	 a	 powerful	 technique	 in	 emerging	 nanoscience	 developments.	 The	fundamental	principle	of	XPS	is	described	in	the	Appendix	A-4.	
In	this	work,	we	used	XPS	to	evaluate	the	purity,	elemental	composition,	electronic	state	and	 chemical	 conformation	 of	 as	 synthetized,	 mono	 and	 bimetallic	 platinum	 based	nanoparticles.	
2.5.1 Instrumentation	
XPS	 measurements	 were	 performed	 in	 collaboration	 with	 Dr.	 Diana	 Dragoë	 (ICMMO	 -	UMR8182	 CNRS).	 We	 used	 a	 K	 Alpha	 XPS	 spectrometer	 (Thermo	 Fisher	 Scientific)	working	with	a	pressure	 in	 the	 low	10-9	mbar	range.	This	XPS	spectrometer	 is	equipped	with	a	monochromatic	aluminum	source	(Al	Kα,	1486.7	eV).	
The	XPS	analyses	were	performed	fixing	a	spot	size	of	400	µm,	which	corresponds	to	an	irradiated	zone	of	approximately	1	mm2.	The	hemispherical	analyzer	was	operated	at	0°	take	off	angle	in	the	Constant	Analyser	Energy	(CAE)	mode.	Pass	energy	of	200	eV	and	a	step	of	1	eV	were	used	for	the	acquisition	of	survey	scans.	Pass	energy	of	50	eV	and	a	step	of	 0.1	 eV	 were	 used	 for	 the	 acquisition	 of	 narrow	windows.	 Charge	 compensation	 was	done	by	means	of	a	“dual	beam”	flood	gun.	The	recorded	spectra	were	processed	by	means	of	 the	 Avantage	 software,	 using	 a	 peak-fitting	 routine	 with	 Shirley	 background	 and	
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symmetrical	70%-30%	mixed	Gaussian-Lorentzian	peak	shapes.	In	particular,	a	Doniach-Sunjic	type	function	[13]	was	used	to	fit	the	Pt0	asymmetric	peaks.		
All	the	results	discussed	in	Chapter	III	–	Section	1.3	and	Chapter	IV	–	Section	1.2.1	were	reproductively	obtained	over	at	least	three	independent	NPs	synthesis.	
2.5.2 Samples	preparation	
XPS	analysis	was	performed	 in	dried	 samples.	Commonly,	30	µl	 of	 colloidal	 suspensions	containing	 the	 as-synthetized	NPs	were	deposited	 on	 cover	 glasses	 (Menzel-Glaser)	 and	dried	under	atmospheric	conditions	72h	prior	analysis.	
Figure	 II	 -	 2	 shows	 the	 picture	 of	 the	 sample	 holder	 with	 nanoparticles	 and	 a	 control	(PEG-OH)	 (on	 the	 left)	 and	a	magnified	picture	 that	 shows	different	points	used	 for	XPS	analysis	(on	the	right).	
	
Figure	II	-	2.	Nanoparticles	samples	for	XPS	analysis.	
2.6 Fourier	Transform	Infrared	(FTIR)	spectroscopy		
Infrared	 (IR)	 spectroscopy,	 also	 called	 vibrational	 spectroscopy,	 is	 an	 analytical	 tool	largely	used	to	determine	the	chemical	structure	and	functional	groups	present	in	organic	and	 inorganic	 compounds.	 The	 fundamental	 principle	 of	 FTIR	 is	 described	 in	 the	
Appendix	A-5.	
FTIR	spectroscopy	was	used	in	this	work	to	characterize	the	functional	groups	of	the	NPs	coating.	
																																																																											[13]	Olivero	J	J	and	Longbothum	R	L	(1977)	J.	Quant.	Spectrosc.	Radiat.	Tranfer	17	233–6	
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2.6.1 Instrumentation	
In	 this	 work,	 an	 Alpha	 FTIR	 Spectrometer	 (Bruker	 Optik	 GmbH)	 was	 used	 at	 the	laboratory	of	Nanosciences	et	Innovation	pour	les	Matériaux,	la	Biomédecine	et	l'Énergie	(CEA	 –	 Saclay)	 to	 characterize	 the	 PEGylation	 of	 metallic	 nanoparticles.	 NPs	 were	characterized	 using	 the	 attenuated	 total	 reflection	 (ATR)	 module	 of	 the	 FTIR	spectrometer.	
2.6.2 Samples	preparation	
A	 small	 drop	 of	 the	 as-synthetized	 colloidal	 nanoparticles	 was	 deposited	 on	 the	 ATR	module	and	dried	with	air.	The	transmittance	FTIR	spectra	were	measured	from	4000	to	375	cm-1	 (OPUS	software,	 spectral	 resolution	of	~4	cm-1).	Three	 independent	batches	of	as-synthetized	metallic	 nanoparticles	were	 analysed.	 The	 resulting	 FTIR	 spectra	 are	 the	average	of	60	scans.	Control	samples	consisting	on	the	pure	PtII	complex	and	PEGs	were	also	 measured.	 In	 the	 case	 of	 PtPEG-OH	 NPs,	 results	 are	 presented	 and	 discussed	 in	
Chapter	 III	 –	 Section	 1.4.	 For	 the	 mono-	 and	 bimetallic	 PEGylated	 gold-platinum	nanoparticles,	results	can	be	found	in	Chapter	IV	–	Section	1.2.2.	
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3. Radiation	sources	
In	this	section,	we	present	the	different	radiation	sources	used	in	this	work.	Gamma	rays	were	used	 to	 synthesize	nanoparticles	 and	 to	 irradiate	 biological	 samples	 (cells	 and	 the	bio-nanoprobe).	 Medical	 carbon	 ions	 were	 particularly	 used	 to	 study	 the	 efficiency	 of	nanoparticles	to	improve	the	performance	of	hadrontherapy.	
3.1 Cobalt-60	gamma	source	
Cobalt-60	(60Co)	is	a	widely	used	source	of	highly	penetrating	γ-rays	(MeV).	In	this	work,	the	 panoramic	 cobalt-60	 source,	 managed	 by	 the	 Laboratoire	 de	 Chimie	 Physique,	 was	used	in	the	radiolytic	synthesis	of	nanoparticles	(see	experimental	protocol	in	Section	1)	and	in	all	molecular	scale	experiments	(see	experimental	protocol	in	Section	4.2).	
3.1.1 Description	
60Co	 is	 a	 synthetic	 radioactive	 isotope	 of	 cobalt	 with	 a	 half-life	 of	 ca.	 5.3	 years.	 It	 is	produced	 artificially	 in	 nuclear	 reactors.	 60Co	 decays	 by	 beta-	 decay	 to	 the	 metastable	excited	 isotope	 nickel-60	 (60Ni).	 The	 excited	 nickel	 nucleus	 emits	 then	 two	 gamma	 rays	with	energies	of	1.17	and	1.33	MeV	(LET=	0.2	keV.µm-1)	to	stabilize	(Figure	II	-	3).	
 
Figure	II	-	3.	Schematic	representation	of	the	60Co	radioactive	decay.	
3.1.2 The	source	and	its	dosimetry		
The	dose	rate	of	a	60Co	source	depends	on	its	activity	and	decreases	with	the	square	of	the	distance	from	the	source.	In	this	work	and	for	each	individual	application,	the	dose	rate	of	
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gamma	 rays	was	 determined	 by	 Fricke	 dosimetry	 [14].	 The	 dose	 rate	 at	 the	 position	 of	samples	irradiation	was	determined	once	per	year.	Figure	II	-	4	shows	the	60Co	source	and	the	used	experimental	positions	used.	
	
Figure	II	-	4.	The	cobalt-60	panoramic	source	used	for	NPs	synthesis	and	plasmid	DNA	irradiation.	Briefly,	the	reaction	involved	in	the	Fricke	dosimeter	is	the	radiolytic	oxidation	of	ferrous	ions	 to	 ferric	 ions	 (Fe2+	⟶	Fe3+)	at	 low	pH	and	 in	 the	presence	of	oxygen.	The	standard	dosimeter	solution	contains	10-3	mol.L-1	of	ferrous	sulphate	(FeSO4)	in	a	0.4	mol.L-1	H2SO4	solution	(pH	~	0.46).	Water	radiolysis	(see	mechanism	in	Chapter	I	–	Section	1.1.2.1)	in	presence	of	Fe2+	ions	and	oxygen	leads	to	the	following	reactions:		
H!O! +  e!"!  →  H· +  H!O 	 	 	 	 	 	 	 Equation	II	-	2	H· +  O!  →  HO!· 	 	 	 	 	 	 	 	 Equation	II	-	3	HO· +  Fe!! →  HO!+ Fe!! 	 	 	 	 	 	 	 Equation	II	-	4	HO!·  +  Fe!! →  HO!!  +  Fe!!	 	 	 	 	 	 	 Equation	II	-	5	HO!! +  H!O!  →  H!O!  +  H!O	 	 	 	 	 	 Equation	II	-	6	
																																																																											[14]	Hardwick	T	J	(1951)	Can.	J.	Chem.	30	17–22	
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H!O! + Fe!!  →  HO! +  HO· +  Fe!!	 	 	 	 	 	 Equation	II	-	7	When	O2	is	present,	the	yield	of	Fe3+	is	calculated	by:		
G Fe!! = 2G H!O! + G(OH⋅) + 3G H⋅ 	 	 	 	 	 Equation	II	-	8	As	the	G(Fe3+)	depends	on	the	molecular	yields	of	primary	radicals,	 it	mainly	varies	with	pH	and	LET.	For	instance,	the	yield	of	Fe3+	using	a	60Co	gamma	source	(LET=	0.2	keV.µm-1)	is	equal	 to	16.2x10-6	mol.J-1.	The	 formation	of	Fe3+	generates	a	spectral	signal	at	304	nm	which	 can	 be	 easily	 measured	 by	 absorption	 spectrophotometry.	 The	 dose	 response	 is	linear	 up	 to	 ca.	 400	 Gy.	 The	 absorbed	 dose	 (D)	 is	 then	 determined	 by	 using	 the	 follow	relationship:	
D(Gy) =  !!.!.!	 	 	 	 	 	 	 	 	 Equation	II	-	9	where	 A=	 absorbance,	 ε=	molar	 absorption	 coefficient=	 2204	 l.mol-1.cm-1	 and	 l=	 optical	path=	1	cm.	Thus,	 the	dose	rate	 is	 finally	determined	by	plotting	the	absorbed	dose	D	as	function	of	the	irradiation	time.		
Figure	 II	 -	5	 shows	 the	dose	as	 function	of	 time	at	one	of	 the	 irradiation	positions.	The	linear	 response	 has	 a	 slope	 of	 about	 8.4	 Gy.min-1	 (R2	 =	 0.997),	 which	 represents	 the	average	dose	rate.	At	positions	closer	to	the	source	(positions	7,	8	and	9	in	Figure	II	-	4),	we	obtained	an	average	dose	rate	of	95.5	Gy.min-1.	
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Figure	II	-	5.	Dosimetry	of	the	60Co	source	measured	at	position	407.	
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3.2 Caesium-137	gamma	source	
In	 this	 work,	 a	 Caesium-137	 source	 was	 used	 to	 irradiate	 in	 vitro	 cells	 (see	 cell	 line	description	 in	Section	4.1.4).	 This	 source,	which	has	 a	 dose	 rate	 lower	 than	 that	 of	 the	cobalt-60	source,	is	more	adapted	to	the	irradiation	of	living	cells.	
3.2.1 Description		
Caesium-137	is	a	radioactive	isotope	of	caesium	formed	by	the	nuclear	fission	of	uranium-235.	137Cs	has	a	half-life	of	about	30.17	years.	It	decays	in	about	95%	by	beta-	emission	to	a	metastable	nuclear	isotope	of	barium	( Ba!"!"# *).	The	remainder	(ca.	5%)	directly	populates	the	 ground	 state	 of	 the	 barium-137.	 The	metastable	Ba-137	has	 a	 half-life	 of	 about	 153	seconds	and	completely	decays	by	the	emission	of	gamma	rays	with	energy	of	about	0.662	MeV	(LET=	0.2	keV.µm-1)	(Figure	II	-	6).	
	
Figure	II	-	6.	Schematic	representation	of	the137Cs	radioactive	decay.	
3.2.2 The	source	and	its	dosimetry		
Living	cells	were	irradiated	with	a	GSR-D1,	a	common	137Cs	gamma	rays	irradiator	used	in	radiobiology	 (Figure	 II	 -	 7).	 This	 source	 located	 at	 the	 Institut	 Curie	 -	Orsay,	 France,	 is	used	in	collaboration	with	Dr.	Evelyne	Sage.		
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Figure	II	-	7.	The	caesium-137	GSR-D1	irradiator	used	for	in	vitro	experimentation. The	 dose	 rate	 was	 determined	 considering	 the	 deactivation	 of	 137Cs.	 It	 was	 calculated	using	a	programmed	macro	furnished	by	the	radioprotection	professionals	from	Institute	Curie.	A	dose	difference	of	<10%	is	achieved	by	considering	the	isodoses	describing	each	level	of	the	irradiator	chamber	(in	red	Figure	II	-	7).	Cells	were	irradiated	with	an	average	dose	rate	of	1	Gy.min-1	and	doses	 ranging	 from	0	up	 to	5	Gy.	The	experimental	protocol	used	 to	 irradiate	 cells	 is	 presented	 in	 Section	 4.1.4.	 The	 results	 are	 presented	 and	discussed	in	Chapter	III	–	Section	2.2.	
3.3 Medical	carbon	ions	
These	 experiments	 were	 performed	 at	 the	 Heavy	 Ion	 Medical	 Accelerator	 (HIMAC)	 in	Chiba,	 Japan	 in	 collaboration	 with	 Dr.	 Ryoichi	 Hirayama	 (NIRS,	 Chiba,	 Japan)	 and	 Dr.	Noriko	Usami	from	the	High	Energy	Accelerator	Research	Organization	(KEK,	Japan).	Only	the	effect	of	the	PtPEG-OH	NPs	activated	by	carbon	ions	was	evaluated	on	HeLa	cells.	The	results	are	presented	and	discussed	in	Chapter	III	–	Section	2.2.1.	
3.3.1 Description:	the	irradiation	facility	
The	 HIMAC	 is	 considered	 as	 the	 first	 specialized	 heavy	 ion	 cancer	 treatment	 facility	worldwide.	 It	 mainly	 consists	 of	 a	 primary	 accelerator	 (synchrotron)	 that	 accelerates	carbon	beams	and	other	heavy	particle	beams,	 from	He2+	 to	Xe54+,	 to	800	MeV	of	energy	per	 nucleus,	 an	 injector	 (linear	 accelerator)	 and	 treatment	 rooms	 for	 patients	 [15]	 (see	illustration	in	Figure	II	-	8).		
																																																																											[15]	http://www.nirs.go.jp/ENG/core/ace/index.html	
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Figure	II	-	8.	Illustration	of	the	HIMAC	facility	in	Chiba,	Japan	(http://www.nirs.go.jp/ENG/core/ace/index.html) Fortunately,	the	HIMAC	has	special	experimental	rooms	exclusively	dedicated	to	research	in	biology	and	physics.	The	radiation	enhancing	effect	(REE)	of	platinum	nanoparticles	in	combination	with	carbon	ions	was	firstly	elucidated	by	the	group	using	bio-nanoprobes	in	2010.	 Since	 then	 this	 project	 focused	 on	 the	 evaluation	 of	 different	 high-Z	 based	nanoparticles,	 such	as	gold	and	gadolinium	based	nanoparticles,	with	 the	perspective	 to	develop	applications	in	hadrontherapy.	
3.3.2 Irradiation	conditions	
HeLa	cells	were	prepared	as	described	in	Section	4.1.4	and	exposed	to	C6+	ions	using	an	experimental	 setup	 specifically	 dedicated	 to	 irradiate	 cells	 (as	 shown	 in	 the	picture	 and	scheme	of	Figure	II	-	9).	
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a)	 b)	
Figure	II	-	9.	(a)	Experimental	set	up	used	to	irradiate	cells	by	carbon	ions	at	the	HIMAC	(NIRS,	Chiba,	Japan).	(b)	Scheme	showing	the	conditions	used	to	irradiate	cells.	Cells	were	placed	 vertically	 to	 the	 beam	and	 irradiated	 at	 the	middle	 of	 the	 Spread	Out	Bragg	 Peak	 (SOBP)	 within	 an	 average	 LET	 of	 110	 keV.µm-1	 and	 a	 dose	 rate	 of	approximately	 15	 Gy.min-1.	 The	 SOBP	 had	 a	 size	 of	 5	 mm.	 The	 energy	 of	 the	 incident	particles	was	290	MeV/uma.	The	beam	delivered	a	uniform	flux	within	2%	variation	in	a	10	cm	diameter	circle	[see	more	details	in	4].	Cells	were	irradiated	at	doses	ranging	from	0	up	to	2.5	Gy.		
	
	
	
	
	
	
	
	
[4]	Porcel	E	(2011)	Thèse	de	Doctorat	(Université	Paris-Sud	11)	
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4. Biological	models:	description	and	methods	
In	this	work,	we	adopted	a	multi-scale	approach	to	characterize	the	impact	and	the	action	mechanisms	of	NPs	on	bio	systems.	The	REE	of	nanoparticles	was	evaluated	in	living	cells.	The	nanoscale	 impact	of	NPs	was	 investigated	on	plasmid	DNA	used	as	a	molecular	bio-nanoprobe.		
In	this	section	we	present	the	biological	models,	as	well	as,	the	methods	and	experimental	protocols	optimized	during	my	thesis.	
The	cell	lines	and	culture	conditions,	the	methods	used	to	determine	the	toxicity	and	REE	of	 NPs	 in	 living	 cells,	 as	 well	 as,	 the	 techniques	 used	 to	 quantify	 the	 cell	 uptake	 and	evaluate	the	intracellular	localization	of	NPs	are	presented	in	Section	4.1.	This	study	has	been	performed	only	for	the	PtPEG-OH	NPs.	
In	Section	4.2	we	present	 the	quasi-standardized	method	used	 in	 the	group	 to	quantify	the	 radio-induced	 nanometer	 size	 molecular	 damages,	 which	 allows	 elucidating	 the	physico-chemical	processes	and	radio-enhancement	mechanism.	
4.1 Cellular	models	
The	biological	impact	of	PtPEG-OH	NPs	was	evaluated	using	two	human	immortalized	cell	lines,	HeLa	and	U87-MG.	
4.1.1 Cell	lines	description	
HeLa	 cells	 were	 derived	 from	 cervical	 cancer	 in	 1951.	 They	 are	 widely	 used	 in	radiobiology	 and	 cancer	 research	 due	 to	 their	 remarkable	 durability	 and	 proliferation	[16].	They	have	a	doubling	time	of	about	24	hours	and	a	platting	efficiency	of	about	60%.	In	this	work,	we	particularly	evaluated	the	toxicity	and	REE	of	PtPEG-OH	NPs	in	HeLa	cells	irradiated	by	gamma	rays	and	medical	carbon	ions.	
Glioblastoma	 is	 the	 most	 common	 and	 aggressive	 malignant	 primary	 brain	 tumor	 in	humans	[17],	which	cannot	be	efficiently	treated	by	conventional	therapeutic	modalities.	In	this	work,	we	used	the	U87-MG	cell	line,	which	was	derived	from	malignant	gliomas	in	
																																																																											[16]	Rahbari	R	et	al.	(2009)	Biotechniques	46	277–84	[17]	Clark	M	J	et	al.	(2010)	PLoS	Genet.	6	
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1966,	to	evaluate	the	toxicity	of	PtPEG-OH	NPs	and	their	REE	only	under	gamma	radiation.	U87-MG	cells	have	a	doubling	time	of	about	36	hours	and	platting	efficiency	of	~10%.	
HeLa	and	U87	MG	cells	were	obtained	from	the	American	Type	Culture	Collection	(ATCC).	
Table	II	-	3	summarizes	the	main	characteristics	of	each	cell	line.		
Table	II	-	3.	Main	information	of	HeLa	and	U87-MG	cells	from	the	ATCC	(https://www.lgcstandards-atcc.org/)	
HeLa		
(ATCC®	CCL-2TM) 
Organism	 Homo	sapiens,	human	
Tissue	 Cervix	
Disease	 Adenocarcinoma	
Morphology	 Epithelial	
Growth	properties	 Adherent	
U87-MG		
(ATCC®	HTB-14TM)	
Organism	 Homo	sapiens,	human	
Tissue	 Brain	
Disease	 Glioblastoma	-	astrocytoma	
Morphology	 Epithelial	
Growth	properties	 Adherent	
4.1.2 Cell	culture	conditions	
Cells	 were	 grown	 in	monolayer	 using	 Dulbecco’s	 Modified	 Eagle	 Medium	 (DMEM).	 The	DMEM	was	 enriched	with	10%	Fetal	Bovine	 Serum	 (FBS),	 1%	antibiotics	 (100	units/ml	penicillin	+	100	µg/ml	streptomycin)	and	1%	glutamine.	In	the	particular	case	of	U87-MG	cells,	1%	of	non-essential	amino	acids	(NE	AA)	was	added.	Cells	were	cultured	at	37°C	in	a	humidified	95%	air	/	5%	CO2	atmosphere.		
Commonly,	 when	 cells	 were	 70	 -	 90%	 confluents,	 they	 were	 splitted	 into	 new	 culture	vessels.	For	this,	the	culture	medium	was	removed	and	discarded,	the	cell	layer	was	rinsed	twice	with	phosphate	buffered	saline	(PBS)	solution	(pH	7.4)	and	0.05%	trypsin	solution	was	then	added	to	the	culture	flask.	Trypsin	cleaves	peptide	chains	mainly	at	the	carboxyl	side	of	the	amino	acids,	which	allows	the	detachment	of	the	cells	monolayer.	Thus,	trypsin	was	incubated	for	about	5	minutes	at	37°C,	5%	CO2	until	the	cell	layer	was	detached	from	the	substratum	and	dispersed.	Complete	growth	medium	was	then	added	and	cells	were	collected	by	gently	pipetting.	Appropriate	aliquots	of	the	cell	suspensions	were	placed	into	new	culture	vessels	for	further	culture.		
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4.1.3 Cytotoxicity	evaluation	of	PtPEG-OH	NPs	by	clonogenic	assay	
The	cytotoxicity	of	the	as-synthesized	PtPEG-OH	NPs	was	evaluated	in	HeLa	and	U87-MG	cells	by	clonogenic	assay.	
4.1.3.1 Principle	of	the	method	
Clonogenic	assay	or	colony	formation	assay	(CFA)	is	an	in	vitro	cell	survival	assay	based	on	the	 ability	 of	 a	 single	 cell	 to	 grow	 and	 proliferate	 to	 form	 a	 colony.	 The	 method	 was	developed	by	T.T.	Puck	and	coworkers	from	the	University	of	Colorado	in	1955	[18].	We	used	the	CFA	to	evaluate	the	cytotoxicity	of	PtPEG-OH	NPs	in	HeLa	and	U87-MG	cells,	and	to	determine	the	impact	of	NPs	on	cells	survival	after	radiation	treatment	(Section	4.1.4).	
4.1.3.2 Experimental	protocol:	samples	preparation	
Exponentially	 grown	 cells	 (2x105)	 were	 plated	 in	 T25	 culture	 flasks	 and	 maintained	overnight	in	a	5%	CO2	atmosphere	at	37°C.	Cells	were	then	incubated	for	6	h	with	enriched	culture	medium	containing	PtPEG-OH	NPs	at	 two	different	Pt	concentrations,	5x10-4	and	10-3	 mol.L-1.	 The	 control	 samples	 consisted	 in	 cells	 incubated	 with	 enriched	 medium	containing	 a	 water	 volume	 equivalent	 to	 that	 of	 the	 nanoparticle	 suspension.	 After	incubation,	 cells	 were	 trypsinized	 and	 re-seeded	 into	 10	 cm	 petri	 dishes	 at	 different	densities	in	order	to	achieve	ca.	100	colonies	per	dish	14	days	after.	For	each	condition	6	petri	dishes	were	prepared.	
Colonies	were	 fixed	 and	 stained	with	 a	 0.5%	methylene	 blue	 -	methanol	 solution	 (50%	v/v).	Those	colonies	containing	more	than	50	cells	were	scored.	The	results	presented	in	
Chapter	 III	 -	 Section	2.1.1	 correspond	 to	 the	 plating	 efficiency	 (PE)	 of	 the	 control	 and	cells	incubated	with	NPs.	The	PE	was	calculated	as	follows:		
PE = !"#$%& !" !"#"$%&! !"#$%&' !"#$%& !" !"##$ !""#"# ⨉100	 	 	 	 	 	 Equation	II	-	10	The	experimental	protocol	is	illustrated	in	Figure	II	-	10.		
																																																																											[18]	Puck	T	T	et	al.	(1955)	J.	Exp.	Med.	103	273–84	
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Figure	II	-	10.	Schematic	representation	of	the	CFA	protocol.	
4.1.3.3 Statistical	evaluation:	ANOVA	
The	analysis	of	variance	(ANOVA)	 is	a	commonly	used	statistical	method	 in	biology.	 It	 is	used	 to	 determine	whether	 there	 are	 any	 statistical	 significant	 differences	 between	 the	means	 of	 three	 or	 more	 independent	 groups.	 It	 was	 developed	 by	 the	 statistician	 and	biologist	Ronald	Fisher	in	1921	[19].	ANOVA	is	the	extension	of	the	t-test,	which	is	limited	to	the	analysis	of	two	independent	groups.	
Specifically,	ANOVA	tests	the	null	hypothesis	(H0):	
H!: µ! = µ! = µ! = ⋯  µ!	 	 	 	 	 	 	 Equation	II	-	11	where	μ=	group	mean	and	k=	number	of	groups.	The	key	output	of	ANOVA	test	 is	the	p-value	that	is	compared	to	a	significance	level	(α).	If	the	p-value	is	less	than	or	equal	to	the	significance	 level	 (p≤α),	 the	 null	 hypothesis	 is	 rejected	 concluding	 that	 not	 all	 the	population	 means	 are	 equal.	 If	 the	 p-value	 is	 greater	 than	 the	 significance	 level	 (p>α),	there	is	not	enough	evidence	to	reject	the	null	hypothesis	concluding	that	the	means	of	all	populations	are	equal.	Often	α	is	set	to	0.05,	implying	that	it	is	acceptable	to	have	a	5%	of	error	rejecting	the	H0.		
In	this	work,	each	group	is	defined	as:	a	different	NPs	treatment	applied	to	the	same	cell	line.	The	mean	of	each	group	is	the	PE	of	three	independent	CFA,	which	correspond	to	9	countable	petri	dishes.	Here,	we	applied	 the	ANOVAOneWay	method	 from	OriginPro	8.5	
																																																																											[19]	Fisher	R	A	S	(1921)	Fish.	Collect.	Pap.	Relat.	to	Stat.	Math.	theory	Appl.	3–32	
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(OriginLab,	 Northampton,	 USA)	 using	 a	 significance	 level	 of	 0.05.	 The	 results	 are	presented	in	Chapter	III	–	Section	2.1.1.	
4.1.4 Cell	survival	experiments	with	irradiation	
The	 REE	 of	 PtPEG-OH	 NPs	 was	 evaluated	 by	 means	 of	 CFA	 in	 HeLa	 and	 U87-MG	 cells.	Comparative	 studies	 were	 performed	 using	 gold	 nanoparticles	 (Au-DTDTPA	 NPs)	 (see	results	Chapter	III	–	Section	2.2).		
Cell	 survival	was	 assessed	by	 a	 standard	14	days	 colony	 formation	 assay.	 Exponentially	grown	cells	 (2x105)	were	plated	 in	T25	culture	 flasks	and	maintained	overnight	 in	a	5%	CO2	 atmosphere	 at	 37°C.	 Cells	 were	 then	 incubated	 6	 h	 with	 enriched	 culture	 medium	containing	PtPEG-OH	NPs	at	a	final	Pt	concentration	of	5x10-4	mol.L-1.	An	equivalent	water	volume	 was	 added	 into	 control	 samples.	 Cells	 were	 then	 irradiated	 in	 fresh	 enriched	medium	under	atmospheric	conditions	at	room	temperature.		
The	 impact	 of	NPs	on	 γ-rays	 (137Cs)	 effects	was	performed	with	Hela	 and	U87-MG	 cells.	The	 impact	 of	 NPs	 on	 carbon	 ion	 beams	 was	 probed	 on	 Hela	 cells	 only.	 The	 survival	fraction	(SF)	of	the	control	was	calculated	as	follows:		
SF = !"#"$%&' !"#$%&' !"##$ !""#"# ! !"!""	 	 	 	 	 	 	 	 Equation	II	-	12	The	results	are	presented	in	Chapter	III–	Section	2.2.1	and	2.2.2	as	the	normalized	SF	of	cells	with	regard	to	the	SF	of	the	control.	
4.1.5 Intracellular	nanoparticles	characterization:	methods	and	protocols		
We	quantified	 the	uptake	of	nanoparticles	by	 Inductively	Coupled	Plasma	(ICP)	using	an	Optical	 Emission	 Spectrophotometer	 (OES)	 and	 a	 Mass	 Spectrometer	 (MS)	 (Section	
4.1.5.1).	
The	 intracellular	 localization	 of	 PtPEG-OH	 NPs	 was	 investigated	 by	 Ion	 Microscopy	(NanoSIMS)	and	TEM	(Sections	4.1.5.2	and	4.1.5.3).		
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4.1.5.1 Inductively	Coupled	Plasma	(ICP)	spectroscopy	
a) Instrumentation	
An	ICP-OES	Varian	720	ES	(Figure	II	-	11a)	was	used	to	quantify	the	uptake	of	platinum	and	gold	nanoparticles	 in	HeLa	and	U87-MG	cells	with	a	detection	 limit	of	20	µg.L-1	 (0.1	μg/sample).		
A	GC-ICP-MS	Thermo	Scientific	XSERIES	2	(Figure	II	-	11b)	was	also	used	to	evaluate	the	uptake	 of	 PtPEG-OH	 NPs	 in	 HeLa	 cells	 with	 higher	 precision	 (detection	 limit	 of	 0.001	μg/sample).	This	analysis	was	performed	by	the	company	Ultra	Traces	Analyses	Aquitaine	in	Pau,	France.	
	 	
a)	 b)	
Figure	II	-	11.	ICP	principle	and	instrumentation	of	(a)	the	ICP-OES	Varian	720	ES	and	(b)	the	GC-ICP-MS	Thermo	Scientific	XSERIES	2.	b) Samples	preparation	
For	ICP-OES	analysis,	close	to	2x106	HeLa	and	U87-MG	cells	were	incubated	for	6	h	with	platinum	 (PtPEG-OH	 NPs)	 or	 gold	 (Au-DTDTPA	 NPs)	 at	 a	 final	 concentration	 of	 5x10-4	mol.L-1	 in	 the	 culture	 medium.	 After	 incubation,	 the	 medium	 was	 removed,	 cells	 were	rinsed	with	1x	PBS	and	collected	by	trypsination.	Cells	were	then	counted	and	centrifuged	(7	min	at	1200	rpm).	The	cells	pellets	were	dissolved	in	aqua	regia	(a	mixture	of	nitric	acid	and	hydrochloric	acid	in	a	molar	ratio	of	1:3)	and	diluted	in	ultrapure	water	(VT=	5	ml)	for	the	analysis.	The	results	from	one	replicate	are	presented	and	discussed	in	Chapter	III	–	
Section	2.1.2.1.		
For	 ICP-MS	 analysis,	 around	 2x106	 HeLa	 cells	 were	 incubated	 for	 6	 and	 24	 hours	 with	PtPEG-OH	NPs	at	a	final	concentration	of	5x10-4	mol.L-1.	Cells	pellets	were	sent	at	-80°C	to	
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Pau,	France,	for	further	analysis.	Results	from	one	replicate	are	presented	in	Chapter	III	–	
Section	2.1.2.2.	
4.1.5.2 Ion	Microscopy:	NanoSIMS	Imaging	
Ion	 microscopy	 is	 an	 alternative	 method	 to	 fluorescent	 microscopy,	 which	 does	 not	require	 the	 presence	 of	 any	 fluorescent	 tag.	 Its	 use	 for	 the	 characterization	 of	 the	intracellular	distribution	of	free-labelled	PtPEG-OH	NPs	in	HeLa	cells	was	developed	in	my	thesis	for	the	first	time.	
a) Fundamental	principle	
Introduced	in	the	early	sixties	by	Castaing	and	Slodzian	[20],	ion	microscopy	is	a	technique	optimized	 for	 the	 composition	 analysis	 of	 solid	 surfaces	 and	 thin	 films.	 Figure	 II	 -	 12	illustrates	the	fundamental	principle	of	a	typical	ion	microscope.		
	
Figure	II	-	12.	Schematic	representation	of	Nano	SIMS	principle	(adapted	from	[21]).	In	 brief,	 the	 phenomenon	 of	 secondary	 ion	 emission	 results	 from	 the	 collision	 of	 high	energy	particles	(focused	ion	beam)	with	a	solid	sample.	Under	the	impact,	the	energy	of	the	primary	ion	beam	dissipates	into	the	sample	inducing	a	collision	cascade	which	breaks	most	chemical	bonds.	The	atoms	or	combinations	of	atoms	(fragments	of	molecules)	are	released	(sputtering	process)	from	a	few	atomic	layers	of	the	sample	surface,	in	a	neutral	or	charged	 form	(ions).	These	 ions	are	 then	 focused	and	guided	to	a	mass	spectrometer.	The	mass/charge	 ratio	 analysis	 of	 secondary	 ions	 allows	measuring	 the	 ion	 current	 and	imaging	 the	 elemental	 composition	 of	 the	 sample.	 Imaging	 is	 achieved	 by	 scanning	 the	
																																																																											[20]	Castaing	R	and	Slodzian	G	(1962)	J.	Microsc.	(Paris).	1	395–410	[21]	Jiang	H	et	al.	(2014)	J.	Lipid	Res.	55	2156–66	
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focused	primary	 ion	beam	across	 the	sample	and	by	recording	 the	number	of	secondary	ions	for	each	pixel	of	the	scan	(raster).	
b) Instrumentation	
The	 experiments	 have	 been	 performed	 with	 the	 CAMECA	 NanoSIMS	 50™	 (instrument	developed	 by	 G.	 Slodzian,	 Professor	 of	 Université	 Paris-Sud,	 Orsay	 (France),	 the	 French	Space	Agency	ONERA,	B.	Daigne	and	the	CAMECA	company)	in	collaboration	with	Dr.	Jean-Luc	Guerquin-Kern	and	Dr.	Ting-Di	Wu	at	Institut	Curie	–	Orsay	(France)	(Figure	II	-	13).	
The	 NanoSIMS	 50™	 contains	 a	 source	 of	 primary	 ions	 (Cs+	 or	 O2+,	 O-,	 etc.),	 a	 mass	spectrometer	and	a	detection	device.	The	whole	system	works	under	ultra-high	vacuum,	ranging	from	10−10 Torr	(analysis	chamber)	to	10−8 Torr	(detector	compartment).	Its	main	characteristics	are	[22]:	
• High	lateral	resolution	(≤50	nm	in	caesium,	≤150	nm	in	oxygen). 
• Ability	to	measure	up	to	5	masses	(ions)	in	parallel,	from	the	same	micro-volume,	and	ensuring	perfect	 isotopic	ratio	 from	the	same	small	volume	or	perfect	 image	superimposition. 
• Very	good	transmission	even	at	high	mass	resolution	(60%	at M/ΔM=	5000). 
• Direct	optical	 observation	of	 the	 sample	within	 the	 ionization	 chamber,	 allowing	fast	selection	of	the	area	of	interest. 
• Charge	compensation	for	insulating	samples	(in	secondary	negative	ion	mode). 
	
Figure	II	-	13.	The	Cameca	NanoSIMS	50	ion-probe	for	element	analysis	at	the	CMIB	platform	(Institut	Curie).	
																																																																											[22]	Guerquin-Kern	J-L	et	al.	(2005)	Biochim.	Biophys.	Acta	-	Gen.	Subj.	1724	228–38	
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c) Samples	preparation:	cryo-fixation	
This	preparation	protocol	 is	 long	and	 involves	 several	 steps.	Each	 step	 is	 critical	 for	 the	good	preservation	of	biological	specimens	and	their	post-analysis.		
In	brief,	 about	35	000	HeLa	 cells,	 in	 a	60	μl	 volume,	were	plated	on	1	 cm2	Melinex	 film	support	(Agar	Scientific	Ltd.,	Stansted,	Essex,	UK)	and	let	to	attach	at	37°C	in	a	humidified	5%	CO2	atmosphere	for	2	h.	After	attachment,	wells	containing	the	Melinex	supports	were	filled	with	enriched	culture	medium.	Cells	were	grown	overnight	and	then	incubated	for	6	hours	 with	 5x10-4	 mol.L-1	 PtPEG-OH	 NPs	 (conditions	 used	 for	 irradiation).	 After	incubation,	those	non-internalized	NPs	were	removed,	by	washing	twice	with	1x	PBS,	and	new	enriched	medium	was	added.		
The	Melinex	supports	were	then	cut	in	small	squares	(9	mm2)	and	cells	were	fixed	by	slam	freezing	on	a	metal	mirror	precooled	with	liquid	nitrogen	to	-180°C.	This	fixation	method	was	used	to	avoid	chemical	interference	during	NanoSIMS	analysis.	The	cryofixation	was	performed	 in	 a	 Leica	 EM	CPC	 system.	 Samples	were	 dehydrated	 following	 a	 two	weeks	freeze	drying	protocol	which	started	at	-130°C.	By	reaching	0°C	dehydrated	samples	were	embedded	in	resin	and	polymerized	at	60°C	for	8	h.	After	polymerization	several	sections	of	ca.	0.2	µm	were	deposited	on	a	silicon	holder	and	analysed.		
d) Analysis	
The	primary	 incident	 ion	beam	was	generated	 from	a	caesium	source	with	energy	of	16	keV	and	a	probe	size	of	ca.	50	nm	in	diameter.	The	magnetic	field	was	set	to	detect	Pt,	the	heaviest	 element	 (mPt=	 195)	 on	 one	 of	 the	 largest	 detectors	 while	 the	 other	 movable	detectors	were	 positioned	 to	 analyze	CN-	 and	P-.	 The	mass	 spectrometer	was	 calibrated	with	a	control	sample	consisting	of	a	platinum	layer	deposed	on	a	gold	film.	Figure	II - 14	shows	 the	 count	 rates	 (count	per	 second,	 cps)	 as	 function	of	 the	 ions	mass	 (a.m.u.).	We	clearly	 observe	 the	 peaks	 corresponding	 to	 the	 main	 platinum	 isotopes	 with	 their	respective	proportions;	33%	194Pt	and	 195Pt,	25%	196Pt	and	7%	198Pt.	The	 small	 signal	 at	197	a.m.u.	corresponds	to	the	gold	support.	
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Figure	II	-	14.	Calibration	of	the	Cameca	NanoSIMS	50	by	means	of	a	Pt	layer.	The	spatial	analysis	was	performed	as	follows:	firstly	the	CN-	emission	was	analysed	over	a	large	area	(240	μm	⨉	720	μm)	and	secondly,	a	complete	analysis	(CN-,	P-	and	194Pt-)	was	performed	for	two	selected	cells.	In	Chapter	III–	Section	2.1.3.1,	we	present	the	complete	analysis	performed	in	one	HeLa	cell	loaded	with	PtPEG-OH	NPs.	It	is	important	to	highlight	that	 these	 measurements	 were	 performed	 close	 to	 the	 end	 of	 this	 project	 and	 a	complementary	statistical	analysis	is	in	process.	
4.1.5.3 Transmission	Electron	Microscopy		
TEM	was	used	to	better	elucidate	the	localization	and	uptake	mechanism(s)	of	PtPEG-OH	NPs	in	HeLa	and	U87-MG	cells.		
TEM	 has	 a	 better	 spatial	 resolution	 (atomic	 resolution	 ≤10-9	 m)	 in	 comparison	 with	NanoSIMS	 (50	nm).	TEM	 is	 commonly	used	 to	 image	biological	 specimens	 ranging	 from	intact	eukaryotic	cells	to	individual	proteins	>150	kDa.		
a) Instrumentation	
The	 localization	 of	 PtPEG-OH	 NPs	 in	 HeLa	 and	 U87-MG	 cells	 was	 performed	 in	collaboration	with	Dr.	 Sergio	Marco	 and	Dr.	 Sylvain	 Trepout	 at	 the	BioImaging	 Cell	 and	
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Tissue	Core	Facility	from	Institut	Curie	–Orsay,	France	(PICT-IBiSA	platform),	with	a	JEOL	2200FS	microscope	(Figure	II	-	15).	
	
Figure	II	-	15.	The	JEOL	2200FS	used	at	the	PICT-IBiSA	platform	for	cells	imagery.	b) Samples	preparation:	chemical	fixation	
About	60	000	HeLa	and	U87-MG	cells	were	plated	on	microscopic	slides	(Menzel-Glaser,	ϕ=	 20	mm)	 placed	 in	 a	 6	wells-plate	 and	 let	 to	 attach	 at	 37°C	 in	 a	 humidified	 5%	 CO2	atmosphere	for	2	h.	After	attachment,	wells	containing	the	slides	were	filled	with	enriched	culture	medium.	Cells	were	grown	overnight	and	then	incubated	for	6	h	with	5x10-4	mol.L-1	PtPEG-OH	NPs.	Control	samples	were	incubated	at	same	conditions	but	using	pure	water	instead	of	nanoparticles.	The	slides	were	then	rinsed	with	PBS	1X	and	fixed	for	35	min	at	4°C	in	a	mixture	of	2.5%	glutaraldehyde	and	4%	paraformaldehyde	prepared	in	the	same	buffer	 solution.	 Cells	 were	 then	 rinsed	 3	 times	with	 PBS	 to	 remove	 all	 reagents	 traces.	After	rinsing	with	PBS,	the	cells	were	dehydrated	using	ethanol	in	gradient	concentrations,	from	40%	to	pure	ethanol,	and	embedded	step	by	step	in	Epon	resin	[23].	Samples	were	then	 polymerized	 at	 60°C.	 From	 selected	 areas	 consisting	 on	 a	 homogenous	 cells	 layer,	resin	blocks	were	formed.	They	were	finally	cut	into	ultrathin	(~100	nm)	square	sections	using	an	ultramicrotome.	The	obtained	slices	were	deposited	on	200	mesh	copper	grids	(Agar	scientific)	and	observed.	
Measurements	 were	 performed	 for	 close	 to	 20	 HeLa	 and	 20	 U87-MG	 cells,	 including	control	and	PtPEG-OH	NPs	loaded	samples.	They	correspond	to	3	different	slices	regions.	
																																																																											[23]	Luft	J	H	(1961)	J.	Biophys.	Biochem.	Cytol.	9	409–14	
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In	Chapter	III	–	Section	2.1.3.2,	we	show	the	most	representative	images	obtained	in	this	study.	Notably,	a	robust	statistical	analysis	is	in	process	at	the	PICT-IBiSA	platform.	
4.2 Bio-nanoprobe:	pBR322	plasmid	DNA	
In	 this	 work,	 we	 used	 a	 molecular	 probe	 to	 quantify	 the	 radiation	 induced	 complex	(nanometer	 size)	 damage	 in	 the	 presence	 of	 nanoparticles.	 This	 probe	 is	 the	 pBR322	plasmid	DNA,	which	is	a	circular	double-stranded	DNA	of	4361	base	pairs	(2.83x106	Da).	It	is	 commercially	 supplied	 (Thermo	 Scientific)	 in	 solution	 at	 0.5	 μg.µL-1	 in	 a	 TE	 buffer	consisting	 on	 10	mmol.L-1	 Tris-HCl	 (pH=7.6)	 and	 1	mmol.L-1	 ethylenediaminetetraacetic	acid	(EDTA).		
Depending	on	its	degradation	level,	plasmid	DNA	presents	the	advantage	of	having	three	different	conformations	namely	supercoiled,	relaxed	and	linear	(see	Figure	II	-	16),	which	can	be	easily	separated	and	quantified.		
	
Figure	II	-	16.	Scheme	of	the	three	different	plasmid	conformations.	The	native	morphology	consists	of	the	supercoiled	conformation	for	more	than	95%	and	
ca.	5%	of	the	relaxed	conformation,	which	corresponds	to	the	plasmid	with	single	strand	break	(SSB).	The	linear	conformation	that	corresponds	to	the	plasmid	with	two	breaks	in	two	 strands	 separated	 by	 less	 than	 ten	 base	 pairs	 (DSB)	 is	 not	 present	 in	 the	 native	product.	
4.2.1 Samples	preparation	and	irradiation	
In	 this	 work,	 a	 protocol	 developed	 before	 (thesis	 of	 Dr.	 Erika	 Porcel)	 was	 used	 and	adapted	to	evaluate	the	nanoscale	effect	of	nanoparticles	on	the	induction	of	simple	breaks	
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(SSB)	 and	 complex	 breaks	 (DSB)	 by	 radiation	 [5].	 An	 illustration	 of	 the	 experimental	protocol	is	presented	in	Figure	II	-	17.	
	
Figure	II	-	17.	Scheme	of	the	experimental	protocol	used	for	molecular	experiments.	Briefly,	 initial	 samples	 consisted	 on	 5	 μg	 plasmid	 DNA	 diluted	 in	 10	 µl	 of	 1x	 TE	 buffer	solution.	 In	 this	 buffer,	we	 assured	 a	 constant	 counter	 ions	 concentration,	 an	 important	parameter	 to	 keep	 the	 plasmid	 conformation	 unchanged.	 The	 as-synthesized	 NPs	 were	diluted	 in	ultrapure	water	 to	 reach	a	Pt	 concentration	of	4.23x10-5	mol.L-1.	 For	 instance,	this	 concentration	 corresponds	 to	 the	 addition	 of	 one	 PtPEG-OH	 NP	 (around	 1000	 Pt	atoms,	see	estimation	Chapter	III	–Section	1.2.2)	per	2	plasmids	[5].	This	ratio	was	used	in	 all	 the	 experiments	 (evaluation	 of	 mono-	 and	 bimetallic	 PEGylated	 nanoparticles).	Control	samples	were	prepared	by	adding	47	μL	of	ultrapure	water	to	the	plasmid	in	order	to	mimic	the	effect	of	the	water	added	with	NPs.		
For	each	condition,	6	aliquots	(18	µL)	were	prepared	and	irradiated	at	doses	ranging	from	0	up	 to	250	Gy	with	 a	dose	 rate	of	ca.	 8.4	Gy/min.	The	dose	 rate	of	 the	panoramic	 60Co	source	was	determined	by	Fricke	dosimetry	(Section	3.1.2).	
	
[5]	Porcel	E	et	al.	(2010)	Nanotechnology	21	85103	
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In	some	samples,	the	contribution	of	indirect	effects	to	the	radiation	induced	damage	was	evidenced	 by	 adding	 dimethylsulfoxide	 (DMSO)	 [24]	 to	 the	 samples	 at	 a	 final	concentration	of	1.0	mol.L-1	(see	results	Chapter	III	-	Section	2.3.3	for	PtPEG-OH	NPs	and	
Chapter	 IV	 –	 Section	 2	 for	 mono-and	 bimetallic	 PEG-2NH2	 NPs).	 DMSO	 is	 known	 to	possess	 important	 radioprotective	 properties	 which	 are	 generally	 associated	 with	 its	rapid	reaction	with	OH·	radicals.	In	the	radiolysis	of	aqueous	systems,	the	rate	constant	of	this	 reaction	 is	 4.2x109	 M-1.s-1	 (neutral	 pH)	 [25].	 In	 Table	 II	 -	 4	 we	 present	 a	 model	protocol	used	to	prepare	samples	of	pure	plasmid	DNA,	plasmid	DNA	in	presence	of	DMSO,	plasmid	 DNA	 loaded	with	 nanoparticles	 and	 plasmid	 DNA	 loaded	with	 nanoparticles	 in	presence	of	DMSO.	
Table	II	-	4.	Experimental	protocol	for	the	samples	preparation	with	and	without	nanoparticles.	
Sample	 Plasmid	(μl)	
1x	TE	
buffer	(μl)	
NPs	
(μl)	
H2O	
(μl)	
DMSO	
7.8	mol.L-1	(μl)	
Total	
Volume	(μl)	Control	 10	 123	 0	 47	 0	 180	Control	+	DMSO	 10	 123	 0	 24	 23	 180	DNA+NPs	 10	 123	 24	 23	 0	 180	DNA+NPs+DMSO	 10	 123	 24	 0	 23	 180	
A	complementary	study	on	the	effect	of	NP	concentration	was	evaluated	by	changing	the	ratio	of	PtPEG-OH	NPs	over	plasmids	(between	0	up	to	8	NPs	per	plasmid).	The	results	are	presented	in	Appendix	B.	
4.2.2 Radio-induced	nanosize	damage:	analysis	and	quantification	
After	 irradiation,	 the	 radiation-induced	 damage	 was	 analysed	 by	 agarose	 gel	electrophoresis.	 The	 three	plasmid	DNA	 conformations	were	 separated	 in	 a	1%	agarose	gel.	 It	was	prepared	by	dissolving	1.5	g	of	agarose	powders	in	150	mL	of	1x	Tris	Acetate	EDTA	 buffer	 solution	 (TAE).	 Samples	 were	 then	 gently	 mixed	 with	 a	 DNA	 gel	 loading	buffer	consisting	of	0.21%	bromophenol	blue,	0.21%	xylene	cyanol	FF,	0.2	M	EDTA,	pH	8.0	and	 50%	 glycerol	 (5-PRIME).	 These	 final	 mixtures	 were	 carefully	 deposited	 into	 the	agarose	gel	immersed	in	a	1x	TAE	solution	for	electrophoresis	migration.		
																																																																											[24]	Chapman	J	D	et	al.	(1979)	Radiat.	Environ.	Biophys.	16	29–41	[25]	Meissner	G	et	al.	(1967)	Zeitschrift	für	Naturforsch.	22	13–9	
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The	 migration	 was	 performed	 at	 4°C	 for	 about	 2	 hours	 20	 minutes	 at	 80	 V.	 DNA	 was	stained	after	migration	 in	a	0.02%	ethidium	bromide	 (EtBr)	aqueous	bath	 (30	min)	and	rinsed	with	pure	water	prior	imaging.	The	EtBr	is	an	intercalating	agent	commonly	used	as	a	fluorescent	tag	for	nucleic	acids	stain.	It	is	classified	as	a	mutagen	because	it	intercalates	DNA	 (i.e.,	 inserts	 itself	 between	 the	 DNA	 strands	 breaks)	 which	 affects	 DNA	 biological	processes	 as	 its	 replication	 and	 transcription	 [26].	 For	 this	 reason,	 it	 is	 treated	 as	hazardous	waste.	Hence,	EtBr	was	strictly	handled	and	disposed	according	to	regulations.	
After	 staining,	 the	 lines	 corresponding	 to	 plasmids	 with	 different	 conformations	 were	revealed	under	UV	light	at	302	nm	and	recorded	with	a	CCD	camera.	The	ImageQuant	5.0	software	 was	 used	 to	 quantify	 the	 intensity	 of	 the	 different	 DNA	 conformations	(densitometry).		
The	supercoiled	plasmids	(S)	bind	1.47	times	less	EtBr	than	the	relaxed	(R)	and	the	linear	(L)	 conformations.	 The	 intensity	 of	 S	 is	 then	multiplied	 by	 1.47	 and	 the	 intensities	 are	normalized	by:		
Total = 1.47⨉S + R + L	 	 	 	 	 	 	 Equation	II	-	13 S! = !.!"⨉!!"#$% 	 	 	 	 	 	 	 	 	 Equation	II	-	14	L! = !!"#$%	 	 	 	 	 	 	 	 	 Equation	II	-	15	R! = !!"#$%	 	 	 	 	 	 	 	 	 Equation	II	-	16	From	S’	and	L’,	the	yields	of	single	and	double	strand	breaks	are	calculated	according	to	a	Poisson	law,	which	is	time	independent	and	finds	applicability	for	low	probabilities	as	in	here	[27].	The	SSB	and	DBS	(nanosize	damage)	yields	were	calculated	by:	
SSB yield breaks per plasmid = ln !!!"!" 	 	 	 	 	 Equation	II	-	17 DSB yield breaks per plasmid = !!!!!!	 	 	 	 	 	 Equation	II	-	18	The	 dose-response	 curves	 were	 thus	 obtained	 by	 plotting	 the	 yields	 as	 function	 of	 the	irradiation	 dose.	 The	 results	 for	 mono-	 and	 bimetallic	 nanoparticles	 are	 presented	 and	discussed	in	Chapter	III	and	IV.	
																																																																											[26]	Waring	M	J	(1965)	J.	Mol.	Biol.	13	269–82	[27]	Spotheim-Maurizot	M	et	al.	(1990)	Int.	J.	Radiat.	Biol.	57	301–13	
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Chapter	III:	RESULTS	AND	DISCUSSION	
PEGylated	platinum	nanoparticles	In	 this	 chapter	we	present	 and	discuss	 the	 characterization	and	biological	 impact	of	 the	novel	 PEGylated	 platinum	 nanoparticles	 (PtPEG-OH	 NPs).	 The	 physico-chemical	characterization	of	 these	nanoparticles	 is	 shown	 in	Section	1.	Their	biological	 impact	 in	two	 different	 human	 cancer	 cell	 lines	 is	 then	 presented	 in	 Section	 2.1	 while	 their	nanoscale	effect	using	the	bio-nanoprobe	already	described	is	finally	presented	in	Section	
2.3.	
1. Nanoparticles	characterization	
During	my	thesis,	I	developed	a	unique	one-step	green	method	to	synthesize	ready-to-use	(sterilized)	 biocompatible	 Pt	 NPs	 for	 biomedical	 applications.	 I	 performed	 the	characterization	 of	 these	 nano-agents	 by	 using	 complementary	 techniques.	 In	 this	perspective	I	contributed	to	bring	new	methods	to	the	group.		
The	radiolytic	reduction	of	the	PtII	precursor	and	thus	nanoparticles	formation	were	firstly	characterized	by	 spectrophotometry	UV-Vis	 (Section	1.1).	The	 size	and	shape	of	 the	as-synthetized	PtPEG-OH	NPs	were	characterized	by	TEM	and	DLS,	these	results	are	shown	in	Section	1.2.	In	Section	1.3	the	oxidation	state	and	chemical	composition	of	PtPEG–OH	NPs	determined	by	XPS	is	presented.	The	functional	characterization	using	FTIR	is	shown	and	discussed	 in	Section	1.4.	Finally,	 the	stability	of	PtPEG-OH	NPs	 in	different	relevant	media	was	investigated	by	DLS	and	is	presented	in	Section	1.5.	
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1.1 Characterization	by	spectrophotometry	UV-Vis		
The	 PtPEG-OH	 NPs	 were	 synthetized	 by	 means	 of	 γ-rays	 water	 radiolysis.	 For	 these	measurements,	 NPs	 synthesized	 in	 water	 containing	 10-2	 mol.L-1	 of	 Pt(NH3)4Cl2	 and	 1	mol.L-1	of	PEG-OH	(Mw=	1000	g.mol-1)	(PEG-OH:Pt	molar	ratio	of	ca.	100)	were	diluted	to	10-3	mol.L-1	(in	Pt)	and	used.		
Metallic	 nanoparticles	 display	 strong	 optical	 absorption	 due	 to	 the	 excitation	 of	 the	surface	plasmon	resonance	of	the	metal	(SPR)	[1].	The	reduction	of	PtII	and	the	formation	of	platinum	nanoparticles	were	followed	by	UV-visible	absorption	spectroscopy.	Figure	III	
-	 1a	 shows	 the	 UV-visible	 absorption	 spectra	 of	 an	 aqueous	 solution	 containing	Pt(NH3)4Cl2	 and	 PEG-OH	 before	 irradiation	 (in	 blue)	 and	 the	 same	 solution	 after	irradiation	(in	red)	(see	experimental	conditions	Chapter	II	–	Section	1.1.2).		
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Figure	III	-	1.	(a)	UV-vis	absorption	spectra	of	control	solutions	containing	Pt(NH3)4Cl2	(____)and	PEG-OH	(---)	and	samples	consisting	on	diluted	platinum	containing	solutions	(10-3	mol.L-1)	before	(____)	and	after	(____)	irradiation	(optical	path=	2	mm).	Inserted	pictures	correspond	to	an	aqueous	solution	containing	Pt(NH3)4Cl2	and	PEG-OH	before	and	after	irradiation	(10-2	mol.L-1,	D=	100	kGy).	(b)	Absorption	spectra	of	samples	shown	in	(a)	but	in	a	wavelength	range	from	200	to	400	nm.	In	Figure	III	-	1,	the	black	and	blue	absorption	spectra	reveal	that,	before	irradiation,	the	aqueous	solutions	composed	of	Pt(NH3)4Cl2	or	Pt(NH3)4Cl2	in	the	presence	of	PEG-OH	have	a	 main	 absorption	 peak	 close	 to	 240	 nm	 and	 a	 small	 shoulder	 around	 290	 nm,	 which	
																																																																											[1]	Mie	G	(1908)	Ann.	Phys.	330	377–445	
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correspond	to	the	ligand-to-metal	charge	transfer	(LMCT)	band	between	 NH! !!!	and	PtII	ions	[2].	The	absorption	spectrum	of	the	PEG-OH	alone	(---),	does	not	display	any	signal	in	the	UV-visible	 region.	 After	 irradiation,	we	 observe	 the	 disappearance	 of	 the	 two	 initial	absorption	 peaks	 and	 the	 appearance	 of	 a	 stretched	 absorption	 spectrum	with	 a	 single	broad	 peak	 centered	 around	 270	 nm.	 This	 new	 spectrum	 is	 attributed	 to	 platinum-PEG	colloids.	 Notably,	 the	 spectrum	 of	 PtPEG-OH	 NPs	 remains	 unchanged	 during	 several	months,	which	indicates	the	complete	reduction	of	platinum	ions	and	formation	of	stable	nanoparticles.	These	observations	are	in	good	agreement	with	previous	works	where	the	optical	 properties	 of	 colloidal	 platinum	 nanoparticles	 synthetized	 by	 radiolysis	 were	studied	 [2]	 [3].	 The	 inserted	 pictures	 in	 Figure	 III	 -	 1a	 show	 the	 color	 change,	 from	colorless	 before	 irradiation	 to	 dark	 brown	 after	 gamma	 rays	 treatment.	 This	 color	 is	characteristic	of	the	formation	of	platinum	nanoparticles.	
The	 formation	 of	 metallic	 platinum	 nanoparticles	 from	 the	 radiolytic	 reduction	 of	Pt(NH3)4Cl2	in	aqueous	solution	takes	place	through	the	following	mechanisms	[2]:	
1. The	Pt(NH3)4Cl2	 	 platinum	 complex	 in	 solution	dissociates	 into	 [Pt	 (NH3)4]2+	 cations	and	2Cl-	anions.	
Pt (NH!)! Cl! → [Pt NH! !]!! + 2Cl!	 	 	 	 	 Equation	III	-	1	2. The	 solvated	 electrons	 e!"! 	 and	 hydrogen	 radicals	 H·	 produced	 by	 water	 radiolysis	efficiently	reduce	Pt2+	ions	to	Pt0	atoms.	
Pt NH! ! !! + 2e!"!  →  Pt! + 4NH! 	 	 	 	 	 Equation	III	-	2	Pt NH! ! !! + 2H ∙ →  Pt! + 4NH! + 2H! 	 	 	 	 	 Equation	III	-	3	3. The	 coalescence	 of	 the	 neutral	 atoms	 leads	 to	 the	 formation	 of	 the	 metal	 atomic	clusters.	
Pt! + Pt! → Pt!! 	 	 	 	 	 	 	 	 Equation	III	-	4	Pt!! + Pt! → Pt!!!! 	 	 	 	 	 	 	 	 Equation	III	-	5	
																																																																											[2]	Gharibshahi	E	and	Saion	E	(2012)	Int.	J.	Mol.	Sci.	13	14723–41	[3]	Remita	H	et	al.	(2005)	Radiat.	Phys.	Chem.	72	575–86	
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4. During	 the	radiolytic	process,	 the	Pt!!!! 	 clusters	can	also	be	re-combined	with	 [Pt	(NH3)4]2+	 ions	 to	 form	 [Ptm+2(NH3)4]2+.	 These	 recombined	 ions	 might	 form	 larger	Pt!!!! 	nanoparticles	which	agglomerate	until	a	complete	reduction	is	achieved.	
Pt!!!! +  Pt NH! ! !!  →  Pt!!! NH! ! !! 		 	 	 	 Equation	III	-	6	Pt!!! NH! ! !! + 2e!"! →  Pt!!!! + 4NH! 	 	 	 	 	 Equation	III	-	7	To	 obtain	 stable	 and	 homogenous	 clusters,	 the	 coalescence	 must	 be	 limited	 by	 the	presence	of	 ligands	such	as	polymeric	molecules.	 In	 the	present	case,	PEG-OH	molecules	were	used	as	stabilizer	(see	synthesis	in	Chapter	II	–	Section	1.1.2).	
1.2 Size	distribution	and	morphology		
The	 brownish	 color	 of	 the	 platinum	 colloidal	 solution	 after	 irradiation	 (inserted	 picture	
Figure	III	 -	1a)	was	 the	 first	 indication	of	nanoparticles	 formation.	Figure	III	 -	2	 shows	TEM	micrographs	of	PtPEG-OH	NPs	synthetized	with	an	initial	platinum	concentration	of	10-2	 mol.L-1,	 a	 PEG-OH:Pt	 molar	 ratio	 of	 ca.	 100	 and	 a	 total	 radiation	 dose	 of	 100	 kGy.	These	micrographs	 were	 obtained	 with	 the	 JEOL	 2200FS	microscope	 at	 the	 PICT-IBiSA	platform.		
	 	 	
a)	 b)	 c)	
Figure	III	-	2.	TEM	micrographs	of	PtPEG-OH	NPs	synthesized	in	water	with	an	initial	PtII	concentration	of	10-2	mol.L-1	and	a	PEG-OH:Pt	molar	ratio	of	ca.	100	measured	at	three	magnifications.	Scale	bars:	(a)	0.5	μm,	(b)	50	nm	and	(c)	20	nm.	At	 the	 three	different	magnifications,	we	clearly	observe	homogeneity	 in	size	and	shape.	This	 measurement	 shows	 that	 PtPEG-OH	 NPs	 are	 mainly	 spherical	 with	 an	 average	metallic	core	diameter	of	3.2	±	0.8	nm	(Figure	III	-	3a).	DLS	measurements	showed	that	these	NPs	have	an	average	dH	of	8.8	±	3.1	nm	(PdI=	0.238	±	0.004)	 (Figure	 III	 -	3b).	 In	
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agreement	 with	 other	 works	 [4]	 [5],	 the	 –OH	 end-group	 of	 PEG	 conferred	 to	 platinum	nanoparticles	 an	 average	 negative	 ζ-potential	 of	 -16.6	 ±	 5.1	 mV	 in	 water	 (pH	 ∼6	 –	 7,	synthesis	 conditions).	 Figure	 III	 -	 3c	 shows	 the	 electron	 diffraction	 pattern	 of	 these	PtPEG-OH	 NPs.	 This	 tells	 that	 the	 platinum	 core	 have	 a	 crystal	 structure	 (ordered	arrangement	of	atoms).		
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Figure	III	-	3.	(a)	Diameter	distribution	of	the	metallic	core,	(b)	average	hydrodynamic	diameter	and	(c)	electron	diffraction	pattern	of	PtPEG-OH	NPs.	PtPEG-OH	 NPs	 synthesized	 with	 platinum	 concentrations	 ranging	 from	 10-3	 up	 to	 10-2	mol.L-1	 (PEG-OH:Pt	 molar	 ratio	 of	 ca.	 100)	 are	 very	 similar	 in	 size	 and	 shape.	Nanoparticles	remain	stable	for	several	months	when	stored	at	4	°C	(verified	by	TEM,	DLS,	and	spectrophotometry).	
1.2.1 Influence	of	the	PEG-OH:Pt	ratio	on	the	stability	and	size	of	NPs	
Colloidal	PtPEG-OH	NPs	were	also	synthetized	with	PEG-OH:Pt	molar	ratios	of	ca.	1,	5,	10,	25	 and	 50.	 The	 PtPEG-OH	 NPs	 with	 a	 PEG-OH:Pt	 molar	 ratio	 of	 ca.	 1	 precipitated	immediately	 after	 irradiation	while	 the	 other	 colloids	were	 stable	 for	 longer	 time.	 PEG-OH:Pt	molar	 ratio	 of	 ca.	 5	 precipitated	 in	 a	week	 and	 thus	 no	 further	 investigation	was	carried	out.	Therefore,	colloids	containing	PEG-OH:Pt	molar	ratio	of	ca.	10,	25	and	50	were	further	 characterized.	 Table	 III	 -	 1	 summarizes	 the	 stability,	 core	 diameter	 and	hydrodynamic	diameter	of	fresh	PtPEG-OH	NPs	synthetized	at	different	PEG-OH:Pt	molar	ratios.		
	
	
																																																																											[4]	Doane	T	L	et	al.	(2012)	Acc.	Chem.	Res.	45	317–26	[5]	Gilles	M	et	al.	(2014)	Colloids	Surfaces	B	Biointerfaces	123	770–7	
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Table	III	-	1.	Influence	of	the	PEG-OH:Pt	molar	ratio	on	the	stability	and	size	distribution	of	PtPEG-OH	NPs.	
PEG-OH:Pt	 Colloidal	stability*	 Core	diameter	(nm)	
Hydrodynamic	
diameter	(nm)	1	 non	 -	 -	5	 weak	 -	 -	10	 medium	 3.0	±	0.6	 17.7	±	5.5	25	 medium	 2.8	±	0.8	 14.7	±	6.1	50	 good	 2.8	±	1.0		 11.8	±	2.8	100	 good	 3.2	±	0.8		 8.8	±	3.1		*The	stability	corresponds	to	a	qualitative	determination	by	the	presence	of	turbidity	or	colloids	precipitates	when	the	solutions	are	stored	at	4°C.		weak=	colloids	precipitation	in	a	week,		medium=	colloids	precipitation	in	less	than	3	weeks,		good=	colloids	are	stable	for	more	than	6	week	up	to	3	months.	In	Table	 III	 -	 1,	we	 observe	 that	 the	 platinum	 core	 diameter	was	 constant	 for	 colloids	containing	PtPEG-OH	NPs	with	a	PEG-OH:Pt	molar	ratio	of	ca	10,	25,	50	and	100.	On	the	other	hand,	the	dH	of	 fresh	colloids	increased	from	8.8	nm	(PtPEG-OH	NPs	-	100)	to	17.7	nm	(PtPEG-OH	NPs	-10)	indicating	the	presence	of	small	NPs	aggregates.	
In	particular,	the	PtPEG-OH	NPs	prepared	with	a	PEG-OH:Pt	molar	ratio	of	ca.	50	exhibited	good	 colloidal	 stability	 and	 identical	 morphological	 characteristics	 as	 those	 NPs	synthetized	with	a	PEG-OH:Pt	molar	ratio	of	ca.	100	(see	Figure	III	-	1).		
In	 summary,	 the	 PEG-OH:Pt	 molar	 ratios	 of	 ca.	 50	 and	 100	 are	 the	 best	 conditions	 to	prepare	well	stable	biocompatible	PtPEG-OH	NPs.		
The	 impact	 of	 the	 PtPEG-OH	NPs	 in	 biological	 systems	 (Section	2)	was	 evaluated	using	nanoparticles	 synthetized	 with	 a	 PEG-OH:Pt	 molar	 ratio	 of	 about	 100,	 which	 were	considered	as	the	most	stable	nano-agents	for	biomedical	concerns.		
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1.2.2 Estimation	on	the	number	of	Pt	atoms	per	NP	
Commonly,	 platinum	 atoms	 are	 organized	 in	 a	 face-centered	 cubic	 lattice	 (fcc)	 [6].	The	platinum	fcc	crystal	structure	have	4	atoms	per	unit	cell	and	a	lattice	constant	of	3.912	Å	(0.3912	 nm).	 By	 considering	 the	 approach	 that	 there	 is	 an	 outer	 shell	 of	 atoms	surrounding	the	spherical	core	of	the	nanoparticle,	with	finite	thickness	that	corresponds	to	 half	 of	 the	 lattice	 constant	 (0.1956	 nm),	 we	 calculated	 the	 configuration	 of	 platinum	atoms	in	the	3.2	nm	nanocrystal	as	follow:	
The	volume	of	the	inner	platinum	core	is:	
V!"#$ = 4πr!3 = 4π (1.6 − 0.1956)!3 = 11.60 nm! 
The	total	volume	of	a	3.2	nm	diameter	NP	is:	
V!"! = 4π(1.6)!3 = 17.15 nm!  	
The	volume	of	the	shell	is	the	difference	between	the	total	volume	and	the	volume	of	the	core:	
Vshell = Vtot − Vcore = 17.15 − 11.60 = 5.55 nm3	
Since	the	lattice	constant	of	the	Pt	unit	cell	is	0.3912	nm	the	volume	of	a	single	unit	cell	is:	
Vunit = (0.3912)3 = 0.0599 nm3	
Thus,	we	determine	the	number	of	unit	cells	making	up	the	shell	from:	
Unit cellsshell = VshellVunit = 5.550.0599 ≈ 93	
Considering	4	atoms	per	unit	cell,	the	total	number	of	platinum	atoms	in	the	surface	is:	
Pt atomssurface = 93 4 = 372 atoms	
																																																																											[6]	Davey	W	P	(1925)	Phys.	Rev.	25	753–61	
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Then,	the	total	number	of	atoms	in	the	entire	particle	is	calculated	with	the	total	number	of	unit	cells	as:	
Unit cellstot = VtotVunit = 17.150.0599 ≈ 286 atoms	
Pt atomstot = 286 4 = 1144 atoms	
We	find	the	fraction	of	surface	atoms	as:	
! = Pt atoms!"#$%&'Pt atoms !"! = 3721144 ≈ 0.33	
As	 illustrated	 in	Figure	 III	 -	4,	 one	3.2	nm	platinum	nanoparticle	 contains	around	1000	atoms	and	~33%	of	them	are	on	the	surface.	
	
Figure	III	-	4.	Schematic	representation	of	a	3.2	nm	platinum	nanoparticle.	
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1.3 Oxidation	state	and	chemical	composition	by	XPS	
In	 this	 work,	 we	 investigated	 the	 elemental	 composition,	 oxidation	 state	 and	 chemical	structure	 of	 the	 as-synthetized	PtPEG-OH	NPs	 nanoparticles	 by	XPS.	 The	PtPEG-OH	NPs	synthesized	at	10-2	mol.L-1	(PEG-OH:Pt	molar	ratio	of	ca.	100)	with	a	total	dose	of	100	kGy	were	analyzed.		
1.3.1 Qualitative	elemental	composition	
The	 survey	 XPS	 spectrum	 of	 PtPEG-OH	 NPs	 is	 shown	 in	 Figure	 III	 -	 5.	 Only	 peaks	characteristic	of	Pt,	C,	O,	N	and	Cl	were	observed.	This	confirms	that	the	PtPEG-OH	NPs	are	composed	of	these	elements	only.	
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Figure	III	-	5.	Survey	XPS	spectrum	of	PtPEG-OH	NPs	synthesized	with	a	total	gamma	dose	of	100	kGy.	
1.3.2 Platinum	core	oxidation	state	
Figure	 III	 -	 6a	 shows	 the	 high-resolution	 XPS	 spectra	 of	 the	 platinum	 complex	(Pt(NH3)42+)	 powder	 (in	 black).	 For	 comparison	 we	 also	 measured	 the	 spectrum	 of	 a	platinum	 solid	 sample	 (in	 blue).	 Figure	 III	 -	 6b	 corresponds	 to	 the	 high-resolution	 XPS	spectrum	of	PtPEG-OH	NPs.	
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a)	 b)	
Figure	III	-	6.	XPS	spectra	corresponding	to	the	Pt-4f	core	level	region	of	platinum	on	(a)	the	platinum	complex	(_____)	and	on	a	platinum	solid	sample	(_____)	and	(b)	on	PtPEG-OH	NPs	showing	their	bulk	(_____)	and	surface	(_____)	components.	In	 order	 to	 identify	 the	 oxidation	 state	 of	 the	 PtPEG-OH	 NPs,	 we	 selected	 from	 the	literature	 the	BE	of	 different	 platinum	 samples	 that	 resemble	 the	most	 to	 our	 case.	 The	data	 correspond	 to	 bulk-like	 Pt	 species	 in	 single	 crystals	 and	 films,	 and	 oxidized	 Pt	nanoparticles.	The	BE	values	are	reported	below.	
Table	III	-	2.	Summary	of	binding	energy	values	reported	in	literature	for	the	Pt-4f	7/2	core	level	of	different	Pt	phases.	
4f	7/2	BE	(eV)	
Sample	 Reference	
Pt0	 PtO	70.7	 73.3	 Pt	film	 Kim	K	S	et	al.	(1971)	J.	Am.	Chem.	Soc.	93	6296–7	70.9	(bulk)	70.5	(surf.)	 -	 Pt	(111)	 Puglia	C	et	al.	(1995)	Surf.	Sci.	342	119–33	71.2	–	71.5	 72.2	-72.5	 Pt	film	(400	nm)/glass	 Abe	Y	et	al.	(1999)	Jpn.	J.	Appl.	Phys.	38	4872	71.5	 74.4	 PtO	(<2	nm)powder	 Fleisch	T	H	et	al.	(1986)	J.	Phys.	Chem.	90	5317-20	Pt1	=	73.2	Pt6=	72.5	 -	 Ptn/SiO2/Si	(n=1	–	6)	 Eberhardt	W	et	al.	(1990)	Phys.	Rev.	Lett.	64	780	71.2	 72.3	 Pt	(4	nm)/La2O3-ZrO2	 Pitchon	V	et	al.	(1999)	J.	Catal.	186	64-74	
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71.1	 72.8	 Pt	(3	nm)/MWCN	 Tian	Z	Q	et	al.	(2006)	J.	Phys.	Chem.	B	110(11)	5343-50	72.0	 73.4	 Pt	(10	nm)/ODA	 Kumar	A	et	al.	(2004)	J.	Chem.	Sci.	116	293-300		
The	precursor	compound	presented	a	peak	at	73.0	eV	(Figure	III	-	6a).	From	the	table,	we	attribute	this	signal	to	the	characteristic	Pt-4f7/2	BE	of	platinum	with	a	+2	oxidation	state	[7]	[8].	Knowing	that	the	distance	between	the	Pt-4f7/2	and	Pt-4f5/2	spin-orbit	components	is	3.33	eV,	we	confirm	the	attribution	of	the	second	peak.	Note	that	the	shoulder	observed	at	lower	BE	is	originated	by	the	in	situ	reduction	of	the	PtII	ions	during	measurements.	In	the	blue	spectrum	shown	in	Figure	III	-	6a,	 the	well	separated	Pt-4f7/2	and	Pt-4f5/2	spin-orbit	 components	 are	 observed	 at	 71.1	 and	 74.5	 eV	 respectively,	 which	 is	 specific	 to	metallic	Pt	[9].	
In	Figure	 III	 -	 6b,	 the	 spectrum	of	PtPEG-OH	NPs	 at	 the	Pt-4f	 core	 level	 is	 displayed	 in	black.	Its	deconvolution	shows	two	contributions:	the	contribution	of	the	core	component	(double	 peak	 at	 71.2	 and	 74.4	 eV),	 commonly	 referred	 as	 bulk	 component,	 and	 the	contribution	 of	 the	 main	 surface	 component	 (double	 peak	 at	 70.4	 and	 73.7	 eV).	 This	measurement	is	 in	good	agreement	with	other	works	performed	in	metallic	Pt	films	[10]	and	Pt	NPs	[11]	confirming	the	complete	reduction	of	PtII	 ions	 into	Pt0.	Moreover,	 in	 the	XPS	summary	table	(see		
Table	 III	 -	4	at	 the	end	of	 this	 section)	we	observe	 that	 the	 full	width	at	half	maximum	(FWHM)	 of	 PtPEG-OH	 NPs,	 at	 the	 Pt-4f	 core	 level,	 increased	 by	 about	 33%.	 This	broadening	suggests	that	there	is	a	strong	interaction	between	the	metal	surface	and	the	PEG	molecules	[12].		
The	 same	 result	 was	 found	 for	 tree	 independent	 experiments	 performed	with	 different	NPs	 batches	 (within	 the	 error	 margin	 of	 the	 experimental	 set	 up	 (±	 0.2	 eV)),	 which	demonstrates	the	accuracy	and	the	reproducibility	of	the	synthesis	method.	
																																																																											[7]	Kim	K	S	et	al.	(1971)	J.	Am.	Chem.	Soc.	93	6296–7	[8]	Contour	J	P	et	al.	(1977)	J.	Catal.	48	217–28	[9]	Barr	T	L	(1978)	J.	Phys.	Chem.	82	1801–10	[10]	Puglia	C	et	al.	(1995)	Surf.	Sci.	342	119–33	[11]	Liu	F	et	al.	(2009)	J.	Surf.	Anal.	15	271–3	[12]	Fu	X	et	al.	(2001)	J.	Colloid	Interface	Sci.	243	326–30	
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1.3.3 Insights	on	the	interaction	of	PEG	molecules	with	the	Pt0	core	
The	 arrangement	 of	 the	 PEG	molecules	 at	 the	 surface	 of	 a	 Pt0	 core	was	 investigated	 by	measuring	 the	 BE	 at	 the	 C-1s,	 O-1s	 and	 N-1s	 core	 levels.	 The	 C-1s,	 O-1s	 and	 N-1s	 XPS	spectra	of	PEG-OH,	Pt(NH3)4Cl2	and	PtPEG-OH	NPs	are	shown	in	Figure	III	-	7.		
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Figure	III	-	7.	XPS	spectra	of	(a)	C-1s,	(b)	O-1s	and	(c)	N-1s	in	pure	PEG-OH,	Pt(NH3)4Cl2	and	PtPEG-OH	NPs.	In	order	to	identify	the	C-1s,	O-1s	and	N-1s	peaks,	we	selected	from	the	literature	the	BE	of	different	 aliphatic	 species	 that	 resemble	 the	most	 to	 our	 study.	 The	 data	 are	 shown	 in	
Table	III	-	3.	
Table	III	-	3.	XPS	reference	table	with	C1s,	O1s	and	N1s	binding	energies	of	the	aliphatic	species	here	investigated.	
Atomic	
core	level	
Binding	
energy	(eV)	 Assignment	 Reference	
C-1s	
286.2-286.7	 C-O	 Truica-Marasescu	F	et	al.	(2008)	Plasma	Processes	and	Polymers	5	44	Shard	A	G	et	al.	(2004)	Journal	of	Physical	
Chemistry	B	108	12472	F.	Pippig	et	al.	(2007)	Applied	Surface	Science	
253	6817	285.7-286.0	 C-N	
287.6-288.3	 C=O	 Truica-Marasescu	F	et	al.	(2008)	Plasma	Processes	and	Polymers	5	44	Briggs	D	et	al.	(2003)	Surface	and	Interface	Analysis	35	156	Shard	A	G	et	al.	(2004)	Journal	of	Physical	
Chemistry	B	108		12472	286	 C=O	 Jansen	R	J	J	and	van	Bekkum	H	(1995)	Carbon	N.	Y.	33	1021–7	286.5	 -C-CN	 Deniau	G	et	al.	(2006)	Surf.	Sci.	600	675–84	
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O-1s	 532.7	 C-O-C	H-O-C	 López	G	P	et	al.(1991)	Surf.	Interface	Anal.	17	267–72	532.7	 C=O	 Whelan	C	M	et	al.	(2004)	Thin	Solid	Films	464	388–92	
N-1s	 397.8	–	399.0	 N=C	
Truica-Marasescu	F	et	al.	(2008)	Plasma	
Processes	and	Polymers	5	44	Rangan	S	et	al.	(2005)	Journal	of	Physical	
Chemistry	B	109	12899	399.1-399.6	 NH2	 Truica-Marasescu	F	et	al.	(2008)	Plasma	
Processes	and	Polymers	5	44	Chowdhury	A	K	M	S	et	al.	(1999)	Surface	and	
Coatings	Technology	112	133-139	400.3-400.7	 NHC=O	400.9-401.7	 -NH2/-NH3+	Polymers	 with	 only	 alcohol-	 or	 ether-type	 oxygens,	 such	 as	 PEG-OH,	 exhibit	 C-O	 BEs	ranging	from	286.1	to	286.5	eV	at	the	C-1s	region	and	from	532.3	to	533.1	eV	at	the	O-1s	spectral	region	[13]	[14]	[15].	PEG-OH	(Figure	III	-	7a	and	b	–	upper	spectra)	presented	a	C-1s	 peak	 centred	 at	 286	 eV	 with	 a	 small	 shoulder	 at	 lower	 binding	 energy.	 The	 peak	around	 286	 eV	 is	 characteristic	 of	 carbon	 adjacent	 to	 oxygen	 in	 an	 ether	 environment	(CH2-O)	[13].	The	small	shoulder	observed	at	lower	BE	may	be	interpreted	as	the	carbon-carbon	bonding	 from	the	PEG	chain	 [16].	We	observed	that	 the	appearance	of	 this	small	signal	depends	on	the	sample	preparation	(powders	or	drop	casting)	and	substratum.	The	O-1s	 BE	 of	 PEG	was	 found	 at	 532.3	 eV,	 which	 corresponds	 to	 C-O-C	 (ether)	 and	 C-O-H	(hydroxyl)	oxygens	[13].	
The	PtPEG-OH	NPs	(Figure	III	-	7a	and	b	–	lower	spectra)	presented	identical	XPS	signals	at	 the	 C-1s	 and	 O-1s	 regions	 compared	 to	 those	 of	 PEG-OH	 alone.	 The	 slight	 increases	(≤0.2	 eV)	 observed	 in	 the	 FWHM	at	 the	 C-1s	 and	O-1s	 core	 levels	 of	 nanoparticles	 (see	summary	in		
Table	 III	 -	4)	are	attributed	 to	a	 commonly	encountered	charge	 compensation	difficulty	when	measuring	polymers	[17]	[18].	In	addition,	from	the	reference	table	the	position	of	aminated	 carbons	 (C-N,	 -C-CN)	 is	 found	 at	 286.0	 ±	 0.5	 eV	 [19]	 [20]	 and	 double-bonded	oxygen	atoms	(C=O)	are	found	at	286	eV	(C-1s)	and	532.7	eV	(O-1s)	[21].	An	overlapping	between	the	C-N	and	C=O	binding	energies	and	the	characteristic	C-1s	and	O-1s	peaks	may	
																																																																											[13]	López	G	P	et	al.(1991)	Surf.	Interface	Anal.	17	267–72	[14]	Truica-Marasescu	F	and	Wertheimer	M	R	(2008)	Plasma	Process.	Polym.	5	44–57	[15]	Contarini	S	et	al.	(1991)	Appl.	Surf.	Sci.	51	177–83	[16]	Hong	R	et	al.	(2005)	Chem.	Mater.	17	4617–21	[17]	Drummond	I	W	et	al.	(1993)	Fresenius.	J.	Anal.	Chem.	346	200–4	[18]	Pijpers	A	P	et	al.	(1993)	Fresenius.	J.	Anal.	Chem.	346	104–9	[19]	Jansen	R	J	J	and	van	Bekkum	H	(1995)	Carbon	N.	Y.	33	1021–7	[20]	Deniau	G	et	al.	(2006)	Surf.	Sci.	600	675–84	[21]	Whelan	C	M	et	al.	(2004)	Thin	Solid	Films	464	388–92	
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suggest	the	presence	of	these	chemical	structures	but	the	assignment	cannot	be	confirmed	considering	only	XPS	data.	
The	 precursor	 Pt(NH3)4Cl2	 (Figure	 III	 -	 7c	 –	 upper	 spectrum)	 presents	 at	 400.2	 eV	 the	typical	 signal	of	Pt-NH3+	 [8].	 It	 is	well	known	 that	nitrogen-containing	molecules	are	not	stable	during	XPS	measurement	[19],	which	explains	the	small	shoulder	observed	at	lower	BE.		
Note	that	the	signal	of	nitrogen	(N-1s)	in	the	case	of	PtPEG-OH	NPs	was	much	lower	than	C-1s	and	O-1s	(Figure	III	-	5),	this	is	because	of	the	composition	of	the	sample	(at	similar	geometrical	cross	section).	The	low	nitrogen	content	made	difficult	the	measurements	of	the	 narrow	 windows.	 However,	 in	 order	 to	 decrease	 radiation	 damage	 and	 related	changes	in	the	nitrogen	conformation,	the	average	of	a	few	high	resolution	XPS	scans	(16)	at	the	N-1s	region	was	used	to	determine	the	N-1s	BE	of	the	PtPEG-OH	NPs.	We	observe	(Figure	III	-	7c	–	lower	spectrum)	that	the	Pt-NH3+	BE	vanished,	indicating	an	important	change	on	the	chemical	structure	of	nitrogen	in	the	surface	of	the	NPs.	The	PtPEG-OH	NPs	have	 a	 broadening	 N-1s	 peak	 at	 lower	 binding	 energy	 centered	 at	 398.2	 eV.	 The	broadening	may	 indicate	 the	 presence	 of	 several	 amine	 species.	 The	 assignment	 of	 this	peak	is	very	difficult	due	to	the	lack	of	available	information.	One	study	interpreted	the	N-1s	 chemical	 shift	 to	 lower	BE	 as	 the	 direct	 interaction	 of	 nitrogen-containing	 functional	groups	with	metal	 surfaces	 (Fe,	 Cu	 and	Ni)	 [22].	 Thus,	 these	measurements	 at	 the	N-1s	core	 level	 suggest	 that	amine	groups	 strongly	 interact	 in	proximity	of	Pt0	 surface,	which	confers	 good	 colloidal	 stability	 to	 NPs.	 The	 nature	 of	 this	 interaction	 (covalent	 or	electrostatic)	cannot	be	completely	defined	by	XPS	(see	discussion	Section	1.4	–	Infrared	spectroscopy).	
In	summary,	the	XPS	data	at	the	C-1s,	O-1s	and	N-1s	energy	ranges	show	that	Pt0	NPs	are	grafted	with	PEG	molecules	and	suggest	a	key	role	of	the	precursor	–NH3+	complex	ligand	in	the	stability	and	strength	of	this	Pt-PEG	interaction.	In	addition,	some	studies	addressed	the	 interpretation	 of	 the	 unchanged	 C-1s	 and	 O-1s	 core	 levels	 to	 PEG	 molecules	 that	dominate	 a	monolayer	 configuration	 at	 the	 nanoparticle	 surface	 [16]	 [23]	 [24]	 and	 the	unchanged	FWHM	 to	 a	perpendicular	 grafting	of	PEG	molecules	 [22].	 For	 instance,	with	
																																																																											[8]	Contour	J	P	et	al.	(1977)	J.	Catal.	48	217–28	[16]	Hong	R	et	al.	(2005)	Chem.	Mater.	17	4617–21	[19]	Jansen	R	J	J	and	van	Bekkum	H	(1995)	Carbon	N.	Y.	33	1021–7	[22]	Crispin	X	et	al.	(2001)	J.	Electron	Spectros.	Relat.	Phenomena	121	57–74	[23]	Forbes	L	M	et	al.	(2011)	J.	Mater.	Chem.	21	15788	[24]	Forbes	L	M	et	al.	(2013)	J.	Mater.	Chem.	A	1	10267–73	
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PEG	molecules	grafted	parallel	(flat)	to	the	surface,	we	would	expect	a	broadening	of	the	photopeaks	 as	 due	 to	 the	 interaction	 of	 carbon	 and	 oxygen	 atoms	 with	 the	 metal	(chemisorption)	[22].	
The	XPS	studies	(binding	energies	and	FWHM)	of	the	PtPEG-OH	NPs	 in	comparison	with	the	Pt(NH3)4Cl2	precursor,	the	pure	PEG-OH	ligand	and	a	Pt0	solid	samples	are	summarized	and	presented	below	(	
Table	III	-	4).	
Table	III	-	4.	XPS	data	summary:	BE	and	FWHM	of	platinum,	carbon,	oxygen	and	nitrogen	in	different	environments	(Pt(NH3)4Cl2,	Pt0	solid,	PEG-OH,	and	PtPEG-OH	NPs).	
Compound	 Atomic	core	level	 BE	(eV)	 Assignment	 FWHM	(eV)	
Pt	(NH3)4	Cl2	 Pt-4f7/2	 73.0	 PtII	 1.7	Pt-4f5/2	 76.3	 PtII	 1.7	N-1s	 400.2	 Pt-NH3+	 1.6	Pt0	solid	 Pt-4f7/2	 71.1	 Pt0	 1.2	Pt-4f5/2	 74.5	 Pt0	 1.2	
PEG-OH	 C1s	 286.0	 C-O	 1.2	C1s	 284.4	 C-C	 0.8	O1s	 532.3	 C-O-H	C-O-C	 1.3	
PtPEG-OH	NPs	
Pt-4f7/2	surf.	 70.4	 Pt0	 1.3	Pt-4f5/2	surf.	 73.7	 Pt0	 1.3	Pt-4f7/2	core	 71.2	 Pt0	 1.6	Pt-4f5/2	core	 74.4	 Pt0	 1.6	C-1s	 286.0	 C-O	C-N	C=O	 1.3	C-1s	 284.3	 C-C	 1.0	O-1s	 532.3	 C-O-H	C-O-C	C=O	 1.3	N-1s	 398.2	 Pt	---	NH2-	 3.9	
1.3.4 Quantitative	elemental	composition	
From	 the	 high	 resolution	 spectra	 previously	 presented,	 the	 semi-quantitative	 XPS	elemental	 composition	 (±	 10%)	 of	 the	 PtPEG-OH	NPs	 and	 their	 precursors,	 Pt(NH3)4Cl2	
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and	PEG-OH,	was	determined	(Table	III	-	5).	The	elemental	composition	was	calculated	as	follow:	
% Element = !!!!  x 100	 	 	 	 	 	 	 Equation	III	-	8	
where	AE	is	the	normalized	area	of	the	XPS	peak	for	a	given	element	and	AT	is	the	sum	of	all	the	normalized	areas.	The	data	were	treated	applying	the	respective	atomic	sensitivity	factors	 and	 by	 using	 the	 Avantage	 software	 (see	 spectra	 processing	 in	 Chapter	 II	 –	
Section	2.5.1).	
Table	III	-	5.	XPS	and	theoretical	elemental	composition	of	PtPEG-OH	NPs	and	their	precursors.	
Sample	 %	Pt	 %	N	 %	Cl	 %	C	 %	O	
C/O	 PEG/Pt	
XPS	 Theoretical	 XPS	 Theoretical	Pt	(NH3)4	Cl2	 17	 49	 34	 -	 -	 -	 -	 -	 -	PEG-OH	Mw=	1000	g.mol-1	 -	 -	 -	 66	 34	 2.00	 2.00	 -	 -	PtPEG-OH	NPs	 14	 <1	 <1	 57	 29	 1.96	 2.00	 6.08	 6.20	
The	 measurements	 are	 in	 good	 agreement	 with	 the	 theoretical	 evaluation	 of	 the	composition	(from	the	stoichiometry	of	the	compounds).	
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1.4 Functional	characterization	by	FTIR		
Figure	III	-	8	shows	the	FTIR	spectra	of	(a)	the	native	PEG-OH	(Mw=	1000	g.mol-1),	(b)	the	Pt(NH3)4Cl2	complex,	(c)	the	mixture	of	Pt(NH3)4Cl2	with	PEG-OH	(PEG-OH:Pt	molar	ratio	of	 ca.	 100)	 and	 (d)	 the	 as-synthetized	 PtPEG-OH	 NPs	 obtained	 after	 irradiation.	 We	highlight	in	red	new	IR	bands	and	in	blue	those	remarkable	functional	shifts	appearing	in	spectra	(c)	and	(d).	
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Figure	III	-	8.	FTIR	spectra	of	(a)	PEG-OH,	(b)	PtII	precursor	salt,	(c)	PtII	precursor	mixed	with	PEG-OH	(without	irradiation)	and	(d)	PtPEG-OH	NPs	obtained	after	irradiation	of	the	PtII	precursor	and	PEG-OH	mixture.	
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In	 order	 to	 identify	 the	 IR	 bands	 shown	 in	 Figure	 III	 -	 8,	 the	 infrared	 frequencies	 and	vibrational	assignments	of	various	functional	groups	used	in	this	work	are	summarized	in	
Table	III	-	6.	
Table	III	-	6.	Reference	table	of	characteristic	infrared	absorption	frequencies	and	vibrational	assignments	of	selected	organic	functional	groups.	From	[25]	[26].	
Functional	
Group	 Stretching	Vibrations	 Bending	Vibrations	Range	
(cm-1)	 *Int.	 Assignment	
Range	
(cm-1)	 *Int.	 Assignment	
Alkane	
	
2840-3000	 str	 C-H	CH3,	CH2 &	CH	2	or	3	bands	 1350-1480	 med	 -C-H	CH2 &	CH3 deformation	1370-1390	 med	 CH3 deformation	720-725	 wk	 CH2 rocking	
Alcohol	
	
3584-3700	 var	 O-H		non-hydrogen-bonded		usually	sharp	 1330-1420	 med	 -O-H		in-	plane	3200-3600	 str	 O-H		H-bonded	usually	broad	 650-770	 var	 -O-H		out-of-plane	1000-1260	 str	 C-O	 	 	 	800-900	 	 C-C	aliphatic	alcohol	 	 	 	
Ether 	 1000-1300	1070-1150	 str	str	 C-O	C-O	aliphatic	ether	 	 	 	
Aldehyde	
	
2695-2830	2	bands	 med	 =C-H		 1350-1360	 str	 -C-H	α-CH3	1720-1740	 str	 C=O	 1400-1450	 str	 -C-H	α-CH2	
Carboxyl	
acid	
	
2500-3300	overlap	C-H	 str	 O-H	very	broad	 1395-1440	 med	 C-O-H		1705-1720		 str	 C=O		H-bonded	 590-700	 str	 O-C=O	1210-1320		 med-str	 C-O		 	 	 	
Amine	
	
3400-3500	dil.	soln.	 wk	 N-H		primary	amines	2	bands	 1580-1650	 var	 -N-H primary	amines	scissoring	1020-1250	 med	 C-N	 660-910	 var	 -N-H NH2 &	NH	wagging		shifts	with	H-bonding	
																																																																											[25]	Silverstein	R	M	et	al.	(1991)	Spectrometric	identification	of	organic	compounds	(Wiley)	[26]	Lambert	J	B	(1987)	Introduction	to	organic	spectroscopy	(Macmillan)	
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Amide	
	
1630-1690	overlap	-N-H		 str	 C=O		 535-615	 str	 C=O	out-of-plane	3100-3500	overlap	O-H	 med	 N-H	primary	amides	two	peaks	 1620-1655	 med	 -N-H	NH2	and	NH	1400-1420	 med	 C-N	primary	amides	 660-800	 med	 -N-H		broad	out-of-plane	wagging	*Intensity:	strong	(str),	variable	(var)	and	weak	(wk)	
Figure	 III	 -	8a	 shows	 the	 IR	spectrum	of	 the	native	PEG-OH,	 it	 is	 in	agreement	with	 the	literature	 [27].	 Briefly,	 the	 signal	 observed	 at	 3424	 cm-1	 corresponds	 to	 the	 hydroxyl	stretching	mode	ν!!!	of	the	bonded	hydrogen	in	PEG	chains.	The	peak	centered	at	2885	cm-1	is	characteristic	of	the	alkyl	stretching	mode	ν!"! .	The	peaks	in	the	region	from	1000	to	1300	cm-1	are	characteristic	of	the	stretching	vibrational	modes	of	ether	(ν!!!).		
Figure	 III	 -	 8b	 corresponds	 to	 the	 infrared	 spectrum	 of	 the	 Pt(NH3)4Cl2	 precursor.	 It	displays	 bands	 at	 3242	 and	 3135	 cm-1	 attributed	 to	 the	 asymmetric	 and	 symmetric	vibrational	N-H	stretching	modes	ν!"! .	 From	1564	 to	842	cm-1	 the	bending	and	rocking	vibrational	modes	δ!"!	and	ρ!"! 	are	observed.	The	IR	band	at	510	cm-1	is	due	to	the	Pt-N	stretching	mode	[28].	
Figure	III	-	8c	displays	the	IR	spectrum	of	a	mixture	containing	Pt(NH3)4Cl2	and	PEG-OH	before	irradiation	(colorless	solution	Figure	III	-	1a).	This	spectrum	is	different	from	the	addition	of	the	spectra	(a)	and	(b).	All	the	NH3+	vibrational	modes	of	the	platinum	complex	disappeared	and	new	IR	bands	appeared.	This	 indicates	that	a	reaction	between	the	two	precursors	took	place.	Briefly:	
• The	two	new	peaks	observed	at	3477	and	3286	cm-1	are	characteristic	of	the	N-H	stretching	mode	ν!"	of	an	amide	functional	group	(see	Table	III	-	6).	
• In	addition,	we	observe	an	 IR	band	at	1642	cm-1,	which	may	be	attributed	 to	 the	C=O	stretching	vibrational	mode	of	primary	amides	[25].	This	signal	overlaps	the	1620	to	1655	cm-1	region	which	corresponds	to	the	N-H	bending	vibrational	mode	of	this	functional	group.		
																																																																											[25]	Silverstein	R	M	et	al.	(1991)	Spectrometric	identification	of	organic	compounds	(Wiley)	[27]	Krishnan	K	and	Krishnan	R	S	(1966)	Proc.	Indian	Acad.	Sci.	-	Sect.	A	64	111–22	[28]Nakamoto	K	(2009)	Infrared	and	Raman	spectra	of	inorganic	and	coordination	compounds.	(Wiley)	
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• Finally	the	IR	signal	at	1453	cm-1	may	be	attributed	to	the	C-N	stretching	mode	ν!"	of	primary	amides	although	 it	 is	shifted	by	11	cm-1.	This	can	be	explained	by	 the	overlap	with	the	CH2	bending	mode	δ!"!	of	PEG	at	1468	cm-1.	
Hence,	 all	 these	 new	 features	 converge	 and	 indicate	 the	 formation	 of	 a	 primary	 amide	functional	group.	This	statement	is	confirmed	by	the	observation	of	the	peak	centered	at	541	cm-1	corresponding	to	the	Pt-N	bond	[29].	This	peak	is	broaden	due	to	overlapping	the	535	-	615	cm-1	region	of	the	C=O	bending	vibrational	mode	of	amide.		
In	 summary,	 this	 IR	 analysis	 demonstrate	 the	 reaction	 of	 the	 two	 precursors	 by	conjugation	of	the	PEG-OH	chains	with	(Pt(NH3)4)2+	to	form	an	amide	linker.	The	resulting	intermediate	specie,	formed	before	irradiation,	is	illustrated	in	Figure	III	-	9.		
	
Figure	III	-	9.	Proposed	PtII-PEG	conjugation	before	irradiation.	To	 explain	 the	 way	 the	 precursors	 react	 to	 form	 an	 amide	 linker,	 we	 propose	 the	hypothesis	 that	 PEG-OH	must	 be	 activated	 before	 reacting	with	 the	 –NH3+	 ligand	 of	 the	platinum	 precursor.	 The	 simplest	 method	 to	 form	 an	 amide	 is	 by	 coupling	 a	 carboxyl	group	(C=O)	with	an	amine	group	(-NR2).	In	the	present	case:	
																																																																											[29]	Wysokiski	R	et	al.	(2006)	J.	Mol.	Strucutre	THEOCHEM	758	169–79	
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• PEG-OH	 is	 initially	 activated	 forming	 an	 aldehyde-end	 group	 (-CHO).	 In	 the	presence	 of	 oxygen,	 this	 activation	 takes	 place	 due	 to	 the	 dehydrogenation	(oxidation)	of	the	hydroxyl-end	group	of	PEG	by:	
	
Figure	III	-	10.	Dehydrogenation	of	a	primary	alcohol	to	form	an	active	primary	aldehyde.	The	 oxidation	 of	 alcohols	 and	 thus	 of	 PEG-OH	 is	 thermodynamically	 favorable	 [30].	However,	 in	 this	work	we	suggest	 that	 the	reaction	 is	catalyzed	at	room	temperature	by	platinum	 [31]	 [32]	 [33].	 Primary	 alcohols	 can	 be	 oxidized	 to	 aldehydes	 or	 further	 to	carboxylic	acids	(–COOH),	which	may	react	with	the	platinum	precursor.	However,	little	is	known	about	the	proportion	of	these	species	after	PEG-OH	oxidation.	
• The	 formed	 PEG	 aldehyde-end	 group	 then	 reacts	 preferentially	 with	 ammonium	[34]	to	form	a	primary	amide	as	follows:	
	
Figure	III	-	11.	Formation	of	the	intermediate	specie	before	irradiation	via	amide	linker.	Hence,	an	initial	conjugation	shell	is	formed	through	Figure	III	-	10	and	Figure	III	-	11.		
When	the	above-illustrated	intermediate	species	are	irradiated,	we	obtain	the	IR	spectrum	of	Figure	III	 -	8d	 that	corresponds	 to	 the	spectrum	of	 the	as-synthetized	PtPEG-OH	NPs	
																																																																											[30]	Glastrup	J	(1996)	Polym.	Degrad.	Stab.	52	217–22	[31]	Chibani	S	et	al.	(2013)	Catal.	Sci.	Technol.	3	339–50	[32]	Mallat	T	and	Baiker	A	(1994)	Catal.	Today	19	247–83	[33]	Anderson	R	et	al.	(2003)	Adv.	Synth.	Catal.	345	517–23	[34]	Cox	Gad	S	(2007)	Handbook	of	Pharmaceutical	Biotechnology	(John	Wiley	&	Sons.	Inc.)	
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(brownish	 solution	 Figure	 III	 -	 1a).	 Only	minor	 changes	 are	 observed	 after	 irradiation	because	the	bonds	visible	by	IR	remain	unchanged	(e.g.	C-O,	C=O,	O-H	and	N-H).		
In	 conclusion,	 this	 is	 the	 first	 evidence	 that	 PEGylated	 platinum	 NPs	 are	 successfully	produced	by	radiolysis.	Very	interestingly,	we	demonstrated	that	the	controlled	nucleation	and	growth	take	place	via	 the	 formation	of	stable	PEGylated	 intermediate	species.	These	IR	 results	 are	 in	 good	 agreement	with	 XPS	measurements,	 addressing	 a	 strong	 Pt0-PEG	interaction,	which	may	depend	on	the	–OH	end-group	activation	and	the	reactivity	of	the	platinum	 complex	 ligand	 (–NH3+).	 Recently,	 Wand	 et	 al.	 suggested	 that	 the	functionalization	 of	 small	 Pt	 NPs	 with	 amines	 may	 occurs	 preferentially	 by	 Pt-H-N	moieties	 or	 electrostatic	 interactions	 [35]	 (see	 proposed	 interactions	 in	Figure	 III	 -	 15	adapted	from	[35]),	which	supports	our	spectroscopic	findings	(broadened	N-1s	XPS	peak	and	Pt-N	IR	signal).	
																																																																											[35]	Wand	P	et	al.	(2016)	J.	Colloid	Interface	Sci.	478	72–80	
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1.5 Stability	in	biological	relevant	media	
Firstly,	 we	 studied	 the	 stability	 of	 PtPEG-OH	 NPs	 (PEG-OH:Pt	 ca.	100)	 by	measuring	 at	room	temperature	the	dH	and	ζ-potential	of	nanoparticles	at	pH	ranging	from	3	up	to	11	(Section	1.5.1).	Then,	the	influence	of	time	post	dilution	preparation	was	investigated	in	different	solvents	by	measuring	the	dH	(Section	1.5.2)	of	NPs	at	37°C.	Thus,	the	stability	of	PtPEG-OH	NPs	was	determined	by	dH,	ζ-potential	and	visual	observation	of	turbidity.	
1.5.1 Influence	of	pH	in	NaCl	
PtPEG-OH	NPs	were	diluted	in	NaCl	as	described	in	Chapter	II	–	Section	2.3.2	at	a	final	Pt	concentration	of	5x10-4	mol.L-1.	Figure	III	-	12	shows	the	evolution	of	the	dH	(blue)	and	ζ-potential	(red)	of	PtPEG-OH	NPs	as	function	of	pH.		
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Figure	III	-	12.	Evolution	of	the	hydrodynamic	diameter	(in	blue)	and	ζ-potential	(in	red)	versus	pH	for	PtPEG-OH	NPs	suspensions	at	a	Pt	concentration	of	5x10-4	mol.L-1.	We	 observe	 that	 the	 dH	 of	 the	 nanoparticles	 remained	 almost	 constant	 in	 the	 entire	 pH	range	(in	blue),	with	values	ranging	from	12	up	to	∼20	nm.		
The	PZC	or	 isoelectric	 point	 is	 observed	 at	 pH	3	 (in	 red).	 These	 results	 reflect	 the	 good	stability	 of	 PtPEG-OH	NPs	 at	 the	pH	of	 intracellular	 fluids	 (usually	 form	6.8	 to	7.4).	 The	negative	ζ-potential	is	attributed	to	the	–OH	functional	end-group	of	the	PEG	coating	(pKa	
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=16)	[36].	The	PEG	coating	favours	steric	repulsion	between	particles,	reducing	thus	their	aggregation	 state.	 More	 interesting,	 the	 observation	 of	 a	 negative	 ζ-potential	 for	 all	 pH	values,	 together	 with	 the	 size	 analysis,	 shows	 that	 the	 PEG	 molecules	 remain	 thereby	grafted	at	all	pH.		
It	 is	 worth	 mentioning	 that	 the	 solutions	 did	 not	 present	 any	 turbidity.	 However,	nanoparticles	stored	at	room	temperature	precipitated	one	month	later	with	exception	of	the	nanoparticles	suspension	at	pH	11,	which	corresponds	to	the	most	negatively	charged	and	thus	more	stable	suspension	(red	curve	picture	Figure	III	-	12).	
These	measurements	 show	 that	 in	 the	 proximity	 of	 cells,	where	 the	 pH	 decreases	 from	about	7	 to	6,	 the	ζ-potential	of	 these	PtPEG-OH	NPs	may	vary	slightly	(-10	 to	 -12mV)	by	keeping	their	dH	constant.	This	 is	different	 from	the	work	of	W.	Rima	et	al.	 showing	that	gadolinium	based	NPs,	with	a	PZC	of	∼6.6,	are	strongly	influenced	at	the	proximity	of	the	cell	membrane	[37],	property	that	strongly	defines	the	internalization	pathway	of	NPs.		
1.5.2 Stability	in	different	solvents		
The	stability	of	PtPEG-OH	NPs	with	a	Pt	concentration	of	5x10-4	mol.L-1	was	evaluated	over	time	 by	 measuring	 the	 dH	 of	 NPs	 immediately	 and	 1,	 3,	 6	 and	 22	 h	 after	 samples	preparation.	This	was	studied	for	PtPEG-OH	NPs	(PEG-OH:Pt	ca.	100)	diluted	in	water,	PBS	buffer,	NaCl	and	TE	buffer.	The	measurements	were	performed	at	37°C	to	mimic	biological	conditions.	Figure	III	-	13	shows	the	variation	of	dH	as	function	of	time.		
																																																																											[36]	Benyettou	F	et	al.	(2012)	J.	Bioanal.	Biomed.	4	39–44	[37]	Rima	W	et	al.	(2013)	Biomaterials	34	181–95	
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Figure	III	-	13.	Evolution	of	the	dH	of	PtPEG-OH	NPs	in;	water,	PBS,	NaCl	and	TE	buffer,	after	0,	1,	3,	6	and	22	h	(Pt	concentration	of	5x10-4	mol.L-1).	Firstly,	 we	 observe	 that	 NPs	 diluted	 in	 water	 at	 37°C	 are	 not	 stable	 for	 more	 than	 3h	(increase	of	their	dH	from	~10	up	to	15	nm	and	45	nm	after	22	h).	However,	they	are	more	stable	 in	 buffers	 such	 as	 PBS,	 NaCl	 and	 TE.	 NPs	 are	 very	 stable	 in	 TE.	 Indeed	 their	 dH	remains	unchanged	for	more	than	22h	at	37°C.	This,	due	to	a	screening	effect	between	the	NPs	and	molecules	that	compose	the	buffer	(Tris	and	EDTA)	[38].		
Non-significant	 variation	 of	 the	 PdI	 value	 was	 observed	 (from	 0.21	 to	 0.33	 ±	 0.01),	exhibiting	the	homogeneity	of	solutions.		
We	performed	the	same	experiment	using	enriched	DMEM	as	buffer	in	order	to	reproduce	the	conditions	that	are	used	in	cell	studies.	However,	aggregates	were	found	after	6	hours	with	 similar	 results	 found	 for	 DMEM	 alone,	 showing	 the	 limitation	 of	 the	 technique	 to	characterize	NPs	suspensions	in	complex	media.		
																																																																											[38]	Pfeiffer	C	et	al.	(2014)	J.	R.	Soc.	Interface	11	20130931–20130931	
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1.6 Conclusion	
In	this	chapter,	I	presented	the	advantageous	and	unique	synthetic	route	to	prepare	non-toxic	 and	 sterilized	 solutions	 of	 PEGylated	 platinum	 nanoparticles,	 ready-to-use	 for	biomedical	 applications.	 In	 addition,	 I	 described	 the	 new	 approach	 and	 methods	 that	 I	established	 in	 the	 group	 to	 characterize	NPs.	These	methods	will	 be	 further	used	 in	 the	group	for	the	development	of	novel	potential	nano-agents.	
Table	III	-	7	summarizes	the	main	characteristics	of	the	new	PtPEG-OH	NPs.	To	compare	with	other	NPs	tested	by	the	group	as	potential	nano-radioenhancer	to	improve	the	effects	of	hadrontherapy,	the	main	features	of	PtPEG-OH	NPs	are	presented	together	with	those	of	 Au-DTDTPA	 NPs.	 The	 data	 presented	 here	 for	 Au-DTDTPA	 NPs	 were	 obtained	 and	transmitted	by	our	collaborator	Gloria	Jiménez	Sánchez,	PhD	student	at	the	University	of	Franche-Comté	(Besançon,	France)	supervised	by	Prof	S.	Roux.	
Table	III	-	7.	Main	characteristics	of	the	new	PtPEG-OH	NPs	in	comparison	with	Au-DTDTPA	NPs.	
	 PtPEG-OH	NPs	 Au-DTDTPA	NPs		Plasmon	resonance	wavelength	(nm)	 Shoulder	centered	at	270	 Shoulder	510-530	TEM	diameter	(nm)	 3.2	±	0.8	 2.4	±	0.5	Metallic	surface	atoms	 372	±	224	 ~233	Hydrodynamic	diameter	(nm)	 8.8	±	3.1	 6.6	±	3.1	Zeta	potential	(mV)	 -16.6	±	5.1*	 -31.4**	pH	PZC	 3	 3	Anchoring	ligand	 -NH3	 -SH	Linking	group	 -OH	 -COOH	Surface	ligand	 PEG	 DTDTPA	*measured	at	pH	6.20	(the	as-synthetized	conditions	in	water)	**measured	at	pH	7.22	
In	 conclusion,	 I	 succeeded	 in	 the	 synthesis	 of	 small	metallic	 platinum	NPs	 grafted	with	PEG-OH.	Figure	III	-	14	summarizes	the	novel	radiolytic-PEGylation	method	developed	in	this	work,	which	together	with	Figure	III	-	15	illustrates	the	NPs	I	obtained.		
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Figure	III	-	14.	Scheme	of	the	novel	radiolytic-PEGylation	method	to	synthesize	biocompatible	PtPEG-OH	NPs.	
Figure	III	-	15	shows	a	model	deduced	from	the	physico-chemical	characterization	of	NPs.	Concerning	 the	 mechanisms	 of	 synthesis,	 my	 study	 established	 that	 PtII	 is	 coordinated	with	 PEG-OH	 prior	 to	 irradiation.	 However,	 this	 is	 the	 water	 radiolysis	 that	 is	 used	 to	initiate	 the	 reduction,	 nucleation	 and	 growth	 steps	 of	 the	 NPs	 in	 the	 entire	 reactive	volume.	At	the	end,	ready-to	use,	stable	and	biocompatible	PtPEG-OH	NPs	are	prepared	by	a	simple,	reproductive	and	environmentally	friendly	method.		
	
	
	
Figure	III	-	15.	Illustration	of	the	resulting	PtPEG-OH	NPs	conformation.	
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2. Biological	impact	of	nanoparticles	
A	multi-scale	approach	was	used	to	evaluate	the	capacity	of	the	PtPEG-OH	NPs	to	enhance	radiation	 toxicity	 (called	 radio-enhancement	effect	 -	REE).	 In	 this	 approach,	 cellular	 and	molecular	models	were	 used	 (see	materials	 and	methods	 in	Chapter	 II	 –	 Section	4)	 to	describe	 not	 only	 the	 biological	 impact	 of	 radiation	 activated	NPs	 but	 also	 the	 physico-chemical	processes	that	take	place	in	a	nanometric	volume.	
In	Section	2.1,	we	present	for	the	first	time	the	impact	of	PtPEG-OH	NPs	with	living	cells.	It	 shows	 the	 cytotoxicity	 of	 PtPEG-OH	NPs	 in	Section	2.1.1	 followed	by	 the	 uptake	 and	intracellular	localization	of	NPs	in	Section	2.1.2	and	2.1.3.	The	effect	of	nanoparticles	on	the	radiation	induced	cell	killing	is	discussed	in	Section	2.2.	
In	Section	2.3,	we	present	the	effect	of	PtPEG-OH	NPs	to	amplify	the	induction	of	nanosize	damages	using	the	bio-nanoprobe	(plasmid	DNA).	
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2.1 Interaction	of	NPs	with	human	cells	–	toxicity,	uptake	and	localization	
2.1.1 Cytotoxicity	evaluation	
We	 evaluated	 the	 cytotoxicity	 of	 PtPEG-OH	NPs	 in	 HeLa	 and	 U87-MG	 cells	 by	 CFA	 (see	methodology	Chapter	 II	 –	 Section	 4.1.3).	We	 performed	 these	 studies	 at	 two	 different	PtPEG-OH	NPs	concentrations.		
Figure	III	-	16	shows	the	PE	of	HeLa	cells	without	NPs	(control)	and	of	cells	incubated	for	6	 h	 with	 5x10-4	 and	 10-3	 mol.L-1	 PtPEG-OH	 NPs.	 Since	 NPs	 are	 diluted	 in	 water,	 we	disentangled	 the	 influence	 of	water	 from	 the	 effect	 of	NPs	 by	measuring	 the	 PE	 of	 cells	incubated	with	water	(10	%	of	the	total	volume).		
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Figure	III	-	16.	Survival	fraction	of	HeLa	cells	in	the	presence	of	water	or	incubated	with	PtPEG-OH	NPs.	The	results	are	presented	as	means	±	Standard	Deviation	(SD),	statistically	analysed	using	one-way	ANOVA	(Turkey	test:	*p<0.05	and	**p>0.05).	By	 comparing	 the	 PE	 of	 the	 control	 (+H2O)	 with	 the	 PE	 of	 cells	 incubated	 with	 5x10-4	mol.L-1	PtPEG-OH	NPs,	we	observed	similar	PE	values	(~	65%).	This	indicates	that	at	this	concentration	there	is	not	toxicity	associated	to	the	addition	of	PtPEG-OH	NPs	(p=	0.4227).	However,	a	significant	cytotoxicity	(∼	23%	less	PE)	was	found	at	10-3	mol.L-1	(p=	0.02113).		
Similarly,	we	found	that	5x10-4	mol.L-1	PtPEG-OH	NPs	are	non-toxic	for	U87-MG	cells.	The	PE	of	U87-MG	cells	in	the	control	and	in	the	presence	of	PtPEG-OH	NPs	was	~	5%.		
The	 non-toxic	 conditions	 (PtPEG-OH	NPs	 5x10-4	mol.L-1;	 6h	 incubation	 time)	were	 thus	used	in	all	the	experiments	that	follow.	
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2.1.2 Cell	uptake		
We	quantified	 the	uptake	of	5x10-4	mol.L-1	PtPEG-OH	NPs	 in	HeLa	and	U87-MG	cells,	 by	ICP-OES	and	ICP-MS,	and	we	investigated	the	influence	of	the	incubation	time	on	the	cell	uptake.	 For	 comparison,	we	 also	measured	 the	uptake	 of	Au-DTDTPA	NPs	 (provided	by	Gloria	 Jiménez	 Sánchez,	 PhD	 student	 with	 Prof.	 Stéphane	 Roux	 at	 the	 University	 of	Franche-Comté,	Besançon,	France).		
2.1.2.1 Quantification	of	the	cell	uptake		
ICP	 spectroscopies	 measure	 the	 quantity	 of	 defined	 elements	 in	 a	 sample.	 These	measurements	were	performed	on	cells	gently	rinsed	with	PBS	after	NPs	incubation	(see	samples	preparation	 in	Chapter	 II	 –	 Section	4.1.5.1).	 Thus,	 the	quantified	metal	 comes	from	 NPs	 internalized	 or	 at	 least	 strongly	 attached	 to	 the	 cell	 membrane.	 The	internalization	 of	 NPs	 is	 confirmed	 by	 performing	 cellular	 imaging	 (see	 intracellular	distribution	in	Section	2.1.3).	
Table	 III	 -	 8	 shows	 the	 quantitative	 data	 obtained	 by	 ICP-OES	 for	 PtPEG-OH	 and	 Au-DTDTPA	NPs	incubated	6h	with	HeLa	and	U87-MG	cells.		
Table	III	-	8.	Uptake	of	PtPEG-OH	and	Au-DTDTPA	NPs	in	HeLa	and	U87-MG	cells	after	6h	incubation.	
Cell	line	 Metal	NP	
Mass	
(µg)	 pg/cell	
mol/cell	
(x10-16)	
NPs/cell	
(x105)	 NPs/µm
3	
HeLa	
Pt	 0.495	 0.168	 8.601	 5.178	 241	
Au	 0.100	 0.044	 2.226	 3.261	 152	
U87-MG	
Pt	 1.225	 0.742	 38.06	 22.91	 750	
Au	 0.291	 0.113	 5.716	 8.372	 274	
The	measurement	 gives	 the	mass	of	metal	 contained	 in	ca.	 2x106	 cells	 (see	 column	3	 in	
Table	 III	 -	8).	Hence,	we	calculated	 the	concentration	of	metal	 (mass	and	mole)	per	cell	(columns	4	and	5).		
The	 NPs	 are	 composed	 of	 1000	 Pt	 atoms	 (~3.2	 nm)	 and	 411	 Au	 atoms	 (~	 2.4	 nm)	respectively	(see	values	Table	III	-	7).	The	number	of	NPs	per	cell	was	then	determined	as	follows:	
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# !"#!"## =  !"# !"#!"## ⨉N!	 	 	 	 	 	 	 	 Equation	III	-	9	
where	NA	is	the	Avogadro	constant	(6.022	x	1023	mol-1).	The	data	are	reported	in	column	6	
Table	III	-	8.		
The	diameter	of	cells	in	suspension	was	measured	with	a	LUNA	cell	counter	(trypan	blue	staining).	HeLa	cells	presented	an	average	diameter	of	16	µm	and	U87-MG	of	18	µm.	Thus,	we	 determined	 the	 density	 of	 NP	 per	 volume	 unit	 (see	 column	 7	 in	 Table	 III	 -	 8)	 as	follows:		
Density !"#!!! = # !"#!"## ⨉ !!"!!"##! 	 	 	 	 	 	 	 Equation	III	-	10	
Note	that	the	rate	of	platinum	internalized	in	cells	(0.495	and	1.225	μg	in	HeLa	and	U87-MG	 cells	 respectively)	 is	 very	 low	 (0.06	 to	 0.153%	 of	 the	 initial	 798	 Pt	 μg).	 These	 low	values	 may	 be	 explained	 as:	 i)	 an	 effect	 of	 the	 experimental	 incubation	 conditions	 (2D	culture,	 volume	of	medium	and	number	 of	 cells)	 and	 ii)	 the	 remarkable	 stability	 of	NPs	suspensions	(pH	PZC	∼3).	Interestingly,	these	values	are	higher	than	the	cell	uptake	rate	found	for	Au-DTDTPA	NPs	(0.006	to	0.018%).	This	comparison	shows	that,	 for	the	same	experimental	conditions,	the	uptake	efficiency	of	PtPEG-OH	NPs	is	ca.	10	times	higher	than	the	uptake	of	Au-DTDTPA	NPs.		
In	 Figure	 III	 -	 17a	 we	 observe	 that	 the	 internalization	 of	 nanoparticles	 in	 U87-MG	 is	higher	 than	 that	 in	HeLa	 cells.	 Indeed,	 close	 to	4.4	 times	more	Pt	 per	 cell	 is	 detected	 in	U87-MG	cells,	compared	to	2.6	times	for	Au.	
Stated	 differently	 the	 NPs	 density	 (see	 Figure	 III	 -	 17b),	 defined	 by	 the	 number	 of	internalized	NPs	per	µm3,	is	about	1.6	times	higher	for	PtPEG-OH	NPs	than	for	Au-DTDTPA	NPs	in	HeLa	and	2.7	in	U87-MG	cells.	
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Figure	III	-	17.	(a)	Mass	of	the	metal	per	cell	and	(b)	density	of	internalized	nanoparticles	(NPs/μm3)	in	HeLa	and	U87-MG	cells.	In	 summary,	we	 established	 that	 the	 uptake	 of	NPs	 is	 strongly	 cell	 line	 dependent.	 This	experiment	also	shows	the	strong	dependence	of	the	uptake	as	a	function	of	the	NP	type	and	their	surface	composition	(coating	 ligand	and	ζ-potential).	Finally,	 the	higher	uptake	found	for	PtPEG-OH	NPs	suggests	that	these	NPs	are	promising	and	test	in	vivo	should	be	envisaged.	A	study	 is	currently	 in	progress	 in	 the	group	to	 further	explore	 the	uptake	of	metallic	NPs	in	several	cell	lines.	
2.1.2.2 Influence	of	the	incubation	time	on	the	cell	uptake	
We	performed	ICP-MS	measurements	 in	HeLa	cells	 incubated	with	5x10-4	mol.L-1	PtPEG-OH	NPs	for	6	h	and	24	h.	The	samples	were	prepared	as	presented	in	Chapter	II	–	Section	
4.1.5.	The	results	are	shown	in	Table	III	-	9.	
Table	III	-	9.	Uptake	of	PtPEG-OH	NPs	in	HeLa	cells	after	6	h	and	24	h	of	incubation.	
Inc.	time	
(h)	 Mass	(µg)	 Cells	(x106)	 pg/cell	 mol/cell	(x10-16)	 NPs/cell	(x105)	 NPs/cell	µm3	
6	 5.06±0.04	 3.16	 1.60	 81.82	 49.26	 2297	
24	 5.71±0.01	 4.64	 1.23	 63.22	 38.06	 1775	
Surprisingly,	the	mass	measured	with	ICP-MS	for	5x10-4	mol.L-1	PtPEG-OH	NPs	incubated	during	 6h	with	HeLa	 cells	 is	 ca.	 10	 times	 higher	 than	 the	 values	 obtained	with	 ICP-OES	(Table	 III	 -	 8).	With	 ICP-MS	we	 found	 0.45%	 of	 the	 total	 initial	 platinum	 content.	 This	difference	may	be	due	to	the	technique	sensitivity	or	to	difference	in	the	HeLa	cell	culture	
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(cell	generation).	Nonetheless,	 the	comparison	between	the	ICP-MS	results	obtained	at	6	and	24	h	of	 incubation	indicates	that	the	NPs	uptake	does	not	increase	significantly	with	the	incubation	time.		
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2.1.3 Intracellular	distribution	of	NPs	
The	 intracellular	 distribution	 of	 NPs	 was	 investigated	 by	 NanoSIMS	 and	 TEM	 (see	experimental	 conditions	 in	 Chapter	 II	 –	 Section	 4.1.5).	NanoSIMS	 has	 a	 lower	 spatial	resolution	but	it	allows	chemical	analysis	of	the	elements.	TEM	analysis	has	better	spatial	resolution	 but	 it	 requires	 high	 quality	 and	 accuracy	 of	 sample	 preparation.	 The	 two	methods	have	been	explored.		
2.1.3.1 NanoSIMS	analysis	
NanoSIMS	experiment	 for	 the	detection	of	platinum	 in	cells	was	optimized	before	 in	 the	group	[39].	In	the	present	study,	the	cells	were	prepared	by	cryo-fixation.	Only	HeLa	cells	loaded	with	PtPEG-OH	NPs	were	analyzed.	
The	first	step	consisted	on	the	calibration	of	the	mass	spectrometer	and	the	identification	of	 the	 platinum	 isotopes	 (see	method	 in	Chapter	 II	 –	 Section	4.1.5.2).	 In	 this	 case,	 the	stable	 isotope	platinum-194	with	 its	natural	 occurrence	 (33%)	was	used	as	 the	 isotopic	marker	of	PtPEG-OH	NPs.	The	 in	 situ	 calibration	was	performed	by	measuring	 the	mass	spectrum	of	a	pure	platinum	surface	used	as	reference.	The	mass	spectrum	of	HeLa	cells	loaded	with	PtPEG-OH	NPs	(prepared	as	described	 in	Chapter	 II	–	Section	4.1.5.2)	was	performed	and	compared	to	the	reference.		
Figure	 III	 -	 18	 shows	 the	 mass	 spectrum	 of	 the	 reference	 (black)	 and	 the	 HeLa	 Pt-containing	sample	(blue).	
																																																																											[39]	Usami	N	et	al.	(2008)	Int.	J.	Radiat.	Biol.	84	603–11	
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Figure	III	-	18.	Mass	spectra	recorded	by	NanoSIMS	from	a	platinum	reference	(____)	and	from	HeLa	cells	loaded	with	PtPEG	NPs	(____).	These	 measurements	 clearly	 demonstrate	 the	 presence	 of	 the	 194Pt	 isotopic	 marker	 in	HeLa.	The	species	at	 lower	atomic	masses	were	not	characterized.	These	species	did	not	interfere	with	the	194Pt	band	found	in	the	cell.		
After	 calibration	 and	 identification	 of	 platinum	 in	 the	 cells,	 we	 investigated	 the	intracellular	distribution	of	PtPEG-OH	NPs	through	the	imaging	mode	of	the	NanoSIMS.		
Figure	 III	 -	19	 shows	 the	Nano-SIMS	 imaging	analysis	performed	on	a	HeLa	 cell	 loaded	with	PtPEG-OH	NPs.	Images	were	collected	for	the	CN-,	P-	and	194Pt-	ions.	It	is	noteworthy	to	mention	that	the	images	were	collected	simultaneously	from	the	same	sputtered	micro	volume	of	a	square	frame	of	50	µm	x	50	µm.	
The	morphological	cell	structure	was	derived	from	the	CN-	and	P-	images.	Figure	III	-	19a	shows	 the	 distribution	 of	 carbon	 and	 nitrogen	 containing	 molecules,	 an	 indication	 of	organic	matter	such	as	nucleic	acids	and	proteins.	Figure	III	-	19b	shows	the	phosphorus	distribution.	 It	 is	used	to	distinguish	 the	cell	nucleus	due	 to	 its	high	phosphorus	content	(DNA).	 Figure	 III	 -	 19c	 shows	 the	 distribution	 of	 platinum	 compounds	 (194Pt).	 Finally,	
Figure	III	-	19d	presents	the	merged	image	of	194Pt	and	P-.	
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Figure	III	-	19.	Nano-SIMS	images	of	a	HeLa	cell	loaded	with	PtPEG	NPs.	Panels	a,	b,	and	c	correspond	to	CN-,	P-	and	194Pt-	respectively.	Panel	d	is	the	merged	image	of	194Pt-and	P-.	The	arrows	show	an	identified	low	concentration	P-	region	in	the	cell	cytoplasm.	This	analysis	clearly	demonstrated	the	presence	of	platinum	inside	the	cell.	In	particular,	we	observe	that	PtPEG-OH	NPs	are	localized	in	the	cytoplasm	(Figure	III	-	19d)	and	not	observed	 in	 the	nucleus.	This	 is	 in	agreement	with	other	works	performed	by	 the	group	with	platinum	complexes	[39]	and	other	studies	with	metal-containing	NPs	[40]	[41]	[42].	The	 analysis	 also	 showed	 that	 PtPEG-OH	 NPs	 are	 preferentially	 accumulated	 at	cytoplasmic	sites	found	low	in	phosphorus	concentration	(region	pointed	with	an	arrow).	This	 has	 been	 already	 observed	 in	 other	 works	 where	 15N-labeled	 peptide	 vectors	 co-localize	HeLa	cytoplasmic	zones	with	low	phosphorous	concentration	[43].	
																																																																											[39]	Usami	N	et	al.	(2008)	Int.	J.	Radiat.	Biol.	84	603–11	[40]	Rima	W	et	al.	(2013)	Biomaterials	34	181–95	[41]	Jain	S	et	al.	(2011)	Int.	J.	Radiat.	Oncol.	Biol.	Phys.	79	531–9	[42]	Shah	N	B	et	al.	(2011)	Mol.	Pharm.	8	176–84	[43]	Romer	W	et	al.	(2006)	Appl.	Surf.	Sci.	252	6925–30	
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We	 found	 some	 difficulties	 on	 the	 embedding	 process	 during	 samples	 preparation	 and	thus	 as	 already	 discussed	 in	 Chapter	 II	 –	 Section	 4.1.5.2,	 complementary	 statistical	studies	are	in	process.		
2.1.3.2 TEM	imaging		
We	performed	TEM	 imaging	 to	 provide	 intracellular	 distribution	 of	 PtPEG-OH	NPs	with	better	resolution.	Moreover,	TEM	allows	elucidating	the	NPs	uptake	mechanism(s).	HeLa	cells	 samples	 were	 prepared	 by	 cryo-fixation	 or	 by	 chemical	 fixation.	 U87-MG	 cells	samples	were	only	prepared	by	chemical	 fixation	(see	samples	preparation	Chapter	II	–	
Section	4.1.5).	
For	a	better	understanding	on	the	possible	uptake	mechanisms,	Figure	III	-	20	introduces	different	pathways	 involved	 in	 the	 internalization	of	 nano-agents	with	 variable	physico-chemical	characteristics.		
	
Figure	III	-	20.	Illustration	on	the	cellular	uptake	of	particles.	Adapted	from	[44]	Briefly,	 big	 (>500	 nm)	 and	 opsonized	 NPs	 (deposition	 of	 immunoglobulins	 on	 the	 NP	surface	 [45])	 can	 be	 internalized	 by	 phagocytosis	 (#1	 in	 Figure	 III	 -	 20),	 which	 is	 the	
																																																																											[44]	Mao	Z	et	al.	(2013)	Biomater.	Sci.	1	896–911	[45]	Bandyopadhyay	A	et	al.	(2015)	Nanoparticles	in	Lung	Cancer	Therapy	-	Recent	Trends		
CHAPTER	III	 RESULTS	AND	DISCUSSION:	PtPEG-OH	NPs		
	 138	
process	 by	 which	 cells	 internalize	 matter	 larger	 than	 around	 1	 µm	 in	 diameter.	 The	pinocytic	 pathways	 are	 divided	 into:	 i)	 macro-pinocytosis,	 ii)	 clathrin-,	 iii)	 caveolin-mediated	and	iv)	independent	endocytosis	(#2	in	Figure	III	-	20).	These	processes	involve	the	uptake	of	matter	with	 a	 size	of	~	100	nm	 in	diameter	 [46],	 such	 as	NPs	 aggregates,	functionalized	 and	 non-functionalized	 NPs.	 The	 macropinocytosis	 is	 the	 invagination	 of	the	cell	membrane	to	form	a	pocket,	which	then	pinches	off	into	the	cell	to	form	a	vesicle	(0.5–5	µm	 in	diameter)	 filled	with	a	 large	volume	of	extracellular	 fluid	and	molecules.	 It	can	be	mediated	by	pseudopodial	extensions	[47].	An	endosome	may	be	found	in	two	main	states:	 as	 an	 early	 endosome,	which	by	being	 the	 first	 state	 of	 the	 endocytic	 pathway	 is	often	 located	 in	 the	 periphery	 of	 the	 cell,	 and	 as	 a	 late	 endosome that	 travels	 into	 the	cytosol	 and	 fuses	with	 lysosomes.	Lysosomes	are	 the	 last	 compartment	of	 the	endocytic	pathway.	 They	 are	 acidic	 (pH	 ~4.8)	 with	 a	 diameter	 of	 about	 1	 to	 2	 µm	 [48].	 The	 last	uptake	mechanism	(#3	in	Figure	III	-	20)	 is	the	direct	penetration,	commonly	named	as	passive	 diffusion.	 It	 involves	 the	 internalization	 of	 external	 substances	 across	 the	 cell	membrane	without	need	of	energy	input.	This	mechanism	depends	on	the permeability	of	the	 cell	 membrane	 (lipid	 bilayer),	 size	 and	 charge	 of	 the	 substances.	 This	 pathway	dominates	in	the	uptake	of	small	NPs.	
a) TEM	imaging	of	HeLa	cells	after	cryo-fixation	
Figure	 III	 -	 21	 shows	 some	 representative	 TEM	 images	 recorded	 from	 HeLa	 samples	prepared	 as	 for	NanoSIMS	 analysis.	 Panel	 (a)	 shows	 a	HeLa	 cell	 at	 a	magnification	 that	allows	observation	of	the	cytoplasm.	The	weak	contrast	here	found	did	not	permit	a	clear	identification	of	the	nucleus.	However,	we	analyzed	regions	close	to	the	cells	membrane	to	elucidate	 the	 nanoparticles	 internalization	 pathway(s).	 For	 instance,	 panels	 (b)	 and	 (c)	correspond	respectively	to	magnifications	of	the	squared	regions	(1	&	2)	 in	panel	(a).	 In	panel	 (b),	 we	 particularly	 observe	 cell	 membrane	 projections,	 known	 as	 pseudopods,	which	are	commonly	involved	in	the	process	of	nutrients	ingestion.	Here,	we	observe	that	the	pseudopods	do	not	interfere	with	the	uptake	of	the	electron	dense	objects.	Hence,	we	hypothesize	that	the	NPs	uptake	takes	place	via	passive	diffusion.	Interestingly,	panel	(c)	shows	isolated	electron	dense	objects	and	some	aggregates	in	the	cell	cytoplasm.	
																																																																											[46]	Marsh	M	and	Marsh	M	(2001)	Endocytosis	(Oxford	University	Press)	[47]	Falcone	S	et	al.	(2006)	J.	Cell	Sci.	119	4758–69	[48]	Gruenberg	J	and	Maxfield	F	R	(1995)	Curr.	Opin.	Cell	Biol.	7	552–63	
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a)	 b)	 c)	
Figure	III	-	21.	TEM	images	of	cryo-fixed	HeLa	cells	after	incubation	with	5x10-4	PtPEG-OH	NPs	for	6	hours.	Panel	(a)	corresponds	to	a	cell	showing	a	vast	cytoplasmic	region	while	(b)	and	(c)	are	the	magnified	images	of	the	squared	regions	1	&	2	of	panel	(a).	In	Figure	III	-	22,	we	show	the	enclosed	aggregate	of	Figure	III	-	21c.	We	clearly	observe	that	 the	 internalized	 electron	 dense	 objects	 have	 a	 size	 distribution	 and	 morphology	comparable	to	PtPEG-OH	colloids.	Thus,	internalized	PtPEG-OH	NPs	have	been	identified.	
	
Figure	III	-	22.	Diameter	size	histogram	of	the	enclosed	region	1	of	Figure	III-19c	(inserted	TEM	image).	The	 size	 distribution	 histogram	 was	 built	 by	 measuring	 around	 100	 objects.	 We	complemented	these	results	by	imaging	HeLa	cells	after	chemical	fixation	(next	section).	
b) TEM	imaging	of	HeLa	cells	after	chemical	fixation	
Figure	III	-	23	shows	TEM	images	of	a	control	HeLa	cell	(without	NPs	treatment)	(a)	and	of	a	HeLa	cell	 loaded	with	PtPEG-OH	NPs	(b)	prepared	by	chemical	 fixation.	Figure	III	 -	
23c	 displays	 the	 diameter	 size	 distribution	 of	 the	 squared	 electron	 dense	 region	 1	(inserted	TEM	image)	shown	in	Figure	III	-	23b.	With	this	fixation	protocol,	we	gained	in	contrast	and	we	were	able	to	differentiate	the	nucleus	from	the	cytoplasm.		
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a)	 b)	 c)	
Figure	III	-	23.	TEM	images	of	a	control	(a)	and	of	a	HeLa	cells	incubated	with	5x10-4	mol.L-1	PtPEG-OH	NPs	for	6	hours	(b)	prepared	by	chemical	fixation.	Panel	(c)	shows	the	size	distribution	of	the	squared	aggregate	shown	in	panel	(b).	In	Figure	III	 -	23a	non-electron	dense	objects	were	observed.	Figure	III	 -	23b	confirms	the	presence	of	electron	dense	aggregates	localized	exclusively	in	the	cytoplasm,	which	is	in	good	agreement	with	NanoSIMS	and	TEM	imaging	after	cryo-fixation.	The	diameter	size	distribution	of	internalized	PtPEG-OH	NPs	(Figure	III	-	23c)	fits	with	the	size	distribution	of	colloidal	nanoparticles	(3.1	±	2.2	nm),	identifying	the	aggregates	to	PtPEG-OH	NPs.	
By	 analyzing	 close	 to	 10	 TEM	 image,	 no	 membranes	 surrounding	 NP	 aggregates	 were	observed.	 In	conclusion,	 the	absence	of	vesicles	surrounding	NPs	aggregates	strengthens	the	hypothesis	that	PtPEG-OH	NPs	are	internalized	by	Hela	cells	via	passive	diffusion	(see	pathway	3,	Figure	 III	 -	20).	For	 instance,	as	 stated	 in	Section	1.5.1,	colloidal	PtPEG-OH	NPs	 are	 negatively	 charged	 at	 pH	 of	 extra-	 and	 intracellular	 fluids	 (PZCPtPEG-OH	 NPs=	 3),	property	that	suggests	direct	NPs	penetration.	Hence,	we	hypothesize	that	PtPEG-OH	NPs	might	aggregate	inside	the	cell	by	the	action	of	hydrolytic	enzymes	in	the	cytoplasm	[49].		
c) TEM	imaging	of	U87-MG	cells	after	chemical	fixation	
Figure	 III	 -	 24	 shows	 TEM	 images	 of	 controls	 and	 PtPEG-OH	NPs	 loaded	 U87-MG	 cells	prepared	after	chemical	fixation.		
																																																																											[49]	Fernandez	S	et	al.	(2007)	Biochim.	Biophys.	Acta	-	Mol.	Cell	Biol.	Lipids	1771	633–40	
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a)	 b)	 c)	
Figure	III	-	24.	TEM	images	of	controls	(a)	and	(b)	and	U87-MG	cells	incubated	with	5x10-4	mol.L-1PtPEG-OH	NPs	for	6	hours	(c)	and	(d)	prepared	by	chemical	fixation.	We	 distinguish	 the	 different	 compartments	 (nucleus	 and	 cytoplasm)	 of	 the	 cells.	 In	 the	control	(Figure	III	-	24a),	we	observe	empty	cytoplasmic	vesicles	and	no	electron	dense	objects.	 In	Figure	 III	 -	24b,	 corresponding	 to	a	U87-MG	cell	 loaded	with	NPs,	 the	 image	displays	 also	 vesicles	 in	 the	 cytoplasm.	 In	 this	 case,	 the	 vesicles	 are	 filled	with	 electron	dense	objects.	Figure	III	-	24c	shows	the	diameter	size	distribution	of	the	electron	dense	objects,	which	fits	again	with	the	size	distribution	of	colloidal	nanoparticles	(3.7	±	0.8	nm),	attributing	the	aggregates	to	PtPEG-OH	NPs.	
From	the	analysis	performed	in	more	than	10	U87-MG	cells,	we	observed	that	the	size	of	the	NPs	aggregates	and	vesicles	differ.	These	findings	are	enlisted	below:	
• Highly	 concentrated	NPs	 aggregates	 contained	 in	 small	 vesicles	 of	 about	 0.5	µm	were	 observed	 close	 to	 the	 cell	 membrane.	 They	 were	 attributed	 to	 early	endosomes	[50].		
• Low	concentrated	NPs	aggregates	were	observed	in	bigger	vesicles	of	about	1	µm	containing	 a	 large	 amount	 of	 cellular	 fluid.	 We	 attributed	 this	 structure	 to	 late	endosomes,	which	are	formed	by	fusion	with	lysosomes.	[50].	
• Highly	concentrated	NPs	aggregates	in	vesicles	of	about	1	µm	were	also	observed.	This	was	 attributed	 to	 the	digestion	path	 via	macro-pinocytosis,	which	 generally	occurs	 for	 the	uptake	of	micro-size	nutrients	 or	particles	 agglomerates	 [51]	 (see	pathway	 2,	 Figure	 III	 -	 20).	 In	 addition,	 this	 was	 confirmed	 by	 observation	 of	pseudopodial	extensions.	
																																																																											[50]	Kou	L	et	al.	(2013)	Asian	J.	Pharm.	Sci.	8	1–10	[51]	Leys	S	P	and	Eerkes-Medrano	D	I	(2006)	Biol.	Bull.	211	157–71	
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In	summary,	TEM	analysis	strongly	suggests	that	the	uptake	of	PtPEG-OH	NPs	by	U87-MG	cells	 occurs	 via	 non-mediated	 endocytosis	 and	macro-pinocytosis.	 This	 result	 is	 in	 good	agreement	 with	 our	 previous	 results,	 which	 established	 that	 gadolinium	 based	nanoparticles	are	internalized	in	U87-MG	cells	by	endocytosis	[52].		
2.1.3.3 Conclusion		
The	major	result	of	this	complementary	NanoSIMS	and	TEM	analysis	is	that	PtPEG-OH	NPs	uptake	 is	 cell	 line	 dependent.	 In	 all	 the	 cases,	 internalized	 NPs	 were	 found	 in	 the	cytoplasm	 with	 evidence	 of	 no	 penetration	 in	 the	 cell	 nucleus.	 HeLa	 cells	 internalize	PtPEG-OH	 NPs	 by	 passive	 diffusion	 while	 U87-MG	 cells	 by	 endocytosis	 and	 macro-pinocytosis,	 which	 may	 explain	 ICP	 results	 (see	 Section	 2.1.2).	 The	 scheme	 shown	 in	
Figure	III	-	25	summarizes	these	results.	
	
Figure	III	-	25.	Suggested	PtPEG-OH	NPs	uptake	pathways	in	U87-MG	and	HeLa	cells.	
																																																																											[52]	Stefančíková	L	et	al.	(2014)	Cancer	Nanotechnol.	5	6	
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2.2 Effect	of	PtPEG-OH	NPs	on	radiation	induced	cell-killing	
The	impact	of	PtPEG-OH	NPs	on	the	radiation	 induced	cell-killing	was	evaluated	 in	HeLa	and	U87-MG	cells.	Control	cells	and	cells	incubated	with	5x10-4	mol.L-1	PtPEG-OH	NPs	for	6	hours	were	irradiated	by	γ-rays	and	carbon	ions	in	the	conditions	described	in	Chapter	II	
–	 Section	 3.2.2	 and	 3.3.2.	 The	 effect	 of	 nanoparticles	 was	 determined	 by	 performing	clonogenic	assays	(see	method	in	Chapter	II	–	Section	4.1.4).	Comparative	studies	were	performed	using	Au-DTDTPA	NPs	activated	by	gamma	irradiation.	
2.2.1 HeLa	cells	irradiation	experiments	
2.2.1.1 Cells	survival	curves	
Figure	III	-	26	shows	the	survival	curves	of	controls	(dashed	lines)	and	of	cells	incubated	with	PtPEG-OH	NPs	(solid	 lines).	The	cells	SF	were	determined	for	doses	ranging	from	0	up	to	5	Gy	and	from	0	up	to	2.5	Gy	for	γ-rays	and	carbon	ions	respectively.	The	surviving	fractions	of	cells	are	plotted	on	a	logarithmic	scale	as	function	of	the	increasing	radiation	dose	plotted	on	a	linear	scale.	
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Figure	III	-	26.	Survival	curves	of	HeLa	cells	irradiated	by	γ-rays (l, l) and	carbon	ions (n, n) in	controls	and	in	presence	of	PtPEG-OH	NPs.	The	horizontal	and	vertical	black	lines	indicate	the	dose	at	10%	of	survival.	We	observe	that	the	survival	curves	of	carbon	ions	are	below	those	of	γ-rays.	It	confirms	that	 cell-killing	 increases	with	 the	 linear	 energy	 transfer	 (LET)	 of	 the	 incident	 beam.	 In	this	work,	 carbon	 ions	had	a	LET	of	about	110	keV.μm-1	and	γ-rays	of	0.2	keV.µm-1	 (see	radiation	sources	Chapter	II	–	Section	3.2	and	3.3).	
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We	also	observe	that	the	decrease	of	the	survival	fraction	is	amplified	in	cells	loaded	with	PtPEG-OH	NPs	 (red	 and	blue	 curves	Figure	 III	 -	 26)	 for	 the	 two	 irradiation	modes.	We	highlight	the	doses	at	10%	of	survival,	which	will	be	further	discussed	in	the	quantification	of	nanoparticles	efficiency.	
2.2.1.2 Cell	survival	analysis:	direct	versus	sub-lethal	damages	
A	plot	of	a	biological	effect	observed	(e.g.	cell	response)	against	the	dose	given	is	called	as	a	dose	response	curve.	In	general,	by	increasing	the	dose,	the	effect	increases.		Three	types	of	dose	response	relationship	are	known:		
• linear	
• linear	quadratic	
• sigmoid.		In	 this	work,	we	 simulated	 the	 SF	 of	 the	 cell	 response	 curves	 using	 the	 following	 linear	quadratic	(LQ)	model:		
SF D = e!(!!!!!!)	 	 	 	 	 	 	 	 Equation	III	-	11	where	the	α	parameter	is	attributed	to	the	induction	of	directly	lethal	damage	and	β	to	the	additive	 sub-lethal	 lesions	 leading	 to	 cell	 death	 [53]	 [54].	 This	 mathematical	 model	 is	commonly	used	in	radiobiology	to	study	the	response	of	eukaryotic	cells	to	radiation.	The	values	of	α	and	β	determined	after	data	fitting	are	reported	in	Table	III	-	10.		
Table	III	-	10.	α	and	β	coefficients	for	HeLa	cells	irradiated	by	γ-rays	or	by	carbon	ions	in	the	presence	of	PtPEG-OH	NPs	and	in	the	controls.	
Radiation	 Sample	 α	(Gy-1)	 β	(Gy-2)	 α/	β	(Gy)	 R2	
γ-rays	
Control	 0.15±0.07	 0.071±0.016	 2.11±0.42	 0.997	+PtPEG-OH	NPs	 0.26±0.01	 0.066±0.003	 3.94±0.02	 0.999	
C6+	
Control	 1.50±0.02	 -	 -	 0.999	+PtPEG-OH	NPs	 1.78±0.03	 -	 -	 0.998	
This	analysis	shows	that	PtPEG-OH	NPs	induced	an	increase	of	α,	from	0.15	to	0.26	for	γ-rays	and	from	1.50	to	1.78	for	carbon	ions	irradiation.	We	also	observe	that	β	decreased	from	 0.071	 to	 0.066	 for	 γ-rays	 irradiation.	 The	 negligible	 β	 value	 for	 carbon	 ions	
																																																																											[53]	Tubiana	M,	Dutreix	J	and	Wambersie	A	(1986)	Radiobiologie	Chapitre	IV	pp	73–104	[54]	Douglas	B	G	and	Fowler	J	F	(1976)	Radiat.	Res.	66	401–26	
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irradiation	 is	 in	 agreement	 with	 the	 linear	 dose	 response	 of	 high	 LET	 irradiations.	 In	particular,	the	absence	of	sub-lethal	of	sub-lethal	damages	is	one	of	the	main	advantages	for	hadrontherapy	[55].		
In	order	to	evaluate	the	enhancement	of	the	lethality	of	combining	the	radiation	treatment	with	NPs,	we	also	reported	the	α/β	ratio,	which	describes	the	curvature	of	a	cell	survival	curve.	The	α/β	ratio	gives	the	dose	at	which	the	linear	and	quadratic	components	of	cell-killing	are	equal.	The	higher	 it	 is,	 the	more	 linear	 the	 cell	 response	 is	 (cell	death	mainly	due	to	directly	lethal	lesions).	In	this	work,	we	observe	that	the	α/β	ratio	increased	from	2.11	to	3.94	in	presence	of	PtPEG-OH	NPs	for	gamma	irradiation.	
The	 α/β	 ratio	 also	 characterizes	 the	 effects	 of	 dose-per-fraction	 and	 cell	 repopulation	(damage	repair)	in	fractionated	radiotherapy	[53].	The	enhancement	of	the	α/β	ratio	with	PtPEG-OH	NPs	opens	the	perspective	of	increasing	the	dose-per-fraction	in	the	treatment	because	of	the	linear	trend	of	the	survival	curve.	This	is	of	great	interest	in	clinics.	
The	increase	of	carbon	radiation	effect	as	due	to	the	increase	of	directly	lethal	damages	by	PtPEG-OH	NPs	 is	 a	major	 finding.	 To	 our	 knowledge,	 this	 is	 here	 the	 first	 evidence	 that	core	platinum	nanoparticles	increase	the	lethality	of	medical	carbon	beams.	
2.2.1.3 Quantification	of	the	amplification	efficiency	
The	 efficiency	 of	 PtPEG-OH	 NPs	 to	 amplify	 cancer	 cell-killing,	 i.e.	 the	 REE	 of	 NPs,	 was	quantified	by	calculating	different	indicators	including:	
i)	 The	Amplification	Factor	(AF) 
The	amplification	factor	is	indicative	of	the	cell-killing	enhancement	due	to	the	presence	of	nanoparticles	 at	 a	 defined	 dose	 point.	 It	 is	 equivalent	 to	 the	 radiation	 sensitizing	enhancement	 ratio	 (SER),	 which	 is	 commonly	 used	 to	 describe	 the	 cell-specific	radiosensitization	effect	[41].	The	AF	is	calculate	as	follows:	
AF =  !"!"#$%"&!"##$% !"#$%! !"!"!#$ !"#!"##$% !"#$%!"!"#$%"&!"##$% !"#$%  ⨉ 100 =  %	 	 	 	 	 Equation	III	-	12	
																																																																											[41]	Jain	S	et	al.	(2011)	Int.	J.	Radiat.	Oncol.	Biol.	Phys.	79	531–9	[53]	Tubiana	M,	Dutreix	J	and	Wambersie	A	(1986)	Radiobiologie	Chapitre	IV	pp	73–104	[55]	Suzuki	M	et	al.	(2000)	Int.	J.	Radiat.	Oncol.	48	241–50	
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Figure	III	-	27	shows	the	variation	of	the	AF	for	carbon	ions	(in	blue)	and	γ-rays	(in	red)	as	function	of	the	dose.		
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Figure	III	-	27.	Nanoparticles	amplification	factor	as	function	of	the	γ-rays	and	carbon	ions	radiation	dose.	Firstly,	we	observe	 that	 the	AF	 increases	with	 the	radiation	dose.	Very	 interestingly,	 the	REE	 of	 PtPEG-OH	 NPs	 is	 stronger	 when	 carbon	 ions	 are	 used	 as	 incident	 radiation.	 In	principle,	this	graph	gives	new	insights	into	the	reduction	of	the	total	dose	of	irradiation.	For	instance,	at	2	Gy	(dose	fractionation	regimen	commonly	used	in	clinic),	the	irradiation	dose	 to	 use	 in	 the	 presence	 of	 PtPEG-OH	 NPs	 could	 be	 reduced	 by	 44%	 and	 14%	 for	incident	carbon	ions	and	γ-rays	respectively	[56]	
ii)	The	Dose	Enhancing	Factor	(DEF)	
The	DEF	is	commonly	used	to	evaluate	the	properties	of	nanoparticles	to	amplify/enhance	the	 radiation	 effect	 [57].	 This	 approach	 is	 used	 to	 assess	 the	 enhancement	 of	 in	 vitro	radiotherapy	from	survival	curves.	The	DEFs	for	γ-rays	and	carbon	ions	irradiations	was	determined	from	the	simulated	curves	at	10%	of	survival	(Figure	III	-	26)	as	follows:	
DEF = !!"!"#$%"&!!" !"#$ !"#	 	 	 	 	 	 	 	 Equation	III	-	13	where	D10	corresponds	to	the	dose	at	10%	of	survival.	
Table	III	-	11	shows	D10	for	controls	and	HeLa	cells	loaded	with	PtPEG-OH	NPs.		
																																																																											[56]	Nogier	T	and	Regaud	C	(1914)	Compt.	Rend.	Acad.	Sci.	Paris	58	1711–4	[57]	Taggart	L	E	et	al.	(2014)	Cancer	Nanotechnol.	5	5	
RESULTS	AND	DISCUSSION:	PtPEG-OH	NPs	 CHAPTER	III		
	 147	
Table	III	-	11.	Radiation	doses	(γ-rays	and	carbon	ions)	to	reach	10%	of	survival	with	and	without	PtPEG-OH	NPs.	DEF	and	dose	enhancement	(%).	
Radiation	 Sample	 D10	(Gy)	 DEF	 Dose	
enhancement	(%)	
γ-rays	
Control	 4.75	 -	 -	+PtPEG-OH	NPs	 4.26	 1.11	 10.3	
C6+	
Control	 1.54	 -	 -	+PtPEG-OH	NPs	 1.29	 1.19	 16.2	
These	 results	 show	a	dose	enhancement	of	about	16%	and	10%	respectively	 for	 carbon	ions	and	γ-rays	irradiations	(at	10%	of	survival).	This	again	confirms	that	the	cell-killing	is	more	pronounced	by	combining	PtPEG-OH	NPs	with	incident	carbon	ions.	
iii)	The	Relative	Biological	Effectiveness	(RBE)	
In	 radiation	 biology,	 the	 RBE	 value	 is	 used	 to	 quantify	 differences	 in	 the	 biological	 and	clinical	effects	of	radiations.	The	RBE	 is	an	unambiguous	and	commonly	used	concept	 in	radiobiology	[58].	It	is	the	ratio	of	two	absorbed	doses	delivered	by	two	different	radiation	qualities	(different	LET).	It	compares	the	absorbed	dose	of	a	reference	radiation	(photons,	predominately	60Co	γ-rays)	to	that	of	another	radiation	(protons,	carbon	ions,	etc.),	which	results	 in	 the	 same	 biological	 effect	 under	 identical	 conditions	 [59].	 It	 varies	 with	 the	radiation	 quality,	 biological	 system	 and	 effect.	 The	 RBE	 is	 a	 key	 parameter	 used	 by	oncologists	 and	 medical	 physicists	 to	 adapt	 the	 dose	 delivery	 according	 to	 a	 novel	therapeutic	approach.		
In	this	work,	we	determined	the	RBE	of	carbon	ions	(in	the	absence	and	presence	of	NPs)	using	137Cs	γ-rays	as	reference.	The	RBE	was	evaluated	at	10%	of	survival	by:	
RBE!"#$%"& = !!!"#$ !"#$%"&!"!!!! !"#$%"&!" 	 	 	 	 	 	 	 Equation	III	-	14	and	
RBE!"# = !! !"#$ !"#$%"&!"!!!! !"#$ !"#!" 	 	 	 	 	 	 	 	 Equation	III	-	15	
																																																																											[58]	International	Commission	on	Radiological	Protection	(1963)	Health	Phys.	9	357–86	[59]	IAEA	and	ICRU	(2008)	Relative	Biological	Effectiveness	in	Ion	Beam	Therapy	461	
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We	obtained	a	RBE	value	of	3.09	for	HeLa	cells	treated	only	with	radiation	(control).	This	result	 is	 in	good	agreement	with	other	works	[60].	On	the	other	hand,	in	the	presence	of	PtPEG-OH	NPs,	the	RBE	value	increased	in	about	19%	(RBENPs=	3.68)	(see	Table	III	-	12	below).	
iv)	The	Relative	Enhancing	Factor	(REF)	
By	analogy	with	the	RBE	value,	we	evaluated	the	REF	of	PtPEG-OH	NPs	comparing	the	SF	of	the	control	with	the	SF	in	the	presence	of	NPs	at	2	Gy	as	follows:	
REF!"#$%"& = !"!!"#$ !"#$%"&! !"!"!!! !"#$%"&! !" 	 	 	 	 	 	 	 Equation	III	-	16	
and	
REF!"# = !"!!"#$ !"#$%"&! !"!"!!!!"#$ !"#! !" 		 	 	 	 	 	 	 Equation	III	-	17	
Table	III	-	12.	RBE-D10,	REF-2	Gy	and	NPs	enhancement	values	of	HeLa	cells	treated	with	γ-rays	and	carbon	ions	with	or	without	PtPEG-OH	NPs.	
Sample	 RBE(D10)	 REF(2	Gy)	
Enhancement	(%)	
RBE	 REF	Control	 3.09	 10.5	 -	 -	+PtPEG-OH	NPs	 3.68	 18.7	 19	 44	
The	 RBE(D10),	 REF(2	 Gy)	 and	 respective	 NPs	 enhancement	 are	 summarized	 above	 in	
Table	III	-	12.	Interestingly,	the	REF	value	increased	by	approximately	44%	at	2	Gy,	which	confirmed	 the	 high	 potential	 of	 PtPEG-OH	 NPs	 to	 improve	 cancer	 cell-killing	 in	fractionation	regimens.	
In	 summary,	 we	 demonstrated	 the	 REE	 of	 PtPEG-OH	 NPs.	 Hence,	 the	 combination	 of	PtPEG-OH	 NPs	 with	 radiations	 may	 be	 considered	 as	 a	 very	 promising	 alternative	 to	improve	 the	 biological	 effect	 of	 radiotherapies.	 In	 this	 cellular	model,	we	 observed	 that	PtPEG-OH	 NPs	 have	 the	 unique	 property	 to	 enhance	 the	 lethality	 of	 radiations.	 More	important,	platinum	nanoparticles	strongly	improved	the	effect	of	medical	carbon	ions.		
																																																																											[60]	Kaur	H	et	al.	(2013)	Nucl.	Instruments	Methods	Phys.	Res.	Sect.	B	Beam	Interact.	with	Mater.	Atoms	301	7–11	
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2.2.2 U87-MG	cells	irradiation	experiments	
The	radio-enhancement	effect	of	PtPEG-OH	and	Au-DTDTPA	NPs	was	also	investigated	in	U87-MG	cells	treated	by	gamma	irradiation	only.	U87-MG	cell	samples	were	prepared	and	irradiated	at	the	same	conditions	used	for	HeLa	cells	irradiation	experiments	(see	method	in	Chapter	II	–	Section	4.1.4).	
2.2.2.1 Cells	survival	curves	
The	dose	response	curves	of	individually	PtPEG-OH	and	Au-DTDTPA	NPs	treated	U87-MG	cells	were	found	very	similar.	Hence,	the	survival	curves	of	the	control	and	of	cells	loaded	with	PtPEG-OH	NPs	exposed	to	γ-rays	are	shown	in	Figure	III	-	28.		
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Figure	III	-	28.	Survival	curves	of	U87-MG	cells	irradiated	by	gamma	rays in	control	(l)	and	in	presence	of	PtPEG-OH	NPs	(l).	We	 observe	 that	 the	 exponential	 decrease	 of	 the	 survival	 curves	 was	 amplified	 in	 cells	loaded	 with	 PtPEG-OH	 NPs.	 We	 obtained	 very	 similar	 effect	 using	 Au-DTDTPA	 NPs.	Indeed,	the	survival	curves	for	Pt	and	Au	NPs	overlap.	More	interestingly,	the	shape	of	the	cell	response	curves	changed	from	quadratic	in	the	control	to	linear	shape	in	the	presence	of	metallic	NPs	between	0	and	5	Gy.		
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2.2.2.2 Cell	survival	analysis:	direct	versus	sub-lethal	damages	
The	 values	 of	 α	 and	 β	 coefficients	 determined	 after	 data	 fitting	 are	 reported	 below	 in	
Table	III	-	13.	
Table	III	-	13.	α	and	β	coefficients	for	U87-MG	cells	irradiated	by	γ-rays	in	the	presence	of	metallic	NPs	and	in	the	controls.	
Sample	 α	(Gy-1)	 β	(Gy-2)	 α/	β	(Gy)	 R2	Control	 0.14±0.01	 0.032±0.002	 4.37±0.03	 0.999	+	PtPEG-OH	NPs	 0.34±0.01	 -	 -	 0.997	
Surprisingly,	the	PtPEG-OH	NPs	(and	Au-DTDTPA	NPs)	enhanced	the	induction	of	directly	lethal	 damages	 only.	 Indeed,	 α	 increased	 by	 a	 factor	 of	 two,	 from	 0.14	 to	 0.34	 in	 the	presence	 of	 metallic	 NPs.	 As	 major	 result,	 we	 passed	 from	 a	 linear	 quadratic	 relation	(α/β~	4)	to	a	linear	relation	with	a	negligible	β	value.		
This	 result	 is	 of	 a	 major	 interest;	 it	 demonstrates	 that	 the	 combination	 of	 metallic	nanoparticles	 with	 γ-rays	 produces	 a	 radiobiological	 effect	 that	 is	 similar	 to	 the	 effect	induced	by	high	LET	radiations	(linear	survival	curves).	This	result	suggests	a	highly	local	ionizing	effect	of	NPs	as	already	proposed	by	McMahon	et	al.	[61]	[62].	Very	importantly,	this	effect	is	cell	line	dependent,	as	it	was	only	observed	in	U87-MG	and	not	in	HeLa	cells.	
2.2.2.3 Quantification	of	the	amplification	efficiency	
Figure	III	-	29	shows	the	variation	of	the	AF	as	function	of	the	dose.	In	this	case,	the	AF	does	not	increase	with	the	increasing	dose	(as	observed	with	HeLa).	In	particular,	at	2	Gy	PtPEG-OH	NPs	amplify	by	about	23	%	the	biological	effect	of	γ-rays.	This	behavior	of	the	AF	may	be	explained	as	due	to:	i)	the	absence	of	the	β	component	or	ii)	a	saturation	effect	due	to	the	higher	uptake	of	NPs	in	U87	as	to	compare	with	HeLa.	To	better	elucidate	the	REF	 of	 NPs	 in	 U87-MG	 cells,	 irradiation	 experiments	 are	 being	 performed	 at	 higher	irradiation	doses	to	reach	a	SF	of	at	least	0.01.	
	
																																																																											[61]	McMahon	S	J	et	al.	(2011)	Radiother.	Oncol.	100	412–6	[62]	McMahon	S	J	et	al.	(2011)	Sci.	Rep.	1	18	
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Figure	III	-	29.	Amplification	factor	of	PtPEG-OH	NPs	as	function	of	the	dose.		Complementary	 studies	 in	 different	 human	 cancer	 cell	 lines	 are	 being	 conducted	 in	 the	group	to	evaluate	the	potentialities	of	both	nanoparticles	to	 improve	the	performance	of	hadrontherapy.		
2.2.3 Conclusion	
The	main	results,	 illustrated	 in	Figure	III	 -	30,	and	conclusions	on	the	REE	of	PtPEG-OH	NPs	in	combination	with	γ-rays	and	carbon	ions	are	enlisted	below:	
i) PtPEG-OH	NPs	amplify	the	biological	effects	of	ionizing	radiations	(high	energy	photons	and	carbon	ions).		ii) The	REE	of	NPs	is	stronger	when	carbon	ions	are	used	as	incident	radiation.	iii) The	 combination	 of	 Pt	 NPs	 with	 carbon	 ions	 radiation	 is	 presented	 as	 a	promising	approach	to	improve	the	performance	of	hadrontherapy.	iv) The	unique	property	of	PtPEG-OH	NPs	to	amplify	exclusively	the	 induction	of	directly	lethal	damages	was	here	demonstrated	for	the	first	time.	These	results	open	new	perspectives	on	improving	radiation	tumor	targeting.	v) Metallic	NPs	(Pt	and	Au)	enhance	the	effect	of	γ-rays.		vi) Pt	and	Au	NPs	strongly	 increased	the	 lethality	of	γ-rays,	a	very	advantageous	approach	in	the	treatment	of	glioblastomas	(shown	in	the	U87-MG	model).		vii) Metallic	 NPs	 were	 found	 very	 promising	 for	 fractionated	 radiotherapy	protocols.	
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. 	
Figure	III	-	30.	Schematic	representation	of	the	radio-enhancing	cell	killing	effect	of	PtPEG-OH	NPs.	
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2.3 Proof	of	principle:	enhancement	on	the	radio-induced	nanosize	damage	
The	 interaction	of	 ionizing	radiation	with	biomolecules	such	as	DNA,	 lipids	and	proteins	leads	 to	 bond	 cleavages	 that	 may	 be	 repaired	 or	 not	 by	 living	 cells.	 It	 is	 commonly	accepted	that	single	bond	breaks	are	little	toxic	for	living	organisms	whilst	complex	bond	breaks	are	difficult	to	repair	and	might	induce	cell	killing.	
In	 this	work,	we	used	a	molecular	bio-nanoprobe	to	quantify	 the	effect	at	 the	nanoscale,	particularly	the	damage	that	corresponds	to	nanosize	lesions	which	are	the	most	lethal	for	cells.	 In	 this	 purpose	we	 used	 plasmid	DNA	 as	 probes	 to	 quantify	 double	 strand	 breaks	(DSB),	which	is	the	signature	of	molecular	nanosize	damage,	lesions	being	separated	by	2	nm	 minimum	 (distance	 between	 the	 two	 strands).	 Therefore,	 we	 present	 and	 discuss	below	the	quantification	of	radio-induced	nanosize	breaks	induced	by	γ-rays	and	the	effect	of	NPs.	The	experimental	method	is	described	in	Chapter	II	–	Section	4.2.		
2.3.1 Effect	of	PtPEG-OH	NPs	on	the	induction	of	nanometer	size	damages	
Figure	III	-	31	shows	the	average	number	of	DSBs	induced	in	pure	plasmids	(control)	and	in	plasmids	in	the	presence	of	PtPEG-OH	NPs.	The	ratio,	nanoparticles	per	plasmid,	is	close	to	 4:1.	 The	 effect	 of	 the	 NPs	 concentration	 on	 the	 induction	 of	 nanosize	 damage	 is	presented	 and	 discussed	 on	 Appendix	 B.	 In	 Figure	 III	 -	 31,	 the	 nanosize	 breaks	 per	plasmid	are	plotted	as	function	of	the	irradiation	dose.		
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Figure	III	-	31.	Nanosize	damage	induced	by	γ-rays	in	plasmids	loaded	with	PtPEG-OH	NPs	(n) and	in	the	control (n) as	function	of	the	irradiation	dose.	DMSO	effect	in	plasmids	loaded	with	PtPEG-OH	NPs (o) and	in	the	control (o).	
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We	observe	that	the	radio-induction	of	nanosize	damage	in	the	controls	and	in	the	PtPEG-OH	NPs-loaded	bio-nanoprobes	increases	linearly	with	the	irradiation	dose.	This	indicates	single	 ionizing	 events	 [63].	 In	 the	 presence	 of	 NPs,	 we	 observe	 that	 the	 induction	 of	nanosize	damages	is	strongly	amplified	(red	line).	
In	 some	 experiments,	 DMSO	 was	 added	 to	 investigate	 the	 effect	 of	 water	 radicals.	 We	observe	 that	 the	 induction	 of	 nanosize	 damage	 sharply	 decrease	 in	 presence	 of	 DMSO	(dotted	 lines).	 This	 effect	 is	 in	 agreement	with	previous	 studies	 performed	with	Pt-PAA	NPs	and	GBNs	activated	not	only	by	photons	[64]	but	also	by	incident	ions	[65]	[66]	[67].	
2.3.2 Amplification	efficiency	of	molecular	nanosize	damage	
The	efficiency	of	PtPEG-OH	NPs	to	amplify	the	induction	of	nanometer	size	damages	was	quantified	using	the	amplification	factor	(AF)	defined	as:	
AF =  !"#$%!"#$%"&! !"#$%!"!#$!!" !"# !"#$%!"#$%"& ⨉100	 	 	 	 	 Equation	III	-	18	The	yield	is	defined	as	the	number	of	DSBs	induced	per	plasmid	and	per	Gy.	It	corresponds	to	the	slope	of	the	dose	response	curve.	The	values	are	reported	in	Table	III	-	14.	
Table	III	-	14.	Yields	of	controls	and	plasmids	loaded	with	PtPEG-OH	NPs	with	a	NP:plasmid	ratio	close	4:1.	DMSO	was	added	in	some	experiments.	The	AFs	are	also	reported.	
We	 observe	 that	 in	 the	 presence	 of	 PtPEG-OH	NPs	 the	 induction	 of	 nanosize	 damage	 is	enhanced	by	a	factor	of	83%.	The	nanosize	damage	yield	increased	from	11.4	to	20.9x10-5	breaks	per	plasmid	per	Gy.	This	result	may	well	explain	the	enhancement	of	cell-killing	in	
																																																																											[63]	Śmiałek	M	A	et	al.	(2009)	Radiat.	Res.	172	529–36	[64]	Porcel	E	et	al.	(2012)	J.	Phys.	Conf.	Ser.	373	012006	[65]	Porcel	E	et	al.	(2010)	Nanotechnology	21	85103	[66]	Porcel	E	et	al.	(2014)	Nanomedicine	10	1601–8	[67]	Schlatholter	T	et	al.	(2016)	Int.	J.	Nanomedicine	11	1549	
Sample	 NPs	per	plasmid	
Nanosize	
breaks/plasmid/Gy	
x10-5	
AF	(%)	 OH	effect	(%)	Control	 0:1	 11.40	±	0.25	 -	 -	+PtPEG-OH	NPs	 4:1	 20.90	±	0.21	 83	±	4	 -	Control	+	DMSO	 0:1	 1.34	±	0.18	 -	 88	±	1	PtPEG-OH	NPs	+	DMSO	 4:1	 2.48	±	0.11	 85	±	15	 88	±	1	Control	+	PEG-OH	 0:1*	 12.41	±	0.22	 9	±	1	 -	*sample	prepared	with	a	PEG-OH	concentration	estimated	to	be	similar	to	the	grafting	of	PEG	in	a	Pt	NP.		
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the	presence	of	 PtPEG-OH	NPs	which	 is	 due	 to	 the	 increase	on	 the	 induction	of	 directly	lethal	damages.		
2.3.3 Insight	in	mechanisms:	the	effect	of	!"∙	radicals	
We	investigated	the	effect	of	OH∙	free	radicals	by	performing	experiments	in	the	presence	of	 DMSO	 (see	 materials	 and	 methods	 Chapter	 II	 -Section	 4.2.1).	 The	 results	 were	presented	in	Figure	III	-	31.	
In	Figure	III	-	31	we	observe	that	the	dose	response	curves	drops	drastically	in	presence	of	 DMSO.	 The	 yields	 are	 reported	 in	Table	 III	 -	 14.	The	 yield	 in	 the	 presence	 of	 DMSO	decreased	 from	20.90	 to	 2.48	 x	 10-5	 in	 plasmids	 loaded	with	 PtPEG-OH	NPs.	 This	 study	clearly	 indicates	 that	 the	 amplification	 effects	 are	mediated	 by	water	 radicals	 for	more	than	88%.	Surprisingly,	we	observe	(Table	III	-	14	-	column	4)	that	the	direct	and	indirect	effects	of	radiation	are	amplified	in	the	same	proportion	in	the	presence	of	NPs.	
This	 ability	 of	 platinum	 nanoparticles	 to	 amplify	 nanosize	 molecular	 damage	 has	 been	ascribed	to	a	sequence	of	physical	and	chemical	processes	that	take	place	at	early	stage	in	confined	space	[65]	[61].	
Briefly,	 incident	 highly	 energetic	 photons	 and	 secondary	 electrons	 produced	 along	 the	track	ionize	platinum	atoms.	Deexcitation	processes	such	as	Auger	relaxation	(when	inner	shells	are	ionized)	[68],	plasmons	deexcitation	[69],	electron	capture	[70]	[71]	take	place.	Deexcitation	processes	consecutively	increase	the	number	of	emitted	electrons	leading	to	the	 ionization	 of	 the	 surrounding	 medium	 (water	 molecules	 and	 in	 biomolecules)	 and	production	of	clustered	free	radicals	and	ROS.	These	species	are	highly	toxic	causing	bond	cleavages	 in	biomolecules	and	ultimately	cell	death.	 In	summary,	platinum	nanoparticles	are	 responsible	 for	 the	 local	 enhancement	 of	 the	 ionization	 density	 that	 increases	 of	radiation	effects	because	of	the	spatial	confinement	of	the	resulting	highly	reactive	cluster.	This	 specific	 nanoscale	 effect	 may	 be	 of	 major	 interest	 for	 cancer	 radiotherapy	 in	combination	with	nano-agents.	
																																																																											[61]	McMahon	S	J	et	al.	(2011)	Radiother.	Oncol.	100	412–6	[65]	Porcel	E	et	al.	(2010)	Nanotechnology	21	85103	[68]	Kobayashi	K	et	al.	(2010)	Mutat.	Res.	704	123–31	[69]	Verkhovtsev	A	V	et	al.	(2015)	J.	Phys.	Chem.	C	119	11000–13	[70]	Pešić	Z	D	et	al.	(2009)	J.	Phys.	B	At.	Mol.	Opt.	Phys.	42	235202	[71]	Stumpf	H	(1971)	Phys.	der	Kondens.	Mater.	13	101–17	
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2.4 Conclusion:	Multi-scale	study	
In	this	multi-scale	study,	we	attribute	the	REE	of	PtPEG-OH	NPS	to	the	enhanced	induction	of	 nanoscopic	 bond	breaks	 trigger	 on	 the	 cytosol,	where	 biomolecules,	 such	 as	 proteins	and	lipids,	can	be	lethally	perturbed	inhibiting	the	cell	reparation	pathways	to	lately	cause	cell	death.		
For	instance,	proteins	are	the	major	target	for	biological	oxidants.	The	basic	principles	on	the	oxidation	of	proteins	by	irradiation-generated	ROS	were	established	in	the	pioneering	studies	 of	 Garrison	 [72]	 [73],	 Swallow	 [74]	 and	 Schuessler	 and	 Schilling	 [75]	 who	characterized	 reaction	 products	 formed	 when	 proteins	 were	 exposed	 to	 γ-rays	 under	conditions	 where	 only	OH∙,	O!∙!,	 or	 a	 mixture	 of	 both	 were	 presented.	 Results	 of	 these	studies	 demonstrated	 that	 the	 modification	 of	 proteins	 is	 initiated	 mainly	 by	 reactions	with	OH∙.	This oxidation may adversely affect protein’s activity resulting in an inadequate cell 
functional regulation, e.g. alteration on the activity of DNA repair proteins (γH2aX), and thus 
cell death.  
Another	 biomolecule	 target	 of	 ionizing	 radiation	 is	 the	 lipid	 bilayer	 within	 cell	membranes,	which	 can	be	damaged	via	 ROS.	Lipid peroxidation by ROS was found as the 
main damage to the membranes, leading to an increase in membrane permeability and other 
transmembrane processes [76] [77]. For instance, studies of cell membrane irradiation have 
shown the induction of cell apoptosis. This effect was also observed in cells without a nucleus, 
confirming another pathway of cell-killing independently of nucleic acid damage [78]. 
Therefore,	 it is concluded (as illustrated in Figure	III	-	32) that PtPEG-OH NPs are excellent 
agents to increase the production of free radicals (demonstrated in experiments performed with 
the bio-nanoprobe in the presence of DMSO) inside cells (imaging results) enhancing the 
induction of nanosize damages and cell killing.		
																																																																											[72]	Garrison	W	M	et	al.	(1962)	Radiat.	Res.	16	483–502	[73]	Garrison	W	M	et	al.	(1970)	J.	Phys.	Chem.	74	4506–9	[74]	Swallow	A	J	(1960)	Radiation	Chemistry	of	Organic	Compounds	pp	211–24	[75]	Schuessler	H	and	Schilling	K	(1984)	Int.	J.	Radiat.	Biol.	Relat.	Stud.	Physics,	Chem.	Med.	45	267–81	[76]	Corre	I	et	al.	(2010)	Mutat.	Res.	704	61–7	[77]	Wong-Ekkabut	J	et	al.	(2007)	Biophys.	J.	93	4225–36	[78]	Haimovitz-Friedman	A	et	al.	(1994)	J.	Exp.	Med.	180	525–35	
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Figure	III	-	32.	Multy-scale	study:	the	radiation	enhancing	effect	of	PtPEG-OH	NPs	from	the	nanoscale	to	the	cell.	
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Chapter	IV:	RESULTS	AND	DISCUSSION	
Mono-	and	bimetallic	PEGylated	gold-platinum	nanoparticles	In	this	chapter	we	present	the	characterization	and	molecular	scale	analysis	of	mono-gold,	mono-platinum	 and	 bimetallic	 gold-platinum	 nanoparticles	 prepared	 by	 radiolysis	 and	stabilized	 by	 PEG-diamine	 (PEG-2NH2).	 The	 characterization	 of	 the	 nanoparticles	 is	presented	in	Section	1.	The	radio-enhancement	effect	of	these	nanoparticles	is	shown	and	discussed	in	Section	2.	
1 Nanoparticles	characterization	The	 mono-	 and	 bimetallic	 PEGylated	 gold-platinum	 nanoparticles	 were	 characterized	following	 the	 approach	 developed	 in	 this	 work	 to	 characterize	 the	 physico-chemical	properties	of	PEGylated	NPs	(see	Chapter	II–	Section	2).		
In	 Section	 1.1,	 a	 UV-Vis	 spectrophotometric	 analysis	 of	 nanoparticles	 colloids	 is	presented.	 The	 nanoparticles	 size	 distribution	 was	 determined	 by	 TEM	 and	 DLS.	 The	chemical	composition	of	the	nanoparticles	was	evaluated	by	XPS	(Section	1.2.1)	and	FTIR	(Section	1.2.2).	
1.1 Characterization	of	by	spectrophotometry	UV-Vis,	TEM	and	DLS	
We	 followed	 the	 reduction	 of	 metal	 ions	 and	 nanoparticles	 formation	 by	 UV-Vis	absorption	spectroscopy.	The	size	of	mono-	and	bimetallic	nanoparticles	was	determined	by	TEM	and	DLS.	The	TEM	micrographs	were	obtained	with	the	JEOL	100CXII	microscope.	In	 the	 particular	 case	 of	 gold	 nanoparticles,	 we	 also	 estimated	 their	 size	 by	 a	 simple	method	based	on	the	UV-Vis	data	(using	the	maximum	of	the	plasmon	band).	
1.1.1 Gold	PEG-diamine	nanoparticles	
1.1.1.1 Characterization	by	UV-Vis	absorption	spectroscopy		
Figure	IV	-	1	 shows	the	UV-visible	absorption	spectra	of	controls	consisting	on	aqueous	solutions	containing	the	precursor	AuIIICl4-	(10-3	mol.L-1)	and	the	different	PEG-2NH2	(PEG-2000,	Mw=	2000	g.mol-1	and	PEG-3000,	Mw=	3000	g.mol-1),	as	well	as	the	mixtures	AuIIICl4-/PEG-diamine	2000	and	3000	before	irradiation.	
CHAPTER	IV	 RESULTS	AND	DISCUSSION:	mono-	and	bimetallic	Au:PtPEG-2NH2	NPs		
	 166	
	 	
a)		 b)	
Figure	 IV	 -	 1.	UV-Vis	 absorption	 spectra	 (optical	 path=	 2	mm)	 of	 control	 solutions	 containing	 10-3	mol.L-1	AuIIICl4-	 and	 PEG-2NH2	 before	 irradiation	 (a).	 Panel	 (b)	 corresponds	 to	 the	 absorption	 spectra	 of	 samples	shown	in	(a)	but	in	a	wavelength	range	from	250	to	400	nm.		In	Figure	IV	-	1a,	the	absorption	peak	around	305	nm	is	the	characteristic	LMCT	band	of	AuIIICl4-	 ions,	which	correspond	to	the	well-known	ligand	(chloro)	to	metal	(gold)	charge	transfer.[1]	 [2]	 [3].	PEG-diamine	at	5x10-2	mol.L-1,	presented	an	absorption	peak	around	290	 nm	 (not	 observed	 for	 PEG-OH	 Chapter	 III	 –	 Section	 1.1)	 and	 an	 increasing	absorption	 signal	 at	 lower	 wavelengths.	 These	 features	 are	 attributed	 to	 the	 ! → !∗	transition	of	aliphatic	amines	[4],	not	observed	at	lower	PEG-diamine	concentrations	[5].	When	gold	ions	are	in	the	presence	of	PEG-diamine	2000,	a	complete	disappearance	of	the	LMCT	 is	 observed,	 which	 might	 indicate	 the	 formation	 of	 a	 complex	 AuIII-PEG-diamine	2000	before	irradiation	(intermediated	species).	In	contrast,	at	the	same	molar	ratio,	PEG-3000	does	not	react	with	AuIIICl4-	and	the	LMCT	is	not	quenched.	By	increasing	the	molar	ratio	 to	ca.	 75	and	 thus	amine	groups	 (spectrum	 ---	 in	Figure	 IV	 -	1a	and	b),	 the	LMCT	starts	to	disappear,	indicating	complexation	of	gold	ions	with	the	amine	end-group	of	PEG.	For	all	controls,	no	absorption	signal	is	observed	in	the	visible	spectral	region,	indicating	neither	 reduction	 of	metal	 ions	 nor	metal	 nuclei	 formation	 prior	 irradiation.	Moreover,	these	 solutions	 containing	AuIIICl4-	 ions	 (complexed	 by	 PEG	 or	 not)	 and	 PEGs	 are	 stable	before	irradiation.	
																																								 																					[1]	Remita	S	et	al.	(1999)	Radiat.	Phys.	Chem.	54	463–73	[2]	Esumi	K	et	al.	(2000)	Langmuir	16	2604–8	[3]	Kim	Y-G	et	al.	(2004)	Chem.	Mater.	16	167–72	[4]	Guedira	F	Application	de	la	Spectroscopie	UV-Visible	Université	Mohammed	V-Agdal		[5]	Fernandez-Fernandez	A	et	al.	(2014)	Int.	J.	Nanomedicine	9	4631–48	
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Figure	 IV	 -	 2	 shows	 the	 absorption	 spectra	 of	 solutions	 containing	 AuIIICl4-	 and	 PEG-diamine	 after	 irradiation.	 Figure	 IV	 -	 2a	 corresponds	 to	 irradiated	 samples	 containing	AuIIICl4-	 and	 PEG-2000.	 Figure	 IV	 -	 2b	 corresponds	 to	 irradiated	 solutions	 containing	AuIIICl4-	and	PEG-3000.	The	samples	were	irradiated	at	different	radiation	doses	to	follow	the	radiolytic	reduction	of	AuIII	and	nanoparticles	formation.	
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a)	 b)	
Figure	IV	-	2.	UV-Vis	absorption	spectra	(optical	path=	2	mm)	of	samples	containing	10-3	mol.L-1	AuIIICl4-,	PEG-2000	(a)	or	PEG-3000	(b)	as	function	of	the	irradiation	dose.	Samples	were	prepared	with	a	molar	ration	PEG-2NH2:Au	of	ca.	50.	Inserted	pictures	show	colloids	after	different	irradiation	doses.	After	the	deposition	of	1	kGy	to	the	mixture	containing	AuIIICl4-	and	PEG-2000	(Figure	IV	-	
2a	 in	blue),	 the	appearance	of	a	well-defined	plasmon	band	around	510	nm	is	observed,	which	 is	 characteristic	 of	 a	 homogeneous	 colloidal	 solution	 composed	 of	 small	 gold	nanospheres	in	water	solution	(<10	nm)	[6].	At	this	dose,	the	colloidal	solution	displays	a	red	colour	[7].	For	higher	doses,	the	spectra	display	a	broaden	absorption	plasmon	band	shifted	to	larger	wavelengths	and	important	scattering	of	light	is	observed.	This,	together	with	 the	 new	 purple	 and	 blue	 reflected	 colours,	 suggests	 the	 formation	 of	 large	nanoparticles	 with	 variable	 size	 and	 shapes	 [7]	 [8].	 This	 effect	 at	 higher	 doses	 might	indicate	 that	 PEG-2NH2	 is	 acting	 as	 an	 electron	 donor	 by	 essentially	 reducing	 ions	adsorbed	on	the	initial	nuclei	generated	by	radiolysis	[9].	Summarizing,	the	AuPEG-2000	
																																								 																					[6]	Polte	J	et	al.	(2010)	J.	Am.	Chem.	Soc.	132	1296–301	[7]	NanoEurope	Composix	“Gold	Nanoparticles:	Optical	Properties”	[8]	Kim	F	et	al.	(2002)	J.	Am.	Chem.	Soc.	124	14316–7		[9]	Physico-chimie	(1989)	34	605–17	
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NPs	 colloidal	 solution	 obtained	 after	 1	 kGy	 radiation	 dose	 is	 the	 most	 homogeneous	solution,	which	remains	stable	for	several	months	when	stored	at	4	°C.	
Figure	IV	-	2b	corresponds	to	samples	prepared	using	PEG-2NH2	with	Mw=	3000	g.mol-1.	After	 irradiation	 the	LMCT	 signals	disappears	 and	 the	gold	SPR	band	 raises	 around	524	nm,	which	in	comparison	with	AuPEG-2000	NPs	corresponds	to	 larger	nanoparticles	[6].	These	colloidal	AuPEG-3000	NPs	were	less	stable	than	AuPEG-2000	NPs	and	precipitated	approximately	one	week	after	synthesis.	Notably,	by	keeping	a	molar	ratio	PEG-2NH2:Au	of	 ca.	 50,	 which	 is	 based	 on	 the	 monomeric	 unit,	 the	 mixture	 AuIIICl4-	 with	 PEG-3000,	contains	~33%	 less	 amine	 groups	 than	 the	mixture	 AuIIICl4-	with	 PEG-2000.	 This	might	explain	an	unsaturated	coordination	before	irradiation,	and	thus	the	colloidal	instability.		
The	synthesis	of	gold	nanoparticles	by	radiolysis	has	been	already	investigated	[10]	[11].	In	my	work,	I	demonstrated	the	feasibility	to	synthesize	AuNPs	coated	with	PEG-diamine	in	 a	 biocompatible	medium	 (water)	 using	 a	 one-step	 radiolytic	 process.	 This	 study	 has	shown	 the	 strong	 dependence	 of	 synthesis	 efficiency	 as	 a	 function	 of	 the	 PEG-diamine	molecular	weight,	more	particularly	as	 function	of	 the	amines	concentration.	Finally,	 the	NPs	composed	of	PEG-2000	were	found	more	stable	than	the	ones	coated	with	PEG-3000.	AuPEG-2000	NPs	remained	stable	for	several	months	(up	to	a	year)	at	4	°C.	
1.1.1.2 Size	estimation	from	UV-Vis	spectra	
In	2007,	Haiss	and	co-workers	proposed	a	model	to	determine	the	size	and	concentration	of	spherical	gold	nanoparticles	from	the	UV-Vis	absorption	spectra	[12].	This	method	gives	a	quantitative	description	of	gold	nanoparticles	absorbance	 in	a	 size	 range	 from	5	up	 to	100	 nm.	 We	 applied	 this	 method	 to	 get	 initial	 estimation	 about	 the	 nanoparticles	 size	before	TEM	measurements.	For	small	nanoparticles,	the	absorbance	ratio	of	Table	IV	-	1	was	used	to	determine	the	size	of	gold	nanoparticles.		
	
	
																																									 																					[6]	Polte	J	et	al.	(2010)	J.	Am.	Chem.	Soc.	132	1296–301	[10]	Gachard	E	et	al.	(1998)	New	J.	Chem.	22	1257–65	[11]	Abidi	W	and	Remita	H	(2010)	Recent	Patents	Eng.	4	170–88	[12]	Haiss	W	et	al.		(2007)	Anal.	Chem.	79	4215–21	
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Table	IV	-	1.	Ratio	of	absorbance	of	gold	nanoparticles	at	the	surface	plasmon	resonance	peak	(ASPR)	to	the	absorbance	at	450	nm	(A450)	as	function	of	the	particle	diameter	[12].	
ASPR/A450	 d/nm	 ASPR/A450	 d/nm	1.10	 3	 1.56	 12	1.19	 4	 1.61	 14	1.27	 5	 1.65	 16	1.33	 6	 1.69	 18	1.38	 7	 1.73	 20	1.42	 8	 1.80	 25	1.46	 9	 1.86	 30	1.50	 10	 1.92	 35	
The	 estimated	 sizes	 of	 AuPEG-2000	 (1	 kGy)	 and	 AuPEG-3000	 (4.5	 kGy)	 NPs	 are	summarized	in	Table	IV	-	2.		
Table	IV	-	2.	Nanoparticles	size	determination	by	the	model	reported	by	Haiss	et	al.	
Nanoparticle	 λSPR	 ASPR	 A450	 ASPR/A450	
Size	determination	
(nm)	AuPEG-2000	(1	kGy)	 510	 0.55	 0.53	 1.04	 ~3	AuPEG-3000	(4.5	kGy)	 524	 0.66	 0.42	 1.57	 ~12	
This	method	gives	 size	 evaluation	of	 3	nm	 for	 gold	nanoparticles	 synthetized	with	PEG-2000	and	12	nm	for	those	synthetized	with	PEG-3000.	For	particle	diameters	smaller	than	10	nm,	the	reported	values	should	only	be	considered	as	estimation.	
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1.1.1.3 Size	and	morphology	determination	by	TEM	and	DLS		
Figure	 IV	 -	 3	 shows	 TEM	 micrographs	 of	 AuPEG-2000	 NPs	 synthetized	 with	 a	 total	radiation	dose	of	1	kGy,	as	well	as,	their	core	diameter	size	distribution.		
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Figure	IV	-	3.	TEM	micrographs	(a)	of	AuPEG-2000	NPs	synthesized	at	10-3	mol.L-1	with	a	PEG-2NH2:Au	molar	ratio	of	ca.	50	with	a	total	dose	of	1	kGy.	(b)	Magnified	image	of	AuPEG-2000	NPs.	(c)	Core	size	distribution.	We	observe	well	dispersed	gold	nanoparticles	in	panel	(a).	The	magnified	image	in	panel	
(b)	displays	mainly	spherical	nanoparticles.	These	as-synthetized	AuPEG-2000	NPs	have	an	average	core	diameter	of	3.8	±	1.1	nm	(c)	and	an	hydrodynamic	diameter	of	about	10.3	±	2.7	nm	(PdI=	0.290	±	0.003).		
Figure	IV	-	4	shows	TEM	micrographs	of	fresh	AuPEG-3000	NPs	synthetized	with	a	total	radiation	dose	of	4.5	kGy,	as	well	as,	their	diameter	size	distribution.	
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Figure	IV	-	4.	TEM	micrographs	(a)	of	AuPEG-3000	NPs	synthesized	at	10-3	mol.L-1	with	a	PEG-2NH2:Au	molar	ratio	of	ca.	50.	(b).	Magnified	image	of	AuPEG-3000	NPs.	The	core	size	distribution	is	shown	in	(c).	In	 contrast	 with	 AuPEG-2000	 NPs,	 we	 observe	 higher	 polydispersity.	 We	 found	 nano-spheres,	squares,	triangles	and	rods.	Spherical	particles	have	an	average	size	of	14.2	±	7.1	nm	 (Figure	 IV	 -	 4c).	 DLS	 measurements	 were	 not	 performed	 due	 to	 this	 high	polydispersity.	 TEM	 measurements	 confirmed	 the	 difference	 of	 size	 and	 shape	homogeneity	of	NPs	as	function	of	the	polymeric	chain	length	and	the	amine	content.	
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In	this	work,	we	chose	to	further	focus	on	the	smallest	and	more	stable	Au	NPs	coated	with	PEG-2NH2	Mw=2000	 g.mol-1	 (PEG-2NH2:Au	molar	 ratio	 of	 ca.	 50,	 D=	 1kGy).	 In	 the	 next	sections,	these	nanoparticles	are	simply	named	AuPEG-2NH2	NPs.	
1.1.2 Platinum	PEG-diamine	nanoparticles	
1.1.2.1 Characterization	by	UV-Vis	absorption	spectroscopy	
Figure	 IV	 -	5	 shows	 the	absorption	 spectra	of	 aqueous	 solutions	 containing	10-3	mol.L-1	(Pt(NH3)4)2+	 and	 PEG-2NH2	 (Mw=	 2000	 g.mol-1)	 before	 and	 after	 increasing	 irradiation	doses.	The	maximum	radiation	dose	was	 fixed	 to	10	kGy,	which	 is	 the	required	dose	 for	total	 platinum	 reduction	 in	 the	 presence	 of	 PEG-OH	 (Mw=	1000	 g.mol-1)	 (see	 results	 by	XPS	in	Chapter	III	–	Section	1.3.2).	The	solutions	were	prepared	with	a	molar	ratio	PEG-2NH2:Pt	of	ca.	50.	These	solutions	remained	stable	prior	irradiation.		
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Figure	IV	-	5.	(a)	UV-Vis	absorption	spectra	(optical	path=	2	mm)	of	samples	containing	10-3	mol.L-1	(Pt(NH3)4)2+and	PEG-2000	as	function	of	the	irradiation	dose.	Samples	were	prepared	with	a	molar	ratio	PEG-2NH2:Pt	of	ca.	50.	(b)	Evolution	of	the	absorbance	at	450	nm	as	function	of	the	irradiation	dose.	The	 absorption	 spectrum	before	 irradiation	 reveals	 an	 absorption	 peak	 around	 300	 nm	and	a	small	shoulder	around	240	nm	(Figure	IV	-	5a),	which	are	similar	to	those	steady	signals	 identified	 before	 the	 radiolytic	 synthesis	 of	 PtPEG-OH	 NPs.	 These	 absorptions	correspond	to	the	LMCT	band	of	platinum	complexes	(Pt(NH3)4)2+	(see	the	case	of	PtPEG-OH	NPs	in	Chapter	III–	Section	1.1).	After	irradiation,	we	observed	the	disappearance	of	
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these	two	absorption	peaks	and	the	appearance	of	the	characteristic	stretched	absorption	spectra	in	the	visible	region,	suggesting	the	formation	of	platinum	nanoparticles	[13].	The	inserted	picture	in	Figure	IV	-	5a,	shows	colloidal	solutions	containing	Pt	after	irradiation	at	 doses	 of	 2.5,	 5	 and	 10	 kGy.	 These	 display	 the	 solution	 colour	 change,	 from	 light	 to	darker	 brown,	which	 is	 a	 qualitative	 evidence	 for	 nanoparticles	 formation,	 and	 thus	 the	increasing	nanoparticles	concentration	as	function	of	the	dose.	Figure	IV	-	5b	shows	the	evolution	of	the	absorbance	in	the	visible	region	(at	λ=	450	nm)	when	increasing	the	dose.	An	absorbance	plateau	is	reached	after	10	kGy	suggesting	the	total	reduction	of	PtII	ions.	
The	 platinum	 nanoparticles	 here	 presented	 remain	 stable	 at	 4°C	 for	 several	 months	(verified	 by	 UV-Vis	 spectrophotometry	 and	 DLS).	 We	 further	 characterized	 those	nanoparticles	obtained	after	2.5	and	10	kGy	by	TEM.		
1.1.2.2 Size	and	morphology	determination	by	TEM	and	DLS		
For	 comparison,	Figure	 IV	 -	6	 shows	TEM	micrographs	of	PtPEG-2NH2	NPs	prepared	at	10-3	mol.L-1	after	2.5	kGy	(a)	and	10	kGy	(b).		
	 	
a)	 b)	
Figure	IV	-	6.	TEM	micrograph	of	PtPEG-2NH2	NPs	at	10-3	mol.L-1	prepared	with	a	total	dose	of	2.5	kGy	(a)	and	10	kGy	(b).	We	observe	high	polydispersity	 in	 the	sample	prepared	with	a	radiation	dose	of	2.5	kGy	
(Figure	IV	-	6a).	It	contains	discrete	spherical	particles	of	about	2.3	±	0.9	nm	in	diameter	and	 nanoparticles	 aggregates	with	 variable	 shapes.	 On	 the	 other	 hand,	 after	 10	 kGy	we	mostly	 observe	 nanoparticles	 aggregates	 having	 an	 average	 diameter	 of	 4.9	 ±	 2.7	 nm	
(Figure	IV	-	6b).	
																																								 																					[13]	Henglein	A	et	al.	(1995)	J.	Phys.	Chem.	99	14129–36	
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The	synthesis	of	PtPEG-2NH2	NPs	was	also	performed	at	5x10-3	mol.L-1	(PEG-2NH2:Pt	ca.	50,	50	kGy).	Figure	 IV	 -	7	shows	TEM	micrographs	of	 these	as-synthetized	PtPEG-2NH2	NPs,	as	well	as,	their	size	distribution.	
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Figure	IV	-	7.	TEM	micrographs	at	two	different	magnifications	of	PtPEG-2NH2	NPs	synthetized	at	5x10-3	mol.L-1	prepared	with	a	total	dose	of	50	kGy	(a)	and	(b).	PtPEG-2NH2	NPs	size	distribution	(c).	At	these	conditions,	the	nanoparticles	were	homogeneously	formed	as	aggregates	of	about	14.6	±	7.4	nm.	This	morphology	is	commonly	named	as	nanoflowers	(Pt	NFs)	[14].	These	Pt	 NFs	 consist	 of	 discrete	 nanoparticles	with	 an	 average	 diameter	 size	 of	 3.2	 ±	 1.6	 nm,	which	 is	 equivalent	 to	 the	 size	 of	 the	 individual	 PtPEG-OH	NPs	 (see	 size	 distribution	 in	
Chapter	III	–	Section	1.2).	Platinum	nanoflowers	colloids	have	an	average	hydrodynamic	diameter	of	about	16.1	±	4.6	nm	(PdI=	0.115	±	0.004).	
1.1.2.3 Proposed	nanoparticles	formation	mechanism	
We	 attribute	 the	 formation	 of	 platinum	nanoflowers	 to	 an	 intra-molecular	 cross-linking	induced	 by	 radiolysis	 [15].	 In	 the	 cross-linking	 process	 (see	 irradiation	 of	 polymers	 in	
Chapter	 I	 –	 Section	 1.1.2.4),	 the	 polymeric	 chains	 are	 oxidized	 and	 macroradicals	(polymer	radicals)	are	produced	to	later	form	a	polymer	matrix.		
The	 primary	 products	 of	 radiolysis	 have	 different	 rates	 of	 reaction	 with	 hydrophilic	polymers	[16]	[17].	The	rate	of	reaction	of	solvated	electrons,	entities	that	in	the	present	case	 will	 preferentially	 reduce	 metal	 ions	 to	 neutral	 atoms,	 is	 relatively	 low	 in	 the	presence	 of	 polymers.	 Solvated	 electrons	 have	 a	 rate	 constant	 within	 the	 range	 of	 106	dm3.mol-1.s-1	[17].	In	contrast,	the	rate	constant	of	hydroxyl	radicals	is	higher	with	a	value	
																																								 																					[14]	Dandapat	A	et	al.	(2013)	Nanomater.	Nanotechnol.	3	[15]	Jovanović	Ž	et	al.	(2011)	Radiat.	Phys.	Chem.	80	1208–15	[16]	Rosiak	J	M	et	al.	(1995	)	Radiat.	Phys.	Chem.	46	161–8	[17]	Rosiak	J	M	and	Ulański	P	(1999)	Radiat.	Phys.	Chem.	55	139–51	
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in	 the	 range	 of	 108	 dm3	mol-1	 s-1	 [17].	 Thus,	 OH•	 radicals	 are	 the	main	 species	 of	water	radiolysis	that	react	with	polymer	chains.		
In	 the	 case	 of	 poly	 (ethylene	 oxide)	 chains,	 all	 the	 hydrogen	 atoms	 in	 the	 polymer	 are	equivalent	 (-CH2).	 Therefore,	 only	 one	 type	 of	 macroradicals	 can	 be	 formed	 upon	 OH•	radicals’	attack,	which	is	localized	on	carbon	atoms	(Figure	IV	-	8,	[18]).	This	structure	of	the	 carbon-centered	 polymer	 radicals	 is	 the	 great	 importance	 for	 the	 process	 of	crosslinking.	The	concentration	and	molecular	weight	of	 the	polymer	are	also	 important	aspects	that	determine	the	crosslinking	and	competing	reactions	yields	[17].	
	
Figure	IV	-	8.	Cross-linking	process	and	structure	of	the	poly	(ethylene	oxide)	radical	formed	upon	irradiation	in	aqueous	solution.	It	 is	 suggested	 that	 the	 cross-linking	 occurs	 due	 to	 the	 absence	 of	 the	 intermediated	species	 created	 using	 PEG-OH	 (see	 discussion	 Chapter	 III	 –	 Section	 1.4).	 Before	irradiation,	 the	 amine	 end-groups	 of	 PEG	 do	 not	 interact	 with	 the	 platinum	 complex,	(Pt(NH3)4)2+,	contrary	to	the	hydroxyl	end-groups	of	PEG.	
In	 the	 present	 case,	 the	 synthesis	 of	 nanoflowers	might	 be	 understood	 considering	 two	main	simultaneous	reactions:	i)	direct	oxidation	of	PEG	chains	(macroradicals	formation)	and	ii)	reduction	of	the	metal	precursor.	The	formation	of	nanoflowers	might	be	attributed	to	 the	 induction	 of	 a	 slight	 swelling,	 facilitating	 discrete	 metal	 species	 to	 migrate	 and	aggregate	 (Figure	 IV	 -	 7b).	 This	migration	 has	 been	 already	 observed	 during	 hydrogel	preparation	 by	 radiolysis	 [15].	 The	 proposed	 mechanism	 of	 platinum	 nanoflowers’	formation	is	illustrated	in	Figure	IV	-	9.	
																																								 																					[15]	Jovanović	Ž	et	al.	(2011)	Radiat.	Phys.	Chem.	80	1208–15	[17]	Rosiak	J	M	and	Ulański	P	(1999)	Radiat.	Phys.	Chem.	55	139–51	[18]	Rosiak	J	M	et	al.	(2002)	IAEA-TECDOC-1324	
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Figure	IV	-	9.	Schematic	synthesis	of	PtPEG-2NH2	NPs	(Pt	NFs)	by	the	proposed	mechanism	involving	free	PtII	ions	in	the	presence	of	free	PEG-2NH2	before	irradiation	(1),	the	radiolytic	reduction	of	metal	ions	in	competition	with	the	polymer	cross-linking	process	(2)	and	the	homogenous	formation	of	Pt	NFs	embedded	into	the	PEG	matrix	(3).	By	TEM,	we	observed	 that	 this	 last	process	 is	dose	dependent	 (Figure	 IV	 -	6).	At	 lower	doses	 (as	 shown	 for	 2.5	 kGy),	 it	 is	 suggested	 that	 neither	 the	metal	 ions	 reduction	 nor	cross-linking	 processes	 are	 completed.	 At	 higher	 doses,	 it	 is	 expected	 total	 reduction	(Figure	IV	-	5b).	
We	 used	 the	 PtPEG-2NH2	 NPs	 synthetized	 at	 5x10-3	 mol.L-1	 (50	 kGy)	 for	 all	 further	characterization	 (XPS	 and	 FTIR	 presented	 in	 Section	 1.2).	 The	 synthesis	 of	 these	nanoparticles	was	reproducible.	They	were	found	stable	 for	months	(up	to	a	year)	when	stored	 at	 4°C	 (verified	 by	 UV-vis	 spectrophotometry	 and	 DLS).	 In	 particular,	 diluted	solutions	 of	 PtPEG-2NH2	NPs	were	used	 to	 elucidate	 their	 radiation	 enhancing	 effect	 on	the	induction	of	nanosize	molecular	damage	(see	results	in	Section	2).	
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1.1.3 Bimetallic	gold-platinum	PEG-diamine	nanoparticles	
1.1.3.1 Characterization	by	UV-Vis	absorption	spectroscopy		
Figure	IV	-	10	shows	the	absorption	spectra	of	aqueous	solutions	containing	(Pt(NH3)4)2+	and	AuIIICl4-	 in	 the	 presence	 of	 PEG-2NH2	 (Mw=	2000	 g.mol-1)	 before	 (controls	 (a))	 and	after	 exposure	 to	 increasing	 irradiation	 doses	 (b).	 Bimetallic	 nanoparticles	 were	synthetized	with	a	Pt:Au	molar	ratio	of	1:1	and	by	keeping	a	PEG-2NH2:metal	molar	ratio	of	ca.	50	(see	experimental	conditions	in	Chapter	II	–	Section	1.2).	Before	irradiation	the	precursor	solutions	were	found	stable.	
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Figure	IV	-	10.	UV-Vis	absorption	spectra	(optical	path=	2	mm)	of	controls	before	irradiation	(a)	and	samples	containing	 5x10-4	 mol.L-1	 AuIIICl4-,	 5x10-4	 mol.L-1	 Pt(NH3)4)2+	 and	 5x10-2	 PEG-2NH2	 (Mw=	 2000	 g.mol-1)	 as	function	of	the	irradiation	dose	(b).	Inserted	pictures	in	(b)	show	colloids	after	different	irradiation	doses.	Before	irradiation,	the	absorption	spectrum	of	the	mixture	AuIIICl4-	/	(Pt(NH3)4)2+	in	water	(Figure	 IV	 -	 10a	 (____))	 displays	 the	 LMCT	 of	 the	 AuIIICl4-	 ions	 at	 305	 nm.	 This	 signal	disappears	in	the	presence	of	PEG-2NH2	(Mw=	2000	g.mol-1)	confirming	the	complexation	between	gold	ions	and	PEG-2NH2.	By	irradiating	(Figure	IV	-	10b),	a	rising	band	around	530	nm	is	observed.	This	band	corresponds	to	the	SPR	of	gold,	which	 indicates	that	gold	ions	are	reduced	and	coalesced	into	atomic	nanoclusters.		
By	 increasing	 the	 radiation	 dose,	 the	 SPR	 of	 gold	 disappears	 and	 we	 observe	 the	appearance	of	the	stretched	absorption	spectra	characteristic	of	pure	colloidal	Pt	NPs.	This	
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spectral	evolution	has	already	been	described	[19]	[20]	and	corresponds	to	the	formation	of	bilayered	Aucore-Ptshell	nanoparticles.	A	complete	disappearance	of	 the	SPR	of	gold	was	identified	 after	 2.5	 kGy	 irradiation,	 suggesting	 complete	 reduction	 of	 the	 auric	 ions	 and	formation	of	platinum	coating.		
The	 inserted	picture	 in	Figure	 IV	 -	10b	reveals	 the	 colour	 transition	 from	red	 (gold)	 to	brown	 (platinum),	 which	 suggests	 the	 bilayered	 gold-platinum	 structure.	 When	 PtII	 is	used,	 only	 Aucore/Ptshell	 particles	 might	 be	 obtained	 [11].	 This	 structure	 is	 explained	 by	early	 electron	 transfer	 from	 Pt	 complexes	 or	 nascent	 Pt0	 to	 gold	 complexes	 (AuIII	 and	intermediated	 AuI	 species),	 which	 leads	 to	 a	 faster	 gold	 reduction	 forming	 small	 nuclei	prior	the	creation	of	the	Pt	shell	(Figure	IV	-	11).	
	
Figure	IV	-	11.	Schematic	synthesis	of	Au:PtPEG-2NH2	NPs	by	the	formation	of	an	AuIII-PEG-2NH2	complex	(1),	the	radiolytic	reduction	of	metal	ions	and	early	electron	transfer	from	Pt	to	Au	(2)	and	formation	of	Aucore-Ptshell	structured	nanoparticles	stabilized	by	PEG-2NH2	(3).	In	conclusion,	I	managed	to	produce	biocompatible	bimetallic	gold-platinum	nanoparticles	stabilized	 by	 PEG	 for	 biomedical	 concerns.	 These	Au:PtPEG-2NH2	NPs	 remain	 stable	 for	several	months	(up	to	a	year)	at	4	°C.	
1.1.3.2 Size	and	morphology	determination	by	TEM	and	DLS		
Figure	 IV	 -	12	 shows	TEM	micrographs	of	Au:PtPEG-2NH2	NPs	 synthetized	with	 a	 total	radiation	dose	of	2.5	kGy.		
																																								 																					[11]	Abidi	W	and	Remita	H	(2010)	Recent	Patents	Eng.	4	170–88	[19]	Mirdamadi-Esfahani	M	et	al.	(2010)	Gold	Bull.	43	49–56	[20]	Remita	H	et	al.	(2005)	Radiat.	Phys.	Chem.	72	575–86	
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Figure	IV	-	12.	TEM	micrographs	of	Au:PtPEG-2NH2	NPs	synthesized	at	10-3	mol.L-1	with	a	PEG-2NH2:MT	molar	ratio	of	ca.	50	(a).	Magnified	image	of	Au:PtPEG-2NH2	NPs	(b),	The	core	size	distribution	is	shown	in	(c).	We	observe	well	dispersed	nanoparticles.	They	are	homogeneous	in	size	and	shape	having	an	 average	 spherical	 core	diameter	 of	 2.4	±	0.6	nm	 (c)	 and	 an	dH	 of	 9.3	±	3.0	nm	 (PdI=	0.258	±	0.085).	
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1.2 Chemical	composition	
We	evaluated	 the	oxidation	 state	 and	 chemical	 composition	of	 the	mono-	 and	bimetallic	gold-platinum	PEGylated	nanoparticles	by	XPS	and	FTIR	spectroscopy.	
1.2.1 Oxidation	state	and	chemical	composition	by	XPS	
Figure	 IV	 -	 13	 shows	 the	 survey	XPS	 spectra	 of	 the	mono	 and	bimetallic	 nanoparticles.	Only	the	characteristic	binding	energies	of	Au,	Pt,	C,	O,	N	and	Cl	were	observed.		
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Figure	IV	-	13.	Survey	XPS	spectra	of	the	as-synthetized	PtPEG-2NH2,	AuPEG-2NH2	and	Au:PtPEG-2NH2	NPs.	
1.2.1.1 Gold	PEG-diamine	nanoparticles	
Figure	IV	-	14	shows	the	high-resolution	XPS	spectra	of	a	metallic	gold	surface	(bulk	Au0	control)	and	AuPEG-2NH2	NPs	(D=1	kGy)	at	the	Au-4f	core	level	region.	
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Figure	IV	-	14.	XPS	spectra	corresponding	to	the	Au-4f	core	level	region	of	gold	on	(a)	a	metallic	gold	film	and	(b)	on	AuPEG-2NH2	NPs.	
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In	 agreement	 with	 literature	 [21],	 the	 characteristic	 Au-4f7/2	 and	 Au-4f5/2	 spin-orbit	components	 of	 metallic	 Au	 (Δmetal	 ~	 3.7	 eV)	 were	 measured	 at	 84.1	 and	 87.8	 eV	respectively	 on	 the	metallic	 gold	 surface	 (Figure	 IV	 -	 14a).	 The	 binding	 energy	 of	 Au0	nanoparticles	(Figure	IV	-	14b)	is	observed	~1.2	eV	below	that	for	bulk,	consistent	with	that	expected	for	Au	surface	state	[22].	At	the	Au-4f	core	level	AuPEG-2NH2	NPs	have	BEs	of	~82.9	and	86.6	eV.		
The	C-1s,	O-1s	and	N-1s	XPS	spectra	of	AuPEG-2NH2	NPs	are	shown	in	Figure	IV	-	15.	The	inserted	 vertical	 dotted	 lines	 indicate	 the	 BE	 position	 of	 the	 control	 (pure	 PEG-2NH2	 –	upper	spectra).	
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Figure	IV	-	15.	XPS	spectra	of	AuPEG-2NH2	NPs	at	the	C-1s	(a),	O-1s	(b)	and	N-1s	(c)	regions.	The	XPS	measured	binding	energies,	assignments	and	FWHM	of	controls	(the	metallic	gold	surface	and	PEG-2NH2)	and	nanoparticles	at	the	Au-4f,	C-1s,	O-1s	and	N-1s	core	levels	are	listed	below	in	Table	IV	-	3.	
The	binding	energies	at	the	C-1s	and	O-1s	core	levels	of	AuPEG-2NH2	NPs	are	identical	to	those	 of	 the	 native	 PEG-2NH2.	 This	 has	 been	 already	 observed,	 indicating	 that	 the	poly(ethylene	 oxide)	 chains	 keep	 their	 native	 chemical	 structure	 and	 may	 dominate	 a	monolayer	configuration	[23].	We	also	observe	in	Table	IV	-	3	that,	at	the	C-1s	and	O-1s	core	 levels,	 the	 FWHM	 values	 of	 AuPEG-2NH2	 NPs	 are	 identical	 to	 those	 of	 the	 control	(≤0.2	eV),	which	 is	an	additional	 indication	of	a	perpendicular	grafting	of	PEG	molecules	[24].	The	small	shoulder	observed	at	lower	BE	at	the	C-1s	region	(Figure	IV	-	15a),	which	was	 also	 observed	 in	 the	 case	 of	 PtPEG-OH	 NPs	 (see	 results	 in	 Chapter	 III	 –	 Section	
1.3.3),	may	 be	 attributed	 to	 the	 C-C	 bonding	 [23].	 The	 appearance	 and	 intensity	 of	 this																																									 																					[21]	Moulder	J	F	et	al.	(1992)	Handbook	of	X-ray	Photoelectron	Spectroscopy		[22]	Citrin	P	H	et	al.	(1983)	Phys.	Rev.	B	27	3160–75	[23]	Hong	R	et	al.	(2005)	Chem.	Mater.	17	4617–21	[24]	Crispin	X	et	al.	(2001)	J.	Electron	Spectros.	Relat.	Phenomena	121	57–74	
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peak	depends	on	 the	samples	preparation	protocol.	PEG-2NH2	was	measured	as	powder	(directly	 from	 the	 supplier)	 and	nanoparticles	 as	 colloids	 after	drop	 casting	 and	natural	drying.	 This	 variance	 may	 induce	 a	 different	 interaction	 between	 the	 PEG	 and	 the	substratum	(glass	coverslip)	[25].		
Table	IV	-	3.	XPS	data	summary:	binding	energy,	assignment	and	FWHM	of	AuPEG-2NH2	NPs.	
Compound	 Atomic	core	level	 BE	(eV)	 Assignment	 FWHM	(eV)	
PEG-2NH2	 C-1s	 285.9	 C-O	&	C-N	 1.3	O-1s	 532.4	 C-O-HC-O-C	 1.4	N-1s	 398.8	 C-N	 1.4	N-1s	 399.8	 C-NH2	 1.4	Au0	solid	 Au-4f7/2	 84.1	 Au0	 0.9	Au-4f5/2		 87.8	 Au0	 0.9	
AuPEG-2NH2	NPs	
Au-4f7/2	surf.	 82.9	 Au0	 0.8	Au-4f5/2	surf.	 86.6	 Au0	 0.8	C-1s	 285.9	 C-O	&	C-N	 1.2	C-1s	 284.4	 -	 1.0	O-1s	 532.2	 C-O-H		C-O-C	 1.3	N-1s	 399.0	 C-NH2	Au-NH2	 1.9	N-1s	 400.9	 ---NH2	 1.6	
At	 the	 N-1s	 core	 level	 (Figure	 IV	 -	 15c),	 the	 control	 sample	 presents	 two	 N-1s	contributions	 around	 398.8	 and	 399.8	 eV.	 These	 BEs	 are	 characteristic	 of	 the	 primary	amine	end-group	of	PEG	 [21].	For	nanoparticles,	 the	N-1s	spectrum	contains	 two	steady	peaks	 at	 399.0	 and	 400.9	 eV,	 which	 are	 attributed	 to	 non-protonated	 and	 protonated	amines,	 respectively.	 In	 agreement	 with	 other	 works	 [26],	 the	 lower	 binding	 energy	component	is	particularly	assigned	to	nitrogen	in	the	pendant	amine	groups	directly	bond	to	gold	nanoparticles.	We	also	observe	a	broadening	of	about	36%,	 from	1.4	to	1.9	eV	at	this	BE,	which	confirms	the	Au-N	binding	[26]	[24].	The	higher	binding	energy	component	
																																								 																					[21]	Moulder	J	F	et	al.	(1992)	Handbook	of	X-ray	Photoelectron	Spectroscopy	[24]	Crispin	X	et	al.	(2001)	J.	Electron	Spectros.	Relat.	Phenomena	121	57–74	[25]	Kovach	K	M	et	al.(2014)	J.	Biomed.	Mater.	Res.	A	102	4195–205	[26]	Kumar	R	et	al.	(2004)	Nanotechnology	in	Catalysis	Kluwer	Academic/Plenum	Publishers	
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also	 suggest	 the	 presence	 of	 hydrogen	 bonded	 amines	 (---NH2),	 which	 might	 be	consequence	of	a	high	graft	density	[27].	
In	conclusion,	AuPEG-2NH2	NPs	consist	on	Au0	atoms	only.	It	is	suggested	that	PEG-2NH2	chains	 are	 grafted	 perpendicularly	 [24]	 to	 the	 NP	 surface	 and	 that	 amine	 groups	 are	directly	bonded	to	nanoparticles	[26].	
1.2.1.2 Platinum	PEG-diamine	nanoparticles	
Figure	 IV	 -	 16	 shows	 the	 high-resolution	XPS	 spectrum	of	 the	 PtPEG-2NH2	NPs	 (D=	10	kGy)	at	the	Pt-4f	core	level	region.	The	spectrum	deconvolution	shows	two	contributions,	one	 at	 72.0	 and	 75.3	 eV	 (in	 blue)	 and	 another	 at	 70.4	 and	 73.7	 eV	 (in	 red).	 These	 BEs	correspond	the	Pt-4f7/2	and	Pt-4f5/2	spin-orbit	components	of	platinum	[21].	At	lower	BEs	it	is	clearly	observed	the	surface	component	of	Pt0	[28].	
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Figure	IV	-	16.	XPS	spectrum	of	PtPEG-2NH2	NPs	at	the	Pt-4f	core	level	region.	The	peaks	at	72.0	and	75.3	eV	are	attributed	to	the	core	component	of	Pt0.	This	statement	was	confirmed	by	performing	XPS	analysis	 in	samples	prepared	with	an	irradiation	dose	of	 2.5	 kGy.	 Those	 platinum	 nanoparticles	 (see	 Figure	 IV	 -	 6a)	 were	 not	 completely	reduced	as	we	observed	a	main	contribution	of	the	intermediated	PtI	around	72.6	eV	(XPS	spectrum	not	presented	here).	
																																								 																					[21]	Moulder	J	F	et	al.	(1992)	Handbook	of	X-ray	Photoelectron	Spectroscopy	[24]	Crispin	X	et	al.	(2001)	J.	Electron	Spectros.	Relat.	Phenomena	121	57–74	[26]	Kumar	R	et	al.	(2004)	Nanotechnology	in	Catalysis	Kluwer	Academic/Plenum	Publishers	[27]	Graf	N	et	al.	(2009)	Surf.	Sci.	603	2849–60	[28]	Puglia	C	et	al.	(1995)	Surf.	Sci.	342	119–33	
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The	 intensity	ratio	between	the	 two	platinum	contributions	was	not	consistent,	even	 for	different	replicates	of	 the	same	sample	 likely	due	to	the	heterogeneous	NPs	 layer,	which	was	 prepared	 from	 colloidal	 solutions	 by	 drop	 casting	 and	 natural	 drying	 (see	method	
Chapter	 II	–	Section	2.5.2).	However,	more	 important,	 the	BEs	were	 found	at	 the	same	position	 for	 all	 the	 independent	 batches,	 confirming	 the	 presence	 of	 both	 steady	 Pt	components.	
In	comparison	with	PtPEG-OH	NPs	(presented	in	Chapter	III	–	Section	1.3.2),	the	BEs	at	the	Pt-4f	 core	 level	 is	 shifted	by	about	1	eV,	which	 is	attributed	 to	a	 chemical	 shift	 [29].	This	 suggests	 a	 strong	 interaction	 between	 the	 Pt0	 nanoflowers	 and	 the	 PEG	matrix	 by	chemisorption	of	PEG	molecules	in	the	surface	of	the	Pt	NFs	(Pt-O	interaction)	[30]	[31].	
We	 also	 investigated	 the	 C-1s,	 O-1s	 and	 N-1s	 core	 level	 BEs	 of	 nanoparticles	 to	 better	elucidate	the	chemical	configuration	of	the	polymeric	matrix.	The	C-1s,	O-1s	and	N-1s	XPS	spectra	of	PtPEG-2NH2	NPs	are	shown	in	Figure	IV	-	17.		
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Figure	IV	-	17.	XPS	spectra	of	a	control	consisting	on	pure	PEG-2NH2	and	PtPEG-2NH2	NPs	at	the	C-1s	(a),	O-1s	(b)	and	N-1s	(c)	regions.	At	 the	 C-1s	 and	 O-1s	 core	 levels	 (Figure	 IV	 -	 17a	 and	 b),	 the	 characteristic	 binding	energies	 of	 PEG	 around	 286.0	 and	 532.3	 eV	 [32]	were	 observed.	 These	 results	 indicate	that	 the	poly	 (ethylene	oxide)	 chains	of	PEG-2NH2	 conserve	 their	native	C-O,	C-N,	C-O-C	and	 C-O-H	 chemical	 structure	 after	 cross-linking	 [33]	 [34].	 The	 C-1s	 signal	 observed	 at	lower	binding	energy	is	assigned	to	C-C	chemical	structures,	which	might	characterize	the																																									 																					[29]	Feldman	L	C	and	Mayer	 J	W	(1986)	X-ray	photoelectron	spectroscopy	Fundamentals	of	surface	and	thin	
film	analysis	p	224	[30]	Ono	L	K	et	al.	(2010)	J.	Phys.	Chem.	C	114	22119–33	[31]	Parmigiani	F	et	al.	(1990)	J.	Electron	Spectros.	Relat.	Phenomena	50	39–46	[32]	Beamson	G	and	Briggs	D	(1992)	High	resolution	XPS	of	organic	polymers,	the	scienta	ESCA300	database	[33]	Truica-Marasescu	F	and	Wertheimer	M	R	(2008)	Plasma	Process.	Polym.	5	44–57	[34]	Jansen	R	J	J	and	van	Bekkum	H	(1995)	Carbon	N.	Y.	33	1021–7	
CHAPTER	IV	 RESULTS	AND	DISCUSSION:	mono-	and	bimetallic	Au:PtPEG-2NH2	NPs		
	 184	
cross-linking	process	as	illustrated	in	Figure	IV	-	8.	This	signal	was	clearly	more	intense	than	 that	of	AuPEG-2NH2	NPs	 (background	due	 to	 interaction	with	 the	 substratum).	For	instance,	 for	 one	 measured	 point,	 the	 area	 of	 the	 C-1s	 peak	 (cps/eV)	 increased	 from	3795.2	(AuPEG-2NH2	NPs)	to	7869.1	(PtPEG-2NH2	NPs).		
Remarkably,	the	XPS	spectrum	of	nanoparticles	at	the	N-1s	core	level	differs	greatly	from	the	 control	 (see	 upper	 spectrum	 Figure	 IV	 -	 15c)	 and	 three	 stable	 components	 were	detected.	The	XPS	peak	around	401.1	eV	is	assigned	to	the	protonated	form	of	alkylamines	(C-NH3+)	 [33]	 [21]	 while	 the	 contribution	 at	 ~399.5	 eV	 is	 assigned	 to	 non-protonated	alkylamines	(-NH2)	both	species	may	originate	from	radiolysis	and	the	in	situ	cross-linking	process.	More	interestingly,	the	shoulder	observed	around	398.2	eV	may	overlap	the	C-N	and	 C=N	 chemical	 structures.	 This	 result	 also	 suggests	 a	 grafting	 polymerization	 (see	irradiation	of	polymer	described	 in	Chapter	 I	–	Section	1.1.2.4)	between	 the	polymeric	radicals	induced	by	radiation	and	the	amine	end-groups	of	PEG.	The	N-1s	binding	energy	of	aliphatic	C=N	species	are	commonly	found	in	a	BE	interval	from	397.8	to	399.0	eV	[33]	[35].	Non–significant	broadening	was	observed	(±	0.2	eV)	at	the	N-1s	core	level.		
The	XPS	measured	binding	energies,	assignments	and	FWHM	of	PtPEG-2NH2	NPs	at	the	Pt-4f,	C-1s,	O-1s	and	N-1s	core	levels	are	summarized	in	Table	IV	-	4.	
We	observed	 in	Table	 IV	 -	4	 that	 the	FWHM	of	PtPEG-2NH2	NPs,	at	 the	Pt-4f	core	 level,	increased	in	about	43%,	from	~1.4	to	~2.0.	This	broadening	confirms	the	interaction	of	Pt	NPs	with	PEG	suggesting	as	well	a	flat	PEG	grafting	[24].	
	
	
	
	
	
																																									 																					[21]	Moulder	J	F	et	al.	(1992)	Handbook	of	X-ray	Photoelectron	Spectroscopy	[24]	Crispin	X	et	al.	(2001)	J.	Electron	Spectros.	Relat.	Phenomena	121	57–74	[33]	Truica-Marasescu	F	and	Wertheimer	M	R	(2008)	Plasma	Process.	Polym.	5	44–57	[35]	Rangan	S	et	al	(2005)	J.	Phys.	Chem.	B	109	12899–908	
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Table	IV	-	4.	XPS	data	summary:	binding	energy,	assignment	and	FWHM	of	the	control	(pure	PEG-2NH2)	and	PtPEG-2NH2	NPs.	
Compound	 Atomic	core	level	 BE	(eV)	 Assignment	 FWHM	(eV)	
PtPEG-2NH2	NPs	
Pt-4f7/2	surf.	 70.4	 Pt0	 1.4	Pt-4f5/2	surf.	 73.7	 Pt0	 1.4	Pt-4f7/2	core	 72.0	 *PtO	 2.0	Pt-4f5/2	core	 75.3	 *PtO	 2.0	C-1s	 285.9	 C-O	&	C-N	 1.2	C-1s	 284.4	 C-H	&	C-C	 1.2	O-1s	 532.2	 C-O-H	C-O-C	 1.3	N-1s	 399.5	 C-NH2	 1.6	N-1s	 401.1	 C-NH3+	 1.5	N-1s	 398.2	 C-N	&	C=N	 1.4	*chemisorbed	oxygen	[28]	[31]	
In	 conclusion,	 these	 XPS	 results	 show	 that	 PtPEG-2NH2	NPs	 consist	 in	 Pt0	 atoms,	which	might	 strongly	 interact	 with	 the	 formed	 polymeric	 matrix	 by	 chemisorption	 of	 PEG	molecules	on	the	surface	of	the	Pt	NFs.	At	the	C-1s	and	O-1s	core	levels	we	observed	that	the	 poly(ethylene	 oxide)	 chains	 keep	 their	 chemical	 structure.	 Finally,	 at	 the	 N-1s	 core	level	 we	 observed	 the	 presence	 of	 three	 different	 nitrogen	 species,	 which	 might	 also	indicate	 the	 formation	 of	 intra-molecular	 C-C	 bonds	 (cross-linking)	 and	 C=N	 bonds	(grafting	polymerization).	
1.2.1.3 Bimetallic	gold-platinum	PEG-diamine	nanoparticles	
Figure	 IV	 -	 18	 shows	 the	 high-resolution	 XPS	 spectra	 of	 bimetallic	 Au:PtPEG-2NH2	NPs	(D=	2.5	kGy)	at	the	Au	and	Pt-4f	core	levels.	
	
	
	
	
	[28]	Puglia	C	et	al.	(1995)	Surf.	Sci.	342	119–33	[31]	Parmigiani	F	et	al.	(1990)	J.	Electron	Spectros.	Relat.	Phenomena	50	39–46	
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Figure	IV	-	18.	XPS	spectrum	corresponding	to	the	Au	and	Pt-4f	core	level	region	of	bimetallic	PEG-diamine	nanoparticles.	In	 Figure	 IV	 -	 18,	 the	 presence	 of	 both	metals	 at	 their	 respective	 core	 level	 regions	 is	observed.	 Quantitative	 estimates	 of	 Au/Pt	 ratio	 using	 XPS	 revealed	 ~3	 times	 more	detected	 platinum	 than	 gold,	 from	 22	 (Au)	 to	 78	 (Pt)	 atomic	%,	which	 indicate	 surface	segregation	of	Pt	atoms	in	gold	seeds	and	thus	a	core/shell	structure.		
Different	signal	 intensities	(Au/Pt)	were	measured	for	different	replicates	resulting	from	the	sample	deposition	protocol.	However,	gold	and	platinum	BEs	were	found	at	the	same	positions	in	all	replicates.	Moreover,	we	consistently	observed	a	higher	contribution	from	the	 core	 component	 of	 platinum,	 observed	 at	 higher	 BEs.	 This	 result	might	 suggest	 not	only	 the	 presence	 of	 Pt0	 but	 also	 the	 presence	 of	 the	 intermediated	 PtI	 indicating	uncompleted	radiolytic	reduction	of	the	platinum	complex.	The	presence	of	PtI	is	not	clear	at	 this	 stage	because	Pt0	has	been	already	characterized	at	 this	BE	 in	bimetallic	 systems	[36]	 [37].	The	binding	energies	of	 the	Au-4f	spin-orbit	components	are	observed	at	82.8	and	 86.5	 eV.	 This	 agrees	with	 the	 gold	 surface	 type	 also	 observed	 in	 the	monometallic	AuPEG-2NH2	NPs.	
Figure	IV	-	19	shows	the	XPS	spectra	of	bimetallic	nanoparticles	at	the	C-1s,	O-1s	and	N-1s	core	levels	region.	
																																								 																					[36]	Li	S	et	al.	(2013)	Int.	J.	Electrochem.	Sci.	8	8662–8	[37]	Ilayaraja	N	et	al.	(2013)	J.	Mater.	Chem.	A	1	4048–56	
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Figure	IV	-	19.	XPS	spectra	of	Au:PtPEG-2NH2	NPs	corresponding	to	the	C-1s	(a),	O-1s	(b)	and	N-1s	(c)	core	levels	regions.	The	C-1s	 and	O-1s	 signals	 are	observed	at	 the	 same	binding	 energies	of	 the	native	PEG.	The	FWHM	at	this	core	levels	do	not	present	any	broadening.	These	nanoparticles	present	at	 the	 N-1s	 core	 level	 region	 two	 main	 contributions.	 The	 lower	 BE	 at	 399.1	 eV	corresponds	to	the	direct	binding	of	nanoparticles	with	the	amine	end-group	of	PEG.	This	is	 confirmed	 by	 the	 broadening	 in	 about	 50%,	 from	 1.4	 to	 2.1,	 of	 the	 N-1s	 peak	 and	 of	about	58%,	from	1.2	(Pt0	metallic	surface)	to	~1.9,	at	the	Pt-4f	core	level	of	nanoparticles.	The	measured	XPS	binding	energies,	assignments	and	FWHM	of	bimetallic	nanoparticles	at	the	Au	and	Pt-4f,	C-1s,	O-1s	and	N-1s	core	levels	are	summarized	in	Table	IV	-	5.		
Table	IV	-	5.	XPS	data	summary:	binding	energy,	assignment	and	FWHM	of	Au:PtPEG-2NH2	NPs.	
Compound	 Atomic	core	level	 BE	(eV)	 Assignment	 FWHM	(eV)	
Au:PtPEG-2NH2	NPs	
Au-4f7/2	surf.	 82.8	 Au0	 1.0	Au-4f5/2	surf.	 86.5	 Au0	 1.0	Pt-4f7/2	surf.	 70.2	 Pt0	 1.9	Pt-4f5/2	surf.	 73.5	 Pt0	 1.9	Pt-4f7/2	core	 72.1	 Pt0/PtI	 1.8	Pt-4f5/2	core	 75.4	 Pt0/PtI	 1.8	C-1s	 285.9	 C-H	&	C-N	 1.2	C-1s	 284.3	 C-C	 0.9	O-1s	 532.2	 C-O-C	 1.3	N-1s	 399.1	 C-NH2	Au:Pt-NH2	 2.1	N-1s	 401.0	 ---NH2/NH3+	 1.5	
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In	summary,	Au:PtPEG-2NH2	NPs	consist	in	Au0	atoms	in	the	core	and	Pt	in	the	shell	as	Pt0	and	PtI.	It	is	suggested	that	PEG	chains	are	grafted	perpendicularly	[24]	to	the	NPs	surface	and	that	amine	groups	are	directly	bonded	to	nanoparticles.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
[24]	Crispin	X	et	al.	(2001)	J.	Electron	Spectros.	Relat.	Phenomena	121	57–74	
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1.2.2 Functional	characterization	by	FTIR	
Figure	IV	-	20	shows	the	FTIR	spectra	of	(a)	the	native	PEG-2NH2	(Mw=	2000	g.mol-1),	(b)	the	as-synthetized	AuPEG-2NH2	NPs	after	1	kGy,	(c)	the	PtPEG-2NH2	NPs	obtained	after	10	kGy	(nanoflowers)	and	(d)	the	Au:PtPEG-2NH2	NPs	obtained	after	2.5	kGy.	We	highlight	in	red	new	IR	bands	in	spectra	(b),	(c)	and	(d).	
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Figure	IV	-	20.	FTIR	spectra	of	(a)	PEG-2NH2,	(b)	AuPEG-2NH2	NPs,	(c)	PtPEG-2NH2	NPs	and	(d)	Au:PtPEG-2NH2	NPs	obtained	by	radiolysis.	
Figure	 IV	 -	 20a	 shows	 the	 IR	 spectrum	 of	 the	 native	 PEG-2NH2.	 This	 spectrum	 is	 very	similar	to	that	of	the	standard	PEG-OH,	which	has	been	already	described	in	Chapter	III	–
Section	1.4.	In	particular,	the	IR	bands	centered	at	1658	and	1576	cm-1	are	attributed	to	
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the	 C-N-H	 scissoring	mode	 that	 characterizes	 the	 amine	 end-group	 of	 PEG.	 At	 the	 same	time,	 the	 C-N	 stretching	 mode	 is	 observed	 at	 1096	 cm-1,	 signal	 that	 overlaps	 the	 ν!!!	vibrational	 mode	 of	 ether	 groups	 in	 PEG.	 The	 very	 weak	 signal	 around	 3400	 cm-1	 is	attributed	to	the	N-H	stretching	mode	of	primary	amines.	
Figure	 IV	 -	 20b	 displays	 the	 IR	 spectrum	 of	 AuPEG-2NH2	 NPs.	 We	 observe	 the	 N-H	stretching	vibrational	frequency	at	~3480	cm-1.	The	IR	band	at	1627	cm-1	is	attributed	to	the	N-H	bending	vibration	of	the	amine	group	while	the	broad	peak	centered	around	525	cm-1	 corresponds	 to	 the	 gold-polymer	 interactions,	 mainly	 Au-N.	 In	 conclusion,	 this	 IR	analysis	 indicated	 the	 presence	 of	 amine	 groups.	 This	 result	 is	 in	 agreement	 with	 XPS	measurements	suggesting	the	presence	of	different	aliphatic	amine	species	and	the	direct	bonding	to	gold	nanoparticles.	
Figure	IV	-	20c	corresponds	to	the	infrared	spectrum	of	the	PtPEG-2NH2	nanoflowers.	In	comparison	with	the	native	PEG-2NH2,	we	identified	three	main	new	signals	around	3490,	1638	 and	 ~525	 cm-1.	 The	 new	 broadening	 band	 at	 3490	 cm-1	 is	 attributed	 to	 the	asymmetrical	N-H	stretching	mode	of	primary	amines	while	the	weak	shoulder	observed	around	 3250	 cm-1	 corresponds	 to	 their	 symmetrical	N-H	 stretching	mode	 [38].	 At	 1638	cm-1	we	identify	the	C=N	stretching	band	for	imines	(-N=C-)	that	occurs	in	the	region	from	1690	 to	 1620	 cm-1	 [39].	 In	 agreement	 with	 the	 literature,	 the	 conjugation	 of	 C=N	containing	 systems,	 for	 instance	 with	 PEG	 molecules,	 produce	 a	 decrease	 in	 the	 C=N	stretching	frequency	[39].	This	signal	is	different	to	that	observed	in	AuPEG-2NH2	NPs	as	ATR-FTIR	measurements	were	performed	with	a	4	cm-1	spectral	resolution	(ALPHA-P	with	diamond	ATR	-	Bruker).	This	IR	band	also	supports	(as	shown	by	XPS)	the	hypothesis	that	the	 intra-molecular	 cross-linking	 process	 is	 accompanied	 by	 a	 simultaneous	 grafting	polymerization	and	the	 formation	of	 imine	groups	between	the	polymer	radical	–O-CH2–ĊH-O-CH2-CH2-	 and	 the	 amine	 end-group	 of	 PEG	 (Figure	 IV	 -	 21).	 Finally,	 the	 IR	 signal	centered	at	~525	cm-1	corresponds	to	the	platinum-PEG	vibrational	frequency.	
																																								 																					[38]	Silverstein	R	M	et	al.(1991)	Spectrometric	identification	of	organic	compounds	(Wiley)	[39]	Socrates	G	(2001)	Infrared	and	Raman	Characteristic	Group	Frequencies:	Tables	and	Charts		
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Figure	IV	-	21.	Proposed	configuration	of	the	radiolysis	induced	grafting	polymerization	of	PEG-2NH2	chains.	In	summary,	this	IR	analysis	shows	that	the	cross-linking	process	is	accompanied	by	the	in	
situ	 formation	 of	 imines	 during	 radiolysis.	 It	 confirms	 the	 attribution	 of	 the	 N-1s	 XPS	signal	observed	at	398.2	eV	to	the	presence	of	C=N	chemical	species	in	PtPEG-2NH2	NPs.	
Finally,	 in	Figure	IV	-	20d	we	observed	that	Au:PtPEG-2NH2	NPs	present	very	similar	IR	frequencies	 as	 those	 of	 AuPEG-2NH2	 NPs.	 At	 the	 lower	 spectral	 range	 frequencies,	 the	metal-polymer	interaction	is	observed.	
Complementary	FTIR	measurements	using	the	precursors’	mixtures	before	irradiation	are	in	process	to	investigate	the	formation	of	any	intermediated	specie,	expected	in	the	case	of	monometallic	 gold	 and	 bimetallic	 gold-platinum	 PEGylated	 nanoparticles.	 Far-infrared	measurements	 are	 proposed	 to	 better	 elucidate	 the	 metallic	 functional	 groups	 formed	during	nanoparticles	synthesis	(Pt-O,	Au-N,	Au/Pt-N).	
1.3 Conclusion	
The	optimal	 radiolytic	 conditions	used	 to	 synthetize	 stable,	biocompatible	and	 ready-to-use	mono-	and	bimetallic	gold-platinum	PEG-diamine	nanoparticles	were	presented.	The	performed	characterization	allowed	describing	the	mechanism	of	nanoparticles	formation.		
We	stated	that	the	radiolytic	synthesis	of	mono-	and	bimetallic	Au:Pt	nanoparticles	in	the	presence	of	PEG-2NH2	is	strongly	influenced	by	the	metal	complex	/	PEG	interaction	prior	irradiation,	 amine	 group	 content	 and	 PEG	 chain	 lengths	 (UV-Vis	 spectroscopy).	 The	
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PEGylation	 process	 is	 performed	 through	 two	mechanisms;	 polymeric	matrix	 formation	and	the	direct	bonding	of	PEG	chains	with	the	metal	(coordination	saturation).		
PtPEG-2NH2	 NPs	 were	 obtained	 as	 aggregated	 nanoparticles,	 named	 nanoflowers,	resulting	from	an	in	situ	intra-molecular	PEG	cross-linking	process.	Platinum	nanoflowers	are	stabilized	by	the	flat	interaction	between	platinum	cores	and	the	PEG	matrix.	AuPEG-2NH2	 and	 Au:PtPEG-2NH2	 NPs	were	 obtained	 as	well	 dispersed	 spherical	 nanoparticles	suggesting	initial	complexation	of	gold	ions	by	PEG.	When	the	precursor	solution	contains	gold	(mono-	and	bimetallic	developments),	PEG	is	grafted	perpendicularly	to	the	metal	in	a	monolayer	conformation.	Figure	IV	-	22	summarizes	these	statements.	
	
Figure	IV	-	22.	Schematic	representation	of	mono	and	bimetallic	gold-platinum	PEGylated	nanoparticles.		
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2 Proof	of	principle:	enhancement	on	the	radio-induced	nanosize	damage	In	 this	 work,	 we	 used	 the	 molecular	 bio-nanoprobe	 to	 quantify	 the	 radio-induction	 of	nanosize	damage.	The	method	is	described	in	Chapter	II	–	Section	4.2.	
Figure	IV	-	23	shows	the	average	number	of	DSBs	induced	in	pure	DNA	plasmids	(control)	and	in	DNA	plasmids	loaded	with	PtPEG-2NH2,	AuPEG-2NH2	and	Au:PtPEG-2NH2	NPs	with	a	ratio	 that	corresponds	 to	1	nanoparticle	per	2	plasmids	 [1:2].	This	molecular	nanosize	damage	is	here	plotted	as	function	of	the	irradiation	dose.		
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Figure	IV	-	23.	Induced	molecular	nanosize	damage	in	the	control (n) and in	plasmids	loaded	with	PtPEG-2NH2	NPs	(n), AuPEG-2NH2	NPs (n) and Au:PtPEG-2NH2	NPs (n)as	function	of	the	irradiation	dose.	DMSO	effect	in	the	control (o) and in	plasmids	loaded	with	PtPEG-2NH2	NPs (o), AuPEG-2NH2	NPs (o) and 
Au:PtPEG-2NH2	NPs (o).	As	already	observed	for	PtPEG-OH	NPs	(see	results	Chapter	III	–	Section	2.2.1),	we	found	that	the	radio-induction	of	nanosize	damage,	in	the	controls	and	in	plasmids	loaded	with	NPs,	 increases	 linearly	 with	 the	 irradiation	 dose.	 More	 interestingly,	 in	 the	 presence	 of	nanoparticles,	the	induction	of	nanosize	damages	is	strongly	amplified.	We	also	observed	that	the	induction	of	nanosize	damage	sharply	decreases	in	the	presence	of	DMSO	(dotted	lines).	
The	efficiency	of	mono	and	bimetallic	core/shell	nanoparticles	to	amplify	the	induction	of	nanometer	size	damages	was	quantified	through	the	amplification	factor	(AF)	previously	described	(see	definition	in	Chapter	III	–	Equation	III-18).	Table	IV	-	6	summarizes	this	
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quantitative	analysis.	It	enlists	the	yields	(nanosize	breaks	/	plasmid	/	Gy)	of	controls	and	plasmids	loaded	with	NPs,	the	AFs	and	.OH	radicals’	effect.		
Table	IV	-	6.	Yields	of	the	control	and	plasmids	loaded	with	mono-	and	bimetallic	gold-platinum	NPs	([2:1]	ratio).	The	AFs	and	DMSO	effect	are	also	reported.	
Sample	 Nanosize	breaks/plasmid/Gy		(x10-5)	 AF	(%)	 OH	effect	(%)	Control	 17.47	±	0.51	 -	 -	PtPEG-2NH2	NPs	 32.59	±	0.92	 87	±	1	 -	AuPEG-2NH2	NPs	 23.49	±	0.94	 34	±	2	 -	Pt:AuPEG-2NH2	NPs	 33.18	±	0.54	 90	±	2	 -	Control	+	DMSO	 2.91	±	0.22	 -	 83	±	1	Pt	NPs	+	DMSO	 3.52	±	0.23	 21	±	1	 89	±	1	Au	NPs	+	DMSO	 3.56	±	0.13	 22	±	4	 85	±	1	Pt:Au	NPs	+	DMSO	 4.14	±	0.36	 42	±	2	 86	±	1	
These	 results	 show	 that	 in	 the	 presence	 of	 PEGylated	 (PEG-2NH2)	 NPs	 the	 induction	 of	nanosize	damage	is	strongly	enhanced.	AuPEG-2NH2	NPs	are	the	less	efficient	nano-agents	with	 an	 amplification	 factor	 of	 about	 34%.	We	 observe	 that	 platinum	 atoms	 at	 the	 NPs	surface	 induced	 higher	 nanoscopic	 damage	 (PtPEG-2NH2	 NPs	 and	 bilayed	 Aucore-Ptshell	PEG-2NH2	NPs).	Platinum	based	nanoparticles	have	very	similar	amplification	factors,	of	about	87%	for	monometallic	Pt	NPs	and	of	about	90%	for	bimetallic	Aucore/Ptshell	NPs.		
In	Figure	IV	-	23,	we	observe	that	the	dose	response	curves	drops	drastically	in	presence	of	DMSO	(see	yields	in	Table	IV	-	6).	This	study	indicates	that	water	radicals	mediate	the	amplification	effect	for	more	than	85%.	In	comparison	with	PtPEG-OH	NPs	(see	results	in	
Chapter	III	–	Section	2.3.3),	we	observe	(Table	IV	-	6	-	column	3)	that	the	direct	effects	of	radiation	are	less	amplified	in	the	presence	of	these	three	NPs.	
The	amplification	effect	of	metallic	NPs	can	be	explained	as	due	to	early	stage	mechanisms	of	 individual	 and	 collective	 electronic	 excitations	 [40]	 [41],	which	might	 depend	 on	 the	thickness	of	the	outer	platinum	shell	and	the	overall	size	of	metallic	nanoparticles	[42].		
																																								 																					[40]	Verkhovtsev	A	V	et	al.	(2015)	J.	Phys.	Chem.	C	119	11000–13	[41]	Verkhovtsev	A	V	et	al.	(2015)	Phys.	Rev.	Lett.	114	063401	[42]	Karam	T	E	et	al.	(2015)	J.	Phys.	Chem.	119	18573–80	
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Interestingly,	 in	 order	 to	 explain	 the	 enhancing	 effect	 of	 bimetallic	 systems,	 XPS	 inputs	(see	 results	 Section	 1.2.1.3)	 such	 as	 the	 ratio	 of	 the	 normalized	 integrated	 intensities	(NPs	shell/core)	and	the	relative	electron	attenuation	lengths	may	allow	determining	the	thickness	 of	 the	metallic	 overlayers	 [43],	 and	 thus	 the	modeling	 of	 electron	 energy	 loss	and	secondary	electron	emission.	This	modeling	is	very	important	in	the	understanding	of	physical	 processes	 involved	 in	 the	 REE	 of	 metallic	 nanoparticles	 in	 biological	 systems.	New	collaborations	have	been	established	to	perform	these	calculations	to	better	elucidate	the	enhancing	mechanisms.	
An	interesting	hypothesis,	which	may	explain	the	experimental	results,	has	been	recently	proposed	 by	 Verkhovtsev	 et	 al.	 They	 demonstrated	 that	 the	 surface	 plasmon	 gives	 the	dominating	 contribution	 to	 the	 electron	 production	 by	 metallic	 NPs	 such	 as	 Au	 and	 Pt	exceeding	that	of	the	volume	plasmon	or	individual	atomic	excitations	(5d	electrons).	For	instance,	 it	 was	 shown	 that	 Pt	 nanoclusters	 (~1	 nm)	 are	 more	 efficient	 for	 electron	production	than	Au	(Figure	IV	-	24),	effect	that	strongly	depends	on	the	nanocluster	size	[40].		
	
Figure	IV	-	24.	Yield	enhancement	from	1	nm	metallic	NPs.	Dashed	lines	show	the	contribution	of	individual	atomic	excitations	while	solid	lines	show	the	resulting	sum	of	the	individual	and	plasmonic	excitations	(from	[41]).	When	 irradiating	pure	water,	 an	 important	 enhancement	 of	 the	 electron	 yield	 (of	 about	one	 order	 of	 magnitude)	 may	 be	 expected	 in	 the	 presence	 of	 metallic	 NPs.	 Higher	 the	electron	production,	higher	the	production	of	 free	radicals	and	ROS,	which	may	 increase	the	 nanosize	 molecular	 damage	 and	 cell	 killing.	 The	 plasmon	 effect	 of	 metallic	nanoparticles	in	biomolecules	is	illustrated	in	Figure	IV	-	25.	
																																								 																					[40]	Verkhovtsev	A	V	et	al.	(2015)	J.	Phys.	Chem.	C	119	11000–13	[41]	Verkhovtsev	A	V	et	al.	(2015)	Phys.	Rev.	Lett.	114	063401	[43]	Shard	A	G	(2012)	J.	Phys.	Chem.	C	116	16806–13	
CHAPTER	IV	 RESULTS	AND	DISCUSSION:	mono-	and	bimetallic	Au:PtPEG-2NH2	NPs		
	 196	
	
Figure	IV	-	25.	The	radiation	enhancement	mechanism	of	metallic	nanoparticles.	Representation	of	the	early-stage	physical	processes:	collective	electronic	excitation,	follow	by	the	chemical	stage	consisting	on	ROS	production	that	ends	with	bond	cleavage	in	biomolecules,	which	might	induce	cell	death.	Notably	 to	 point,	 at	 the	 same	 experimental	 conditions	 (platinum	 concentration),	 this	exploratory	study	showed	that	PtPEG-2NH2	nanoflowers	are	~2	times	more	efficient,	from	42	±	2%	to	87	±	1%,	 than	discrete	PtPEG-OH	NPs	(see	results	at	 ratio	1:2	 for	PtPEG-OH	NPs	in	Appendix	B),	which	may	be	explained	as	an	enhanced	cross-section.	In	the	present	case,	 the	 REE	 of	 mono-	 and	 bimetallic	 NPs,	 which	 were	 synthetized	 at	 the	 same	experimental	 conditions	 (total	 metal	 content	 and	 PEG-2NH2:M	 ratios),	 might	 also	 be	attributed	to	the	presence	of	free	Cl-	ions	in	the	NPs	solution.	Indeed,	halides	are	known	by	scavenging	solvated	electrons	[44]	resulting	on	less	ROS	production.		
In	 conclusion,	 the	 quantification	 of	 the	 radio-induced	 nanosize	 damage	 using	 the	 bio-nanoprobe	 opened	 new	 perspectives	 to	 enhance	 the	 cell	 killing	 efficiency	 of	 platinum	based	 nanoparticles.	 We	 suggest	 a	 main	 contribution	 of	 the	 platinum	 plasmon	 on	 the	enhancing	mechanism	by	comparing	similar	nanosize	particles,	the	monometallic	gold	and	bimetallic	 gold-platinum	 nanoparticles.	 Currently,	 different	 studies	 at	 cellular	 level	 are	been	performed	in	the	group	using	these	well	stable	and	biocompatible	PEGylated	metallic	nanoparticles.	
																																								 																					[44]	Buxton	G	V	(2008	)	An	overview	of	the	radiation	chemistry	of	liquids	Radiation	Chemistry		
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CONCLUSIONS	The	main	goal	 of	my	PhD	was	 to	develop	new	platinum	based	nanoparticles,	 stable	 and	biocompatible,	able	to	enhance	the	biological	impact	of	ionizing	radiations	which	includes	NPs	 toxicity,	 uptake,	 localization	 and	 enhancing	 effect	 in	 combination	 with	 radiations	(called	radio-enhancement).	
In	this	perspective:		
i) I	 optimized	 a	 new	 method	 of	 nanoparticle	 synthesis	 by	 radiolysis	 and	 I	produced	 different	 kind	 of	 platinum	 core	 nanoparticles	 as	well	 as	 bimetallic	nanoparticles.		ii) The	 radio-enhancing	 properties	 of	 nanoparticles	 were	 probed	 on	 cellular	models,	 to	 characterize	 the	 biological	 impact,	 and	 experiments	 with	 a	 bio-nanoprobe	were	performed	to	characterize	the	molecular	scale	mechanisms	of	radio-enhancement.	
1) Summary	on	the	synthesis	and	characterization	of	nanoparticles	
Biocompatible	Pt	NPs	were	prepared	using	a	unique	environmental	friendly	method.	This	last	 consisted	 on	 the	 reduction	 of	metal	 complexes	 via	 water	 radiolysis	 in	 combination	with	 in	 situ	 PEGylation.	 This	 new	 one-step	 synthesis	 allows	 the	 production	 of	homogeneous	in	size	and	stable	biocompatible	nanoparticles.	The	final	solution,	which	is	sterilized	by	radiation,	is	ready-to-use	for	adding	to	biological	systems.		
In	 this	 work,	 I	 developed	 four	 nanoparticles,	 PtPEG-OH,	 PtPEG-2NH2,	 AuPEG-2NH2	 and	Au:PtPEG-2NH2.	 Complementary	 techniques	 were	 used	 to	 describe	 the	 size,	 shape,	chemical	 composition	 and	 stability	 of	 the	 nanoparticles.	 My	 work	 was	 focused	 on	 the	characterization	of	PtPEG-OH	essentially.	
The	 main	 findings	 concerning	 the	 different	 nanoparticles	 I	 developed	 are	 summarized	below.	
• PtPEG-OH	NPs		
The	 PtPEG-OH	NPs	 are	 small	 spherical	 nanoparticles	 (~3	 nm).	 They	 are	 composed	 of	 a	platinum	core	coated	with	biocompatible	PEG-OH	molecules.	They	have	a	hydrodynamic	
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diameter	of	about	9	nm	and	ζ-potential	of	about	-16	mV	at	the	pH	range	of	physiological	fluids.		
The	stability	of	the	nanoparticles	depends	on	the	PEG-OH:Pt	molar	ratio	used	during	the	synthesis.	The	remarkable	colloidal	 stability	 (stable	up	 to	3	months	when	stored	at	4°C)	was	 attributed	 to	 the	 strong	 interaction	 between	 platinum	 and	 PEG-OH	 coating.	 The	production	of	a	strong	binding	was	confirmed	by	the	shift	of	the	nitrogen	peak	observed	in	the	XPS	measurements.	 Interestingly,	 the	creation	of	an	intermediated	amide	takes	place	before	 the	 radiolysis.	 The	 complementary	 spectrometric	 methods	 suggested	 that	 PEG	molecules	interact	with	the	platinum	cores	by	keeping	their	chemical	structure,	which	was	interpreted	 as	 the	 presence	 of	 a	 perpendicular	 monolayer	 of	 PEG	 molecules	 at	 the	platinum	surface.	These	NPs	were	found	non-toxic	at	an	incubation	molar	concentration	of	5x10-4	mol.L-1.	
• PtPEG-2NH2	NPs	
PtPEG-2NH2	NPs	have	different	size	and	shape	than	PtPEG-OH	NPs.	They	formed	platinum	nanoflowers	of	~15	nm,	which	are	composed	of	aggregated	~3	nm	metallic	platinum	NPs.	Their	 synthesis	 consists	 on	 the	 reduction	 of	 the	 Pt	 complex	 simultaneously	 with	 PEG	cross-linking.	 Pt	 NFs	 have	 remarkable	 stability	 up	 to	 a	 year.	 Their	 PEG	 coating	 was	attributed	to	the	chemisorption	of	PEG	molecules	at	the	nanoparticles	surface.	Preliminary	results,	not	discussed	in	this	manuscript,	showed	that	these	nanoparticles	are	non-toxic	in	human	cell	lines	and	are	internilazed.	It	is	noteworthy	to	mention	that	the	presence	of	an	amine	 group	 offers	 the	 perspectives	 to	 graft	 new	 molecules	 at	 the	 surface	 such	 as	 a	fluorescent	tag.	This	would	be	the	first	time	in	the	case	of	platinum	nanoparticles.	This	has	been	initiated	at	the	end	of	me	PhD	and	is	not	presented	here.	
• AuPEG-2NH2	NPs	
The	AuPEG-2NH2	NPs	are	small	spherical	nanoparticles	(~3	nm)	with	a	gold	core	coated	with	 PEG	 diamine.	 The	 stability	 and	 homogeneity	 of	 these	 nanoparticles	 strongly	depended	on	the	concentration	of	the	amine	end-groups	of	PEG	in	the	precursor	mixture	and	 the	 length	 of	 the	 PEG	 chain.	 In	 this	 case,	 it	 was	 suggested	 the	 presence	 of	intermediated	species	leading	to	a	perpendicular	grafting	of	PEG-2NH2	and	well	stabilized	colloids.	The	citotoxicity	evaluation	of	these	NPs	is	in	process.	
• Au:PtPEG-2NH2	NPs	
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The	 Au:PtPEG-2NH2	 NPs	 are	 small	 spherical	 nanoparticles	 (~3	 nm)	 composed	 of	 two	metals	and	covalently	bonded	to	PEG	(as	in	the	case	of	the	monometallic	gold).	These	NPs	presented	a	core-shell	 structure	with	Au	at	 the	centre	and	Pt	at	 the	periphery.	This	was	explained	in	terms	of	redox	potentials	of	each	precursor	compound.	It	was	suggested	the	presence	of	 intermediated	species	formed	by	the	interaction	between	the	gold	precursor	and	 the	 PEG-2NH2,	 leading	 to	 a	 perpendicular	 grafting	 of	 the	 polymer	 at	 the	 bimetallic	nanoparticle	surface.	
These	 results	 and	 optimized	 method	 opens	 new	 perspectives	 in	 the	 group	 to	 the	preparation	of	multimodal	bimetallic	NPs	by	radiolysis.		
2) Summary	on	the	biological	impact	of	PtPEG-OH	NPs	
In	the	frame	of	my	PhD,	the	biological	 impact	of	only	PtPEG-OH	NPs	was	evaluated.	Two	human	cancer	cell	lines,	HeLa	and	U87-MG,	were	chosen	as	cellular	models.	Nanoparticles	were	not	toxic	in	the	experimental	conditions	used	in	this	work	(5x10-4	mol.L-1	in	Pt,	6	h).		
First,	 we	 found	 that	 the	 NPs	 uptake	 is	 cell	 dependent.	 In	 particular,	 U87-MG	 cells	internalize	of	about	5	times	more	NPs	than	HeLa	cells.	As	expected	from	previous	studies,	the	 PtPEG-OH	 NPs	 were	 found	 located	 in	 the	 cytoplasm	 exclusively.	 Interestingly,	 the	internalization	 pathways	 for	 the	 two	 cell	 lines	 were	 different:	 NPs	 enter	 in	 HeLa	 via	passive	diffusion	while	they	enter	in	U87-MG	via	endocytosis.		
Second,	it	was	demonstrated	that	the	combination	of	PtPEG-OH	NPs	with	γ-rays	or	carbon	ions	 strongly	amplifies	 cancer	 cell	killing.	 In	particular,	 it	was	 found	 that	PtPEG-OH	NPs	amplify	 by	 44%	 the	 cell	 killing	 of	 HeLa	 cells	 treated	 by	 carbon	 ions.	 This	 effect	 was	attributed	to	the	induction	of	directly	lethal	damages.	This	result	is	a	major	finding,	which	demonstrates	that	Pt	NPs	may	strongly	improve	the	performance	of	hadrontherapy.		
A	 significant	 increase	of	 radiation	 effects	was	 also	observed	 in	 the	 case	of	U87-MG	cells	treated	 by	 γ-rays,	with	 an	 amplification	 factor	 of	 20%	 at	 2	 Gy.	 By	 performing	 radiation	experiments	 with	 the	 bio-nanoprobe,	 it	 was	 shown	 that	 NPs	 are	 responsible	 for	 the	increase	of	nanosize	molecular	damage.	This	phenomenon	 is	attributed	 to	 the	electronic	activation	followed	by	re-neutralisation	of	the	NP,	which	generates	a	large	perturbation	in	the	surrounding	nanometer	volume	and	 thus	 the	production	of	highly	reactive	and	 toxic	free	 radical	 clusters.	 Other	 collective	 process	 such	 as	 the	 plasmon	 excitation	 and	 also	charge	 transfer	 with	 water	 molecules	 may	 contribute	 to	 this	 process.	 Finally,	 the	
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amplification	 of	 cell	 killing	 is	 attributed	 to	 the	 induction	 of	 this	 highly	 local	 and	 strong	perturbation	 that	 is	 initiated	 in	 the	 cytoplasm	 of	 the	 cells.	 The	 study	 of	 the	 biological	response	is	still	in	progress.	
In	 conclusion,	 the	 goal	 of	my	 project	was	 fully	 achieved	 and	 new	 biocompatible	 Pt	 NPs	were	successfully	prepared,	characterized	and	evaluated	in	different	bio-systems	under	γ-rays	and	carbon	ions	 irradiation.	Last	but	not	 least,	 this	work	at	 the	 interface	of	physics,	chemistry	 and	 biology	 shows	 the	 high	 potentialities	 of	 platinum	 based	 nanoparticles	 to	improve	radiation	therapies.		
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1. Transmission	Electron	Microscopy	(TEM)		
The	transmission	electron	microscope	is	a	powerful	tool	used	in	material	science.	It	uses	a	focused	beam	of	high	 energy	 electrons	 (in	 the	 range	of	 kV)	 that	 allows	 the	 imaging	 and	analysis	 of	 specimens	 in	 the	 sub-micrometer	 (10-6	m)	 range.	Because	 the	wavelength	 of	electrons	 is	much	 smaller	 than	 that	 of	 light,	 the	 resolution	 attainable	 for	TEM	 images	 is	many	orders	of	magnitude	better	than	that	from	a	light	microscope.	For	this	reason,	TEM	finds	application	in	nanoscience	research.		
Electrons	have	both	wave	and	particle	properties	as	theorized	by Louis-Victor	de	Broglie	in	 1924	 [1].	 The	 wavelength	 of	 electrons	 is	 related	 to	 their	 kinetic	 energy	 via	 the	 de	Broglie	equation:	
!! = !!!!!(!! !!!!!!	 	 	 	 	 	 	 	 Equation	A	-	1 where	h is Planck's	 constant,	m0 is	 the rest	mass of	 an	 electron,	E is	 the	 energy	 of	 the	accelerated	electron	and	c	is	the	speed	of	light.	For	instance,	the	wavelength	of	electrons	in	a	 200	 kV	 TEM	 is	 2.5	 pm.	 Thus,	 the	 use	 of	 electrons	 leads	 on	 a	 detailed	 structural	examination	through	high-resolution	and	high-magnification	imaging,	which	in	particular	cases	allow	the	visualization	of	individual	atoms.		
	
Figure	A	-	1.	Typical	TEM	configuration	(Encyclopædia	Britannica,	Inc).																																									 																					
[1]	De	Broglie	L	(1924)	Thése:	Recherches	sur	la	théorie	des	Quanta		
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Figure	A	-	1	illustrates	the	components	of	a	basic	TEM.	From	the	top	down,	a	TEM	consists	mainly	on	the	source,	the	optics	and	the	display.	
The	 electron	 gun	 is	 usually	 a	 tungsten filament	 connected	 to	 a	 high	 voltage	 source	 in	 a	typical	range	from	~100	to	300	kV	that	provides	sufficient	current	to	emit	electrons	either	by thermionic or field	 electron	 emission into	 the	 vacuum. High	 vacuum	 (10-7	 mbar)	 is	used	mainly	to	avoid	collisions	of	electrons	with	gas	atoms	and	thus	accurately	focus	the	electron	beam	into	the	sample	by	the	use	of	electrostatic	and	electromagnetic	lenses.	The	lensing	stages	in	a	standard	TEM	allow	to	form	the	beam	(condenser	lenses),	to	focus	the	beam	 (objective	 lenses)	 and	 to	 expand	 the	 beam	 onto	 the	 imaging	 device	 (projector	lenses).	
The	 transmitted	beam,	 after	 electrons	 interaction	with	 the	 sample,	 contains	 information	about	electron	density, phase and periodicity	which	is	used	to	form	the	image.	TEM	also	enables	the	investigation	of	crystal	structures,	through	an	electron	diffraction	pattern,	and	the	chemical	composition	of	phases	by	X-ray	and	electron-energy	analysis.	
2. Dynamic	Light	Scattering	(DLS)	
Dynamic	Light	Scattering	(DLS)	is	used	to	characterize	particles,	emulsions	or	molecules,	which	have	been	dispersed	or	dissolved	in	a	solvent.	The	Brownian	motion	of	particles	in	suspension	induces	scattering	of	the	incident	 laser	 light	(commonly	633	nm)	at	different	intensities.	The	analysis	on	 the	 intensity	 fluctuations	yields	 the	velocity	of	 the	Brownian	motion	 (the	 larger	 the	 particles,	 the	 slower	 the	 Brownian	 motion).	 The	 particle	 size	 is	determined	by	the	following	Stokes-Einstein	relationship	[2]:		
d! = !"!!"!	 	 	 	 	 	 	 	 	 Equation	A	-	2	where	dH=	hydrodynamic	diameter,	D=	 translational	diffusion	coefficient,	k=	Bolzmann’s	constant,	T=	absolute	temperature	and	η=	viscosity.	
Figure	A	-	2a	shows	the	fundamental	principle	of	DLS	and	Figure	A	-	2b	represents	the	hydrodynamic	diameter	in	a	metal	nanoparticle.	
																																								 																					
[2]	Malvern	Instruments	(2014)	Dynamic	Light	Scattering:	An	introduction	in	30	minutes	(Note	technique)	
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a)	 b)	
Figure	A	-	2.	Schematic	representation	of	the	fundamental	principle	of	DLS	(a)	and	the	hydrodynamic	diameter	of	a	metal	nanoparticle	(b).	Adapted	from	https://en.wikipedia.org/wiki/Dynamic_light_scattering.	The	 Zetasizer	 Nano-ZSTM	 (Malvern	 Instruments	 Ltd)	 used	 in	 this	 work	 allows	 to	characterize	nanoparticles,	polymer	and	protein	solutions.	Sizes	ranging	from	0.3	nm	to	10	μm	can	be	determined	at	temperatures	ranging	from	0	to	90°C.	
3. Zeta	potential		
The	zeta	potential,	also	namely	ζ-potential,	is	defined	as	the	surface	charge	acquired	by	a	particle	 or	 molecule	 in	 a	 given	 medium.	 The	 electronic	 properties	 of	 the	 liquid	 layer	surrounding	 the	 particle	 are	 described	 as	 a	 double	 shell.	 It	 consists	 in	 an	 inner	 region	(stern	layer)	where	the	ions	are	strongly	bound	and	an	outer	(diffuse	layer)	region	where	ions	are	less	associated	to	the	core	[3].		
In	 the	 diffuse	 layer,	 there	 is	 a	 hypothetical	 boundary	 inside	 which	 particles	 are	 stable.	When	a	particle	moves,	 ions	 inside	 the	boundary	move	with	 it.	When	a	particles	moves,	ions	beyond	the	boundary	stay	with	the	bulk	fluid	(commonly	water).	The	potential	at	this	boundary	(surface	of	hydrodynamic	shear)	is	called	zeta	potential.	Figure	A	-	3	shows	the	schematic	description	of	ζ-potential.	
																																								 																					
[3]	Malvern	I	(2015)	Zeta	potential	-	An	introduction	in	30	minutes	1–15	
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Figure	A	-	3.	Schematic	representation	of	the	fundamental	principle	of	the	zeta	potential.	The	ζ-potential	of	particles	in	suspension	is	determined	by	electrophoresis.	The	velocity	of	suspended	 colloidal	 particles	 is	 measured	 while	 they	 migrate	 across	 an	 electrolyte	subjected	to	an	electric	field.	Viscous	forces	(ηF)	acting	on	the	particles	tend	to	limit	their	movement	 until	 reaching	 equilibrium	 and	 thus	 constant	 velocity	 (VE).	 This	 velocity	depends	on	 the	 strength	of	 the	 electric	 field	 (E),	 the	dielectric	 constant	 (ε)	 and	 the	 zeta	potential.	Thus,	the	electrophoretic	mobility	(UE)	is	given	by:	
U! = !!! 	 	 	 	 	 	 	 	 	 Equation	A	-	3	and	the	ζ-potential	is	determined	by	the	Henry	law	as	follow:  
U! = !"!(!!)!!!!          Equation	A	-	4 where	f(κa)	=	Henry's	function.	
The	 ζ-potential	 strongly	 depends	 on	 the	 composition	 of	 the	 particles	 suspensions.	 It	 is	mainly	affected	by:	
• ionic	concentration,		
• type	of	ions,		
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• presence	of	surfactants	or	polyelectrolytes		
• pH	
In	this	work,	we	determined	the	ζ-potential	of	colloidal	nanoparticles	using	the	Zetasizer	Nano-ZS	 already	 described.	 In	Figure	A	 -	 4,	we	present	 the	 optical	 configuration	 of	 the	Zetasizer	Nano-ZS	used	to	perform	ζ-potential	measurements.		
	
Figure	A	-	4.	Optical	configuration	of	the	Zetasizer	Nano-ZS	for	zeta	potential	measurements.	
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4. X-ray	Photoelectron	Spectroscopy	(XPS)	
X-ray	 Photoelectron	 Spectroscopy	 (XPS)	 is	 based	 on	 the	 photoelectric	 effect.	 Each	 atom	has	core	electrons	with	characteristic	binding	energies	(EB,	also	referred	as	BE).	These	EB	are	conceptually	equal	to	the	ionizing	energy	of	the	core	electrons.	They	thus	describe	the	electronic	environment	and	the	atomic	species	to	which	the	electron	is	bound	[4].		
If	 the	energy	of	 the	 incident	photon	(hν)	 is	 large	enough,	 the	core	electron	escapes	 from	the	atom	and	emits	out	of	the	material	surface	with	a	kinetic	energy	Ek.	The	binding	energy	of	that	electron	is	determined	by:	
hν = E! + E! + ϕ!	 	 	 	 	 	 	 	 Equation	A	-	5	where	hν	is	the	incident	X-ray	photon	energy	(Mg	Kα:	1253.6	eV	or	Al	Kα:	1486.6	eV),	Ek	is	the	kinetic	energy	of	the	photoelectron,	which	is	measured	by	the	energy	analyser,	and	ϕs	is	the	photometer	work	function	induced	by	the	analyser.	Since	the	work	function	can	be	compensated	artificially,	it	is	eliminated,	giving	the	EB	as	follow:	
E! = hν − E!	 	 	 	 	 	 	 	 	 Equation	A	-	6	
Figure	A	-	5	illustrates	the	physical	principle	of	XPS	in	a	model	atom.	
	
Figure	A	-	5.	XPS	principle:	energy	band	structure	and	emission	process	for	a	model	atom.	In	a	typical	XPS	spectrum	the	number	of	detected	electrons	is	plotted	as	function	of	their	binding	 energy	 in	 a	 range	 from	 0	 to	 hν.	 Each	 element	 is	 directly	 identified	 by	 it	characteristic	 XPS	 peaks.	 These	 characteristic	 spectral	 peaks	 correspond	 to	 the	 electron																																									 																					
[4]	Moulder	J	F	et	al.	(1992)	Handbook	of	X-ray	Photoelectron	Spectroscopy	Perkin-Elmer	Corporation	
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configuration	 of	 the	 atoms,	 e.g.1s,	 2s,	 2p,	 3s,	 etc.	 The	 number	 of	 detected	 electrons	 is	proportional	to	the	amount	of	element	within	the	XPS	sampling	volume.	
5. Fourier	Transform	Infrared	(FTIR)	spectroscopy		
Infrared	 (IR)	 spectroscopy,	 also	 called	 vibrational	 spectroscopy,	 is	 an	 analytical	 tool	largely	used	to	determine	the	chemical	structure	and	functional	groups	present	in	organic	and	inorganic	compounds.	
Infrared	is	electromagnetic	radiation	with	longer	wavelengths	than	those	of	visible	light.	It	extends	from	the	nominal	red	edge	of	the	visible	spectrum	at	700	nm	(1.24	meV)	to	1	mm	(1.7	eV).	Photons	within	this	range	are	not	enough	energetic	to	excite	electrons,	however,	they	 induce	 vibrational	 excitation	 of	 covalently	 bonded	 atoms	 and	 groups	 through	 a	change	 in	 the	 dipole	 moment	 of	 a	 molecule.	 With	 exception	 of	 diatomic	 homonuclear	molecules,	such	as	O2,	N2,	Cl2	etc.,	all	molecules	absorb	IR	light,	which	makes	this	technique	one	of	the	most	used	in	analytical	chemistry.	
In	 IR	 spectroscopy	molecules	 absorb	 specific	 IR	 frequencies	which	 are	 characteristic	 to	their	structure.	These	absorptions	are resonant	frequencies	which	mainly	depend	on	the	masses	of	 the	atoms	and	their	associated	vibronic	coupling.	For	 instance,	a	molecule	can	vibrate	 in	many	ways	called	vibrational	modes. Molecules	with	N	number	of	atoms	have	3N	degrees	of	 freedom,	six	of	which	are	translations	and	rotations	of	 the	molecule	 itself.	This	 leaves	 3N-6	 degrees	 of	 vibrational	 freedom	 (3N-5	 if	 the	 molecule	 is	 linear).	Vibrational	 modes	 are	 often	 given	 by	 descriptive	 names,	 such	 as	 stretching,	 bending,	scissoring,	 rocking	 and	 twisting.	 Figure	 A	 -	 6	 illustrates	 the	 IR	 region	 and	 vibrational	modes.	
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Figure	A	-	6.	IR	region	and	vibrational	modes	[5].	The	 blue	 colored	 sections	 above	 the	 dashed	 line	 refer	 to	 stretching	 vibrations	 and	 the	green	colored	band	below	the	line	refers	to	bending	vibrations.	The	infrared	region	from	1450	 to	600	cm-1	 is	often	called	 the	 fingerprint	 region.	Absorption	bands	 in	 the	4000	 to	1450	cm-1	region	are	usually	due	to	stretching	vibrations	of	diatomic	units	and	this	is	often	called	the	group	frequency	region.	In	general:	
• Stretching	frequencies	are	higher	than	corresponding	bending	frequencies.		
• Bonds	to	hydrogen	have	higher	stretching	frequencies	than	those	to	heavier	atoms.	
• Triple	bonds	have	higher	stretching	frequencies	than	corresponding	double	bonds,	which	in	turn	have	higher	frequencies	than	single	bonds.	
In	FTIR	spectroscopy,	 the	 IR	 light	 is	guided	through	an	 interferometer	and	then	through	the	 sample.	 In	 principle,	 a	moving	mirror	 inside	 the	 system	alters	 the	distribution	of	 IR	light	 that	 passes	 through	 the	 interferometer.	 The	 signal	 directly	 recorded	 from	 the	interferometer	 build	what	 is	 called	 an	 interferogram	which	 represents	 light	 output	 as	 a	function	of	the	mirror	position.	This	raw	data	is	then	mathematically	processed	using	the	Fourier	 Transform	 to	 obtain	 the	 commonly	 known	 FTIR	 spectrum	 [6].	 A	 basic	 FTIR	spectrum	 is	 essentially	 a	 graph	 of	 infrared	 light	 absorbance	 or	 transmittance	 on	 the	vertical	 axis	 as	 function	of	 the	 frequency,	wavelength	or	wavenumber	on	 the	horizontal	axis.	Figure	A	-	7	illustrates	a	classical	FTIR	spectrometer	within	its	data	processing.	
																																								 																					[5]	Reusch	W	Infrared	Spectroscopy	https://www2.chemistry.msu.edu	[6]	Griffiths	P	R	and	De	Haseth	J	A	(2007)	Fourier	Transform	Infrared	Spectrometry	(Wiley)	
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Figure	A	-	7.	Schematically	representation	of	a	FTIR	spectrometer	and	signal	processing.	In	 the	 Attenuated	 Total	 Reflection	 (ATR)	 IR	 mode,	 the	 changes	 occurring	 when	 the	 IR	beam	 is	 internally	 reflected	 by	 a	 crystal	 and	 the	 sample	 are	 measured	 (Figure	 A	 -	 8).	Briefly,	an	IR	beam	is	directed	onto	an	optically	dense	crystal	(commonly	a	diamond)	with	a	high	refractive	 index	at	a	certain	angle.	This	 internal	reflectance	creates	an	evanescent	wave	that	extends	beyond	the	surface	of	 the	crystal	 into	the	sample	held	 in	contact	with	the	 crystal.	 The	 attenuated	 energy	 from	 each	 evanescent	wave	 is	 passed	 back	 to	 the	 IR	beam,	which	then	exits	the	opposite	end	of	the	crystal	and	is	passed	to	the	detector	in	the	IR	spectrometer.	
	
Figure	A	-	8.	Principle	of	ATR	infrared	(adapted	from	http://las.perkinelmer.com/content/TechnicalInfo/TCH_FTIRATR.pdf).		
6. Inductively	Coupled	Plasma	Spectroscopy	(ICP-OES	and	ICP-MS)	
Inductively	 Coupled	 Plasma	 -	 Optical	 Emission	 Spectroscopy	 (ICP-OES)	 is	 a	 type	 of	emission	spectroscopy	that	uses	inductively	coupled	plasma	to	produce	excited	atoms	and	ions	 that	 emit	 electromagnetic	 radiation	 at	 the	 characteristic	 wavelengths	 of	 elements.	
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The	ICP	generates	a	temperature	in	a	range	from	6000	to	10000	K	to	thermally	excite	all	the	 elements	 presented	 in	 liquid	 samples.	 The	 photon	 emission	 is	 then	 collected	 by	 the	spectrophotometer,	diffracted	and	amplified	to	yield	an	intensity	which	can	be	converted	to	an	elemental	concentration	by	comparing	with	calibration	standards.		
In	 plasma	mass	 spectroscopy	 (ICP-MS),	 the	 ICP	 is	 as	well	 used	 as	 the	 excitation	 source.	However,	 in	 contrast	 with	 the	 emission	 spectroscopy,	 the	 plasma	 in	 ICP-MS	 is	 used	 to	generate	 ions	 that	 are	 then	 redirected	 to	 the	 mass	 analyser.	 These	 ions	 are	 finally	separated	 and	 collected	 according	 to	 their	 mass	 to	 charge	 ratios	 (GC).	 Thus,	 all	 the	constituents	of	samples	can	be	identify	and	measured.	ICP-MS	offers	higher	sensitivity	to	detect	a	wider	range	of	elements	compared	to	ICP-OES.		
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Influence	of	platinum	concentration	
We	 evaluated	 the	 radio-enhancement	 effect	 as	 a	 function	 of	 the	 PtPEG-OH	 NPs	concentration.	Different	concentrations,	 from	0.5	up	to	8	NPs	per	plasmid,	were	studied.	For	better	clarity,	the	set	of	dose	response	curves	are	not	presented	here.		
Table	 B	 -	 1	 summarizes	 the	 quantitative	 analysis	 of	 the	 curves.	 It	 enlists	 the	 yields	(nanosize	breaks	/	plasmid	/	Gy)	of	controls	and	plasmids	loaded	with	PtPEG	NPs	and	the	AFs.	 Figure	 B	 -	 1	 shows	 the	 variation	 of	 the	 AF	 as	 function	 of	 the	 nanoparticles	concentration.	
Table	B	-	1.	The	yields	of	controls	and	plasmids	loaded	with	PtPEG	NPs	at	different	concentrations.	DMSO	was	added	in	some	experiments.	The	AFs	are	also	reported.	
	
These	 results	 show	 that	 in	 presence	 of	 PtPEG	NPs	 the	 induction	 of	 nanosize	 damage	 is	enhanced	 from	 27	 up	 to	 83	 %.	 In	 addition,	 we	 observed	 that	 the	 induction	 of	 simple	molecular	 breaks	 (not	 presented)	 remains	 constant	 in	 the	 presence	 of	 PtPEG	 NPs.	 A	negligible	amplification	of	3%	was	observed	for	simple	molecular	damage	(SSBs).		
We	also	observe	in	Table	B	-	1	(Control	+	PEG)	that	PEG	chains	enhanced	by	about	9%	the	induction	of	nanosize	damage.	 It	 is	attributed	 to	 the	 length	of	 the	PEG	chain	and	thus	 to	presence	of	a	high	number	of	ether	groups,	which	cause	an	oxygen	enhancement	effect.	
This	result	points	out	the	unique	property	of	PtPEG	NPs	to	specifically	amplify	nanometer	size	 damage,	 which	 confirms	 the	 property	 of	 NPs	 to	 amplify	 directly	 lethal	 damages	(results	in	cells	Chapter	III).		
Sample	 NPs	per	plasmid	
Nanosize	breaks/plasmid/Gy	
x10-5	 FA	(%)	Control	 0:1	 11.40	±	0.25	 -	Pt	NPs-1	 0.5:1	 14.49	±	0.25	 27	±	1	Pt	NPs-2	 1:1	 15.10	±	0.40	 32	±	1	Pt	NPs-3	 2:1	 16.16	±	0.23	 42	±	2	Pt	NPs-4	 4:1	 20.90	±	0.21	 83	±	4	Pt	NPs-5	 8:1	 18.31	±	0.24	 61	±	3	Control	+	DMSO	 0:1	 1.34	±	0.18	 -	Pt	NPs-4	+	DMSO	 4:1	 2.48	±	0.11	 85	±	15	Control	+	PEG	 0:1	 12.41	±	0.22	 9	±	1	
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Figure	B	-	1.	Amplification	factor	of	nanosize	damage	by	PtPEG	NPs	as	function	of	concentration.	The	effect	was	maximum	at	a	concentration	of	4	NPs	per	1	plasmid	(results	presented	in	
Chapter	III	–	Section	2.3).	At	higher	NPs	concentration	the	AF	decreases,	it	is	ascribed	to	a	saturation	effect.		
